Name   , Term                                                                                                                                        , ES                  , NES                 , NOM p-val           , FDR q-val         , FWER p-val, Tag %  , Gene %, Lead_genes
prerank, Reactome_2022__Basigin Interactions R-HSA-210991                                                                                            , 0.39928535054101183 , 1.8066907758899775  , 0.0                 , 0.6584286803966438,       0.6 , 4/20   , 2.87% , SLC7A8;ITGA3;ITGB1;L1CAM
prerank, Reactome_2022__RND1 GTPase Cycle R-HSA-9696273                                                                                              , -0.46173346085643713, -1.8001597577635895 , 0.0                 , 1.0               ,       0.81, 11/35  , 15.11%, EPSTI1;TXNL1;ARHGAP35;DST;ARHGAP5;PIK3R1;TFRC;DLG5;STIP1;KIDINS220;VANGL1
prerank, Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654                                                              , -0.41839732140994423, -1.7525802141413271 , 0.0                 , 1.0               ,       0.93, 28/54  , 28.74%, RNF181;PEX2;PAF1;UBC;CTR9;SHPRH;UBE2B;UBE2L3;RAD18;LEO1;UBE2N;H2BC11;UBE2E1;BCL10;UBE2J2;CDC73;RNF20;UBB;RPS27A;RNF40;PEX5;PEX14;VCP;UBE2D1;PRKDC;SKIC8;UBE2D2;HLTF
prerank, Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163                                          , -0.5349032583277382 , -1.733208677055518  , 0.014492753623188406, 1.0               ,       0.94, 8/15   , 19.10%, TMED7-TICAM2;UBC;TAB3;TICAM1;LY96;MAP3K7;UBB;RPS27A
prerank, Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948                                                                   , -0.5059050990023033 , -1.7303411224880707 , 0.0                 , 1.0               ,       0.94, 14/25  , 25.79%, DTX4;JAG1;ARRB1;NCSTN;UBC;ITCH;MIB1;NUMB;UBB;RPS27A;PSENEN;ADAM10;APH1B;DTX2
prerank, Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596                                                                               , -0.5076166451689481 , -1.7218594014926694 , 0.015151515151515152, 1.0               ,       0.95, 10/16  , 31.49%, PTPN11;MKNK1;UBC;MAPK1;GRB2;UBB;RPS27A;PPP2CA;SRC;SPRY2
prerank, Reactome_2022__Branched-chain Amino Acid Catabolism R-HSA-70895                                                                             , -0.47903852469250097, -1.7003327783241746 , 0.0                 , 1.0               ,       0.97, 9/21   , 22.44%, BCKDK;HIBADH;ACADSB;IVD;ALDH6A1;BCKDHA;LDHD;ECHS1;HSD17B10
prerank, Reactome_2022__Other Interleukin Signaling R-HSA-449836                                                                                     , -0.485135838679309  , -1.6951593249580865 , 0.0                 , 1.0               ,       0.97, 6/19   , 14.11%, CASP3;STX4;SNAP25;STXBP2;TYK2;CSF1
prerank, Reactome_2022__Signaling By NOTCH4 R-HSA-9013694                                                                                            , -0.3926990798740799 , -1.692232467300884  , 0.0                 , 1.0               ,       0.97, 44/78  , 33.55%, JAG1;PSMD6;NCSTN;UBC;PSMD7;PSMD9;HEY1;PSMC3;ACTA2;PSMB2;CUL1;PSME2;SMAD3;GATD3;TACC3;MAML2;KAT2B;RBPJ;UBB;RPS27A;AKT1;PSENEN;PSMD8;PSME3;ADAM10;PSMB6;APH1B;MAMLD1;CREBBP;PSMA1;PSMB4;PSMF1;KAT2A;PSME1;PSMA3;MAML1;FBXW7;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Protein Ubiquitination R-HSA-8852135                                                                                         , -0.3782220111628213 , -1.6792742028674847 , 0.0                 , 1.0               ,       0.98, 34/74  , 27.30%, RNF181;PEX2;PAF1;UBC;CTR9;USP9X;UBE2C;SHPRH;UBE2B;UBE2L3;RAD18;LEO1;UBE2N;UBE2G1;H2BC11;UBE2E1;BCL10;USP7;UBE2J2;CDC73;RNF20;UBB;RPS27A;RNF40;PEX5;UBE2Z;UBE2E3;PEX14;VCP;UBA1;UBE2D1;PRKDC;SKIC8;UBE2D2
prerank, KEGG_2021_Human__Mucin type O-glycan biosynthesis                                                                                           , -0.4706544967944887 , -1.6775164252232093 , 0.0                 , 0.9929968188622754,       0.98, 7/22   , 15.24%, C1GALT1;GALNT2;ST6GALNAC4;ST6GALNAC1;GALNT12;GALNT1;GALNT11
prerank, Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534                                                    , -0.5157699914173794 , -1.6625624261787495 , 0.013513513513513514, 1.0               ,       0.98, 6/16   , 15.78%, TMED7-TICAM2;FASLG;CASP8;TICAM1;LY96;TANK
prerank, KEGG_2021_Human__Galactose metabolism                                                                                                       , 0.386939424065068   , 1.653779295236916   , 0.02857142857142857 , 1.0               ,       0.96, 11/24  , 16.65%, GANC;GLA;HKDC1;PGM1;GALM;PFKL;MGAM2;GALK1;GALT;PFKM;GLB1
prerank, Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964                                                            , -0.516319916172596  , -1.6484493439732741 , 0.0                 , 1.0               ,       0.99, 9/17   , 19.10%, PTPN11;TMED7-TICAM2;UBC;TICAM1;TBK1;LY96;TANK;UBB;RPS27A
prerank, Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436                                                                , -0.4239783656796447 , -1.6432651251606458 , 0.013513513513513514, 1.0               ,       0.99, 17/32  , 30.30%, GALNT2;RAB6A;PAFAH1B3;ACTR1A;ACTR10;CAPZA2;DYNC1LI1;DCTN3;CAPZB;GALNT1;BICD1;DYNC1H1;DYNC1LI2;RAB18;PAFAH1B2;AGPAT3;RAB3GAP1
prerank, Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346                                                                                     , -0.393009560000229  , -1.6366771478741653 , 0.012195121951219513, 1.0               ,       0.99, 31/57  , 33.55%, PSMD6;HHAT;UBC;SCUBE2;PSMD7;PSMD9;DISP2;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;PSMD8;PSME3;VCP;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;P4HB;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;ERLEC1;PSMD10
prerank, Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727                                                                         , -0.4642500047865089 , -1.6361438065517886 , 0.013888888888888888, 0.9417664670658682,       0.99, 11/19  , 31.49%, PTPN11;MKNK1;UBC;MAPK1;GRB2;UBB;RPS27A;FGFR2;PPP2CA;SRC;SPRY2
prerank, Reactome_2022__RND3 GTPase Cycle R-HSA-9696264                                                                                              , -0.3970005546341708 , -1.6187140672687135 , 0.013888888888888888, 1.0               ,       1.0 , 10/34  , 15.53%, TXNL1;ARHGAP35;DST;ARHGAP5;KTN1;PIK3R1;DLG5;KCTD13;VANGL1;CKB
prerank, Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371                                                           , -0.47379244571285273, -1.6150790555345418 , 0.02857142857142857 , 0.9880597261359633,       1.0 , 8/18   , 20.03%, BCL2A1;CEBPB;MAPK1;RNASEH2A;CUL1;ZC3HC1;CLTC;RPS6
prerank, Reactome_2022__Hedgehog On State R-HSA-5632684                                                                                              , -0.3716796263022184 , -1.6107226925352645 , 0.023809523809523808, 0.962234385395875 ,       1.0 , 37/67  , 35.46%, PSMD6;SMURF1;ARRB1;UBC;PSMD7;CUL3;PSMD9;ULK3;ITCH;PSMC3;PSME4;PSMB2;PSME2;IQCE;NUMB;CDC73;SMURF2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;GLI1;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5;KIF3A
prerank, Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780                                                                              , -0.38925255102785844, -1.6071504620790897 , 0.0                 , 0.9425696304758903,       1.0 , 31/56  , 33.55%, PSMD6;UBC;PSMD7;PSMD9;ITCH;PSMC3;PSME4;PSMB2;CUL1;PRKCA;PSME2;NUMB;PRKACB;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;GLI1;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601                                                          , -0.3972820143273715 , -1.5984586291407454 , 0.025               , 0.9690166541916168,       1.0 , 28/49  , 35.04%, PSMD6;UBC;PSMD7;CHEK1;PSMD9;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;PSMD8;PSME3;CHEK2;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, KEGG_2021_Human__Regulation of lipolysis in adipocytes                                                                                      , -0.42280474338431545, -1.593676873231364  , 0.0                 , 0.968549508126604 ,       1.0 , 19/33  , 34.46%, ADCY7;PIK3R3;TSHR;IRS1;GNAI3;PIK3R1;PTGS1;PLAAT3;PRKACB;AKT1;PIK3CA;GNAI1;ADCY9;PTGS2;PRKG1;INSR;AKT2;ADRB2;PIK3CB
prerank, Reactome_2022__Interleukin-10 Signaling R-HSA-6783783                                                                                       , 0.30951499489500095 , 1.5930341393212712  , 0.0                 , 1.0               ,       0.98, 6/37   , 4.75% , IL1RN;IL6;CCL2;CCR5;TIMP1;IL1R2
prerank, Reactome_2022__RND2 GTPase Cycle R-HSA-9696270                                                                                              , -0.4100794283140261 , -1.588810963030527  , 0.05194805194805195 , 0.9577202129831248,       1.0 , 12/37  , 15.11%, TXNL1;ARHGAP35;DST;ARHGAP5;KTN1;PIK3R1;FNBP1;TFRC;DLG5;KIDINS220;KCTD13;VANGL1
prerank, Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732                                                                         , -0.4516516179304377 , -1.587822804264522  , 0.028169014084507043, 0.9274541948711272,       1.0 , 10/18  , 31.49%, PTPN11;MKNK1;UBC;MAPK1;GRB2;UBB;RPS27A;PPP2CA;SRC;SPRY2
prerank, Reactome_2022__Signaling By Hedgehog R-HSA-5358351                                                                                          , -0.3462069828937075 , -1.5850599822870874 , 0.0                 , 0.9119729291417166,       1.0 , 54/108 , 33.55%, ADCY7;PSMD6;SMURF1;ARRB1;HHAT;UBC;SCUBE2;PSMD7;CUL3;PSMD9;DISP2;ULK3;IFT122;ITCH;PSMC3;PSME4;PSMB2;CUL1;PRKCA;PSME2;FUZ;PRKAR2A;DYNC2H1;RPGRIP1L;IQCE;NUMB;CDC73;PRKACB;SMURF2;UBB;RPS27A;PSMD8;PSME3;WDR35;VCP;MKS1;PSMB6;ADCY9;PSMA1;PRKAR1A;PSMB4;PSMF1;PSME1;PSMA3;P4HB;GLI1;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;ERLEC1;PSMD10
prerank, Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497                                , -0.41733650181596715, -1.5764631851587687 , 0.014084507042253521, 0.9360984281437127,       1.0 , 15/35  , 23.99%, NR3C2;ACTR1A;ACTR10;AREG;CAPZA2;DYNC1LI1;DCTN3;STIP1;CAPZB;HSPA1A;DYNC1H1;FKBP4;DYNC1LI2;DNAJA4;HSPA2
prerank, Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585                                                                            , -0.3796294983583544 , -1.5735191155418502 , 0.039473684210526314, 0.9189601566098573,       1.0 , 28/51  , 35.04%, PSMD6;UBC;PSMD7;CUL5;PSMD9;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;ELOC;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__Extracellular Matrix Organization R-HSA-1474244                                                                              , -0.316391016813702  , -1.570352064023383  , 0.010526315789473684, 0.9067247449545355,       1.0 , 54/175 , 20.65%, ITGB3;P3H2;MADCAM1;DST;COL6A3;TGFB3;ITGB5;ADAM19;CAPN3;DAG1;CASP3;NCSTN;KLK2;P3H1;ITGAV;CAPN5;CD44;COL28A1;CEACAM1;ELANE;BMP1;CEACAM6;ITGAL;CEACAM8;LOXL1;SPARC;BSG;PRKCA;ITGAD;ADAMTS2;ITGA10;CTSK;SH3PXD2A;P4HA1;TNXB;TIMP2;HTRA1;ITGA9;MMP9;MMP14;DMTF1;ITGA1;ITGAM;NID2;COL9A1;BMP7;ADAM8;LOXL2;COL8A1;LTBP4;TPSAB1;CRTAP;ITGA2B;PLOD1
prerank, Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174                                                                                   , -0.3533548393969104 , -1.5701096865498907 , 0.047619047619047616, 0.8766774486740805,       1.0 , 34/67  , 33.55%, PSMD6;VEGFA;UBC;CITED2;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;HIF1A;UBB;RPS27A;PSMD8;PSME3;PSMB6;UBE2D1;CREBBP;PSMA1;UBE2D2;PSMB4;CUL2;EGLN1;PSMF1;PSME1;PSMA3;ELOC;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276                                                          , -0.3743761122734858 , -1.567631024416373  , 0.025974025974025976, 0.8652404243237662,       1.0 , 30/57  , 33.55%, PSMD6;TP53;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;FKBPL;UBB;RPS27A;CDKN1A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;MAPRE1;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;HSP90AA1;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Metabolism Of Porphyrins R-HSA-189445                                                                                        , -0.49205575939947205, -1.5647390381282553 , 0.028985507246376812, 0.8516591816367266,       1.0 , 9/20   , 18.84%, COX15;HMBS;COX10;FLVCR1;BLVRA;ALAS2;CPOX;UROS;HMOX2
prerank, KEGG_2021_Human__Other types of O-glycan biosynthesis                                                                                       , -0.4030078440328046 , -1.5581347519423894 , 0.0379746835443038  , 0.8635672203979139,       1.0 , 10/34  , 15.24%, C1GALT1;RFNG;GALNT2;EOGT;B4GALT1;B4GALT3;LFNG;GALNT12;GALNT1;GALNT11
prerank, Reactome_2022__Peroxisomal Protein Import R-HSA-9033241                                                                                     , -0.3637358390917729 , -1.553549871024155  , 0.024691358024691357, 0.8658746959206588,       1.0 , 22/57  , 23.81%, PEX2;PEX6;PAOX;ACOT8;ACOX2;UBC;AGXT;CRAT;USP9X;PIPOX;PEX26;ACOT4;ACOX1;UBB;RPS27A;HSD17B4;DECR2;PEX5;ECH1;PEX14;SYCP2;UBE2D1
prerank, Reactome_2022__EGFR Downregulation R-HSA-182971                                                                                             , -0.44042755208127027, -1.552037927821598  , 0.04411764705882353 , 0.8492149224278714,       1.0 , 11/27  , 19.10%, PTPRK;UBC;SH3GL1;AREG;STAM2;TGFA;CDC42;GRB2;EPS15L1;UBB;RPS27A
prerank, Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004                                                                            , -0.48506165245001975, -1.5519938708197263 , 0.014492753623188406, 0.8242380129446988,       1.0 , 8/19   , 19.10%, UBC;PTPRJ;USP8;SH3GL1;STAM2;GRB2;UBB;RPS27A
prerank, Reactome_2022__Signaling By NOTCH1 R-HSA-1980143                                                                                            , -0.3648869809435346 , -1.5488819823457771 , 0.011904761904761904, 0.8237342279726262,       1.0 , 29/65  , 26.95%, DTX4;JAG1;HDAC3;ARRB1;NCSTN;UBC;TLE2;HEY1;ITCH;CUL1;HIF1A;NCOR2;GATD3;MIB1;HDAC11;MAML2;NUMB;KAT2B;RBPJ;UBB;RPS27A;HDAC9;PSENEN;ADAM10;APH1B;MAMLD1;CREBBP;DTX2;HDAC6
prerank, Reactome_2022__Degradation Of DVL R-HSA-4641258                                                                                             , -0.38214980984165603, -1.548875654303261  , 0.04054054054054054 , 0.8014582813539588,       1.0 , 29/52  , 35.04%, PSMD6;UBC;PSMD7;CUL3;PSMD9;PSMC3;DACT1;PSME4;PSMB2;PSME2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;DVL3;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072                                                    , -0.47483179114291574, -1.5450901963299881 , 0.06153846153846154 , 0.7971784471597345,       1.0 , 8/16   , 19.10%, TMED7-TICAM2;UBC;TAB3;TICAM1;LY96;MAP3K7;UBB;RPS27A
prerank, Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973                                                                     , -0.4968051035876506 , -1.5445530142312298 , 0.015384615384615385, 0.7787816636463913,       1.0 , 8/18   , 15.60%, HDAC3;YES1;MAPK1;HEY1;AREG;BGLAP;RB1;GATD3
prerank, Reactome_2022__Metabolism Of Polyamines R-HSA-351202                                                                                        , -0.37714611201800496, -1.5445067216479924 , 0.0125              , 0.7590923921387993,       1.0 , 28/54  , 35.04%, PSMD6;PAOX;OAZ1;OAZ2;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;OAZ3;PSMD8;PSME3;PSMB6;SLC38A1;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, "Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397"                                                     , -0.4113081235828473 , -1.5431346586423047 , 0.013333333333333334, 0.745020116017964 ,       1.0 , 8/31   , 10.81%, SLC29A4;SLC35B3;ARL2;SLCO1A2;ARL2BP;SLC35D2;SLC5A6;SLC28A2
prerank, Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615                                                                                      , -0.36746701088178957, -1.5369888426124634 , 0.011494252873563218, 0.7606125401635754,       1.0 , 33/65  , 33.55%, PSMD6;TP53;UBC;PSMD7;MDM4;CCNA1;CHEK1;PSMD9;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;CDKN1A;PSMD8;PSME3;CHEK2;CCNA2;PSMB6;ZNF385A;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Translesion Synthesis By POLH R-HSA-110320                                                                                   , -0.45056259254598297, -1.535915071289     , 0.09210526315789473 , 0.7489908575705732,       1.0 , 9/19   , 23.01%, UBC;SLC19A1;UFD1;RPA3;RFC5;POLR1B;UBB;RPS27A;VCP
prerank, Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274                                                                             , -0.45668427491582886, -1.5344253680288547 , 0.05714285714285714 , 0.7386701886923827,       1.0 , 8/18   , 19.10%, USP18;CASP8;TP53;UBC;IKBIP;TANK;UBB;RPS27A
prerank, Reactome_2022__ECM Proteoglycans R-HSA-3000178                                                                                              , -0.43589008455640604, -1.5321489958636825 , 0.0                 , 0.7345164075258575,       1.0 , 10/29  , 15.60%, ITGB3;TGFB3;ITGB5;DAG1;ITGAV;SPARC;TNXB;ITGA9;DMTF1;COL9A1
prerank, Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009                                                                            , -0.42661575875721675, -1.531211498499837  , 0.024691358024691357, 0.7254605372588157,       1.0 , 10/27  , 24.28%, ITGB3;PDPK1;CRK;MPL;RASGRP2;GRB2;AKT1;ITGA2B;RAPGEF3;RAP1A
prerank, Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652                                                      , -0.40649944188079085, -1.530462572237747  , 0.024691358024691357, 0.7137179445456912,       1.0 , 14/30  , 23.81%, UBC;USP9X;UBE2C;UBE2B;UBE2L3;UBE2G1;UBE2E1;USP7;UBB;RPS27A;UBE2Z;UBE2E3;UBA1;UBE2D1
prerank, Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563                                                                             , -0.3640798713221897 , -1.5296048254183376 , 0.023255813953488372, 0.7029388696012231,       1.0 , 32/63  , 33.55%, PSMD6;TP53;UBC;PSMD7;MDM4;CCNA1;PSMD9;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;CDKN1A;PSMD8;PSME3;CHEK2;CCNA2;PSMB6;ZNF385A;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562                                                                     , -0.38337599680983   , -1.5290181488866372 , 0.05128205128205128 , 0.6919276681012974,       1.0 , 26/48  , 35.04%, PSMD6;OAZ1;OAZ2;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;OAZ3;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742                                   , -0.4888516797035227 , -1.5262262925721737 , 0.08450704225352113 , 0.688929220640352 ,       1.0 , 6/17   , 13.42%, RASGRF2;PDPK1;MAPK1;DLG1;RPS6KA3;CAMK2G
prerank, Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949                                                                                      , -0.3557402882210971 , -1.5240255343055817 , 0.024390243902439025, 0.6864867140718562,       1.0 , 34/66  , 33.55%, PSMD6;UBC;MCM5;PSMD7;CCNA1;PSMD9;ORC3;PSMC3;PSME4;PSMB2;CUL1;PSME2;SLC25A15;CDC6;CDT1;UBB;RPS27A;PSMD8;PSME3;CCNA2;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;MCM6;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390                                                                           , -0.37430223728076695, -1.5231705050573918 , 0.04938271604938271 , 0.677728183339204 ,       1.0 , 29/53  , 35.04%, PSMD6;HHAT;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;PSMD8;PSME3;VCP;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;ERLEC1;PSMD10;PSMD5
prerank, Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408                                                                     , -0.3682954028270902 , -1.5195476337556322 , 0.05194805194805195 , 0.6791585099032704,       1.0 , 28/52  , 35.04%, PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;HNRNPD;HSPA1A;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, KEGG_2021_Human__Glutathione metabolism                                                                                                     , -0.3810878033762254 , -1.5177554386896912 , 0.03529411764705882 , 0.6749819935600497,       1.0 , 16/45  , 20.43%, OPLAH;RRM1;GGT1;GPX3;GSTP1;G6PD;PRDX6;GSTM1;TXNDC12;MGST1;GGT5;GSTO1;GGT7;RRM2;ODC1;GSR
prerank, Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733                                                                         , -0.4257536680500508 , -1.5158593522508126 , 0.02857142857142857 , 0.6701527500554447,       1.0 , 10/19  , 31.49%, PTPN11;MKNK1;UBC;MAPK1;GRB2;UBB;RPS27A;PPP2CA;SRC;SPRY2
prerank, Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419                         , -0.34114064243466563, -1.515492237632884  , 0.024691358024691357, 0.6603463527490473,       1.0 , 42/71  , 37.71%, PSMD6;UBC;PSMD7;CCNA1;PSMD9;CDC20;UBE2C;PSMC3;PSME4;PSMB2;CDC26;PSME2;UBE2E1;UBB;RPS27A;PSMD8;PSME3;CCNA2;PSMB6;UBE2D1;PSMA1;PSMB4;NEK2;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;BUB1B;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;BUB3;PSMD5;UBE2S;MAD2L1;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507                                                        , -0.469506940059511  , -1.5086806562872002 , 0.02666666666666667 , 0.6810600339499572,       1.0 , 11/20  , 24.24%, JAG1;NCSTN;UBC;NOTCH3;MIB1;TACC3;UBB;RPS27A;PSENEN;ADAM10;APH1B
prerank, Reactome_2022__Integrin Signaling R-HSA-354192                                                                                              , -0.45496508550350245, -1.5077685449596023 , 0.04                , 0.6744660350351928,       1.0 , 11/22  , 30.99%, ITGB3;PDPK1;CRK;RASGRP2;GRB2;AKT1;ITGA2B;RAPGEF3;RAP1A;SYK;SRC
prerank, Reactome_2022__Phospholipid Metabolism R-HSA-1483257                                                                                        , 0.2035925422065881  , 1.5071742587986698  , 0.0                 , 1.0               ,       0.99, 32/174 , 10.48%, MFSD2A;OSBPL8;STARD7;OSBPL10;PIK3CG;MTMR2;LPCAT2;MTMR9;SLC44A2;INPPL1;PIP5K1C;LPGAT1;SELENOI;MTMR14;MIGA1;PI4KA;CHPT1;PLEKHA5;CHKA;ABHD3;PLEKHA2;PTPMT1;GNPAT;SBF1;LPCAT3;GDPD3;CDS2;GPAT4;INPP5D;PIP4P1;PLEKHA8;PLBD1
prerank, KEGG_2021_Human__Pyrimidine metabolism                                                                                                      , -0.3553875462493247 , -1.5052629444878731 , 0.06493506493506493 , 0.6735494528185009,       1.0 , 22/50  , 27.95%, RRM1;NME6;ENTPD5;UCKL1;CMPK2;TK2;CDA;NUDT2;NT5C3B;TK1;NME4;RRM2;NT5C3A;DTYMK;NME3;CANT1;DPYD;NME7;UCK2;RRM2B;DCTD;NT5M
prerank, Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425                                                                     , -0.381678879311061  , -1.504040352942439  , 0.02631578947368421 , 0.6691537475895666,       1.0 , 27/49  , 35.04%, PSMD6;TP53;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370                                                           , -0.3508541745348573 , -1.5017438198586308 , 0.047619047619047616, 0.6687195920658683,       1.0 , 18/54  , 20.03%, SQSTM1;BCL2A1;MYH9;CEBPB;MAPK1;TFG;IRS1;EEF1G;PIK3R1;RNASEH2A;CUL1;HIP1;ZC3HC1;STRN;GRB2;CLTC;RRBP1;RPS6
prerank, Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975                                                                          , -0.32598797043499417, -1.5011462881281177 , 0.022222222222222223, 0.6599012528222244,       1.0 , 46/94  , 35.04%, PSMD6;ITGB5;STX4;UBC;ITGAV;PSMD7;TIRAP;PSMD9;HLA-G;CYBB;VAMP3;PSMC3;PSME4;SEC61B;PSMB2;PSME2;MRC2;LY96;UBB;RPS27A;PSMD8;PSME3;PSMB6;HMGB1;PSMA1;SEC14L2;PDIA3;BTK;PSMB4;NCF2;SEC22B;PSMF1;NCF1;PSME1;PSMA3;TLR2;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;S100A9;IKBKG;PSMD5
prerank, Reactome_2022__Stabilization Of P53 R-HSA-69541                                                                                             , -0.3739496949989016 , -1.4987415250893774 , 0.024691358024691357, 0.6603335667374928,       1.0 , 29/54  , 35.04%, PSMD6;TP53;UBC;PSMD7;MDM4;PSMD9;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;PSMD8;PSME3;CHEK2;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, KEGG_2021_Human__Sphingolipid signaling pathway                                                                                             , -0.31050836974942075, -1.4985097754489751 , 0.0                 , 0.6508901839178785,       1.0 , 39/110 , 24.58%, FCER1G;SPHK2;SGPP2;BAX;PLCB2;PPP2R3A;PDPK1;TP53;PPP2R5E;CERS5;PLCB1;MAPK1;PIK3R3;GNAI3;PIK3R1;SPTLC1;NOS3;PRKCA;PPP2R5B;MAPK8;ROCK2;NSMAF;S1PR4;TNFRSF1A;PLD2;GNA12;CERS2;FCER1A;AKT1;ACER2;GAB2;S1PR1;S1PR5;PPP2R2A;MAPK11;PIK3CA;MAP3K5;BID;GNAI1
prerank, Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249                                                                                  , 0.29905169992063313 , 1.496853889173128   , 0.10526315789473684 , 1.0               ,       0.99, 12/39  , 13.51%, PLCB4;INPP1;MTMR9;PLCE1;INPPL1;IP6K1;MIOX;ITPKC;INPP5D;ITPK1;PLCD1;IP6K2
prerank, Reactome_2022__Oncogene Induced Senescence R-HSA-2559585                                                                                    , -0.40555004368389147, -1.49679293420132   , 0.047619047619047616, 0.649406021940494 ,       1.0 , 13/33  , 19.15%, TP53;UBC;MDM4;MAPK1;TNRC6C;AGO3;RB1;CDKN2D;CDKN2C;AGO1;UBB;RPS27A;DAND5
prerank, Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769                                                   , -0.43249914599219874, -1.4965196733392272 , 0.08108108108108109 , 0.6399182404421925,       1.0 , 8/23   , 18.40%, TMED7-TICAM2;CASP3;FASLG;CASP8;TICAM1;LY96;TANK;DAPK2
prerank, Reactome_2022__Signaling By NOTCH2 R-HSA-1980145                                                                                            , -0.43354257569656257, -1.4933018805407412 , 0.05263157894736842 , 0.6447559426601343,       1.0 , 14/27  , 25.18%, JAG1;NCSTN;UBC;GZMB;GATD3;MIB1;MAML2;RBPJ;UBB;RPS27A;PSENEN;ADAM10;APH1B;MAMLD1
prerank, Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184                                                            , -0.33730655822905886, -1.4918308854576132 , 0.024390243902439025, 0.6418029146930021,       1.0 , 41/70  , 37.71%, PSMD6;UBC;PSMD7;CCNA1;PSMD9;CDC20;UBE2C;PSMC3;PSME4;PSMB2;CDC26;PSME2;UBE2E1;UBB;RPS27A;PSMD8;PSME3;CCNA2;PSMB6;UBE2D1;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;BUB1B;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;BUB3;PSMD5;UBE2S;MAD2L1;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531                                             , -0.3243827291905951 , -1.491406476315061  , 0.06896551724137931 , 0.6341278839380063,       1.0 , 41/85  , 35.35%, EXOSC6;PSMD6;TNFSF13;KHSRP;UBC;PSMD7;PSMD9;YWHAB;PSMC3;PSME4;PARN;PSMB2;PRKCA;PSME2;HNRNPD;HSPA1A;XPO1;SET;UBB;RPS27A;AKT1;PSMD8;PSME3;MAPK11;EXOSC2;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;DCP1A;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5;ZFP36L1
prerank, Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858                                                                    , -0.3649489635399078 , -1.4883281229277137 , 0.023809523809523808, 0.6367855321964766,       1.0 , 29/54  , 35.04%, PSMD6;SMURF1;UBC;PSMD7;PSMD9;PSMC3;PSMB2;PSME2;RUNX3;SMURF2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;SRC;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176                                       , -0.35146222224674806, -1.486627094476646  , 0.05128205128205128 , 0.6360972251924722,       1.0 , 31/60  , 33.55%, PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;HIF1A;UBB;RPS27A;PSMD8;PSME3;PSMB6;UBE2D1;PSMA1;UBE2D2;PSMB4;CUL2;EGLN1;PSMF1;PSME1;PSMA3;ELOC;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726                                                                         , -0.4225447432303478 , -1.48615849350588   , 0.029411764705882353, 0.628366286792612 ,       1.0 , 10/19  , 31.49%, PTPN11;MKNK1;UBC;MAPK1;GRB2;UBB;RPS27A;PPP2CA;SRC;SPRY2
prerank, Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204                                         , -0.503196142826161  , -1.4860648918785808 , 0.028985507246376812, 0.6200931470392548,       1.0 , 11/18  , 29.92%, PPP1R13B;BAX;TP53;PMAIP1;BNIP3L;STEAP3;BID;CREBBP;AIFM2;PRELID1;PRELID3A
prerank, Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159                                                                            , -0.33058394897469806, -1.4859786727093278 , 0.034482758620689655, 0.6115987203674842,       1.0 , 43/89  , 33.55%, JAG1;PSMD6;SMURF1;TP53;UBC;PSMD7;PSMD9;ITGAL;PSMC3;PSMB2;PSME2;LEF1;SMAD3;RUNX3;GATD3;MAML2;KAT2B;RBPJ;SMURF2;UBB;RPS27A;CDKN1A;PSMD8;PSME3;PSMB6;MAMLD1;CREBBP;PSMA1;PSMB4;PSMF1;KAT2A;PSME1;PSMA3;SRC;MAML1;PSMB1;TCF7L1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, KEGG_2021_Human__Drug metabolism                                                                                                            , -0.3520361414133765 , -1.485745285827799  , 0.024691358024691357, 0.6043649609564654,       1.0 , 23/59  , 25.06%, RRM1;NME6;UCKL1;GSTP1;ADH5;CYP2C9;FMO4;IMPDH1;TK2;CDA;GSTM1;MGST1;TK1;NME4;GSTO1;RRM2;NME3;DPYD;ITPA;FMO5;NME7;UCK2;RRM2B
prerank, Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050                                           , -0.36724622841277216, -1.4843250904634044 , 0.0759493670886076  , 0.6013934630738523,       1.0 , 28/51  , 35.04%, PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;CUL1;PSME2;FBXL18;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409                                                                                              , -0.3621762563648685 , -1.4816661880269857 , 0.06578947368421052 , 0.6039501999290892,       1.0 , 17/50  , 18.09%, FMNL3;ARHGAP35;ARHGAP5;CDC42BPB;PIK3R1;WAS;VAMP3;FNBP1;FNBP1L;TFRC;NIPSNAP2;WIPF2;VANGL1;STOM;TMPO;CDC42;CPNE8
prerank, Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230                                                                     , 0.35275936192134866 , 1.4810152561182328  , 0.0625              , 1.0               ,       0.99, 5/23   , 5.78% , SLC43A2;SLC7A8;SLC6A15;SLC38A5;SLC16A10
prerank, Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870                                                                        , -0.3639827744876604 , -1.4803834059877958 , 0.04938271604938271 , 0.60120282973015  ,       1.0 , 29/54  , 35.04%, PSMD6;SMURF1;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;SMURF2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;SCRIB;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409                                                            , -0.3335668757789464 , -1.4740855955871452 , 0.024096385542168676, 0.623400434707508 ,       1.0 , 42/73  , 37.71%, PSMD6;UBC;PSMD7;CCNA1;PSMD9;CDC20;UBE2C;PSMC3;PSME4;PSMB2;CDC26;PSME2;UBE2E1;UBB;RPS27A;PSMD8;PSME3;CCNA2;PSMB6;UBE2D1;PSMA1;PSMB4;NEK2;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;BUB1B;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;BUB3;PSMD5;UBE2S;MAD2L1;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814                                    , -0.32814930481219257, -1.473363092371213  , 0.03529411764705882 , 0.6181308269536876,       1.0 , 42/74  , 37.71%, PSMD6;UBC;PSMD7;CCNA1;PSMD9;CDC20;UBE2C;PSMC3;PSME4;PSMB2;CDC26;PSME2;UBE2E1;UBB;RPS27A;PSMD8;PSME3;CCNA2;PSMB6;UBE2D1;PSMA1;PSMB4;NEK2;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;BUB1B;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;BUB3;PSMD5;UBE2S;MAD2L1;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__Dual Incision In GG-NER R-HSA-5696400                                                                                        , -0.3418598258597922 , -1.472642564888568  , 0.06097560975609756 , 0.6132654612649701,       1.0 , 22/41  , 36.51%, GTF2H3;UBC;SLC19A1;RPA3;POLK;RFC5;PARP2;XPA;POLR1B;DDB2;UBB;RPS27A;POLD4;ERCC1;GTF2H4;POLE3;POLD2;ERCC3;GTF2H1;POLE4;ERCC4;POLE
prerank, KEGG_2021_Human__Dilated cardiomyopathy                                                                                                     , -0.35037927855468903, -1.4715631255293653 , 0.024096385542168676, 0.6101350539661418,       1.0 , 12/59  , 8.82% , ITGB3;ADCY7;TGFB3;CACNG8;ITGB5;DAG1;CACNG6;CACNB3;SGCA;ITGAV;SGCB;ATP2A3
prerank, Reactome_2022__Regulation Of Apoptosis R-HSA-169911                                                                                         , -0.36678794812550386, -1.471237834355541  , 0.1                 , 0.6041565877391558,       1.0 , 28/50  , 35.04%, PSMD6;UBC;PSMD7;MED12;PSMD9;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;OMA1;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768                                                                                , -0.3612897767806826 , -1.4707526793743992 , 0.05                , 0.5995041167664671,       1.0 , 28/52  , 35.04%, PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;PSMD8;PSME3;VCP;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;ERLEC1;PSMD10;PSMD5
prerank, Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005                                                                     , -0.3288083429955583 , -1.4689008389096048 , 0.011363636363636364, 0.5985957771956089,       1.0 , 45/104 , 32.14%, ITGB3;SCCPDH;PHACTR2;SGPP2;TGFB3;CD9;VTI1B;ENDOD1;NHLRC2;F5;VEGFA;STX4;PIKFYVE;LOC112694756;F13A1;STXBP2;SPARC;QSOX1;PRKCA;ORM2;PPBP;CAP1;PFN1;CDC37L1;ABCC4;VPS72;CYB5R1;ITGA2B;CALU;PCYOX1L;SERPING1;SYTL4;CTSW;APLP2;PROS1;HSPA5;WDR1;SERPINA1;CYRIB;APP;CLEC3B;TEX264;FERMT3;BRPF3;TMX3
prerank, Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815                                                                      , -0.3616162635505799 , -1.468805451549413  , 0.0759493670886076  , 0.5916817101091933,       1.0 , 26/49  , 35.04%, PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577                                                                       , -0.3451668193384107 , -1.4681530176701643 , 0.036585365853658534, 0.5873365913521793,       1.0 , 30/59  , 33.55%, PSMD6;UBC;PSMD7;CCNA1;PSMD9;PSMC3;PSMB2;CUL1;PSME2;UBB;RPS27A;CDKN1A;PSMD8;PSME3;CCNA2;PTK6;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;CKS1B;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Synthesis Of PC R-HSA-1483191                                                                                                , 0.3574736971856165  , 1.467482188694202   , 0.10714285714285714 , 1.0               ,       1.0 , 6/23   , 5.70% , MFSD2A;STARD7;SLC44A2;CHPT1;CHKA;ABHD3
prerank, KEGG_2021_Human__SNARE interactions in vesicular transport                                                                                  , -0.40415154097176853, -1.466826473996925  , 0.06944444444444445 , 0.5857224129327552,       1.0 , 10/32  , 16.97%, VAMP7;VTI1B;STX4;STX17;USE1;VAMP3;VAMP5;STX7;STX6;VAMP1
prerank, Reactome_2022__Mitochondrial Translation Initiation R-HSA-5368286                                                                           , -0.31981201639658   , -1.4649848798149214 , 0.03333333333333333 , 0.5866222101252042,       1.0 , 32/80  , 28.80%, MTFMT;CHCHD1;MRPL53;MRPS18B;MRPS30;MRPL21;MRPS23;MRPL3;MRPL57;MRPL20;MRPL18;MRPS25;MRPL39;MRPS7;MRPL43;MRPL24;MRPL16;MRPL23;MRPL15;AURKAIP1;MRPS17;MRPL30;MRPS27;MRPS16;MRPL55;MRPL1;MRPL52;MRPS21;MTIF2;MRPL4;MRPS14;MRPL14
prerank, Reactome_2022__Hedgehog Off State R-HSA-5610787                                                                                             , -0.32784468351640667, -1.4646500804497742 , 0.046511627906976744, 0.5818680406041848,       1.0 , 41/85  , 33.55%, ADCY7;PSMD6;UBC;PSMD7;PSMD9;IFT122;ITCH;PSMC3;PSME4;PSMB2;CUL1;PRKCA;PSME2;FUZ;PRKAR2A;DYNC2H1;RPGRIP1L;NUMB;PRKACB;UBB;RPS27A;PSMD8;PSME3;WDR35;MKS1;PSMB6;ADCY9;PSMA1;PRKAR1A;PSMB4;PSMF1;PSME1;PSMA3;GLI1;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, "Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824"                                                        , -0.3617157374348837 , -1.4638508311547036 , 0.03571428571428571 , 0.5781884148369926,       1.0 , 16/51  , 19.20%, CETP;TRNP1;PLTP;LDLRAP1;UBC;LSR;BMP1;PRKCA;CUBN;LPL;LCAT;PRKACB;CLTC;UBB;RPS27A;ABCA1
prerank, Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323                                                                        , -0.3606454365918786 , -1.4580555611009587 , 0.06493506493506493 , 0.5951919992432717,       1.0 , 29/53  , 35.04%, PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSMB2;CUL1;PSME2;TACC3;UBB;RPS27A;AKT1;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;FBXW7;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326                                                                               , -0.43754367225032886, -1.453994593854409  , 0.056338028169014086, 0.6043617588193179,       1.0 , 9/22   , 18.53%, HDAC3;YES1;MAPK1;HEY1;AREG;BGLAP;RB1;GATD3;RBM14-RBM4
prerank, Reactome_2022__Platelet Degranulation R-HSA-114608                                                                                          , -0.32861278634030966, -1.451060909766567  , 0.011764705882352941, 0.610169781404932 ,       1.0 , 43/100 , 32.14%, ITGB3;SCCPDH;PHACTR2;SGPP2;TGFB3;CD9;VTI1B;ENDOD1;NHLRC2;F5;VEGFA;PIKFYVE;LOC112694756;F13A1;STXBP2;SPARC;QSOX1;ORM2;PPBP;CAP1;PFN1;CDC37L1;ABCC4;VPS72;CYB5R1;ITGA2B;CALU;PCYOX1L;SERPING1;SYTL4;CTSW;APLP2;PROS1;HSPA5;WDR1;SERPINA1;CYRIB;APP;CLEC3B;TEX264;FERMT3;BRPF3;TMX3
prerank, Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783                                                                              , -0.35030266981995006, -1.4502103159150528 , 0.05128205128205128 , 0.6013399188465176,       1.0 , 28/55  , 33.55%, PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;CUL1;PRKCA;PSME2;PRKACB;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785                                                                       , -0.35030266981995006, -1.4502103159150528 , 0.05128205128205128 , 0.6013399188465176,       1.0 , 28/55  , 33.55%, PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;CUL1;PRKCA;PSME2;PRKACB;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, "KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action"                                                                      , -0.3368589768127    , -1.4494531858815676 , 0.05333333333333334 , 0.5976874376247504,       1.0 , 28/76  , 25.37%, MMP25;ADCY7;CREB3L4;LRP6;PLCB2;ARRB1;MEF2D;MAFB;PLCB1;MAPK1;GNAI3;PRKCA;LRP5;BGLAP;CREB3L2;MMP14;EGR1;PLD2;GNA12;ARHGEF11;MEF2C;PRKACB;CDKN1A;AKAP13;PDE4D;GNAI1;ADCY9;ARHGEF1
prerank, Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096                                                        , -0.48267444016681427, -1.4478421379221071 , 0.07042253521126761 , 0.5971443067473301,       1.0 , 9/17   , 24.24%, JAG1;NCSTN;UBC;MIB1;UBB;RPS27A;PSENEN;ADAM10;APH1B
prerank, Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758                                                                   , -0.40184727097874834, -1.4455789374949293 , 0.05063291139240506 , 0.6008388198093608,       1.0 , 6/29   , 6.44% , PML;KAT6A;GATAD2A;ING5;TP53;CHD4
prerank, Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128                                                                                          , -0.32911870323451475, -1.4453156378817664 , 0.05747126436781609 , 0.5956505549507047,       1.0 , 40/80  , 33.55%, MAPK6;PSMD6;CDC42EP2;UBC;PSMD7;IGF2BP1;PSMD9;PSMC3;CDC42EP3;PSME4;TNRC6C;PSMB2;PRKCA;PSME2;AGO3;XPO1;AGO1;CDC42;PRKACB;UBB;RPS27A;NCOA3;PSMD8;PSME3;PSMB6;FOXO1;MOV10;PSMA1;PSMB4;PSMF1;PSME1;AGO2;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360                                                     , -0.3675591854420001 , -1.443970032712346  , 0.0410958904109589  , 0.5940540793413174,       1.0 , 24/46  , 32.77%, KCNMA1;TRIOBP;PLS1;OTOF;MYH9;SNAP25;PJVK;SYP;CAPZA2;TWF2;MYO15A;CAPZB;DNAJC5;CIB2;KCNMB1;TPRN;RAB3A;CDH23;SPTBN1;WHRN;ESPN;STX1A;CLIC5;CASK
prerank, Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978                                                   , -0.37549092529640477, -1.4438078788883564 , 0.08                , 0.5889278065156814,       1.0 , 24/44  , 35.04%, PSMD6;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;MRC2;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166                                                                            , -0.30895969922686145, -1.4432350687024638 , 0.047058823529411764, 0.5853981375484325,       1.0 , 45/96  , 33.55%, PSMD6;HDAC3;YES1;SMURF1;BAX;UBC;PSMD7;MAPK1;PSMD9;HEY1;AREG;PSMC3;PSME4;PSMB2;CUL1;PSME2;BGLAP;RB1;GATD3;RBM14-RBM4;UBB;RPS27A;AKT1;CDKN1A;PSMD8;PSME3;ITGA5;PSMB6;PSMA1;HDAC6;PSMB4;PSMF1;PSME1;PSMA3;SRC;FBXW7;PSMB1;PSMC4;NR3C1;SEM1;PSMA6;PSMD11;PSMA2;AKT2;PSMD10
prerank, Reactome_2022__ER-Phagosome Pathway R-HSA-1236974                                                                                           , -0.31288321288673515, -1.4374501022192798 , 0.03409090909090909 , 0.6025730698796582,       1.0 , 40/82  , 35.04%, PSMD6;STX4;UBC;PSMD7;TIRAP;PSMD9;HLA-G;VAMP3;PSMC3;PSME4;SEC61B;PSMB2;PSME2;LY96;UBB;RPS27A;PSMD8;PSME3;PSMB6;HMGB1;PSMA1;SEC14L2;PDIA3;BTK;PSMB4;SEC22B;PSMF1;PSME1;PSMA3;TLR2;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;S100A9;IKBKG;PSMD5
prerank, Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406                                                                                              , -0.3395082386162507 , -1.4363644621170164 , 0.04819277108433735 , 0.6019147102429756,       1.0 , 18/55  , 20.72%, CDC42EP4;ARHGAP35;GOPC;CDC42EP2;ARHGAP5;CDC42BPB;VAMP3;FNBP1;TFRC;CDC42EP3;OBSCN;ARHGAP33;VANGL1;STOM;CDC42;CPNE8;TRIP10;IQGAP1
prerank, Reactome_2022__ABC Transporter Disorders R-HSA-5619084                                                                                      , -0.3250588921661121 , -1.4354438077972271 , 0.056818181818181816, 0.5999193577131451,       1.0 , 34/69  , 33.55%, ABCC9;PSMD6;ABCB4;UBC;RNF185;PSMD7;ABCD4;PSMD9;PSMC3;PSME4;PSMB2;PSME2;ABCB11;UBB;RPS27A;ABCA1;PSMD8;PSME3;VCP;KCNJ11;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;ERLEC1;PSMD10
prerank, Reactome_2022__Signaling By NOTCH3 R-HSA-9012852                                                                                            , -0.3678422477202285 , -1.4320732392070077 , 0.075               , 0.607216433877528 ,       1.0 , 18/40  , 25.22%, JAG1;NCSTN;UBC;HEY1;NOTCH3;GATD3;MIB1;TACC3;MAML2;KAT2B;RBPJ;UBB;RPS27A;PSENEN;ADAM10;APH1B;MAMLD1;CREBBP
prerank, Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955                                                , -0.3795116051229074 , -1.4309385241536856 , 0.06097560975609756 , 0.607042486289104 ,       1.0 , 14/36  , 24.97%, ITGB3;ARRB1;MAPK1;YWHAB;PHB1;CAMK2G;MARK3;ITGA2B;IQGAP1;MAP3K11;RAP1A;CNKSR2;RNASE3;KSR1
prerank, Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113                                                                      , -0.3595832485663375 , -1.425783818930921  , 0.10810810810810811 , 0.622919092370814 ,       1.0 , 28/52  , 35.04%, PSMD6;UBC;PSMD7;PSMD9;CDC20;PSMC3;PSME4;PSMB2;CUL1;PSME2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213                                                                           , -0.39529563348240304, -1.4248082321702598 , 0.06493506493506493 , 0.6215042678404659,       1.0 , 17/34  , 30.06%, ABI1;CYFIP2;MAPK1;WAS;ABI2;WIPF2;ARPC5;NCKAP1L;CDC42;GRB2;WASF1;ARPC3;ARPC2;NCKIPSD;BTK;WIPF1;ACTR3
prerank, Reactome_2022__Metal Ion SLC Transporters R-HSA-425410                                                                                      , -0.4217114750956037 , -1.4243253958463238 , 0.07352941176470588 , 0.6179351524224278,       1.0 , 9/18   , 25.97%, SLC39A1;SLC39A6;SLC39A8;SLC41A1;SLC30A7;SLC39A3;SLC11A2;SLC11A1;SLC30A5
prerank, Reactome_2022__Sensory Processing Of Sound R-HSA-9659379                                                                                    , -0.35560231454092583, -1.4231446980355753 , 0.04225352112676056 , 0.6185546980363597,       1.0 , 25/49  , 32.77%, KCNMA1;TRIOBP;PLS1;OTOF;MYH9;SNAP25;PJVK;SYP;CAPZA2;TWF2;MYO15A;CAPZB;DNAJC5;CIB2;KCNMB1;TPRN;RAB3A;CDH23;SPTBN1;KIF20B;WHRN;ESPN;STX1A;CLIC5;CASK
prerank, KEGG_2021_Human__Thyroid cancer                                                                                                             , -0.3516000202843081 , -1.420289959109485  , 0.05263157894736842 , 0.6254891166328058,       1.0 , 12/35  , 22.14%, BAX;TP53;GADD45G;MAPK1;TFG;POLK;CDH1;LEF1;DDB2;PPARG;CDKN1A;GADD45A
prerank, KEGG_2021_Human__Mannose type O-glycan biosynthesis                                                                                         , -0.431383104761466  , -1.4167712801089944 , 0.08108108108108109 , 0.634712323141328 ,       1.0 , 6/20   , 13.77%, FKRP;B4GALT1;B4GALT3;LARGE2;FKTN;B4GAT1
prerank, Reactome_2022__Signaling By ERBB2 R-HSA-1227986                                                                                             , -0.3565298955171671 , -1.413611855355635  , 0.075               , 0.6427219574009876,       1.0 , 21/43  , 32.94%, YES1;DIAPH1;UBC;CUL5;USP8;PTPN18;PIK3R1;PRKCA;ERBB3;GRB2;UBB;RPS27A;ERBIN;AKT1;PTK6;PIK3CA;RNF41;SRC;HSP90AA1;HBEGF;AKT2
prerank, Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862                                                        , -0.34960026780754627, -1.4092530448704108 , 0.058823529411764705, 0.6558053729497527,       1.0 , 25/51  , 31.46%, JAG1;HDAC3;NCSTN;UBC;HEY1;CUL1;NCOR2;GATD3;MIB1;HDAC11;MAML2;KAT2B;RBPJ;UBB;RPS27A;HDAC9;PSENEN;ADAM10;APH1B;MAMLD1;CREBBP;HDAC6;KAT2A;MAML1;FBXW7
prerank, KEGG_2021_Human__DNA replication                                                                                                            , -0.37506962573228647, -1.408951597410975  , 0.11428571428571428 , 0.6518432692804047,       1.0 , 9/36   , 12.26%, RNASEH2B;LIG1;RFC1;MCM5;RPA3;PRIM2;RNASEH2A;RFC5;MCM2
prerank, Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733                                             , -0.3530199514148688 , -1.4088440423608524 , 0.10126582278481013 , 0.6469241005169148,       1.0 , 26/47  , 35.04%, PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, KEGG_2021_Human__Hedgehog signaling pathway                                                                                                 , -0.3703863227562324 , -1.403760843258683  , 0.12195121951219512 , 0.6648121923525829,       1.0 , 12/36  , 18.47%, DISP1;CSNK1D;SMURF1;ARRB1;HHAT;SCUBE2;CUL3;MGRN1;CUL1;IQCE;PRKACB;SMURF2
prerank, Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534                                                                                 , -0.3458521495350635 , -1.4032364583957866 , 0.10526315789473684 , 0.6620650505711267,       1.0 , 26/49  , 35.04%, PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__Signaling By FGFR3 R-HSA-5654741                                                                                             , -0.3653244139646856 , -1.402248795007899  , 0.1038961038961039  , 0.6605445359281437,       1.0 , 12/28  , 31.49%, PTPN11;MKNK1;UBC;MAPK1;PIK3R1;GRB2;UBB;RPS27A;PIK3CA;PPP2CA;SRC;SPRY2
prerank, Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542                                                                                 , 0.3250799424941779  , 1.399824066090512   , 0.07142857142857142 , 1.0               ,       1.0 , 6/25   , 7.26% , NFKB2;RIGI;S100A12;TRIM4;NFKB1;IFIH1
prerank, Reactome_2022__Signaling By Hippo R-HSA-2028269                                                                                             , -0.461389508449236  , -1.3957747744655928 , 0.16216216216216217 , 0.682560885460484 ,       1.0 , 5/16   , 11.75%, LATS2;CASP3;NPHP4;YWHAB;MOB1A
prerank, KEGG_2021_Human__Proteasome                                                                                                                 , -0.3493574686703935 , -1.3943167033555381 , 0.10810810810810811 , 0.6824161615294003,       1.0 , 22/44  , 32.85%, PSMD6;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;ADRM1;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2
prerank, "Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002"                                                                 , -0.280778189875067  , -1.3936946225203046 , 0.010416666666666666, 0.6796152359914318,       1.0 , 63/210 , 24.68%, ITGB3;SCCPDH;FCER1G;PHACTR2;SGPP2;TGFB3;CD9;VTI1B;ENDOD1;NHLRC2;PTPN11;ARRB1;F5;TRPC6;VEGFA;STX4;PIKFYVE;PDPK1;CRK;MPL;LOC112694756;F13A1;GNA15;STXBP2;MAPK1;DGKG;PIK3R3;RASGRP2;PRKCH;GNAI3;PIK3R1;SPARC;QSOX1;PRKCA;GNB5;GNGT2;ORM2;PPBP;CAP1;PFN1;DGKA;CDC37L1;ABCC4;GNA12;GNG5;VPS72;CDC42;GRB2;GNG11;CYB5R1;AKT1;GNG3;ITGA2B;CALU;PCYOX1L;SERPING1;SYTL4;PIK3CA;CTSW;RAPGEF3;RAP1A;GNAI1;RNASE3
prerank, Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862                                                                                  , -0.42442454035333366, -1.3924567645288275 , 0.09210526315789473 , 0.6795845053843925,       1.0 , 10/17  , 25.87%, UBC;SLC19A1;RPA3;POLK;RFC5;POLR1B;UBB;RPS27A;MAD2L2;REV3L
prerank, Reactome_2022__Citric Acid Cycle (TCA Cycle) R-HSA-71403                                                                                    , 0.3562928043741438  , 1.39004081201279    , 0.16666666666666666 , 1.0               ,       1.0 , 4/19   , 6.03% , DLST;IDH3A;SUCLG1;CS
prerank, Reactome_2022__RHOF GTPase Cycle R-HSA-9035034                                                                                              , -0.352576241894398  , -1.3892371446039142 , 0.15384615384615385 , 0.6874895209580838,       1.0 , 16/37  , 32.23%, FAM169A;AKAP12;DIAPH1;ARHGAP5;PIK3R1;VAMP3;RHOF;CAPZB;VANGL1;TMPO;BAIAP2L1;STEAP3;SRGAP2;ADD3;SOWAHC;ARHGAP12
prerank, Reactome_2022__Signaling By FGFR4 R-HSA-5654743                                                                                             , -0.36332914496279095, -1.3882612874254776 , 0.0945945945945946  , 0.6862721729160727,       1.0 , 12/28  , 31.49%, PTPN11;MKNK1;UBC;MAPK1;PIK3R1;GRB2;UBB;RPS27A;PIK3CA;PPP2CA;SRC;SPRY2
prerank, Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368                                            , -0.44657789945656734, -1.3864912281711133 , 0.10666666666666667 , 0.6896228458437456,       1.0 , 10/16  , 34.56%, AKR1C3;ACOT8;ACOX2;SLC27A5;ABCB11;HSD17B4;SYCP2;NCOA1;AKR1C1;BAAT
prerank, KEGG_2021_Human__Thyroid hormone synthesis                                                                                                  , -0.3446835042078861 , -1.3856868342476072 , 0.03488372093023256 , 0.687385970247006 ,       1.0 , 22/51  , 29.33%, ADCY7;CREB3L4;PLCB2;GPX3;PLCB1;DUOX1;TSHR;PRKCA;IYD;TG;ASGR2;CREB3L2;ATP1B1;PRKACB;GSR;ATP1A3;PDIA4;ADCY9;SLC5A5;HSP90B1;HSPA5;GPX1
prerank, Reactome_2022__SUMOylation Of Transcription Factors R-HSA-3232118                                                                           , 0.3760980633041099  , 1.3822438592393316  , 0.07142857142857142 , 1.0               ,       1.0 , 3/15   , 5.65% , PIAS2;PIAS3;HIC1
prerank, Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948                                                                 , -0.3770312601439987 , -1.381299553448725  , 0.10126582278481013 , 0.7017451289281902,       1.0 , 11/29  , 24.97%, ITGB3;ARRB1;MAPK1;YWHAB;MARK3;ITGA2B;IQGAP1;RAP1A;CNKSR2;RNASE3;KSR1
prerank, Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442                                                                                      , -0.33191100633854603, -1.378122084429122  , 0.07692307692307693 , 0.711187960617227 ,       1.0 , 32/60  , 37.62%, PSMD6;UBC;PSMD7;CUL3;PSMD9;PSMC3;PSME4;PSMB2;PSME2;RASA2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;SPRED1;PSMB4;PSMF1;KBTBD7;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5;PSMD13;NF1
prerank, Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228                                                                            , -0.3221639178432072 , -1.3778353211752514 , 0.023529411764705882, 0.7069239383827765,       1.0 , 19/61  , 23.59%, CAPN3;CASP3;NCSTN;KLK2;CAPN5;CD44;ELANE;BMP1;BSG;CTSK;TIMP2;HTRA1;MMP9;MMP14;COL9A1;ADAM8;TPSAB1;ADAM10;DCN
prerank, Reactome_2022__Signaling By EGFR R-HSA-177929                                                                                               , -0.3415673705425376 , -1.3767801199386387 , 0.12195121951219512 , 0.7061927281800037,       1.0 , 15/43  , 23.85%, PTPRK;PTPN11;UBC;SH3GL1;PIK3R1;AREG;STAM2;TGFA;CDC42;GRB2;EPS15L1;UBB;RPS27A;ADAM10;PIK3CA
prerank, Reactome_2022__RHOA GTPase Cycle R-HSA-8980692                                                                                              , -0.28795637771221655, -1.3759592237450127 , 0.033707865168539325, 0.7041612264193418,       1.0 , 47/128 , 27.96%, FMNL3;RHPN2;RASGRF2;RTKN;ARHGAP35;ARHGAP23;GMIP;DIAPH1;ARHGAP6;ARHGAP5;FAF2;KTN1;PIK3R1;VAMP3;DDRGK1;TFRC;FAM13A;ARHGEF15;TEX2;OBSCN;ARHGAP9;ROCK2;VANGL1;STOM;ARHGEF11;ARHGAP29;TMPO;LMAN1;HMOX2;ERBIN;ARHGAP22;IQGAP1;ARHGAP30;DHDDS;AKAP13;ARHGAP42;YKT6;PRPF38B;SLK;DAAM1;ARHGEF1;JUP;ARHGEF4;ARHGAP8;ARHGEF2;ARAP2;ARHGAP31
prerank, KEGG_2021_Human__One carbon pool by folate                                                                                                  , -0.4510877111984043 , -1.3747246908514499 , 0.1                 , 0.7050070800563052,       1.0 , 5/17   , 12.29%, MTFMT;ST20-MTHFS;MTHFD1;MTHFD2;DHFR
prerank, Reactome_2022__Mitochondrial Translation Elongation R-HSA-5389840                                                                           , -0.29693241128900094, -1.371319581524595  , 0.054945054945054944, 0.7156100992459525,       1.0 , 30/80  , 28.80%, CHCHD1;MRPL53;MRPS18B;MRPS30;MRPL21;MRPS23;MRPL3;MRPL57;MRPL20;MRPL18;MRPS25;MRPL39;MRPS7;MRPL43;MRPL24;MRPL16;MRPL23;MRPL15;AURKAIP1;MRPS17;MRPL30;MRPS27;MRPS16;MRPL55;MRPL1;MRPL52;MRPS21;MRPL4;MRPS14;MRPL14
prerank, KEGG_2021_Human__Peroxisome                                                                                                                 , -0.31057596732823056, -1.3701618555117692 , 0.10344827586206896 , 0.715477707269285 ,       1.0 , 24/75  , 23.30%, PMVK;PEX2;ACSL1;PEX6;PAOX;ACOT8;ACOX2;AGXT;CRAT;ABCD4;SLC25A17;PIPOX;CAT;PEX26;ACSL5;SOD2;ACOX1;HSD17B4;DECR2;PEX5;ACSL4;ECH1;PEX14;PEX1
prerank, KEGG_2021_Human__Hypertrophic cardiomyopathy                                                                                                , -0.32791451048791254, -1.3696690146137709 , 0.0875              , 0.7124829947768696,       1.0 , 12/60  , 8.82% , ITGB3;TGFB3;CACNG8;ITGB5;DAG1;CACNG6;CACNB3;SGCA;ITGAV;SGCB;PRKAG2;ATP2A3
prerank, Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892                                                                                 , -0.45186001813622656, -1.3672164499712092 , 0.08450704225352113 , 0.7181411633255229,       1.0 , 8/18   , 23.44%, CACNG8;RANGRF;FGF12;CACNG6;CAMK2G;SCN1B;FGF11;SCN11A
prerank, Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400                                                                  , 0.31377109911171813 , 1.3664255790430118  , 0.0967741935483871  , 1.0               ,       1.0 , 9/25   , 15.31%, BAD;AKT1S1;RPS6KB2;CREB1;MTOR;NR4A1;GSK3B;FOXO3;AKT3
prerank, Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017                                                                 , -0.31140039567635786, -1.3656040222194987 , 0.08333333333333333 , 0.7199538647525094,       1.0 , 38/70  , 37.71%, PSMD6;UBC;PSMD7;CCNA1;PSMD9;UBE2C;PSMC3;PSME4;PSMB2;CDC26;PSME2;CDC6;UBE2E1;UBB;RPS27A;PSMD8;PSME3;CCNA2;PSMB6;UBE2D1;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;PSMD5;UBE2S;PSMD13;ANAPC16;ANAPC2
prerank, KEGG_2021_Human__Citrate cycle (TCA cycle)                                                                                                  , 0.31560340285091526 , 1.3620477621647966  , 0.14285714285714285 , 1.0               ,       1.0 , 6/27   , 6.03% , DLST;PC;MDH1;IDH3A;SUCLG1;CS
prerank, Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223                                                                                      , -0.3665470427611445 , -1.3608302537653312 , 0.0975609756097561  , 0.7352879063301967,       1.0 , 12/33  , 24.97%, ITGB3;ARRB1;MAPK1;YWHAB;CAMK2G;MARK3;ITGA2B;IQGAP1;RAP1A;CNKSR2;RNASE3;KSR1
prerank, Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105                                                                                      , -0.3617327668481162 , -1.360628350760641  , 0.08108108108108109 , 0.7310780699239817,       1.0 , 17/32  , 27.10%, ACSL1;ELOVL6;OLAH;SCD;TECR;PPT1;ACSL5;SCD5;ELOVL1;ACSL4;ELOVL3;ACSBG1;MORC2;ACLY;HTD2;ELOVL5;CBR4
prerank, KEGG_2021_Human__TNF signaling pathway                                                                                                      , -0.29449198911698127, -1.358886845174271  , 0.07142857142857142 , 0.7346803971282786,       1.0 , 28/100 , 19.46%, JAG1;CREB3L4;CASP3;CASP8;TAB3;CEBPB;SOCS3;MAPK1;PIK3R3;PIK3R1;BCL3;RPS6KA4;ITCH;MAPK8;CSF1;MMP9;CREB3L2;MMP14;IL18R1;MAP3K8;TNFRSF1A;CCL20;MAP3K7;MAP2K7;CASP7;JUNB;TNFAIP3;AKT1
prerank, KEGG_2021_Human__Aldosterone-regulated sodium reabsorption                                                                                  , -0.37641354835145097, -1.358790501779972  , 0.12162162162162163 , 0.7299238934717975,       1.0 , 15/26  , 35.25%, NR3C2;PDPK1;MAPK1;PIK3R3;IRS1;PIK3R1;PRKCA;ATP1B1;ATP1A3;PIK3CA;SFN;INSR;PIK3CB;NEDD4L;ATP1A1
prerank, Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409                                                                              , -0.4116816850832863 , -1.3533847696003536 , 0.11764705882352941 , 0.7509697402070858,       1.0 , 6/21   , 9.11% , DUSP2;PTPN11;PEA15;TYK2;MAPK1;DUSP6
prerank, Reactome_2022__RHOC GTPase Cycle R-HSA-9013106                                                                                              , -0.3240214689716373 , -1.3513258498298006 , 0.0963855421686747  , 0.7539844879207103,       1.0 , 24/64  , 26.05%, FMNL3;RTKN;ARHGAP35;DIAPH1;ARHGAP5;PIK3R1;VAMP3;TFRC;FMNL2;ROCK2;VANGL1;STOM;ARHGEF11;TMPO;LMAN1;ERBIN;RHOC;IQGAP1;DHDDS;AKAP13;SLK;DAAM1;ARHGEF1;JUP
prerank, Reactome_2022__RHOB GTPase Cycle R-HSA-9013026                                                                                              , -0.3197627427582155 , -1.3495543111772186 , 0.12790697674418605 , 0.7566593055327702,       1.0 , 22/58  , 28.61%, RHPN2;RTKN;ARHGAP35;DIAPH1;ARHGAP5;PIK3R1;VAMP3;TFRC;ROCK2;VANGL1;STOM;ARHGEF11;ERBIN;DHDDS;AKAP13;PRPF38B;SLK;DAAM1;ARHGEF1;JUP;ARHGEF2;RHOB
prerank, Reactome_2022__Metabolism Of Folate And Pterines R-HSA-196757                                                                               , -0.4640745450287968 , -1.3478901106859318 , 0.17647058823529413 , 0.7605582839423194,       1.0 , 6/15   , 17.91%, ST20-MTHFS;MTHFD1;SLC19A1;MTHFD2;DHFR;FPGS
prerank, Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499                                                                           , 0.25181380050893337 , 1.347878398712037   , 0.041666666666666664, 1.0               ,       1.0 , 10/48  , 10.39%, PIK3CG;MTMR2;MTMR9;INPPL1;PIP5K1C;MTMR14;PLEKHA5;PLEKHA2;INPP5D;PLEKHA8
prerank, Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420                                                                                  , -0.4340927133016643 , -1.3477174526523317 , 0.10810810810810811 , 0.756229517316718 ,       1.0 , 6/18   , 13.74%, RFNG;RAB6A;B4GALT1;ATP2A3;LFNG;NOTCH3
prerank, Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206                                                                               , 0.20513156378460384 , 1.3445280790587035  , 0.07692307692307693 , 1.0               ,       1.0 , 17/100 , 9.15% , MFSD2A;OSBPL8;STARD7;OSBPL10;LPCAT2;SLC44A2;LPGAT1;SELENOI;MIGA1;CHPT1;CHKA;ABHD3;PTPMT1;GNPAT;LPCAT3;CDS2;GPAT4
prerank, Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154                                                                     , -0.31866338508583275, -1.344495641323805  , 0.0875              , 0.7660777438411768,       1.0 , 36/65  , 37.71%, PSMD6;UBC;PSMD7;PSMD9;CDC20;UBE2C;PSMC3;PSME4;PSMB2;CDC26;PSME2;UBE2E1;UBB;RPS27A;PSMD8;PSME3;PSMB6;UBE2D1;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;PSMD5;UBE2S;PSMD13;ANAPC16;ANAPC2
prerank, KEGG_2021_Human__Starch and sucrose metabolism                                                                                              , 0.31581414153876275 , 1.3439447947166252  , 0.125               , 1.0               ,       1.0 , 7/24   , 11.86%, GANC;PYGB;HKDC1;PGM1;ENPP1;ENPP3;MGAM2
prerank, Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397                                                        , -0.38675292005539497, -1.343199212542432  , 0.13513513513513514 , 0.7666385978043913,       1.0 , 17/24  , 43.01%, UBC;SLC19A1;RPA3;POLK;RFC5;POLR1B;UBB;RPS27A;POLD4;XRCC1;POLE3;POLD2;POLE4;POLE;RFC2;RFC3;POLD1
prerank, Reactome_2022__Signaling By Retinoic Acid R-HSA-5362517                                                                                     , -0.3611708625520902 , -1.3402106146599153 , 0.17073170731707318 , 0.7760708921560852,       1.0 , 7/30   , 10.53%, AKR1C3;DHRS9;RDH14;PDPK1;PDK4;PDHB;RARB
prerank, Reactome_2022__Mitochondrial Translation R-HSA-5368287                                                                                      , -0.28930796334370096, -1.3399523037095828 , 0.05555555555555555 , 0.7721842499212102,       1.0 , 32/86  , 28.80%, MTFMT;CHCHD1;MRPL53;MRPS18B;MRPS30;MRPL21;MRPS23;MRPL3;MRPL57;MRPL20;MRPL18;MRPS25;MRPL39;MRPS7;MRPL43;MRPL24;MRPL16;MRPL23;MRPL15;AURKAIP1;MRPS17;MRPL30;MRPS27;MRPS16;MRPL55;MRPL1;MRPL52;MRPS21;MTIF2;MRPL4;MRPS14;MRPL14
prerank, Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685                                                                                  , -0.3849555717614427 , -1.3390536976800997 , 0.14634146341463414 , 0.7714118331963523,       1.0 , 13/23  , 37.98%, ARHGAP35;MYH9;ROCK2;RRAS;ARHGEF11;RHOC;LIMK1;RHOB;MYL12B;LIMK2;ARHGEF12;MYL9;ROCK1
prerank, Reactome_2022__HSF1 Activation R-HSA-3371511                                                                                                , -0.36080295830718484, -1.3383171815054349 , 0.16                , 0.7694461928415897,       1.0 , 11/26  , 26.95%, EEF1A1;MRPL18;RPA3;POLR1B;HSPA1A;HSPH1;UBB;FKBP4;VCP;TNFRSF21;HDAC6
prerank, KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy                                                                            , -0.3191027564955813 , -1.337084484586553  , 0.10126582278481013 , 0.7698968997488893,       1.0 , 14/52  , 15.20%, ITGB3;CACNG8;ITGB5;DAG1;CACNG6;CACNB3;SGCA;ITGAV;SGCB;ATP2A3;LEF1;ITGA10;ITGA9;ITGA1
prerank, Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709                                                                                , -0.34656110301404985, -1.3370350149804393 , 0.08823529411764706 , 0.7652411523107631,       1.0 , 7/30   , 15.24%, C1GALT1;GALNT2;ST6GALNAC4;B4GALT6;GALNT12;GALNT1;GALNT11
prerank, Reactome_2022__Mitochondrial Translation Termination R-HSA-5419276                                                                          , -0.29218554858384294, -1.336881664586068  , 0.045454545454545456, 0.7613389860406574,       1.0 , 30/80  , 28.80%, CHCHD1;MRPL53;MRPS18B;MRPS30;MRPL21;MRPS23;MRPL3;MRPL57;MRPL20;MRPL18;MRPS25;MRPL39;MRPS7;MRPL43;MRPL24;MRPL16;MRPL23;MRPL15;AURKAIP1;MRPS17;MRPL30;MRPS27;MRPS16;MRPL55;MRPL1;MRPL52;MRPS21;MRPL4;MRPS14;MRPL14
prerank, Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511                                                                                           , -0.2864238886163038 , -1.3354304227272746 , 0.11627906976744186 , 0.7623843491813841,       1.0 , 41/95  , 33.55%, SRXN1;SQSTM1;PSMD6;TKT;UBC;PSMD7;UFD1;CUL3;PSMD9;CSNK2A2;PSMC3;PSME4;PSMB2;CUL1;PSME2;MUL1;SESN1;UBB;RPS27A;AKT1;GSR;PSMD8;PSME3;VCP;PSMB6;CREBBP;PSMA1;PSMB4;HMOX1;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;AKT2;MAFG;PSMD10
prerank, Reactome_2022__Activation Of Matrix Metalloproteinases R-HSA-1592389                                                                        , -0.43589140981396823, -1.3353320369912967 , 0.14492753623188406 , 0.7580008026400031,       1.0 , 7/17   , 19.74%, KLK2;ELANE;CTSK;TIMP2;MMP9;MMP14;TPSAB1
prerank, Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733                                                                                 , -0.3117816314418645 , -1.334454859588703  , 0.09523809523809523 , 0.7576233275636228,       1.0 , 14/57  , 15.95%, USP18;MX1;PTPN11;GBP2;SOCS3;TYK2;HLA-G;IFITM2;IFITM3;OAS2;KPNA1;IFIT3;EGR1;IFI35
prerank, Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408                                                  , -0.29840777804149893, -1.3335383752775298 , 0.10588235294117647 , 0.7565735183359987,       1.0 , 42/78  , 37.71%, PSMD6;UBC;PSMD7;CCNA1;PSMD9;CDC20;UBE2C;PSMC3;PSME4;PSMB2;CUL1;CDC26;PSME2;UBE2E1;UBB;RPS27A;PSMD8;PSME3;CCNA2;PSMB6;UBE2D1;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;BUB1B;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;BUB3;PSMD5;UBE2S;MAD2L1;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204                                                                            , 0.33069445728205343 , 1.3320888325342184  , 0.125               , 1.0               ,       1.0 , 7/21   , 12.63%, PLCB4;PLCE1;INPPL1;ITPKC;INPP5D;ITPK1;PLCD1
prerank, Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941                                                              , -0.422245447908605  , -1.3320732157090636 , 0.14864864864864866 , 0.7586990371109632,       1.0 , 6/15   , 25.48%, DTX4;XRCC5;TBK1;TREX1;IFI16;PRKDC
prerank, Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571                                                                               , -0.3392891579711933 , -1.3299470446797912 , 0.10256410256410256 , 0.7646770301421697,       1.0 , 17/47  , 25.48%, RAD50;H2AX;BABAM1;XRCC5;POLM;BRCA1;DCLRE1C;UBE2N;H2BC11;PAXIP1;ABRAXAS1;BABAM2;XRCC4;UIMC1;NHEJ1;RNF168;PRKDC
prerank, Reactome_2022__Signaling By MET R-HSA-6806834                                                                                               , -0.3182209991455468 , -1.3298910280010015 , 0.12048192771084337 , 0.7601472930663064,       1.0 , 16/54  , 19.10%, TNS3;PTPN11;UBC;CRK;PTPRJ;USP8;SPINT1;RANBP9;SH3GL1;PIK3R1;RANBP10;STAM2;ARF6;GRB2;UBB;RPS27A
prerank, KEGG_2021_Human__Mismatch repair                                                                                                            , -0.3755590825125676 , -1.3297407165446704 , 0.15873015873015872 , 0.7562670114316821,       1.0 , 15/23  , 43.01%, LIG1;RFC1;RPA3;RFC5;RPA1;MLH3;POLD4;MSH2;MLH1;POLD2;PMS2;MSH6;RFC2;RFC3;POLD1
prerank, Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168                                                   , -0.25548101532099915, -1.328540418283103  , 0.08421052631578947 , 0.7570955603852536,       1.0 , 116/278, 32.85%, HECTD2;PSMD6;TRAIP;ARIH2;UBE3A;UBE2E2;SMURF1;CBLB;UBE4A;SIAH1;RBBP6;UBC;RNF130;RNF123;PSMD7;DZIP3;CUL5;SOCS3;FBXL14;LTN1;UBA3;CUL3;PSMD9;PJA2;HACE1;TRIM36;HECTD1;LRRC41;CDC20;UBE2C;KCTD7;ITCH;PSMC3;PSME4;MGRN1;UBE2B;PSMB2;CUL1;RNF14;FBXO32;ASB13;CDC26;PSME2;KBTBD6;FBXO44;UBE2L3;TRIM9;UBOX5;UBE2J1;UBE2N;FBXL18;ASB2;UBE2G1;FBXO7;RNF6;FBXO41;KLHL22;UBE2E1;RLIM;BLMH;HECW2;RNF25;UBE2J2;SMURF2;UBB;TPP2;RPS27A;CUL7;TRIM11;FBXO11;ANAPC13;UBE2Z;FBXO21;FBXW4;DCAF1;PSMD8;HERC5;PSME3;UBE2E3;ZNRF2;NEDD4;PSMB6;UBAC1;UBA1;UBE2D1;FBXO31;RNF182;BTBD1;FBXO4;FBXL4;PSMA1;GLMN;UBE2Q1;RNF115;UBE2D2;PSMB4;CUL2;UBR1;FBXO2;PSMF1;KBTBD7;PSME1;ASB1;PSMA3;RNF217;RNF41;FBXO6;FBXW7;ELOC;PSMB1;PSMC4;SEM1;PSMA6;AREL1;PSMD11;PSMA2
prerank, Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008                                                               , -0.343863036398141  , -1.3281057718430271 , 0.1232876712328767  , 0.7538021823120227,       1.0 , 19/42  , 33.64%, PPP1R13B;BAX;TP53;CRADD;BCL2L14;PMAIP1;BNIP3L;STEAP3;BID;CREBBP;AIFM2;MPZ;BCL6;RABGGTA;PRELID1;PRELID3A;NDRG1;PERP;BIRC5
prerank, Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135                                                                                      , -0.3473068354936186 , -1.3255973368904372 , 0.13414634146341464 , 0.7589825928500143,       1.0 , 12/33  , 24.97%, ITGB3;ARRB1;MAPK1;YWHAB;WDR83;MARK3;ITGA2B;IQGAP1;RAP1A;CNKSR2;RNASE3;KSR1
prerank, Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590                                                                            , -0.31730819819373896, -1.325444672024316  , 0.1518987341772152  , 0.7555235313396875,       1.0 , 28/56  , 33.55%, PSMD6;UBC;PSMD7;UBA3;PSMD9;PSMC3;PSME4;PSMB2;CUL1;PSME2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;RELB;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169                                                        , -0.2537598828291117 , -1.3245537987460472 , 0.052083333333333336, 0.7547981243395562,       1.0 , 138/341, 32.85%, HECTD2;PSMD6;TRAIP;ARIH2;SEC24D;UBE3A;ITGB5;UBE2E2;SMURF1;CBLB;UBE4A;SIAH1;RBBP6;SEC24C;STX4;UBC;RNF130;RNF123;ITGAV;PSMD7;DZIP3;CUL5;SOCS3;FBXL14;TIRAP;LTN1;UBA3;CUL3;PSMD9;PJA2;HACE1;HLA-G;TRIM36;HECTD1;CYBB;LRRC41;CDC20;UBE2C;KCTD7;ATG14;VAMP3;ITCH;PSMC3;PSME4;SEC61B;MGRN1;UBE2B;PSMB2;CUL1;RNF14;FBXO32;ASB13;CDC26;PSME2;KBTBD6;FBXO44;UBE2L3;TRIM9;MRC2;LY96;UBOX5;UBE2J1;UBE2N;FBXL18;ASB2;UBE2G1;FBXO7;RNF6;FBXO41;KLHL22;UBE2E1;RLIM;BLMH;HECW2;RNF25;UBE2J2;SMURF2;UBB;TPP2;RPS27A;CUL7;TRIM11;FBXO11;ANAPC13;UBE2Z;FBXO21;FBXW4;DCAF1;PSMD8;HERC5;PSME3;UBE2E3;ZNRF2;NEDD4;PSMB6;UBAC1;UBA1;UBE2D1;HMGB1;FBXO31;RNF182;BTBD1;FBXO4;FBXL4;PSMA1;GLMN;SEC14L2;UBE2Q1;RNF115;PDIA3;BTK;UBE2D2;PSMB4;CUL2;HSPA5;UBR1;FBXO2;NCF2;SEC22B;PSMF1;KBTBD7;NCF1;PSME1;ASB1;PSMA3;TLR2;RNF217;RNF41;FBXO6;FBXW7;ELOC;PSMB1;PSMC4;SEM1;PSMA6;AREL1;PSMD11;PSMA2
prerank, KEGG_2021_Human__Non-small cell lung cancer                                                                                                 , -0.2961485583685367 , -1.3234680870528808 , 0.09090909090909091 , 0.7549098622929579,       1.0 , 22/66  , 23.85%, BAX;PDPK1;TP53;GADD45G;MAPK1;PIK3R3;POLK;PIK3R1;RARB;PRKCA;RASSF1;RB1;TGFA;DDB2;GRB2;HGF;KIF5A;AKT1;CDKN1A;GADD45A;RASSF5;PIK3CA
prerank, Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361                                                     , -0.32797285300601275, -1.3229681355157366 , 0.16216216216216217 , 0.7523586547834564,       1.0 , 17/34  , 32.77%, KCNMA1;TRIOBP;PLS1;MYH9;PJVK;TWF2;MYO15A;CIB2;KCNMB1;TPRN;CDH23;SPTBN1;KIF20B;WHRN;ESPN;CLIC5;CASK
prerank, Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895                                                                          , -0.3112063899401366 , -1.3215669630975155 , 0.14457831325301204 , 0.753617313782839 ,       1.0 , 28/57  , 33.55%, PSMD6;UBC;RNF185;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;PSMD8;PSME3;VCP;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;ERLEC1;PSMD10
prerank, Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576                                                              , -0.3905731399341488 , -1.3213203132754805 , 0.1518987341772152  , 0.7502884855289421,       1.0 , 10/19  , 30.10%, B4GALT1;B4GALT3;B4GALT6;FUCA1;MGAT5;MOGAT3;FUT8;MAN2A2;ST8SIA6;B4GALT4
prerank, Reactome_2022__Signaling By FGFR1 R-HSA-5654736                                                                                             , -0.33661381799845913, -1.3210385947645216 , 0.11538461538461539 , 0.7471222733105217,       1.0 , 13/31  , 31.49%, PTPN11;MKNK1;UBC;MAPK1;PIK3R1;GRB2;UBB;RPS27A;PIK3CA;SPRED1;PPP2CA;SRC;SPRY2
prerank, Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114                                                             , -0.32621628680905107, -1.3202141300365888 , 0.14666666666666667 , 0.74715058519325  ,       1.0 , 26/51  , 35.04%, PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSMB2;CUL1;PSME2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202                                                                , -0.29649256785969086, -1.3183763192862084 , 0.13953488372093023 , 0.7505656060759837,       1.0 , 41/82  , 35.30%, PSMD6;UBC;LIN9;PSMD7;CCNA1;PSMD9;PSMC3;PSMB2;CUL1;PSME2;RB1;CCNH;UBB;RPS27A;AKT1;MNAT1;CDKN1A;PSMD8;PSME3;CCNA2;PTK6;PSMB6;RBBP4;PSMA1;PSMB4;PSMF1;LIN54;PSME1;PSMA3;CKS1B;RBL2;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;AKT2;PSMD10;PSMD5;TFDP2
prerank, Reactome_2022__Cargo Concentration In ER R-HSA-5694530                                                                                      , -0.37128270880170017, -1.3173559467121516 , 0.18518518518518517 , 0.7513090917883335,       1.0 , 9/29   , 18.33%, SEC24D;F5;SEC24C;LMAN2L;AREG;LMAN2;MCFD2;TGFA;LMAN1
prerank, KEGG_2021_Human__Fanconi anemia pathway                                                                                                     , 0.2265918911101968  , 1.3144082355785491  , 0.0                 , 1.0               ,       1.0 , 6/54   , 3.57% , FANCE;REV1;FANCI;FANCB;BRIP1;RMI2
prerank, Reactome_2022__GPER1 Signaling R-HSA-9634597                                                                                                , -0.35393340174407917, -1.3127727833828218 , 0.1518987341772152  , 0.7669024729869869,       1.0 , 15/33  , 26.82%, ADCY7;GPER1;GNAI3;PRKCA;GNB5;GNGT2;PRKAR2A;GNG5;PRKACB;GNG11;GNG3;ITGA5;GNAI1;ADCY9;PRKAR1A
prerank, Reactome_2022__Interferon Gamma Signaling R-HSA-877300                                                                                      , -0.29352735614948056, -1.311939622071031  , 0.09523809523809523 , 0.7662752619760478,       1.0 , 14/79  , 13.42%, PML;TRIM68;TRIM46;PTPN11;GBP2;TRIM35;CD44;SOCS3;TRIM22;HLA-G;OAS2;TRIM8;PTAFR;CAMK2G
prerank, "Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927"                                                                 , -0.3674666052163721 , -1.3098836018733735 , 0.15584415584415584 , 0.7704726941145333,       1.0 , 8/19   , 27.30%, UBC;TICAM1;UBE2N;TLR3;UBB;RPS27A;UBE2D1;UBE2D2
prerank, Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117                                                                                     , -0.39992373225289857, -1.3080997898316813 , 0.1780821917808219  , 0.773725642807791 ,       1.0 , 12/18  , 40.85%, MYH9;ROCK2;VPS72;RHOC;LIMK1;RHOB;MYL12B;LIMK2;MYL9;ROCK1;PPP1CB;PPP1R12A
prerank, Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422                                                                                   , -0.32635857820264447, -1.3069750865410503 , 0.13253012048192772 , 0.7737861878701613,       1.0 , 23/55  , 30.99%, YES1;ABI1;CYFIP2;MYH9;CRK;MAPK1;WAS;ABI2;WIPF2;ARPC5;NCKAP1L;FGR;CDC42;GRB2;WASF1;ARPC3;ARPC2;NCKIPSD;BTK;WIPF1;SYK;ACTR3;SRC
prerank, Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789                                                                    , -0.3490367169505147 , -1.3056241005227214 , 0.14102564102564102 , 0.7761564167859931,       1.0 , 14/41  , 19.12%, ITGB3;TGFB3;ITGB5;SMURF1;BAMBI;UBC;ITGAV;SMAD3;XPO1;SMAD7;SMURF2;UBB;RPS27A;LTBP4
prerank, Reactome_2022__Degradation Of AXIN R-HSA-4641257                                                                                            , -0.32304648064977354, -1.3053808729777048 , 0.1518987341772152  , 0.7730215245185306,       1.0 , 27/52  , 35.04%, PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;PSME2;SMURF2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5
prerank, Reactome_2022__RHO GTPase Cycle R-HSA-9012999                                                                                               , -0.24556708981568148, -1.3028273350071398 , 0.05102040816326531 , 0.7801757875378276,       1.0 , 129/386, 28.19%, CDC42EP4;FMNL3;RHPN2;RASGRF2;FAM169A;EPSTI1;JAG1;DNMBP;STK38;TXNL1;RTKN;ARHGAP35;DST;ABI1;ARHGAP23;GOPC;AKAP12;CYFIP2;GMIP;MTX1;DIAPH1;ARHGAP6;RBBP6;PARD6B;CDC42EP2;ARHGAP5;USP9X;CUL3;PIK3R3;CDC42BPB;FAF2;KTN1;PIK3R1;CYBB;WAS;VAMP3;FNBP1;FNBP1L;DDRGK1;RHOF;TFRC;CDC42EP3;HINT2;RHOU;CEP97;ABI2;FAM13A;FMNL2;NIPSNAP2;WIPF2;ARHGEF15;OSBPL11;TEX2;DLG5;SH3PXD2A;OBSCN;STIP1;ARHGAP33;ARHGAP9;CAPZB;ARHGAP25;ROCK2;KIDINS220;KCTD13;VANGL1;PEAK1;CKB;STAM2;PLD2;STOM;DOCK9;ARHGEF11;NCKAP1L;ARHGAP29;TMPO;RALGAPA1;CDC42;CPNE8;GRB2;LMAN1;RNF20;CLTC;HMOX2;ERBIN;ARHGAP22;BAIAP2L1;RHOC;NCOA3;CKAP4;FARP2;TRIP10;IQGAP1;UACA;SRRM1;ARHGAP30;DHDDS;ANKLE2;SHKBP1;AKAP13;ARHGAP42;MAP3K11;CDC42SE2;VCP;WASF1;EMD;PIK3CA;STEAP3;YKT6;PRPF38B;SLK;DAAM1;DSG2;ARHGEF1;SRGAP2;SWAP70;JUP;MPZ;TNFAIP1;ARHGEF4;SPTBN1;GOLGA3;ARHGAP8;ARHGEF2;CPSF7;CCT2;ARAP2;WIPF1;ARHGAP31;NCF2
prerank, Reactome_2022__Elastic Fibre Formation R-HSA-1566948                                                                                        , -0.3712961177638997 , -1.3017316450673295 , 0.14102564102564102 , 0.7808417256396298,       1.0 , 16/24  , 37.33%, ITGB3;TGFB3;ITGB5;ITGAV;LOXL1;BMP7;LOXL2;LTBP4;ITGA5;EFEMP2;FBLN2;FBLN1;MFAP5;LOXL3;MFAP3;FBN2
prerank, Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253                                                              , -0.28749543472793465, -1.301423307345088  , 0.10975609756097561 , 0.7783117276086124,       1.0 , 38/82  , 35.04%, PSMD6;TLE5;UBC;PPP2R5E;PSMD7;PSMD9;TLE2;PSMC3;PSME4;PSMB2;CUL1;PSME2;LEF1;PPP2R5B;ZRANB1;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;FRAT1;PSMB4;PPP2CA;AMER1;PSMF1;PSME1;PSMA3;PSMB1;TCF7L1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PROC;PSMD5
prerank, Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052                                                                 , -0.28839812908952883, -1.3009765712519505 , 0.13095238095238096 , 0.7764428979342902,       1.0 , 45/87  , 37.71%, PSMD6;UBC;MCM5;PSMD7;CCNA1;PSMD9;UBE2C;ORC3;PSMC3;PSME4;PSMB2;CUL1;CDC26;PSME2;SLC25A15;CDC6;UBE2E1;CDT1;UBB;RPS27A;PSMD8;PSME3;CCNA2;PSMB6;UBE2D1;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;MCM6;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;GMNN;PSMD5;UBE2S;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995                                                           , -0.3649361545354114 , -1.2999331825289961 , 0.14634146341463414 , 0.7770605991963443,       1.0 , 8/30   , 13.77%, C1GALT1;DAG1;ADAMTS6;LFNG;ADAMTS2;GALNT12;NOTCH3;B4GAT1
prerank, Reactome_2022__Metalloprotease DUBs R-HSA-5689901                                                                                           , -0.37344038497611676, -1.298268185945327  , 0.18055555555555555 , 0.7807535289368907,       1.0 , 12/30  , 23.40%, BABAM1;UBC;H2AC19;H2AC21;H2AC7;BRCA1;ABRAXAS1;KAT2B;UBB;RPS27A;BABAM2;UIMC1
prerank, KEGG_2021_Human__Fatty acid degradation                                                                                                     , -0.32684383949812373, -1.2968349404397155 , 0.11538461538461539 , 0.7837267359811627,       1.0 , 15/36  , 23.30%, ACSL1;ALDH9A1;ACADSB;ADH5;CPT2;CYP2U1;HADHB;ALDH1B1;ACAT1;ACSL5;ACOX1;ACSL4;GCDH;ECHS1;ACSBG1
prerank, Reactome_2022__Syndecan Interactions R-HSA-3000170                                                                                          , -0.42002317215762575, -1.2962354463838235 , 0.19117647058823528 , 0.7831675541404237,       1.0 , 4/16   , 11.13%, ITGB3;ITGB5;ITGAV;PRKCA
prerank, Reactome_2022__PCP/CE Pathway R-HSA-4086400                                                                                                 , -0.3103937510052759 , -1.2959194004247818 , 0.10256410256410256 , 0.7804228849003025,       1.0 , 40/76  , 38.41%, PSMD6;SMURF1;UBC;PSMD7;PSMD9;FZD6;PSMC3;PSME4;PSMB2;PRKCA;PSME2;PFN1;SMURF2;CLTC;UBB;RPS27A;NCOA3;PSMD8;PSME3;PSMB6;DAAM1;PSMA1;PSMB4;DVL3;PSMF1;PSME1;PSMA3;SCRIB;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PSMD5;AP2S1;PSMD13;RORA;FZD2
prerank, Reactome_2022__Plasma Lipoprotein Remodeling R-HSA-8963899                                                                                  , -0.4137950968644142 , -1.295296592433216  , 0.16901408450704225 , 0.7791597094272992,       1.0 , 3/17   , 2.78% , CETP;TRNP1;PLTP
prerank, Reactome_2022__Detoxification Of Reactive Oxygen Species R-HSA-3299685                                                                      , -0.3912244424173951 , -1.2945185953648393 , 0.12162162162162163 , 0.7785767750213858,       1.0 , 14/25  , 34.44%, GPX3;GSTP1;CYBB;NUDT2;ERO1A;TXNRD2;CCS;GSR;NCF2;NCF1;GPX1;P4HB;CYCS;GPX7
prerank, KEGG_2021_Human__Transcriptional misregulation in cancer                                                                                    , -0.266193478746737  , -1.2937111257010367 , 0.11956521739130435 , 0.7778337677437004,       1.0 , 49/159 , 22.88%, PML;LMO2;BCL2A1;BAX;H3C2;FUS;TSPAN7;TP53;SPI1;MLF1;HOXA10;PLAT;CEBPB;GADD45G;H3C15;CCNA1;H3C6;SPINT1;JMJD1C;ELANE;PAX5;POLK;RUNX1T1;DUSP6;H3C10;DEFA3;MEIS1;PBX3;AFF1;MMP9;GZMB;TAF15;CDKN2C;ITGAM;DOT1L;H3-3B;DDB2;MEF2C;FUT8;PPARG;ETV6;ATF1;ETV5;EWSR1;CDKN1A;CD14;GADD45A;DDX5;CCNA2
prerank, Reactome_2022__Downstream TCR Signaling R-HSA-202424                                                                                        , -0.279392321649705  , -1.2931642273375021 , 0.12345679012345678 , 0.7761624005776327,       1.0 , 40/90  , 35.04%, PSMD6;CD3D;PDPK1;UBC;PSMD7;PSMD9;PIK3R1;PSMC3;PSME4;PSMB2;CUL1;PSME2;UBE2N;BCL10;MAP3K7;UBB;RPS27A;PSMD8;PSME3;PSMB6;UBE2D1;PIK3CA;PSMA1;UBE2D2;PSMB4;PSMF1;PSME1;RIPK2;PSMA3;HLA-DRB1;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PIK3CB;IKBKG;PSMD5
prerank, Reactome_2022__Aquaporin-mediated Transport R-HSA-445717                                                                                    , -0.3625913978146963 , -1.291526796782453  , 0.1125              , 0.7791088676917521,       1.0 , 12/31  , 19.82%, ADCY7;PRKCA;GNB5;AQP3;GNGT2;PRKAR2A;AQP6;RAB11A;GNG5;PRKACB;GNG11;GNG3
prerank, Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761                                                                 , -0.3094177672369676 , -1.2913942021494451 , 0.175               , 0.7760853293413174,       1.0 , 28/57  , 33.55%, PSMD6;UBC;PSMD7;UBA3;PSMD9;PSMC3;PSME4;PSMB2;CUL1;PSME2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;RELB;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480                                                                 , -0.30040175031382055, -1.290889887901593  , 0.09302325581395349 , 0.7743391481961451,       1.0 , 29/81  , 28.39%, YES1;ABI1;NF2;CYFIP2;MYH9;PLPP5;CRK;MAPK1;PIK3R1;WAS;ABI2;WIPF2;PLD3;PLD2;ARPC5;NCKAP1L;VPS72;FGR;CDC42;GRB2;LIMK1;WASF1;PIK3CA;ARPC3;ARPC2;NCKIPSD;BTK;WIPF1;SYK
prerank, Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482                                                      , -0.31914925742919487, -1.2902063653907776 , 0.0963855421686747  , 0.7728800598061303,       1.0 , 22/57  , 28.39%, ABI1;NF2;CYFIP2;MYH9;CRK;MAPK1;WAS;ABI2;WIPF2;ARPC5;NCKAP1L;VPS72;CDC42;GRB2;LIMK1;WASF1;ARPC3;ARPC2;NCKIPSD;BTK;WIPF1;SYK
prerank, Reactome_2022__RHO GTPase Effectors R-HSA-195258                                                                                            , -0.25046724408412974, -1.290103949584244  , 0.07216494845360824 , 0.7693949385711337,       1.0 , 92/254 , 30.23%, FMNL3;NUP85;RHPN2;SCAI;RTKN;CENPO;ABI1;NF2;GOPC;CYFIP2;H2AX;REXO2;DIAPH1;MYH9;KLK2;PDPK1;CENPA;H2AC19;CENPU;RANGAP1;PPP2R5E;CTTN;MAPK1;CENPT;ITGB3BP;KTN1;CLASP2;CYBB;CDC20;WAS;YWHAB;AREG;DYNC1LI1;KIF18A;PRKCA;ABI2;FMNL2;WIPF2;H2AC7;CLASP1;NUP107;PPP2R5B;EVL;H2BC11;ROCK2;PFN1;PPP1R14A;NUP98;ARPC5;KDM4C;NCKAP1L;H3-3B;VPS72;XPO1;CDC42;DYNC1H1;GRB2;CENPS-CORT;KIF5A;RHOC;IQGAP1;DHDDS;CDC25C;CKAP5;CENPM;DYNC1LI2;LIMK1;INCENP;MAPK11;WASF1;ARPC3;DAAM1;SRGAP2;PMF1-BGLAP;ARPC2;NCKIPSD;BTK;DVL3;WIPF1;PPP2CA;YWHAQ;NCF2;MAPRE1;SKA2;RHOB;MYL12B;KDM1A;NCF1;KNL1;H2AC6;ACTR3;LIMK2
prerank, Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091                                                                             , -0.30882433301388656, -1.289671660575259  , 0.1375              , 0.7673332104174004,       1.0 , 31/64  , 35.04%, NFKBIE;PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;CUL1;PSME2;BCL10;MAP3K7;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;IKBKG;PSMD5
prerank, Reactome_2022__Synthesis Of DNA R-HSA-69239                                                                                                 , -0.2707912112188117 , -1.2894520957695583 , 0.12359550561797752 , 0.7643345169417264,       1.0 , 58/116 , 37.71%, PSMD6;UBC;SLC19A1;MCM5;PSMD7;CCNA1;RPA3;PSMD9;UBE2C;PRIM2;ORC3;PSMC3;PSME4;PSMB2;CUL1;CDC26;PSME2;RFC5;SLC25A15;CDC6;POLR1B;UBE2E1;CDT1;FEN1;UBB;RPS27A;PSMD8;PSME3;CCNA2;POLD4;PSMB6;UBE2D1;PSMA1;PSMB4;PSMF1;GINS1;PSME1;POLE3;PSMA3;POLD2;MCM6;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;GMNN;CDC45;PSMD5;POLE4;UBE2S;POLE;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__O-linked Glycosylation R-HSA-5173105                                                                                         , -0.3104337478907664 , -1.289189599481734  , 0.15                , 0.7619469798267543,       1.0 , 12/54  , 15.24%, C1GALT1;GALNT2;ST6GALNAC4;DAG1;ADAMTS6;LARGE2;B4GALT6;ADAMTS2;GALNT12;B4GAT1;GALNT1;GALNT11
prerank, Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074                                                                             , -0.38427532250197627, -1.288384046038285  , 0.19718309859154928 , 0.7611622316960283,       1.0 , 6/22   , 13.77%, GNS;B4GALT1;SLC35D2;B4GALT3;B4GALT6;B4GAT1
prerank, Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083                                                                              , -0.33111657710503106, -1.2869762454483922 , 0.1566265060240964  , 0.7630576437269692,       1.0 , 13/48  , 15.60%, ITGB3;MADCAM1;ITGB5;ITGAV;CD44;ITGAL;BSG;ITGAD;ITGA10;ITGA9;ITGA1;ITGAM;COL9A1
prerank, Reactome_2022__Regulated Necrosis R-HSA-5218859                                                                                             , -0.3153469352612162 , -1.2867515073027767 , 0.14814814814814814 , 0.7606061799845286,       1.0 , 14/55  , 19.10%, RRM1;CHMP4B;BAX;CASP3;FASLG;CASP8;TP53;UBC;ELANE;CHMP6;GZMB;TANK;UBB;RPS27A
prerank, Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312                                                                                   , -0.3974688074936727 , -1.2859309917401873 , 0.21052631578947367 , 0.7608252245508982,       1.0 , 9/16   , 25.87%, UBC;SLC19A1;RPA3;RFC5;POLR1B;UBB;RPS27A;MAD2L2;REV3L
prerank, Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912                                                                     , -0.2674202694708334 , -1.2856778161308549 , 0.1411764705882353  , 0.7580459637596844,       1.0 , 38/96  , 28.84%, PLK4;CSNK1D;B9D1;NPHP4;CEP76;IQCB1;AHI1;AKAP9;HAUS2;ACTR1A;NPHP1;CEP250;CEP97;PRKCA;CLASP1;CEP72;DCTN3;C2CD3;CC2D2A;KIF24;CEP57;NINL;RAB11A;RPGRIP1L;RAB3IP;DYNC1H1;CKAP5;CEP70;MKS1;CEP164;TMEM216;TCTN2;NEDD1;RAB8A;CEP78;MAPRE1;SFI1;NEK2
prerank, KEGG_2021_Human__Terpenoid backbone biosynthesis                                                                                            , -0.386544406790341  , -1.2855760330216701 , 0.18461538461538463 , 0.7547787679358265,       1.0 , 8/20   , 24.98%, PCYOX1;PMVK;GGPS1;NUS1;ACAT1;DHDDS;ICMT;FNTA
prerank, "Reactome_2022__Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741"                                                         , 0.3717473550540248  , 1.2840904953870096  , 0.21052631578947367 , 1.0               ,       1.0 , 4/15   , 3.96% , MMAB;LMBRD1;CD320;TCN1
prerank, Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105                                                                          , -0.37087096729044644, -1.2836689139391075 , 0.175               , 0.758348400030924 ,       1.0 , 9/24   , 23.27%, AKR1C3;ACOT8;ACOX2;SLC27A5;OSBPL3;ABCB11;HSD17B4;OSBP;SYCP2
prerank, Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402                                                           , -0.3342291726442721 , -1.2792345441230042 , 0.15789473684210525 , 0.770237999468353 ,       1.0 , 11/35  , 19.46%, SOX13;KMT2D;UBC;BCL9L;TLE2;LEF1;XPO1;ASH2L;UBB;RPS27A;AKT1
prerank, Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148                                                                                             , -0.2743819485969377 , -1.2791511156085522 , 0.10465116279069768 , 0.766908987258042 ,       1.0 , 47/129 , 27.96%, CDC42EP4;FMNL3;RASGRF2;DNMBP;ARHGAP35;GMIP;CDC42EP2;ARHGAP5;CDC42BPB;KTN1;PIK3R1;WAS;VAMP3;FNBP1;FNBP1L;TFRC;CDC42EP3;FMNL2;WIPF2;ARHGEF15;SH3PXD2A;ARHGAP33;ARHGAP9;VANGL1;STOM;DOCK9;ARHGEF11;ARHGAP29;TMPO;CDC42;CPNE8;ARHGAP22;IQGAP1;ARHGAP30;SHKBP1;ARHGAP42;MAP3K11;CDC42SE2;STEAP3;YKT6;DAAM1;SRGAP2;JUP;ARHGEF4;ARAP2;WIPF1;ARHGAP31
prerank, Reactome_2022__G2/M Transition R-HSA-69275                                                                                                  , -0.24886566926162074, -1.2781152127027184 , 0.07526881720430108 , 0.7679001805416944,       1.0 , 76/177 , 33.55%, PLK4;PSMD6;CSNK1D;CEP76;TP53;UBC;LIN9;PSMD7;AKAP9;HMMR;HAUS2;CCNA1;ACTR1A;PSMD9;CEP250;PSMC3;PSME4;PSMB2;CUL1;PRKCA;PSME2;CLASP1;CEP72;DCTN3;FBXL18;CEP57;NINL;CDK11B;XPO1;FOXM1;DYNC1H1;CCNH;FKBPL;UBB;RPS27A;MNAT1;CDC25C;CKAP5;CEP70;CDKN1A;PSMD8;PSME3;PPP2R2A;CCNA2;MZT1;PSMB6;NME7;RBBP4;CEP164;PSMA1;TUBGCP6;NEDD1;RAB8A;LCMT1;PSMB4;PPP2CA;CEP78;MAPRE1;SFI1;NEK2;PSMF1;LIN54;PSME1;HAUS7;TUBGCP5;PSMA3;CEP63;PSMB1;PSMC4;SEM1;PSMA6;HSP90AA1;PSMD11;PSMA2;HAUS5;PSMD10
prerank, Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565         , -0.3071681710310882 , -1.2767977937875008 , 0.13253012048192772 , 0.7708914687905296,       1.0 , 17/53  , 24.75%, RAD50;H2AX;BABAM1;TP53;UBC;BRCA1;MAPK8;UBE2N;H2BC11;ABRAXAS1;UBB;RPS27A;EYA3;CHEK2;BABAM2;UIMC1;RNF168
prerank, Reactome_2022__Circadian Clock R-HSA-400253                                                                                                 , -0.30130531569727276, -1.2761607141525755 , 0.1111111111111111  , 0.7695552844998077,       1.0 , 21/64  , 22.81%, HDAC3;CSNK1D;MEF2D;UBC;LIN9;CLOCK;NAMPT;NR1D1;CARM1;CUL1;HIF1A;SIRT1;MEF2C;LOC102724428;NRIP1;UBB;RPS27A;HSD17B4;ELOVL3;CRY2;CREM
prerank, Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555                                                                                      , -0.3327299448496748 , -1.273091499589647  , 0.1375              , 0.7786336573428485,       1.0 , 12/29  , 28.39%, PTPN11;UBC;CUL5;SOCS3;TYK2;GRB2;UBB;RPS27A;GAB2;UBE2D1;UBE2D2;SYK
prerank, Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638                                         , -0.37223644686935636, -1.2730305138057787 , 0.20833333333333334 , 0.7753421424197059,       1.0 , 6/21   , 19.46%, UHMK1;MAPK1;AREG;TGFA;XPO1;AKT1
prerank, Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314                                                , -0.3302184489041693 , -1.2719411379708494 , 0.19736842105263158 , 0.775976821808871 ,       1.0 , 18/30  , 43.01%, UBC;SLC19A1;RPA3;UBE2B;RFC5;RAD18;POLR1B;UBB;RPS27A;POLD4;POLE3;POLD2;POLE4;POLE;RFC2;DTL;RFC3;POLD1
prerank, Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656                                                                 , -0.28589113638008684, -1.271922867885165  , 0.16091954022988506 , 0.7726287290284296,       1.0 , 41/84  , 35.30%, PSMD6;UBC;LIN9;PSMD7;CCNA1;PSMD9;PSMC3;PSMB2;CUL1;PSME2;RB1;CCNH;UBB;RPS27A;AKT1;MNAT1;CDKN1A;PSMD8;PSME3;CCNA2;PTK6;PSMB6;RBBP4;PSMA1;PSMB4;PSMF1;LIN54;PSME1;PSMA3;CKS1B;RBL2;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;AKT2;PSMD10;PSMD5;TFDP2
prerank, Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685                                                                                  , -0.3633288546291154 , -1.271899525741852  , 0.17333333333333334 , 0.7693106639859295,       1.0 , 14/22  , 42.50%, SQSTM1;UBC;MTERF3;TOMM40;UBB;ATG12;RPS27A;ATG5;TOMM7;MFN1;MFN2;PINK1;MAP1LC3B;PRKN
prerank, Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760                                                                   , -0.3767368241006001 , -1.27131788044472   , 0.18518518518518517 , 0.7680659885585971,       1.0 , 7/19   , 22.14%, TP53;UBC;MDM4;TTC5;UBB;RPS27A;CHEK2
prerank, KEGG_2021_Human__Arachidonic acid metabolism                                                                                                , -0.32629383446526095, -1.2711146335800805 , 0.17567567567567569 , 0.7654759231536927,       1.0 , 9/38   , 11.87%, GGT1;AKR1C3;GPX3;CYP4F3;CYP2C9;PLB1;PTGS1;PLAAT3;CYP2U1
prerank, Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221                                                                            , -0.33043393509259633, -1.2710277514240698 , 0.19718309859154928 , 0.762426474484659 ,       1.0 , 14/39  , 24.97%, DUSP2;UBC;PPP2R5E;MAPK1;DUSP6;YWHAB;PPP2R5B;MARK3;UBB;RPS27A;DUSP7;DUSP16;RNASE3;KSR1
prerank, Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138                                                                             , -0.26664524105183957, -1.270050460358772  , 0.15                , 0.7630052395209581,       1.0 , 27/102 , 19.10%, TNIP2;ECSIT;USP18;TMED7-TICAM2;IRAK1;CASP8;TP53;UBC;TAB3;IKBIP;MAP3K1;MAPK1;TICAM1;DUSP6;EEA1;CUL1;RPS6KA3;LY96;MAPK8;UBE2N;MAP3K8;TANK;MAP3K7;MAP2K7;MEF2C;UBB;RPS27A
prerank, Reactome_2022__Molecules Associated With Elastic Fibres R-HSA-2129379                                                                       , -0.40952000266663746, -1.2696320108920602 , 0.2                 , 0.7615710191459186,       1.0 , 4/17   , 4.95% , ITGB3;TGFB3;ITGB5;ITGAV
prerank, Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143                                                               , -0.2797050583742164 , -1.269438652545137  , 0.12941176470588237 , 0.7591973531103732,       1.0 , 44/85  , 37.71%, PSMD6;UBC;PSMD7;CCNA1;PSMD9;CDC20;UBE2C;PSMC3;PSME4;PSMB2;CUL1;CDC26;PSME2;RB1;UBE2E1;UBB;RPS27A;PSMD8;PSME3;CCNA2;PSMB6;UBE2D1;PSMA1;PSMB4;NEK2;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;BUB1B;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;BUB3;PSMD5;UBE2S;MAD2L1;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123                                                                           , -0.2598697482558757 , -1.2692086506727105 , 0.0967741935483871  , 0.7566547611299141,       1.0 , 69/166 , 34.44%, SRXN1;SQSTM1;PSMD6;HDAC3;TKT;COX6C;HBA1;GPX3;GSTP1;COX5A;UBC;STAP2;LIN9;PSMD7;UFD1;CUL3;PSMD9;CYBB;CARM1;CSNK2A2;PSMC3;PSME4;PSMB2;CUL1;NUDT2;PSME2;BLVRA;NCOR2;MUL1;SESN1;ERO1A;TXNRD2;HMOX2;UBB;CCS;RPS27A;AKT1;GSR;PSMD8;PSME3;VCP;PTK6;PSMB6;CREBBP;PSMA1;COX4I1;PSMB4;HMOX1;NCF2;PSMF1;NCF1;GPX1;PSME1;PSMA3;NCOA1;P4HB;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;AKT2;MAFG;CYCS;PSMD10;COX18;NLRP3;GPX7
prerank, KEGG_2021_Human__Nucleotide excision repair                                                                                                 , -0.29551655531635235, -1.2682302120609885 , 0.18181818181818182 , 0.7578619141586956,       1.0 , 23/46  , 36.51%, LIG1;RFC1;GTF2H3;RPA3;RFC5;XPA;RPA1;DDB2;XPC;CCNH;MNAT1;POLD4;ERCC1;ERCC6;GTF2H4;POLE3;POLD2;ERCC3;GTF2H2C_2;GTF2H1;POLE4;ERCC4;POLE
prerank, Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068                                                                              , -0.35762521927714197, -1.2675684712641462 , 0.175               , 0.7577431344208134,       1.0 , 13/28  , 31.14%, AKR1C3;ACOT8;ACOX2;SLCO1A2;SLC27A5;OSBPL3;ABCB11;HSD17B4;OSBP;SYCP2;ABCC3;NCOA1;AKR1C1
prerank, Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138                                    , -0.26863802340958987, -1.2667737494179592 , 0.11392405063291139 , 0.7578592814371257,       1.0 , 26/97  , 19.10%, TNIP2;ECSIT;USP18;TMED7-TICAM2;IRAK1;CASP8;TP53;UBC;TAB3;IKBIP;MAP3K1;MAPK1;TICAM1;DUSP6;CUL1;RPS6KA3;LY96;MAPK8;UBE2N;MAP3K8;TANK;MAP3K7;MAP2K7;MEF2C;UBB;RPS27A
prerank, Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954                                                                             , 0.32770586307021976 , 1.265699895460015   , 0.0625              , 1.0               ,       1.0 , 4/15   , 9.40% , PKN2;FES;PLXNA1;PLXNA2
prerank, KEGG_2021_Human__Relaxin signaling pathway                                                                                                  , -0.2776242142638956 , -1.264323592186425  , 0.10227272727272728 , 0.7642629404652235,       1.0 , 32/95  , 24.90%, ADCY7;CREB3L4;PLCB2;ARRB1;VEGFA;GNA15;PLCB1;MAPK1;PIK3R3;GNAI3;PIK3R1;RLN2;ACTA2;NOS3;PRKCA;GNB5;MAPK8;GNGT2;MMP9;CREB3L2;MAP2K7;GNG5;GRB2;PRKACB;GNG11;AKT1;GNG3;MAPK11;PIK3CA;GNAI1;ADCY9;SHC4
prerank, Reactome_2022__Paracetamol ADME R-HSA-9753281                                                                                               , -0.40688046781048903, -1.263797555260818  , 0.2191780821917808  , 0.7633763058988406,       1.0 , 9/19   , 26.48%, GGT1;GSTP1;CNDP2;GSTM1;ABCC4;GGT5;GGT7;SLC38A1;ABCC3
prerank, KEGG_2021_Human__Nicotinate and nicotinamide metabolism                                                                                     , 0.2835377158652977  , 1.2637473955822542  , 0.17857142857142858 , 1.0               ,       1.0 , 9/29   , 12.86%, NUDT12;SIRT3;PNP;ENPP1;NT5C1A;ENPP3;NNMT;BST1;NMRK1
prerank, KEGG_2021_Human__Non-alcoholic fatty liver disease                                                                                          , -0.25739602901612096, -1.2633973959285298 , 0.06521739130434782 , 0.7621276911219933,       1.0 , 41/138 , 24.44%, NDUFB3;SDHC;BAX;COX6C;CASP3;FASLG;CASP8;COX5A;UQCRC1;UQCRFS1;EIF2S1;SOCS3;PRKAG2;MLXIP;NDUFB2;PIK3R3;IRS1;NDUFA7;PIK3R1;UQCRB;ITCH;MAPK8;NDUFB9;LEPR;TNFRSF1A;CASP7;CDC42;NDUFS1;NDUFB7;NDUFB5;AKT1;PPARG;NDUFB4;PRKAG1;NDUFS7;MAP3K11;MAPK11;NDUFV3;PIK3CA;MAP3K5;BID
prerank, KEGG_2021_Human__Insulin secretion                                                                                                          , -0.3051545707447774 , -1.2631687164722796 , 0.14942528735632185 , 0.7596478324995578,       1.0 , 17/51  , 24.78%, KCNMA1;ADCY7;CREB3L4;PLCB2;SNAP25;PLCB1;CHRM3;PRKCA;CAMK2G;CREB3L2;ATP1B1;PRKACB;ATP1A3;KCNMB1;KCNJ11;RAB3A;ADCY9
prerank, Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155                                                                   , -0.26451043775786126, -1.2614078613248751 , 0.12195121951219512 , 0.764516594437176 ,       1.0 , 26/98  , 19.10%, TNIP2;ECSIT;USP18;TMED7-TICAM2;IRAK1;CASP8;TP53;UBC;TAB3;IKBIP;MAP3K1;MAPK1;TICAM1;DUSP6;CUL1;RPS6KA3;LY96;MAPK8;UBE2N;MAP3K8;TANK;MAP3K7;MAP2K7;MEF2C;UBB;RPS27A
prerank, Reactome_2022__Collagen Formation R-HSA-1474290                                                                                             , -0.3049250234183741 , -1.2603361380223073 , 0.189873417721519   , 0.7658784810086939,       1.0 , 15/51  , 20.65%, P3H2;DST;COL6A3;P3H1;COL28A1;BMP1;LOXL1;ADAMTS2;P4HA1;MMP9;COL9A1;LOXL2;COL8A1;CRTAP;PLOD1
prerank, Reactome_2022__G2/M Checkpoints R-HSA-69481                                                                                                 , -0.26092759215194783, -1.2581818896681116 , 0.15217391304347827 , 0.7707715428517964,       1.0 , 58/139 , 35.04%, PSMD6;RAD50;H2AX;REXO2;BABAM1;TP53;UBC;MCM5;PSMD7;CHEK1;RPA3;PSMD9;YWHAB;RAD9B;ORC3;PSMC3;PSME4;PSMB2;PSME2;RFC5;BRCA1;SLC25A15;UBE2N;CDC6;POLR1B;H2BC11;ABRAXAS1;UBB;RPS27A;HUS1;CDC25C;PSMD8;PSME3;CHEK2;BABAM2;UIMC1;PSMB6;RNF168;PSMA1;RHNO1;PSMB4;YWHAQ;RMI1;PSMF1;PSME1;PSMA3;TOP3A;MCM6;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;CDC45;CLSPN;PSMD5
prerank, KEGG_2021_Human__African trypanosomiasis                                                                                                    , -0.3675535571418602 , -1.2573552176012224 , 0.25882352941176473 , 0.7714629739483688,       1.0 , 8/26   , 11.13%, PLCB2;IDO1;HBA1;FASLG;PLCB1;F2RL1;IL10;PRKCA
prerank, Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057                                                                                 , -0.2483761263272676 , -1.2569332644992723 , 0.10309278350515463 , 0.7698065258944919,       1.0 , 100/246, 33.91%, ITGB3;RASGRF2;MAPK6;PSMD6;DUSP2;ARL2;PTPN11;ARRB1;CDC42EP2;UBC;IL2RG;PPP2R5E;PEA15;PSMD7;IGF2BP1;TYK2;MAPK1;CUL3;PSMD9;IRS1;RANBP9;DUSP6;PIK3R1;YWHAB;ZDHHC9;AREG;PSMC3;CDC42EP3;PSME4;IL3RA;TNRC6C;PSMB2;PRKCA;PSME2;AGO3;DLG1;PHB1;PPP2R5B;CHURC1-FNTB;CAMK2G;WDR83;ARHGAP9;RASA2;ERBB3;TGFA;XPO1;AGO1;CDC42;GRB2;PRKACB;MARK3;UBB;RPS27A;NCOA3;ITGA2B;IQGAP1;PSMD8;PSME3;DUSP7;FGFR2;MAP3K11;ICMT;DUSP16;PSMB6;PIK3CA;RAP1A;FOXO1;CNKSR2;RNASE3;ANGPT1;MOV10;KSR1;FNTA;PSMA1;SPTBN1;SPRED1;PSMB4;SHOC2;PPP2CA;GOLGA7;PSMF1;KBTBD7;PSME1;IL6R;AGO2;PSMA3;SRC;CSF2RA;PSMB1;PSMC4;SEM1;PSMA6;DUSP8;PSMD11;HBEGF;PSMA2;VCL;PSMD10;DUSP5;PDGFB
prerank, Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356                                                                                 , -0.3143498666643615 , -1.256670413179517  , 0.14285714285714285 , 0.7672665856558488,       1.0 , 22/56  , 24.58%, PLCB2;SNAP25;CACNB3;GNA15;PLCB1;CHRM3;PRKCA;GNB5;GNGT2;STXBP1;PRKAR2A;GNG5;PRKACB;GNG11;GNG3;ACSL4;IQGAP1;CACNA1E;KCNJ11;RAPGEF3;RAP1A;GNAI1
prerank, KEGG_2021_Human__Human papillomavirus infection                                                                                             , -0.24862928675791698, -1.2565360703458608 , 0.050505050505050504, 0.7647027921615785,       1.0 , 55/253 , 18.28%, ITGB3;JAG1;CREB3L4;TADA3;RFNG;COL6A3;UBE3A;ITGB5;BAX;HES6;PPP2R3A;MX1;CASP3;FASLG;CASP8;VEGFA;PARD6B;TP53;ITGAV;PPP2R5E;WNT10A;CHD4;CCNA1;ATP6V0A1;TYK2;MAPK1;PIK3R3;HLA-G;FZD6;TICAM1;PIK3R1;HEY1;TBK1;DLG1;LFNG;NFX1;ITGA10;TCIRG1;PPP2R5B;RPS6KB1;TNXB;NOTCH3;ITGA9;RB1;CREB3L2;ITGA1;COL9A1;TNFRSF1A;TLR3;HES2;MAML2;CDC42;GRB2;RBPJ;PRKACB
prerank, Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720                                                                                     , -0.3363613852035274 , -1.2549077483939644 , 0.17142857142857143 , 0.7674542496639374,       1.0 , 15/32  , 29.20%, DNASE2;VAMP7;GNS;ARRB1;AP4B1;CLVS1;AP1S2;AP4S1;AP1M1;CLTC;AP1S1;AP1G1;DNM2;CHMP2A;APP
prerank, Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854                                                                                   , -0.3963800791345172 , -1.2531087599511714 , 0.16666666666666666 , 0.7715126150138746,       1.0 , 5/17   , 13.77%, B4GALT1;SLC35D2;B4GALT3;B4GALT6;B4GAT1
prerank, Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084                                                                           , -0.29829298890145994, -1.2522794326950124 , 0.15                , 0.7716105617711945,       1.0 , 34/63  , 37.71%, PSMD6;UBC;PSMD7;PSMD9;UBE2C;PSMC3;PSMB2;CDC26;PSME2;UBE2E1;UBB;RPS27A;PSMD8;PSME3;PSMB6;UBE2D1;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;PSMD5;UBE2S;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274                                                                                          , -0.2429784559104221 , -1.251949878668992  , 0.11578947368421053 , 0.7700375458759899,       1.0 , 75/179 , 33.08%, PLK4;PSMD6;CSNK1D;CEP76;TP53;UBC;LIN9;PSMD7;AKAP9;HMMR;HAUS2;CCNA1;ACTR1A;PSMD9;CEP250;PSMC3;PSME4;PSMB2;CUL1;PRKCA;PSME2;CLASP1;CEP72;DCTN3;FBXL18;CEP57;NINL;CDK11B;XPO1;FOXM1;DYNC1H1;CCNH;FKBPL;UBB;RPS27A;MNAT1;CDC25C;CKAP5;CEP70;CDKN1A;PSMD8;PSME3;PPP2R2A;CCNA2;MZT1;PSMB6;NME7;RBBP4;CEP164;PSMA1;TUBGCP6;NEDD1;RAB8A;LCMT1;PSMB4;PPP2CA;CEP78;MAPRE1;SFI1;NEK2;PSMF1;LIN54;PSME1;HAUS7;TUBGCP5;PSMA3;CEP63;PSMB1;PSMC4;SEM1;PSMA6;HSP90AA1;PSMD11;PSMA2;HAUS5
prerank, Reactome_2022__PI Metabolism R-HSA-1483255                                                                                                  , 0.20315972926082765 , 1.2516422814891015  , 0.08333333333333333 , 1.0               ,       1.0 , 14/75  , 10.39%, PIK3CG;MTMR2;MTMR9;INPPL1;PIP5K1C;MTMR14;PI4KA;PLEKHA5;PLEKHA2;SBF1;GDPD3;INPP5D;PIP4P1;PLEKHA8
prerank, Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657                                                                       , -0.39701974538124163, -1.251157252072843  , 0.16883116883116883 , 0.7670600673652694,       1.0 , 7/17   , 19.82%, PLCB2;PLCB1;GNB5;GNGT2;GNG5;GNG11;GNG3
prerank, Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217                                                                            , -0.39701974538124163, -1.251157252072843  , 0.16883116883116883 , 0.7670600673652694,       1.0 , 7/17   , 19.82%, PLCB2;PLCB1;GNB5;GNGT2;GNG5;GNG11;GNG3
prerank, Reactome_2022__KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604                                                                        , -0.3812189938938253 , -1.2506003289563912 , 0.19047619047619047 , 0.7663925137772264,       1.0 , 6/17   , 23.49%, EXOSC6;KHSRP;PARN;AKT1;MAPK11;EXOSC2
prerank, Reactome_2022__Chemokine Receptors Bind Chemokines R-HSA-380108                                                                             , 0.2575512923756209  , 1.2499351512741406  , 0.2                 , 1.0               ,       1.0 , 7/37   , 6.89% , CCL2;CCR5;ACKR3;CCR8;CX3CR1;CXCL16;CCR9
prerank, Reactome_2022__Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975                                                  , 0.3381797598050915  , 1.2498342663887831  , 0.14705882352941177 , 1.0               ,       1.0 , 7/15   , 19.54%, GFPT1;PGM1;DPM2;GALK1;GALT;SRD5A3;DPM3
prerank, Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781                                                                                , -0.267305949421709  , -1.2473626295168945 , 0.19101123595505617 , 0.774597382615721 ,       1.0 , 26/100 , 20.19%, MED27;MED18;CDK19;HDAC3;ABCB4;ACSL1;MED9;LIN9;MED12;AGXT;MED23;CPT2;CLOCK;NR1D1;CARM1;G0S2;NCOR2;ARHGAP9;MED13;MED21;ACOX1;FHL2;DAND5;ABCA1;NCOA3;PPARG
prerank, Reactome_2022__Pyroptosis R-HSA-5620971                                                                                                     , -0.3765997377264396 , -1.2469433535879975 , 0.2465753424657534  , 0.7735175646730256,       1.0 , 7/24   , 14.75%, CHMP4B;BAX;CASP3;TP53;ELANE;CHMP6;GZMB
prerank, KEGG_2021_Human__ECM-receptor interaction                                                                                                   , -0.30741539861319933, -1.2469188692457618 , 0.18518518518518517 , 0.7705580472912442,       1.0 , 15/55  , 20.60%, ITGB3;COL6A3;ITGB5;DAG1;ITGAV;CD44;HMMR;ITGA10;TNXB;ITGA9;ITGA1;COL9A1;SV2A;LAMB2;ITGA2B
prerank, Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040                                                    , -0.36049165495899527, -1.2465000278756626 , 0.15                , 0.7693743028648585,       1.0 , 11/28  , 19.82%, ADCY7;PRKCA;GNB5;AQP3;GNGT2;PRKAR2A;RAB11A;GNG5;PRKACB;GNG11;GNG3
prerank, KEGG_2021_Human__Apelin signaling pathway                                                                                                   , -0.26755610185686235, -1.2454253495117802 , 0.14457831325301204 , 0.7713080309108347,       1.0 , 30/106 , 21.06%, JAG1;ADCY7;SPHK2;PLCB2;MEF2D;PLAT;CALM2;PLCB1;PRKAG2;MAPK1;GNAI3;CDH1;ACTA2;NOS3;GNB5;SMAD3;RPS6KB1;GNGT2;NOTCH3;RRAS;EGR1;GNG5;MEF2C;PRKACB;GNG11;CALM3;AKT1;GNG3;RPS6;PRKAG1
prerank, KEGG_2021_Human__PPAR signaling pathway                                                                                                     , -0.30371225988397293, -1.2451663781608837 , 0.175               , 0.7690702617139263,       1.0 , 16/50  , 20.26%, ACSL1;PLTP;ACOX2;PDPK1;UBC;SLC27A5;CPT2;PCK2;SORBS1;SCD;ACSL5;SCD5;LPL;ACOX1;PPARG;ACSL4
prerank, Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992                                                                             , -0.2859601755106681 , -1.243489730094274  , 0.11392405063291139 , 0.7727223605115351,       1.0 , 11/69  , 5.75% , DNASE2;VAMP7;PIK3C2A;SNX5;GNS;SNX2;IGF2R;ARRB1;STX4;AP4B1;NAPSA
prerank, "KEGG_2021_Human__Valine, leucine and isoleucine degradation"                                                                               , -0.31828432009862784, -1.2433878792598374 , 0.17721518987341772 , 0.7701176435738561,       1.0 , 12/43  , 16.34%, HIBADH;MMUT;ALDH9A1;ACADSB;IVD;ALDH6A1;PCCA;BCKDHA;HADHB;ALDH1B1;ACAT1;PCCB
prerank, Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665                                                                         , -0.3109946827574307 , -1.2430920336822924 , 0.18072289156626506 , 0.7684972003109166,       1.0 , 25/39  , 44.41%, EPHB3;EFNB1;YES1;NCSTN;EPHB4;MMP9;CLTC;PSENEN;ADAM10;APH1B;SRC;EPHB6;VAV3;EPHA7;AP2S1;EPHA1;CLTA;EFNA3;AP2M1;EFNA4;APH1A;LYN;CLTB;FYN;EPHB2
prerank, Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837                                                                                , -0.2823457861525351 , -1.242630301551211  , 0.2                 , 0.7674320898433019,       1.0 , 37/76  , 35.04%, PSMD6;PDPK1;UBC;TAB3;PSMD7;PSMD9;RASGRP2;PSMC3;PSME4;PSMB2;CUL1;PSME2;UBE2N;BCL10;MAP3K7;UBB;RPS27A;PSMD8;PSME3;PSMB6;UBE2D1;PSMA1;TAB1;UBE2D2;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;IKBKG;PSMD5
prerank, Reactome_2022__S Phase R-HSA-69242                                                                                                          , -0.2536510538672803 , -1.2425659707302463 , 0.0967741935483871  , 0.7645861664076427,       1.0 , 77/158 , 37.71%, PSMD6;UBC;SLC19A1;MCM5;LIN9;PSMD7;CCNA1;RPA3;PSMD9;UBE2C;PRIM2;ORC3;PSMC3;PSME4;PSMB2;CUL1;PDS5B;CDC26;PSME2;RFC5;ESCO2;SMC1A;SLC25A15;CDC6;POLR1B;RB1;UBE2E1;CCNH;CDT1;FEN1;UBB;RPS27A;AKT1;MNAT1;CDKN1A;PSMD8;PSME3;CCNA2;PTK6;POLD4;PSMB6;UBE2D1;WAPL;RBBP4;PMEPA1;PSMA1;PSMB4;PSMF1;LIN54;GINS1;PSME1;POLE3;PSMA3;POLD2;CKS1B;MCM6;RBL2;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;AKT2;PSMD10;ANAPC4;GMNN;CDC45;PSMD5;TFDP2;POLE4;UBE2S;POLE;ESCO1;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957                                                                                       , -0.2786143493243752 , -1.241924225559129  , 0.14634146341463414 , 0.7649117164909724,       1.0 , 38/69  , 42.86%, ITGB3;ARRB1;AKAP9;MAPK1;DUSP6;YWHAB;PHB1;ZC3HAV1;CAMK2G;MARK3;TRIM24;ITGA2B;IQGAP1;DUSP7;MAP3K11;DUSP16;FXR1;RAP1A;CNKSR2;RNASE3;KSR1;SPRED1;SHOC2;TENT4A;QKI;SRC;DUSP8;VCL;MAP2K2;NF1;CALM1;PPP1CB;MPRIP;CAMK2A;MAP2K1;AGK;RAP1B;PAPSS1
prerank, Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695                                                            , -0.4155077980066436 , -1.2408573499206395 , 0.18309859154929578 , 0.7663495806682089,       1.0 , 11/18  , 31.11%, HEY1;ACTA2;SMAD3;GATD3;MAML2;KAT2B;RBPJ;MAMLD1;CREBBP;KAT2A;MAML1
prerank, Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902                                                                    , -0.2838313543030839 , -1.240521981925778  , 0.2077922077922078  , 0.7647739309117614,       1.0 , 29/63  , 33.55%, PSMD6;SMURF1;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;CUL1;PSME2;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;FBXW7;PSMB1;PSMC4;NR3C1;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Signaling By WNT R-HSA-195721                                                                                                , -0.24219560802962511, -1.2396060577152042 , 0.10752688172043011 , 0.7658736802710369,       1.0 , 60/240 , 20.08%, SOX13;VPS26A;KMT2D;PSMD6;LRP6;SMURF1;PLCB2;H2AX;TLE5;UBC;H2AC19;PPP2R5E;PSMD7;WNT10A;PLCB1;USP8;CUL3;PSMD9;BCL9L;FZD6;TLE2;USP34;CSNK2A2;PSMC3;DACT1;PSME4;TNRC6C;PSMB2;CUL1;PRKCA;PSME2;AGO3;LRP5;LEF1;H2AC7;GNB5;PPP2R5B;LEO1;GNGT2;H2BC11;RUNX3;PFN1;CCDC88C;MAP3K7;ZRANB1;GNG5;LGR6;H3-3B;XPO1;ASH2L;AGO1;CDC73;SMURF2;GNG11;CLTC;UBB;RPS27A;AKT1;GNG3;NCOA3
prerank, KEGG_2021_Human__Glyoxylate and dicarboxylate metabolism                                                                                    , -0.3364948407343662 , -1.2373010266401678 , 0.24324324324324326 , 0.7727622353607392,       1.0 , 9/28   , 16.34%, MMUT;GLYCTK;AGXT;ACSS1;PCCA;CAT;ACSS2;ACAT1;PCCB
prerank, Reactome_2022__G1/S Transition R-HSA-69206                                                                                                  , -0.26150467228984103, -1.2356227209743318 , 0.13043478260869565 , 0.7756135350567522,       1.0 , 59/128 , 35.85%, PSMD6;UBC;MCM5;LIN9;PSMD7;CCNA1;RPA3;PSMD9;PRIM2;ORC3;PSMC3;PSMB2;CUL1;PSME2;TK1;DHFR;SLC25A15;CDC6;POLR1B;RB1;E2F6;CCNH;CDT1;UBB;RPS27A;RRM2;AKT1;MNAT1;CDKN1A;PSMD8;PSME3;CCNA2;PTK6;PSMB6;RBBP4;PSMA1;PSMB4;PPP2CA;PSMF1;LIN54;PSME1;POLE3;PSMA3;CKS1B;MCM6;RBL2;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;AKT2;PSMD10;GMNN;CDC45;PSMD5;TFDP2;POLE4
prerank, Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562                                                                         , -0.35566615892757025, -1.2343180187271352 , 0.19230769230769232 , 0.777592700287158 ,       1.0 , 7/22   , 19.29%, CD9;SNAP25;EEF2;ANTXR2;MAP2K7;VAMP1;SV2A
prerank, "Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366"                                     , -0.2828633411307262 , -1.2342585720592556 , 0.2073170731707317  , 0.7749549512086937,       1.0 , 15/48  , 20.80%, SLC44A4;RHBG;SLC6A13;SLC39A1;SLC39A6;SLC39A8;BSG;SLC41A1;SLC13A5;SLC22A15;SLC30A7;SLC39A3;EMB;SLC6A12;SLC11A2
prerank, Reactome_2022__Antimicrobial Peptides R-HSA-6803157                                                                                         , 0.23653637415791426 , 1.2339790264537125  , 0.1875              , 1.0               ,       1.0 , 7/35   , 8.98% , CHAMP1;EPPIN;GNLY;PGLYRP1;ATOX1;RNASE6;TLR1
prerank, Reactome_2022__MET Promotes Cell Motility R-HSA-8875878                                                                                     , 0.2890212722115683  , 1.232592709153598   , 0.21428571428571427 , 1.0               ,       1.0 , 3/22   , 2.00% , ITGA3;CRKL;ITGB1
prerank, Reactome_2022__PTEN Regulation R-HSA-6807070                                                                                                , -0.26356205334699745, -1.2322695372987875 , 0.13043478260869565 , 0.7799385661334157,       1.0 , 55/130 , 33.66%, PML;GATAD2A;PSMD6;HDAC3;TP53;UBC;PSMD7;CHD4;MAPK1;PSMD9;CSNK2A2;PSMC3;PSME4;TNRC6C;PSMB2;RRAGD;PSME2;AGO3;ATN1;RBBP7;EGR1;USP7;AGO1;UBB;RPS27A;AKT1;PPARG;RING1;PSMD8;PSME3;NEDD4;PSMB6;CBX4;RRAGB;RBBP4;MOV10;PSMA1;PSMB4;PSMF1;KDM1A;PSME1;AGO2;PSMA3;RNF2;CBX8;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;AKT2;COMMD3-BMI1;PSMD10;SCMH1
prerank, Reactome_2022__Nucleotide Catabolism R-HSA-8956319                                                                                          , -0.3452733528761951 , -1.2319849517716963 , 0.2191780821917808  , 0.7780329162447165,       1.0 , 9/27   , 22.21%, ENTPD7;ENTPD5;ENTPD2;GDA;NUDT16;NT5C3A;ADPRM;DPYD;ITPA
prerank, Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494                                                                         , -0.2608431350202721 , -1.231607763536409  , 0.18681318681318682 , 0.7765804243162028,       1.0 , 56/125 , 35.04%, PSMD6;SMURF1;PLCB2;UBC;PSMD7;PLCB1;PSMD9;FZD6;PSMC3;PSME4;TNRC6C;PSMB2;PRKCA;PSME2;AGO3;LEF1;GNB5;GNGT2;PFN1;MAP3K7;GNG5;AGO1;SMURF2;GNG11;CLTC;UBB;RPS27A;GNG3;NCOA3;PSMD8;PSME3;PSMB6;DAAM1;MOV10;NLK;PSMA1;PSMB4;DVL3;PRKG1;PSMF1;PSME1;AGO2;PSMA3;SCRIB;PSMB1;TCF7L1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;GNB2;PSMD10;PLCB3;PDE6A;PSMD5
prerank, Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384                                                                   , -0.3829222826331131 , -1.2313938730653802 , 0.1917808219178082  , 0.7745418150924429,       1.0 , 6/17   , 19.10%, UBC;SH3GL1;STAM2;GRB2;UBB;RPS27A
prerank, Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206                                                                     , -0.2625406148961454 , -1.2312624566738712 , 0.18681318681318682 , 0.7724387588459445,       1.0 , 26/102 , 20.19%, MED27;MED18;CDK19;HDAC3;ABCB4;ACSL1;MED9;LIN9;MED12;AGXT;MED23;CPT2;CLOCK;NR1D1;CARM1;G0S2;NCOR2;ARHGAP9;MED13;MED21;ACOX1;FHL2;DAND5;ABCA1;NCOA3;PPARG
prerank, Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178                        , -0.28807073716285386, -1.2293640913227426 , 0.2                 , 0.7769067842575718,       1.0 , 37/71  , 37.71%, PSMD6;UBC;PSMD7;PSMD9;CDC20;UBE2C;PSMC3;PSME4;PSMB2;CDC26;PSME2;RB1;UBE2E1;UBB;RPS27A;PSMD8;PSME3;PSMB6;UBE2D1;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;PSMD5;UBE2S;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795                                                       , -0.30644496524332626, -1.2290665790287358 , 0.24324324324324326 , 0.7751645287943968,       1.0 , 10/30  , 19.10%, UBC;MAPK1;USP9X;SMAD3;NCOR2;TRIM33;SMAD7;SMURF2;UBB;RPS27A
prerank, KEGG_2021_Human__p53 signaling pathway                                                                                                      , -0.2840235888867828 , -1.228554386006538  , 0.13636363636363635 , 0.7742189855899713,       1.0 , 30/68  , 35.29%, BAX;ADGRB1;CASP3;SIAH1;CASP8;TP53;GADD45G;MDM4;CHEK1;PMAIP1;SESN3;SESN1;DDB2;RRM2;CDKN1A;CHEK2;GADD45A;STEAP3;BID;RRM2B;AIFM2;ZMAT3;ATR;SFN;FAS;PERP;SHISA5;CYCS;TSC2;EI24
prerank, Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556                                                                          , -0.2786036084349197 , -1.227614562315237  , 0.18181818181818182 , 0.7751555021677076,       1.0 , 39/91  , 33.55%, ABCA6;ABCC9;PSMD6;ABCB4;UBC;RNF185;PSMD7;EIF2S1;ABCF1;PSMD9;PSMC3;PSME4;PSMB2;PSME2;ABCC4;UBB;RPS27A;PSMD8;PSME3;ABCB1;VCP;KCNJ11;ABCA2;PSMB6;PSMA1;ABCC3;PSMB4;PSMF1;ABCB5;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;ERLEC1;PSMD10
prerank, Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171                                                                         , -0.3372700501422627 , -1.2275106927609565 , 0.22857142857142856 , 0.7728542357249787,       1.0 , 4/30   , 4.95% , ITGB3;ITGB5;DAG1;ITGAV
prerank, Reactome_2022__Interferon Signaling R-HSA-913531                                                                                            , -0.2422396623363995 , -1.2274155330826377 , 0.13829787234042554 , 0.7703366065910883,       1.0 , 38/174 , 19.10%, PML;NUP85;TRIM68;USP18;TRIM46;MX1;NUP88;PTPN11;UBC;GBP2;TRIM35;CD44;SOCS3;TRIM22;TYK2;HLA-G;IFITM2;KPNA3;IFITM3;OAS2;KPNA1;IFIT3;NUP107;TRIM8;PTAFR;UBE2N;CAMK2G;NUP98;UBE2E1;EGR1;IFI35;EIF4A3;PDE12;NUP153;EIF4E3;SMAD7;UBB;RPS27A
prerank, Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181                                                                         , -0.26156431285556897, -1.2273927703103504 , 0.1518987341772152  , 0.767759527487578 ,       1.0 , 26/99  , 19.10%, TNIP2;ECSIT;USP18;TMED7-TICAM2;IRAK1;CASP8;TP53;UBC;TAB3;IKBIP;MAP3K1;MAPK1;TICAM1;DUSP6;CUL1;RPS6KA3;LY96;MAPK8;UBE2N;MAP3K8;TANK;MAP3K7;MAP2K7;MEF2C;UBB;RPS27A
prerank, KEGG_2021_Human__AMPK signaling pathway                                                                                                     , -0.25716013247021535, -1.2258335078189104 , 0.14942528735632185 , 0.7710936342861979,       1.0 , 32/102 , 24.39%, CREB3L4;PPP2R3A;PDPK1;PPP2R5E;CCNA1;PRKAG2;PIK3R3;IRS1;EEF2;PCK2;GYS1;PIK3R1;PPP2R5B;RAB2A;RPS6KB1;SCD;CAB39;RAB11B;SIRT1;CREB3L2;PFKP;LEPR;MAP3K7;SCD5;AKT1;PPARG;PRKAG1;TBC1D1;PPP2R2A;CCNA2;PIK3CA;FOXO1
prerank, Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681                                                                      , -0.24742941559568357, -1.2249873370792335 , 0.10112359550561797 , 0.7717560038373957,       1.0 , 39/159 , 19.46%, SOX13;KMT2D;PSMD6;LRP6;H2AX;UBC;H2AC19;PPP2R5E;PSMD7;USP8;CUL3;PSMD9;BCL9L;FZD6;TLE2;USP34;CSNK2A2;PSMC3;DACT1;PSME4;PSMB2;PSME2;LRP5;LEF1;H2AC7;PPP2R5B;LEO1;H2BC11;RUNX3;CCDC88C;LGR6;H3-3B;XPO1;ASH2L;CDC73;SMURF2;UBB;RPS27A;AKT1
prerank, Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001                                                                                         , -0.24480652834146188, -1.2245938722927607 , 0.14893617021276595 , 0.7701954643344889,       1.0 , 82/207 , 33.91%, ITGB3;RASGRF2;PSMD6;DUSP2;ARL2;ARRB1;UBC;IL2RG;PPP2R5E;PEA15;PSMD7;MAPK1;CUL3;PSMD9;IRS1;RANBP9;DUSP6;PIK3R1;YWHAB;ZDHHC9;AREG;PSMC3;PSME4;IL3RA;PSMB2;PSME2;DLG1;PHB1;PPP2R5B;CHURC1-FNTB;CAMK2G;WDR83;ARHGAP9;RASA2;ERBB3;TGFA;GRB2;MARK3;UBB;RPS27A;ITGA2B;IQGAP1;PSMD8;PSME3;DUSP7;FGFR2;MAP3K11;ICMT;DUSP16;PSMB6;PIK3CA;RAP1A;CNKSR2;RNASE3;ANGPT1;KSR1;FNTA;PSMA1;SPTBN1;SPRED1;PSMB4;SHOC2;PPP2CA;GOLGA7;PSMF1;KBTBD7;PSME1;PSMA3;SRC;CSF2RA;PSMB1;PSMC4;SEM1;PSMA6;DUSP8;PSMD11;HBEGF;PSMA2;VCL;PSMD10;DUSP5;PDGFB
prerank, Reactome_2022__Platelet Homeostasis R-HSA-418346                                                                                            , -0.27702018647130194, -1.22393170853782   , 0.14942528735632185 , 0.7701322115384615,       1.0 , 18/64  , 22.96%, KCNMA1;P2RX1;PTPN11;TRPC6;PPP2R5E;PDE1B;PDE2A;ATP2A3;PDE9A;GNB5;PPP2R5B;GNGT2;GNG5;FGR;GNG11;GNG3;KCNMB1;PTGIR
prerank, KEGG_2021_Human__Glycolysis / Gluconeogenesis                                                                                               , -0.3014286865010307 , -1.2238375265672656 , 0.21052631578947367 , 0.7678665969454819,       1.0 , 12/44  , 15.52%, GAPDH;HK3;ALDH9A1;ADH5;MINPP1;ACSS1;PCK2;PDHB;PGAM1;ACSS2;ALDH1B1;PFKP
prerank, KEGG_2021_Human__Tryptophan metabolism                                                                                                      , -0.3232471815233483 , -1.2231281720439244 , 0.1791044776119403  , 0.7679632596785596,       1.0 , 12/31  , 21.33%, IDO1;ALDH9A1;KYNU;TPH2;TPH1;CAT;INMT;ALDH1B1;ACAT1;CYP1B1;GCDH;ECHS1
prerank, Reactome_2022__Cardiac Conduction R-HSA-5576891                                                                                             , -0.2908083094092113 , -1.2222021326042622 , 0.14634146341463414 , 0.7692661821685349,       1.0 , 22/71  , 24.62%, ABCC9;CACNG8;RANGRF;FGF12;CACNG6;ASPH;KCNE5;AKAP9;KCNK7;ATP2A3;PRKCA;KCNE3;CAMK2G;KCND3;SCN1B;ATP1B1;KAT2B;ATP1A3;FGF11;KCNJ11;SCN11A;KCNH2
prerank, Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764                                                                                    , -0.26054403115244235, -1.2214324735685778 , 0.19540229885057472 , 0.7697332167561429,       1.0 , 42/95  , 35.04%, PSMD6;CASP8;PDPK1;UBC;TAB3;PSMD7;UBA3;PSMD9;PSMC3;PSME4;PSMB2;CUL1;PSME2;UBE2N;BCL10;MAP3K7;UBB;RPS27A;PSMD8;PSME3;PSMB6;UBE2D1;PSMA1;TAB1;NFATC2;UBE2D2;PSMB4;SYK;RELB;PSMF1;PSME1;PSMA3;SRC;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;IKBKG;PSMD5
prerank, Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084                                                                            , -0.31390771581703675, -1.2212532946899985 , 0.1891891891891892  , 0.7674626584459946,       1.0 , 9/26   , 21.50%, GNS;UBC;GYS1;GYG1;UBB;NAGLU;RPS27A;SGSH;ARSB
prerank, Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194                                                                              , -0.2698091798310337 , -1.2207509869293567 , 0.20238095238095238 , 0.7670741030780904,       1.0 , 32/75  , 33.55%, SRXN1;SQSTM1;PSMD6;TKT;UBC;PSMD7;PSMD9;PSMC3;PSMB2;CUL1;PSME2;UBB;RPS27A;GSR;PSMD8;PSME3;PSMB6;CREBBP;PSMA1;PSMB4;HMOX1;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;MAFG;PSMD10
prerank, Reactome_2022__Signaling By NOTCH R-HSA-157118                                                                                              , -0.25268894168343525, -1.220678951718274  , 0.15555555555555556 , 0.764679312450185 ,       1.0 , 75/190 , 32.85%, DTX4;JAG1;PSMD6;HDAC3;RFNG;H2AX;ARRB1;NCSTN;TP53;UBC;RAB6A;H2AC19;B4GALT1;PSMD7;PSMD9;ATP2A3;TLE2;HEY1;ITCH;PSMC3;ACTA2;TNRC6C;PSMB2;CUL1;PSME2;AGO3;LFNG;H2AC7;HIF1A;SMAD3;NCOR2;NOTCH3;H2BC11;GZMB;GATD3;MIB1;TACC3;HDAC11;H3-3B;MAML2;NUMB;AGO1;KAT2B;RBPJ;UBB;RPS27A;AKT1;HDAC9;PSENEN;PSMD8;PSME3;ADAM10;PSMB6;APH1B;MOV10;MAMLD1;CREBBP;PSMA1;DTX2;HDAC6;PSMB4;PSMF1;KAT2A;PSME1;H2AC6;AGO2;PSMA3;MAML1;FBXW7;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2
prerank, Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222                                                                   , 0.22893261646592933 , 1.2202831794348445  , 0.13793103448275862 , 1.0               ,       1.0 , 19/57  , 16.24%, RUNX1;CEBPA;H2AZ2;MYC;CEBPE;H2BC3;GATA2;CREB1;DEK;H2AB1;MYB;CBFB;H2BC17;RARA;H2BC5;H2BC9;H2AC20;H2AZ1;STAT3
prerank, Reactome_2022__Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238                                                             , 0.2769176170768704  , 1.2190542938099727  , 0.2                 , 1.0               ,       1.0 , 5/30   , 6.93% , NELFB;NELFA;POLR2I;SSRP1;POLR2F
prerank, Reactome_2022__Signal Transduction By L1 R-HSA-445144                                                                                       , -0.3657488704064856 , -1.217670238896339  , 0.24324324324324326 , 0.7743502153855554,       1.0 , 7/19   , 23.08%, ITGB3;ITGAV;MAPK1;CSNK2A2;ITGA9;ITGA2B;ITGA5
prerank, "Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841"                                          , -0.30446327641465454, -1.217595678295454  , 0.18840579710144928 , 0.7719469958388309,       1.0 , 14/34  , 26.88%, FN3K;DNAJC24;FN3KRP;EEF2;DHPS;BGLAP;GGCX;DPH2;DPH3;ARSB;ICMT;TPST2;FAM110A;PROS1
prerank, Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996                                                                                          , -0.24328271381641856, -1.217088719351599  , 0.1595744680851064  , 0.7708856990411069,       1.0 , 85/213 , 33.91%, ITGB3;RASGRF2;PSMD6;DUSP2;ARL2;PTPN11;ARRB1;UBC;IL2RG;PPP2R5E;PEA15;PSMD7;TYK2;MAPK1;CUL3;PSMD9;IRS1;RANBP9;DUSP6;PIK3R1;YWHAB;ZDHHC9;AREG;PSMC3;PSME4;IL3RA;PSMB2;PSME2;DLG1;PHB1;PPP2R5B;CHURC1-FNTB;CAMK2G;WDR83;ARHGAP9;RASA2;ERBB3;TGFA;GRB2;MARK3;UBB;RPS27A;ITGA2B;IQGAP1;PSMD8;PSME3;DUSP7;FGFR2;MAP3K11;ICMT;DUSP16;PSMB6;PIK3CA;RAP1A;CNKSR2;RNASE3;ANGPT1;KSR1;FNTA;PSMA1;SPTBN1;SPRED1;PSMB4;SHOC2;PPP2CA;GOLGA7;PSMF1;KBTBD7;PSME1;IL6R;PSMA3;SRC;CSF2RA;PSMB1;PSMC4;SEM1;PSMA6;DUSP8;PSMD11;HBEGF;PSMA2;VCL;PSMD10;DUSP5;PDGFB
prerank, Reactome_2022__Activation Of GABAB Receptors R-HSA-991365                                                                                   , -0.34624154419174796, -1.2169050296288684 , 0.26582278481012656 , 0.7688406331276839,       1.0 , 10/23  , 28.56%, ADCY7;GNAI3;GNB5;GNGT2;GNG5;GNG11;GNG3;GNAI1;ADCY9;KCNJ15
prerank, Reactome_2022__mRNA 3-End Processing R-HSA-72187                                                                                            , -0.28905338678615344, -1.216104939354309  , 0.16455696202531644 , 0.7690770932966282,       1.0 , 26/57  , 37.45%, MAGOH;FYTTD1;CSTF2;SYMPK;THOC1;SRSF3;CPSF1;CPSF4;THOC7;EIF4A3;SRSF1;CDC40;NCBP1;SRRM1;SRSF5;CPSF7;MAGOHB;CPSF3;UPF3B;CSTF2T;DDX39A;THOC2;FIP1L1;WDR33;SRSF9;SRSF7
prerank, Reactome_2022__Signaling By ALK R-HSA-201556                                                                                                , -0.33612287246154415, -1.2155762193947257 , 0.25                , 0.7682912289968559,       1.0 , 5/22   , 11.97%, HDAC3;IL2RG;IRS1;PIK3R1;HIF1A
prerank, Reactome_2022__Translation Of Structural Proteins R-HSA-9683701                                                                             , -0.32862520223592173, -1.2150241916480913 , 0.18309859154929578 , 0.7675469373752496,       1.0 , 8/28   , 19.10%, PARP9;ST6GALNAC4;UBC;GALNT1;PARP14;PARP6;UBB;RPS27A
prerank, Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756                                                               , -0.26745016947746897, -1.214500402317835  , 0.1411764705882353  , 0.7671697199454911,       1.0 , 26/82  , 23.77%, RAD50;TP53;UBC;DYRK2;MDM4;CCNA1;PRKAG2;CHEK1;RPA3;CSNK2A2;RAD9B;TAF11;RFC5;BRCA1;POLR1B;TAF15;UBB;RPS27A;TAF1;HUS1;PRKAG1;TAF5;CHEK2;CCNA2;MAPK11;TAF12
prerank, Reactome_2022__Other Semaphorin Interactions R-HSA-416700                                                                                   , 0.3224713429056765  , 1.2144445199327274  , 0.23529411764705882 , 1.0               ,       1.0 , 5/15   , 14.41%, ITGB1;PLXNA1;PLXNA2;PTPRC;SEMA7A
prerank, Reactome_2022__Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710                                                                 , -0.3886933217268095 , -1.2143726760806484 , 0.234375            , 0.7651347243427052,       1.0 , 7/17   , 27.63%, PIGV;PIGQ;PIGP;PIGM;PIGZ;PIGC;PIGF
prerank, Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713                                                                                    , -0.3505631323396829 , -1.2143131065913084 , 0.25333333333333335 , 0.7628253702990059,       1.0 , 8/22   , 23.85%, UBC;PIK3R1;AREG;TGFA;GRB2;UBB;RPS27A;PIK3CA
prerank, KEGG_2021_Human__Phosphatidylinositol signaling system                                                                                      , 0.20451423255456513 , 1.214110054507808   , 0.0                 , 1.0               ,       1.0 , 17/83  , 9.89% , PLCB4;MTMR2;INPP1;PLCE1;INPPL1;PIP5K1C;MTMR14;IP6K1;PI4KA;DGKH;DGKE;ITPKC;DGKQ;CDS2;INPP5D;ITPR3;PIP4P1
prerank, Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215                                                                            , 0.3067047523919422  , 1.2134712469780884  , 0.21739130434782608 , 1.0               ,       1.0 , 5/21   , 11.05%, PHB2;SLC8B1;PMPCB;PARL;SPG7
prerank, KEGG_2021_Human__Salivary secretion                                                                                                         , -0.29183557766782453, -1.2131155508978926 , 0.20238095238095238 , 0.765658547214781 ,       1.0 , 14/53  , 20.59%, KCNMA1;ADCY7;PLCB2;CD38;CALM2;PLCB1;CHRM3;PRKCA;LYZ;ATP1B1;PRKACB;CALM3;LPO;ATP1A3
prerank, Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573                                                                               , -0.2896610174705743 , -1.2130293444431328 , 0.1875              , 0.7633983569745755,       1.0 , 16/53  , 22.19%, PARP9;ST6GALNAC4;UBC;ZDHHC3;ZDHHC11;ZDHHC9;MGAT5;GALNT1;PARP14;PARP6;ZDHHC2;UBB;RPS27A;EDEM2;FUT8;RPN1
prerank, Reactome_2022__Integration Of Energy Metabolism R-HSA-163685                                                                                , -0.28489424762101334, -1.2118562771817774 , 0.16666666666666666 , 0.7649287821415991,       1.0 , 27/78  , 25.05%, ADCY7;TKT;PLCB2;SNAP25;CACNB3;GNA15;PLCB1;PRKAG2;CHRM3;PRKCA;GNB5;GNGT2;STXBP1;PRKAR2A;GNG5;PRKACB;GNG11;GNG3;ACSL4;IQGAP1;CACNA1E;KCNJ11;RAPGEF3;RAP1A;GNAI1;ADCY9;ACLY
prerank, KEGG_2021_Human__Glycosylphosphatidylinositol (GPI)-anchor biosynthesis                                                                     , -0.3413558972605517 , -1.2104443229769128 , 0.25                , 0.7680469679533442,       1.0 , 10/25  , 27.63%, PIGV;PIGQ;PGAP1;PIGP;PIGS;PIGM;PIGT;PIGZ;PIGC;PIGF
prerank, Reactome_2022__RHOU GTPase Cycle R-HSA-9013420                                                                                              , -0.3237350985980493 , -1.2096538892886355 , 0.23684210526315788 , 0.7681367682654173,       1.0 , 17/38  , 27.96%, TXNL1;DST;USP9X;PIK3R1;RHOU;DLG5;VANGL1;PEAK1;STAM2;CDC42;GRB2;CLTC;IQGAP1;ARHGAP30;SRGAP2;SPTBN1;ARHGAP31
prerank, Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321                             , -0.3815849993114218 , -1.2092087207233155 , 0.22727272727272727 , 0.7673793795903339,       1.0 , 11/18  , 38.01%, IRAK1;TAB3;MAPK8;UBE2N;MAP3K7;MAP2K7;TAB1;RIPK2;IKBKG;MAPK10;TRAF6
prerank, Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947                                                            , -0.2952522411417166 , -1.2073256974072404 , 0.21951219512195122 , 0.7716198148058722,       1.0 , 21/45  , 31.46%, HDAC3;UBC;TLE2;HEY1;CUL1;HIF1A;NCOR2;GATD3;HDAC11;MAML2;KAT2B;RBPJ;UBB;RPS27A;HDAC9;MAMLD1;CREBBP;HDAC6;KAT2A;MAML1;FBXW7
prerank, Reactome_2022__Glutathione Conjugation R-HSA-156590                                                                                         , -0.34204306749033675, -1.2072676491158627 , 0.189873417721519   , 0.7693840614590753,       1.0 , 12/29  , 28.32%, OPLAH;GGT1;GSTP1;CNDP2;GSTM1;MGST1;GGT5;GSTO1;GGT7;GSTZ1;MGST2;GSTO2
prerank, Reactome_2022__tRNA Processing R-HSA-72306                                                                                                  , -0.24242328654216336, -1.207015312348023  , 0.18181818181818182 , 0.767826426473975 ,       1.0 , 24/101 , 19.97%, NUP85;QTRT1;RPP25;METTL1;FTSJ1;NUP88;CSTF2;TRMT61B;ADAT3;CPSF1;CTU2;TRMT9B;NUP107;RAN;CPSF4;FAM98B;LAGE3;RPP14;NUP98;NUP153;ADAT2;NSUN6;URM1;TSEN15
prerank, KEGG_2021_Human__Vasopressin-regulated water reabsorption                                                                                   , -0.31476225038803735, -1.2064067703191055 , 0.2222222222222222  , 0.7677413742801936,       1.0 , 13/34  , 25.20%, CREB3L4;STX4;DYNC1LI1;AQP3;RAB11B;CREB3L2;RAB11A;DYNC2H1;DYNC1H1;PRKACB;DYNC1LI2;ADCY9;RAB5A
prerank, Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041                                                                        , -0.324833326260813  , -1.205832149738183  , 0.23684210526315788 , 0.7675180093634386,       1.0 , 9/23   , 27.30%, TMED7-TICAM2;UBC;TICAM1;LY96;UBE2N;UBB;RPS27A;UBE2D1;UBE2D2
prerank, Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880                                                                               , -0.2454871202683872 , -1.2042964278096326 , 0.11702127659574468 , 0.7711024379811804,       1.0 , 74/174 , 35.17%, TADA3;PSMD6;USP18;ARRB1;TP53;UBC;RNF123;H2AC19;PSMD7;UFD1;USP20;MDM4;CCNA1;USP8;H2AC21;USP9X;PSMD9;CDC20;USP34;AREG;PSMC3;PSME4;PSMB2;PSME2;USP44;H2AC7;ADRM1;HIF1A;SMAD3;MUL1;H2BC11;USP49;TANK;STAM2;MAP3K7;USP7;USP22;SUDS3;DDB2;SMAD7;SMURF2;UBB;RPS27A;MAT2B;PSMD8;PSME3;CCNA2;PSMB6;PSMA1;TAB1;USP25;PSMB4;USP37;PSMF1;KAT2A;PSME1;H2AC6;ATXN7;PSMA3;WDR20;TADA2B;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;FKBP8;PSMA2;ADRB2;PSMD10;IKBKG;CLSPN;PSMD5;FOXO4
prerank, Reactome_2022__mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039                                                                            , -0.3941996817222212 , -1.20177780213228   , 0.21428571428571427 , 0.7783205345637839,       1.0 , 8/15   , 30.43%, DCP1B;EDC3;DDX6;LSM4;LSM6;LSM2;LSM7;DCP1A
prerank, Reactome_2022__RHOD GTPase Cycle R-HSA-9013405                                                                                              , -0.2936698678454648 , -1.2016852286127255 , 0.24691358024691357 , 0.7762091156803114,       1.0 , 12/47  , 18.33%, ARHGAP35;AKAP12;DIAPH1;ARHGAP5;PIK3R1;VAMP3;HINT2;CAPZB;VANGL1;TMPO;CPNE8;LMAN1
prerank, Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032                                                                           , -0.35745653682070155, -1.2012497425821054 , 0.2375              , 0.7753792238635936,       1.0 , 8/21   , 20.06%, TRIM13;UBC;RNF185;AMFR;MARCHF6;UBB;RPS27A;EDEM2
prerank, KEGG_2021_Human__Ubiquitin mediated proteolysis                                                                                             , -0.2340982987422151 , -1.1980714887675032 , 0.24444444444444444 , 0.7853862709533911,       1.0 , 40/133 , 23.81%, PML;UBE3A;UBE2E2;SMURF1;CBLB;UBE4A;SIAH1;UBC;MAP3K1;CUL5;SOCS3;UBA3;CUL3;CDC20;UBE2C;ITCH;MGRN1;UBE2B;CUL1;CDC26;UBE2L3;BRCA1;UBOX5;UBE2J1;UBE2N;UBE2G1;UBE2E1;UBE2J2;DDB2;SMURF2;UBB;RPS27A;CUL7;ANAPC13;UBE2Z;UBE2E3;NEDD4;SAE1;UBA1;UBE2D1
prerank, Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021                                                                  , -0.24745785150876132, -1.197359033372949  , 0.17777777777777778 , 0.785929459440494 ,       1.0 , 51/145 , 30.10%, COPZ1;CSNK1D;SEC24D;F5;SEC24C;COG2;GOLGA2;STX17;LMAN2L;B4GALT1;NAPSA;ACTR1A;TFG;B4GALT3;ACTR10;B4GALT6;AREG;LMAN2;CAPZA2;DYNC1LI1;MCFD2;MAN1A1;FUCA1;MGAT5;DCTN3;CAPZB;TMEM115;KDELR2;MOGAT3;TRAPPC2;TGFA;DYNC1H1;KDELR1;LMAN1;COPE;FUT8;TMED9;MAN2A2;DYNC1LI2;RAB1B;SEC22A;YKT6;SPTBN1;TRAPPC5;PPP6R1;ST8SIA6;SERPINA1;SEC22B;COG8;COPB1;B4GALT4
prerank, Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572                                                          , -0.3608271457170934 , -1.197259498839983  , 0.2625              , 0.7838546038763594,       1.0 , 11/19  , 37.98%, MYH9;ROCK2;ARHGEF11;RHOC;LIMK1;RHOB;MYL12B;LIMK2;ARHGEF12;MYL9;ROCK1
prerank, Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446                                                                             , -0.3223721798376525 , -1.1968237497634975 , 0.2125              , 0.7830112775225946,       1.0 , 15/37  , 30.70%, CETP;HDAC3;PLTP;TNRC6C;AGO3;NCOR2;SCD;AGO1;NRIP1;ABCA1;MOV10;KDM1A;APOE;AGO2;NCOA1
prerank, Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691                                                                                , -0.35834402651287767, -1.1960650617844013 , 0.25                , 0.7835567738362285,       1.0 , 3/17   , 7.04% , PTPN11;SOCS3;TYK2
prerank, Reactome_2022__Processing Of SMDT1 R-HSA-8949664                                                                                            , 0.3053013932104014  , 1.1952910224702837  , 0.24                , 1.0               ,       1.0 , 5/16   , 15.90%, PHB2;PMPCB;PARL;SPG7;MCUB
prerank, KEGG_2021_Human__Endocytosis                                                                                                                , -0.23637417368465624, -1.1951474201668117 , 0.1827956989247312  , 0.7842671139203075,       1.0 , 87/234 , 32.61%, PML;VPS26A;AGAP3;AGAP5;ARF1;SNX5;CHMP4B;SNX2;SMURF1;IGF2R;CBLB;ARRB1;VPS4B;PARD6B;LDLRAP1;IL2RG;CXCR4;USP8;SNX12;HLA-G;SH3GL1;VPS36;ARFGEF2;CYTH2;WASHC3;EEA1;ITCH;CYTH1;TFRC;CAPZA2;PSD3;IQSEC2;WIPF2;CHMP6;SMAD3;CAPZB;RAB11B;SMAP1;STAM2;RAB11A;VPS37A;PLD2;ARPC5;IQSEC1;HSPA1A;PIP5KL1;ARF6;CDC42;SMURF2;EPS15L1;CLTC;KIF5A;RAB11FIP4;IST1;VPS45;CXCR2;SH3GLB2;FGFR2;NEDD4;EHD3;ARPC3;HSPA2;ASAP3;VPS4A;RAB5A;ARPC2;RAB8A;DNM2;SNX1;RUFY2;ARAP2;WIPF1;AGAP4;GRK6;CHMP2A;ACTR3;ARPC5L;RAB5B;SNX6;RNF41;SRC;MVB12A;EHD2;ASAP2;ZFYVE16;CXCR1;ARFGAP1
prerank, Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117                                                                    , -0.37382964125941376, -1.1949674014181622 , 0.21621621621621623 , 0.7827595290188853,       1.0 , 9/17   , 33.93%, FGFR1OP2;PIK3R1;GRB2;TRIM24;GAB2;PIK3CA;ZMYM2;MYO18A;LRRFIP1
prerank, Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795                                                                              , -0.35067202589815927, -1.194741401437262  , 0.23684210526315788 , 0.7810271424176188,       1.0 , 9/24   , 19.46%, UBC;CUL5;USP8;PTPN18;ERBB3;UBB;RPS27A;ERBIN;AKT1
prerank, Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005                                                                                , -0.28106482456219367, -1.1939883185717532 , 0.23809523809523808 , 0.7813386987492904,       1.0 , 12/63  , 11.29%, CSNK1D;SEC24D;F5;SEC24C;GOLGA2;STX17;LMAN2L;NAPSA;TFG;AREG;LMAN2;MCFD2
prerank, KEGG_2021_Human__Inositol phosphate metabolism                                                                                              , 0.22092535279505188 , 1.1939279252584696  , 0.13333333333333333 , 1.0               ,       1.0 , 9/66   , 4.25% , PLCB4;PIK3CG;MTMR2;INPP1;PLCE1;INPPL1;PIP5K1C;MTMR14;PI4KA
prerank, KEGG_2021_Human__Neutrophil extracellular trap formation                                                                                    , -0.2450136821799137 , -1.1939244473259412 , 0.20652173913043478 , 0.7792888879253688,       1.0 , 29/169 , 12.08%, ITGB3;CR1L;HDAC3;PLCB2;H2AX;H3C2;H2AC19;H2AC17;AZU1;CLCN5;PADI4;H3C15;H4C1;PLCB1;H2AC21;H3C6;PPIF;MAPK1;PIK3R3;H2AC8;H2AB2;ELANE;ITGAL;PIK3R1;CYBB;H3C10;PRKCA;H2AC7;C5
prerank, Reactome_2022__TNF Signaling R-HSA-75893                                                                                                    , -0.3004686144273417 , -1.1938065483339348 , 0.2839506172839506  , 0.7773509307373097,       1.0 , 12/43  , 19.31%, SMPD3;CASP8;UBC;SPPL2A;TAB3;NSMAF;TANK;TNFRSF1A;MAP3K7;UBB;RPS27A;TNFAIP3
prerank, Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757                                                                                 , -0.31020221784911844, -1.1930272053003326 , 0.2692307692307692  , 0.7780671611322808,       1.0 , 12/35  , 22.88%, PDPK1;TP53;UBC;MDM4;CCNA1;RFFL;USP7;UBB;RPS27A;AKT1;CHEK2;CCNA2
prerank, KEGG_2021_Human__Glycerolipid metabolism                                                                                                    , -0.28774360374727515, -1.192043952645158  , 0.275               , 0.7796023323443746,       1.0 , 14/46  , 17.87%, ALDH9A1;GLYCTK;PLPP5;GPAT3;DGKG;MBOAT1;MBOAT2;ALDH1B1;DGKA;LPIN1;LCLAT1;MOGAT3;LPIN2;LPL
prerank, Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090                                                   , -0.32448858849953743, -1.1915107480216254 , 0.25675675675675674 , 0.7788957100858523,       1.0 , 8/31   , 18.16%, DST;COL6A3;BMP1;LOXL1;MMP9;COL9A1;LOXL2;COL8A1
prerank, KEGG_2021_Human__Regulation of actin cytoskeleton                                                                                           , -0.2359972350090799 , -1.1899199415144102 , 0.17708333333333334 , 0.7825468151534767,       1.0 , 50/162 , 25.99%, ITGB3;FGD3;ARHGAP35;ITGB5;CYFIP2;DIAPH1;MYH9;PIKFYVE;CRK;ITGAV;CXCR4;MAPK1;PIK3R3;CHRM3;ITGAL;PIK3R1;ABI2;ITGAD;ITGA10;MYL5;ITGA9;ROCK2;PFN1;RRAS;ITGA1;ITGAM;PPP1R12C;ARPC5;GNA12;NCKAP1L;PAK6;CDC42;PAK1;PDGFC;PXN;TMSB4Y;CFL2;SSH1;ITGA2B;IQGAP1;LIMK1;FGFR2;ITGA5;WASF1;PIK3CA;ARPC3;LPAR2;ARHGEF1;ARPC2;ITGAE
prerank, Reactome_2022__Fatty Acid Metabolism R-HSA-8978868                                                                                          , -0.23315117558631757, -1.187411805724444  , 0.12631578947368421 , 0.7897006324177992,       1.0 , 48/141 , 28.28%, GGT1;ACSL1;AKR1C3;ACOT8;MMUT;ACOX2;CYP4F3;CYP2C9;CRAT;PRKAG2;CPT2;PCCA;SLC25A17;THEM5;ELOVL6;PTGS1;OLAH;CYP2U1;HADHB;SCD;TECR;ACSM3;PPT1;GGT5;ACOT4;PCCB;ACSL5;ACOT13;SCD5;ELOVL1;ACOX1;CYP1B1;HSD17B4;DECR2;ACSL4;ELOVL3;MID1IP1;ECHS1;SYCP2;ACSBG1;MORC2;ACLY;HTD2;LTA4H;ELOVL5;CBR4;MECR;PTGS2
prerank, Reactome_2022__Dual Incision In TC-NER R-HSA-6782135                                                                                        , -0.2675154839706022 , -1.1873688434777137 , 0.20253164556962025 , 0.7875385423183484,       1.0 , 30/65  , 36.51%, AQR;GTF2H3;UBC;SLC19A1;RPA3;POLK;RFC5;XPA;POLR2G;POLR1B;USP7;POLR2B;CCNH;POLR2D;UBB;RPS27A;MNAT1;POLD4;ERCC1;ERCC6;TCEA1;GTF2H4;POLE3;POLD2;ERCC3;GTF2H1;POLE4;POLR2E;ERCC4;POLE
prerank, KEGG_2021_Human__Proteoglycans in cancer                                                                                                    , -0.24230317377547297, -1.1864486031674835 , 0.11827956989247312 , 0.7887307137956231,       1.0 , 43/151 , 23.85%, ITGB3;TFAP4;ITGB5;PTPN11;CASP3;FASLG;VEGFA;PDPK1;TP53;ITGAV;CTTN;CD44;WNT10A;MAPK1;PIK3R3;FZD6;PIK3R1;PRKCA;HIF1A;PDCD4;RPS6KB1;CAMK2G;ROCK2;MMP9;RRAS;PPP1R12C;ERBB3;CDC42;GRB2;PRKACB;PAK1;HGF;NANOG;PXN;AKT1;RPS6;IQGAP1;CDKN1A;DDX5;ITGA5;MAPK11;DCN;PIK3CA
prerank, Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121                                                                                  , -0.36870299368694326, -1.1862223750635437 , 0.30434782608695654 , 0.7872312219033744,       1.0 , 9/17   , 25.87%, UBC;SLC19A1;RPA3;RFC5;POLR1B;UBB;RPS27A;MAD2L2;REV3L
prerank, Reactome_2022__Heme Signaling R-HSA-9707616                                                                                                 , -0.31072317211150446, -1.1859229115290617 , 0.24691358024691357 , 0.7860953389079828,       1.0 , 12/40  , 18.81%, HDAC3;HBA1;MEF2D;LIN9;CLOCK;NR1D1;CARM1;LY96;SIRT1;XPO1;MEF2C;NRIP1
prerank, KEGG_2021_Human__Renal cell carcinoma                                                                                                       , -0.272507128049168  , -1.1846623283561637 , 0.2289156626506024  , 0.7879242896949463,       1.0 , 29/64  , 34.46%, FH;TGFB3;PTPN11;VEGFA;CRK;MAPK1;PIK3R3;PIK3R1;HIF1A;PAK6;TGFA;CDC42;GRB2;PAK1;HGF;AKT1;EGLN2;CDKN1A;PIK3CA;RAP1A;CREBBP;CUL2;FLCN;EGLN1;ELOC;ETS1;AKT2;PDGFB;PIK3CB
prerank, Reactome_2022__Hemostasis R-HSA-109582                                                                                                      , -0.2240684594308806 , -1.1845342612069274 , 0.08                , 0.7858633376629094,       1.0 , 99/459 , 18.66%, GLG1;ITGB3;KCNMA1;SCCPDH;FCER1G;CD58;PHACTR2;SGPP2;P2RX1;TGFB3;CD9;YES1;PHF21A;HBG2;VTI1B;ENDOD1;NHLRC2;TSPAN7;PTPN11;ARRB1;F5;TRPC6;VEGFA;STX4;PIKFYVE;PDPK1;TP53;CRK;MPL;ITGAV;KIF21A;LOC112694756;PPP2R5E;KIF22;F13A1;PLAT;CD44;GNA15;STXBP2;PDE1B;MAPK1;CEACAM1;DGKG;PIK3R3;SERPINB2;RASGRP2;PRKCH;JMJD1C;PF4V1;ZNF160;GNAI3;PDE2A;SELL;ATP2A3;CEACAM6;ITGAL;CEACAM8;PIK3R1;SPARC;PDE9A;CAPZA2;BSG;KIF23;QSOX1;KIF18A;PRKCA;GNB5;ITGA10;PPP2R5B;GYPC;GNGT2;ORM2;PPBP;AKAP1;MERTK;CAPZB;CAP1;KIF3C;PFN1;DGKA;HBG1;PRKAR2A;ITGA1;ITGAM;CDC37L1;ABCC4;DOCK9;GNA12;GNG5;H3-3B;VPS72;FGR;ATP1B1;CEACAM21;CDC42;GRB2;PRKACB;GNG11;CYB5R1
prerank, Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652                                                                                  , -0.24850416136038406, -1.1827218666828931 , 0.2222222222222222  , 0.7904951643633553,       1.0 , 31/136 , 16.14%, SQSTM1;TNIP2;PSMD6;USP18;IL18RAP;PTPN11;IRAK1;CASP8;TP53;UBC;TAB3;IKBIP;PSMD7;PSMD9;PTPN18;PSMC3;PSME4;TBK1;PSMB2;CUL1;IL4;PSME2;IL1RL1;MAPK8;SMAD3;UBE2N;MAP3K3;IL18R1;MAP3K8;TANK;MAP3K7
prerank, KEGG_2021_Human__Histidine metabolism                                                                                                       , -0.390884321518617  , -1.1822293710224172 , 0.2                 , 0.7900323256994781,       1.0 , 6/16   , 18.08%, AMDHD1;ALDH9A1;HAL;CNDP2;ALDH1B1;CARNS1
prerank, KEGG_2021_Human__Bile secretion                                                                                                             , -0.30610275674741183, -1.181461910320167  , 0.1794871794871795  , 0.7910657820656065,       1.0 , 14/43  , 26.48%, ADCY7;ABCB4;SLCO1A2;SLC27A5;SLC9A3;CA2;ABCB11;ABCC4;ATP1B1;PRKACB;ATP1A3;ABCB1;ADCY9;ABCC3
prerank, Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702                                                                   , 0.21389454635746194 , 1.1811955023942153  , 0.15                , 1.0               ,       1.0 , 10/56  , 8.93% , RPS24;RPS29;EIF2S3;EIF4A1;EIF4H;RPS15A;RPS4X;RPS20;RPS4Y1;EIF3M
prerank, KEGG_2021_Human__Herpes simplex virus 1 infection                                                                                           , -0.22250684355854033, -1.1809940516226518 , 0.12244897959183673 , 0.7906039755518034,       1.0 , 154/448, 31.50%, ZNF614;ITGB3;PML;ZNF343;TNFSF14;ZNF41;ZNF304;ZNF543;ZNF222;ZNF676;ZNF350;ZNF557;ZNF726;ZNF17;BAX;PTPN11;ZNF563;CASP3;IRAK1;FASLG;CASP8;TP53;ZFP69;ZNF471;EIF2S1;ZNF791;SOCS3;ZNF606;ZNF736;TYK2;ZNF674;SRSF3;ZNF805;ZNF91;PIK3R3;ZNF74;HLA-G;ZNF160;TICAM1;ZNF569;ZNF699;ZNF12;PIK3R1;ZNF157;ZNF354A;ZNF417;ZNF19;ZNF627;ZNF558;OAS2;TBK1;ZNF546;ZFP14;ZNF250;ZNF792;C5;NECTIN2;ZNF20;ZNF30;ZNF714;ZNF331;RBAK;ZNF324;ZNF135;ZNF765;ZNF484;ZNF713;ZNF667;ZFP30;ZNF808;ZNF620;ZNF486;ZNF180;ZNF227;TNFRSF1A;MAP3K7;TLR3;ZNF275;ZNF571;ZNF347;ZNF184;ZNF124;ZNF132;SRSF1;ZNF764;AKT1;ZNF23;ZNF528;ZNF45;BST2;ZNF616;ZNF460;IRF9;ZNF600;ZNF780A;ZNF841;ZNF182;ZFP1;ZNF671;ZNF468;ZNF551;SRSF5;ITGA5;ZNF675;ZNF443;ZNF514;PIK3CA;ZNF761;ZNF37A;ZNF565;OAS1;BID;ZNF709;ZNF613;RNASEL;ZNF790;ZNF14;ZNF641;ZNF492;ZNF286A;ZNF79;ZNF267;EIF2AK1;ZNF431;TAB1;ZNF555;EIF2B3;PDIA3;ZNF302;ZNF177;ZNF829;ZNF273;ZNF415;ZNF398;SYK;IRF7;ZNF285;ZNF589;ZNF300;ZNF595;ZNF7;ZNF665;IRAK4;ZNF845;TLR2;ZFP28;SRC;FAS;HCFC2;ZNF440;ZNF597;HLA-DRB1;ZNF793;ZNF596
prerank, Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751                                                                      , -0.28391886147928574, -1.1808408510673405 , 0.27710843373493976 , 0.7888810693829732,       1.0 , 29/64  , 33.55%, PSMD6;UBC;PSMD7;PSMD9;CSNK2A2;PSMC3;PSME4;PSMB2;PSME2;UBB;RPS27A;AKT1;PSMD8;PSME3;NEDD4;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;AKT2;PSMD10
prerank, Reactome_2022__Activation Of ATR In Response To Replication Stress R-HSA-176187                                                             , -0.329530643597342  , -1.1798693592838505 , 0.32051282051282054 , 0.7902554266467066,       1.0 , 9/33   , 14.06%, MCM5;CHEK1;RPA3;RAD9B;ORC3;RFC5;SLC25A15;CDC6;POLR1B
prerank, Reactome_2022__Neuronal System R-HSA-112316                                                                                                 , -0.23095635729179817, -1.1767870545791927 , 0.1836734693877551  , 0.8008884967816527,       1.0 , 64/203 , 26.82%, KCNMA1;RASGRF2;ABCC9;ADCY7;CACNG8;PLCB2;TSPAN7;PDPK1;SNAP25;CACNB3;PPFIBP2;SLC6A13;KCNK7;PLCB1;PRKAG2;APBA3;MAPK1;PPM1F;GNAI3;BEGAIN;KCNA7;LGALS12;PRKCA;DLG1;RPS6KA3;GNB5;GNGT2;CAMK2G;STXBP1;RTN3;DNAJC5;PRKAR2A;CHRNB4;KCNQ5;PTPRF;CHRFAM7A;LRRTM4;KCND3;GNG5;EPB41L2;NLGN3;SLC1A2;PRKACB;HTR3B;NRXN2;GNG11;SLC6A12;GNG3;PRKAG1;KCNMB1;CACNA1E;KCNJ11;KCNAB3;PPFIBP1;GNAI1;RAB3A;KCNH2;ADCY9;PRKX;SLC38A1;LIN7A;NCALD;KCNK6;PRKAR1A
prerank, Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945                                                                        , -0.2760936130619258 , -1.1767146034819598 , 0.2894736842105263  , 0.7989942797594466,       1.0 , 16/59  , 19.97%, PAOX;ADH5;CYP4F3;CYP2C9;MTARC1;FMO4;ACSS1;NQO2;PTGS1;CYP2U1;MTARC2;ACSS2;ALDH1B1;FDX1;CYP1B1;AURKAIP1
prerank, Reactome_2022__Signaling By BMP R-HSA-201451                                                                                                , -0.38304700139219083, -1.176677797293059  , 0.2898550724637681  , 0.796767362481341 ,       1.0 , 11/18  , 32.42%, SMURF1;ACVR2B;SMAD7;SMURF2;SMAD5;ACVR2A;UBE2D1;BMPR2;FSTL1;SKI;ZFYVE16
prerank, Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465                                                                              , -0.3703792182067068 , -1.1756990938162308 , 0.2537313432835821  , 0.7981346236099229,       1.0 , 10/17  , 33.19%, PIK3R1;TRIP11;GRB2;ETV6;GAB2;CDKN1A;PIK3CA;SPTBN1;ZMYM2;MYO18A
prerank, Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322                                                                    , -0.3647619986916025 , -1.175168673455372  , 0.2463768115942029  , 0.7974755616971185,       1.0 , 6/20   , 16.26%, DTX4;ZBP1;TICAM1;DHX9;TBK1;TLR3
prerank, Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406                                                                  , 0.23464012496560332 , 1.17361652877741    , 0.14285714285714285 , 1.0               ,       1.0 , 7/46   , 6.03% , DLST;D2HGDH;MPC2;IDH3A;SUCLG1;PDPR;CS
prerank, Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003                                                                  , -0.3030172790300719 , -1.1732952361985878 , 0.25316455696202533 , 0.8020844851490202,       1.0 , 12/36  , 22.88%, PDPK1;TP53;UBC;MDM4;CCNA1;RFFL;USP7;UBB;RPS27A;AKT1;CHEK2;CCNA2
prerank, KEGG_2021_Human__Folate biosynthesis                                                                                                        , -0.3739354732346025 , -1.173144036575875  , 0.28169014084507044 , 0.8002445887262303,       1.0 , 7/18   , 21.11%, PTS;AKR1C3;TPH2;TPH1;DHFR;FPGS;PCBD1
prerank, Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115                , 0.28308366543089164 , 1.1723850492955634  , 0.25                , 1.0               ,       1.0 , 4/20   , 4.12% , PLAGL1;PLK3;CNOT7;CNOT9
prerank, Reactome_2022__Amyloid Fiber Formation R-HSA-977225                                                                                         , -0.26736545092386266, -1.1706744099349287 , 0.2857142857142857  , 0.8068826594691972,       1.0 , 19/63  , 22.49%, H2AX;NCSTN;SIAH1;TGFBI;UBC;H2AC19;USP9X;LYZ;H2AC7;TSPAN33;H2BC11;SNCA;GGA1;H3-3B;SORL1;UBB;RPS27A;PSENEN;ADAM10
prerank, KEGG_2021_Human__Porphyrin and chlorophyll metabolism                                                                                       , -0.3407353640772278 , -1.1696699644084836 , 0.32                , 0.8074959675718985,       1.0 , 11/22  , 28.10%, COX15;HMBS;COX10;BLVRA;ALAS2;CPOX;UROS;HMOX2;FXN;UROD;HMOX1
prerank, Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442                                                                 , -0.2281972501863188 , -1.1692471230776662 , 0.20224719101123595 , 0.8066667752977191,       1.0 , 64/167 , 32.92%, GALNT2;COPZ1;IGF2R;COG2;RAB6A;KIF21A;KIF22;VPS51;NAPSA;PAFAH1B3;RABEPK;ACTR1A;ACTR10;CYTH2;VAMP3;TRIP11;CYTH1;USP6NL;CAPZA2;DYNC1LI1;KIF23;KIF18A;MAN1A1;DCTN3;CAPZB;GALNT1;KIF3C;RAB9A;KDELR2;STX6;BICD1;DYNC1H1;KDELR1;COPE;KIF5A;RIC1;SCOC;RAB33B;UBE2Z;TMED9;MAN2A2;VPS45;DYNC1LI2;RAB1B;YKT6;PLIN3;RAB18;PAFAH1B2;STX10;GCC1;AGPAT3;SEC22B;KIF20B;COG8;COPB1;KIF13B;KIF20A;RAB3GAP1;KIF2C;RHOBTB3;RINT1;COPZ2;ARFGAP1;PLA2G4A
prerank, Reactome_2022__Aggrephagy R-HSA-9646399                                                                                                     , -0.3340159568850559 , -1.168693931378693  , 0.2835820895522388  , 0.8063918119643066,       1.0 , 9/21   , 26.95%, UBC;DYNC1LI1;UBE2N;DYNC1H1;UBB;RPS27A;DYNC1LI2;VCP;HDAC6
prerank, Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814                                                                    , -0.2961080741032821 , -1.167794010069828  , 0.25333333333333335 , 0.8075189530157562,       1.0 , 11/37  , 20.65%, P3H2;COL6A3;P3H1;COL28A1;BMP1;ADAMTS2;P4HA1;COL9A1;COL8A1;CRTAP;PLOD1
prerank, Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114                                         , -0.39046420963592743, -1.167703913191027  , 0.2911392405063291  , 0.8056643068320183,       1.0 , 7/18   , 23.89%, BAX;REXO2;TP53;CARM1;CDC25C;GADD45A;ZNF385A
prerank, Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007                                                                                    , -0.2391580533346809 , -1.167187947853414  , 0.21875             , 0.8052430295658682,       1.0 , 40/145 , 23.89%, PML;KAT6A;GATAD2A;RAD50;PPP1R13B;ING5;PDPK1;TP53;UBC;DYRK2;CHD4;MDM4;CCNA1;PRKAG2;CHEK1;TTC5;RPA3;CSNK2A2;RAD9B;TAF11;RFC5;BRCA1;RBBP7;POLR1B;TAF15;RFFL;MEAF6;USP7;UBB;RPS27A;AKT1;TAF1;HUS1;PRKAG1;TAF5;CHEK2;CCNA2;MAPK11;TAF12;ZNF385A
prerank, Reactome_2022__Peroxisomal Lipid Metabolism R-HSA-390918                                                                                    , -0.3335634473760359 , -1.1667574984019238 , 0.3333333333333333  , 0.8047335039063148,       1.0 , 9/26   , 23.27%, ACOT8;ACOX2;CRAT;SLC25A17;ACOT4;ACOX1;HSD17B4;DECR2;SYCP2
prerank, Reactome_2022__Apoptosis R-HSA-109581                                                                                                       , -0.2405984622947118 , -1.1657808922766242 , 0.17894736842105263 , 0.8054914428739207,       1.0 , 70/166 , 35.30%, PSMD6;H1-3;PPP1R13B;BAX;REXO2;TMED7-TICAM2;CASP3;FASLG;CASP8;TP53;UBC;PSMD7;MED12;MAPK1;PSMD9;TICAM1;YWHAB;PSMC3;PSME4;PMAIP1;PSMB2;PSME2;KPNA1;BMX;STK26;LY96;MAPK8;HMGB2;GAS2;GZMB;TANK;CASP7;DAPK2;UBB;RPS27A;AKT1;PPP3CC;UACA;OMA1;PSMD8;PSME3;PSMB6;HMGB1;BID;FNTA;DSG2;PSMA1;DFFB;PSMB4;H1-0;YWHAQ;PSMF1;PSME1;PSMA3;DBNL;PSMB1;GSDME;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;AKT2;BMF;CYCS;PSMD10;PROC;CLSPN;PSMD5;TFDP2
prerank, Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236                                     , -0.25168538032063387, -1.1656194187790794 , 0.23863636363636365 , 0.8038730132709787,       1.0 , 37/90  , 33.55%, LMO2;PSMD6;H2AX;UBC;SPI1;H2AC19;PSMD7;PSMD9;ITCH;PSMC3;PSME4;PSMB2;PSME2;H2AC7;H2BC11;H3-3B;CCNH;UBB;RPS27A;MNAT1;PSMD8;PSME3;PSMB6;PSMA1;PSMB4;PSMF1;PSME1;H2AC6;PSMA3;PSMB1;TCF7L1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__DNA Double Strand Break Response R-HSA-5693606                                                                               , -0.28339676974623584, -1.1639826868213987 , 0.25                , 0.8074739514789103,       1.0 , 17/54  , 24.75%, RAD50;H2AX;BABAM1;TP53;UBC;BRCA1;MAPK8;UBE2N;H2BC11;ABRAXAS1;UBB;RPS27A;EYA3;CHEK2;BABAM2;UIMC1;RNF168
prerank, Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733                                                                      , -0.24826774042887434, -1.1638760852163788 , 0.21978021978021978 , 0.8056499159215815,       1.0 , 17/107 , 10.48%, GLG1;ITGB3;FCER1G;CD58;YES1;TSPAN7;PTPN11;ITGAV;CD44;CEACAM1;PF4V1;SELL;CEACAM6;ITGAL;CEACAM8;PIK3R1;BSG
prerank, KEGG_2021_Human__Basal cell carcinoma                                                                                                       , -0.3123749319829811 , -1.1637979299003949 , 0.25                , 0.8036273763947515,       1.0 , 10/34  , 22.14%, BAX;TP53;WNT10A;GADD45G;FZD6;POLK;LEF1;DDB2;CDKN1A;GADD45A
prerank, Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631                                                                                  , -0.3600153912920542 , -1.16372900979528   , 0.3287671232876712  , 0.8016158588816915,       1.0 , 8/18   , 28.39%, YES1;CRK;PIK3R3;PIK3R1;GRB2;PIK3CA;BLNK;SYK
prerank, Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314                                                 , -0.26067021229818965, -1.160042727471348  , 0.16279069767441862 , 0.8128553100999089,       1.0 , 45/98  , 35.86%, RASGRF2;ADCY7;CACNG8;PLCB2;TSPAN7;PDPK1;PLCB1;PRKAG2;MAPK1;PPM1F;GNAI3;LGALS12;PRKCA;DLG1;RPS6KA3;GNB5;GNGT2;CAMK2G;PRKAR2A;CHRNB4;CHRFAM7A;GNG5;PRKACB;HTR3B;GNG11;GNG3;PRKAG1;GNAI1;ADCY9;PRKX;LIN7A;NCALD;PRKAR1A;KCNJ15;AKAP5;LIN7C;SRC;CHRNE;CASK;GNB2;NPTN;PLCB3;GIT1;NSF;AP2S1
prerank, KEGG_2021_Human__Arginine and proline metabolism                                                                                            , -0.30450769996167465, -1.1597809536765467 , 0.3170731707317073  , 0.8116863326193142,       1.0 , 14/38  , 24.64%, ALDH9A1;AMD1;ARG2;CNDP2;NOS3;P4HA1;ALDH1B1;CKB;CARNS1;ODC1;GAMT;ALDH4A1;ARG1;AOC1
prerank, Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460                                                                              , -0.3023595853106259 , -1.1583923061538615 , 0.2987012987012987  , 0.8144123492879107,       1.0 , 4/31   , 4.56% , RRM1;FASLG;CASP8;UBC
prerank, KEGG_2021_Human__TGF-beta signaling pathway                                                                                                 , 0.19330069152731458 , 1.1580528469095168  , 0.3157894736842105  , 1.0               ,       1.0 , 16/64  , 13.71%, LTBP1;SMAD2;ID2;BMPR1A;SKP1;NEO1;MYC;RPS6KB2;E2F4;TGFBR2;ACVR1;SMAD1;TGIF1;E2F5;PPP2CB;TGFBR1
prerank, Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667                                                                             , -0.35599796484052887, -1.1576028172429444 , 0.24358974358974358 , 0.8160953615007183,       1.0 , 15/23  , 41.60%, AKR1C3;BCO2;PLB1;LRP12;VKORC1L1;LPL;VKORC1;LRP10;APOE;AKR1C1;LRP8;LDLR;HSPG2;GPC2;C1D
prerank, Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871                                                                      , -0.24547792616095837, -1.157245623955248  , 0.25925925925925924 , 0.8150736078246732,       1.0 , 23/92  , 19.10%, TNIP2;ECSIT;USP18;IRAK1;CASP8;TP53;UBC;TAB3;IKBIP;MAP3K1;MAPK1;DUSP6;CUL1;RPS6KA3;MAPK8;UBE2N;MAP3K8;TANK;MAP3K7;MAP2K7;MEF2C;UBB;RPS27A
prerank, KEGG_2021_Human__Pathogenic Escherichia coli infection                                                                                      , -0.2443815980160594 , -1.1571846767160814 , 0.30526315789473685 , 0.8132683192596041,       1.0 , 48/163 , 26.18%, GAPDH;RPS3;ARF1;ABI1;SEC24D;MYO1F;BAX;CYFIP2;PTPN11;CASP3;IRAK1;FASLG;MYH9;CASP8;SEC24C;TAB3;CTTN;TIRAP;MAPK1;CYTH2;CYTH1;CLDN9;WIPF2;MAPK8;ROCK2;TNFRSF1A;MAP3K7;ARPC5;GNA12;ARHGEF11;NCKAP1L;CASP7;ARF6;CDC42;PAK1;CLDN4;BAIAP2L1;IL1R1;CLDN5;TMED10;MAPK11;TUBB6;WASF1;ARPC3;LPAR2;ARHGEF1;ARPC2;TAB1
prerank, KEGG_2021_Human__Pancreatic secretion                                                                                                       , -0.27840828213301483, -1.1563150085143876 , 0.2073170731707317  , 0.8139208297976239,       1.0 , 10/54  , 11.13%, KCNMA1;ADCY7;PLCB2;CTRL;CD38;PLCB1;CHRM3;ATP2A3;CA2;PRKCA
prerank, KEGG_2021_Human__Diabetic cardiomyopathy                                                                                                    , -0.23925906929822366, -1.1557623408203002 , 0.16666666666666666 , 0.8139594560878243,       1.0 , 32/165 , 14.24%, GAPDH;NDUFB3;TGFB3;SDHC;ATP5PB;PLCB2;COX6C;COX5A;UQCRC1;G6PD;UQCRFS1;PDK4;PLCB1;PPIF;NDUFB2;CPT2;PIK3R3;IRS1;NDUFA7;GYS1;ATP2A3;PIK3R1;CYBB;UQCRB;NOS3;PDHB;PRKCA;MAPK8;SMAD3;CAMK2G;NDUFB9;MMP9
prerank, Reactome_2022__Vitamin B5 (Pantothenate) Metabolism R-HSA-199220                                                                            , 0.3031915239194713  , 1.1555029443744558  , 0.2727272727272727  , 1.0               ,       1.0 , 4/17   , 10.66%, SLC25A16;ENPP1;COASY;ENPP3
prerank, KEGG_2021_Human__Notch signaling pathway                                                                                                    , -0.2877683437271244 , -1.155442656486354  , 0.27586206896551724 , 0.813128190095872 ,       1.0 , 21/48  , 31.57%, DTX4;JAG1;RFNG;NCSTN;TLE2;HEY1;LFNG;NCOR2;NOTCH3;MAML2;NUMB;KAT2B;RBPJ;PSENEN;APH1B;CREBBP;DTX2;DVL3;KAT2A;MAML1;DTX3
prerank, KEGG_2021_Human__Melanogenesis                                                                                                              , -0.2667883129997646 , -1.1553606559758656 , 0.25                , 0.8112315653838212,       1.0 , 21/63  , 27.65%, ADCY7;CREB3L4;PLCB2;WNT10A;CALM2;PLCB1;MAPK1;FZD6;GNAI3;PRKCA;LEF1;CAMK2G;CREB3L2;PRKACB;CALM3;MC1R;GNAI1;ADCY9;CREBBP;POMC;DVL3
prerank, Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316                                                                                   , -0.26164371598550107, -1.1546395835345489 , 0.23529411764705882 , 0.8121420848778633,       1.0 , 24/79  , 23.59%, GNS;SLC35B3;B4GALT1;SLC35D2;CD44;HMMR;HS2ST1;CHST13;CHSY1;B4GALT3;B4GALT6;LYVE1;EXT1;CHPF;B4GAT1;CHORDC1;NAGLU;CHPF2;SGSH;ARSB;HYAL3;HAS3;B4GALT7;DCN
prerank, Reactome_2022__Ephrin Signaling R-HSA-3928664                                                                                               , -0.3692676696935108 , -1.1541997978888014 , 0.2222222222222222  , 0.8110345930829634,       1.0 , 2/16   , 1.14% , EPHB3;EFNB1
prerank, Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166                                                                                  , -0.24381377117879482, -1.1539673344836072 , 0.2                 , 0.8095026640797354,       1.0 , 26/103 , 19.10%, TNIP2;USP18;PTPN11;TMED7-TICAM2;IRAK1;CASP8;TP53;UBC;TAB3;IKBIP;MAPK1;TICAM1;DUSP6;TBK1;CUL1;RPS6KA3;LY96;MAPK8;UBE2N;MAP3K8;TANK;MAP3K7;MAP2K7;MEF2C;UBB;RPS27A
prerank, Reactome_2022__RHOV GTPase Cycle R-HSA-9013424                                                                                              , -0.315477391910886  , -1.1532900528816672 , 0.3333333333333333  , 0.809981415122511 ,       1.0 , 13/34  , 22.67%, TXNL1;DST;PARD6B;USP9X;PIK3R1;CEP97;DLG5;VANGL1;PEAK1;CDC42;CLTC;IQGAP1;MAP3K11
prerank, Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385                                                                                      , -0.33557326728347237, -1.1531009166834134 , 0.3088235294117647  , 0.8087741402012729,       1.0 , 12/26  , 26.90%, PTPN11;UBC;PIK3R1;TRIP11;GRB2;UBB;RPS27A;ETV6;GAB2;CDKN1A;PIK3CA;SPTBN1
prerank, KEGG_2021_Human__Autophagy                                                                                                                  , -0.24145563452627403, -1.1517294491448373 , 0.24705882352941178 , 0.8123259437391536,       1.0 , 36/129 , 20.47%, SQSTM1;WDR41;ATG9A;PDPK1;RAB39B;STX17;EIF2S1;SUPT20H;MAPK1;PIK3R3;IRS1;PIK3R1;ATG14;TBK1;RRAGD;HIF1A;MAPK8;ATG10;TP53INP2;RPS6KB1;ATG101;DEPTOR;AMBRA1;RRAS;UVRAG;TANK;WIPI2;MAP3K7;ULK2;ATG2A;PRKACB;DAPK2;ATG12;AKT1;RAB33B;ATG13
prerank, Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108                                                                                           , -0.2715049070335096 , -1.1515007646333038 , 0.2948717948717949  , 0.810976923106911 ,       1.0 , 14/47  , 23.01%, PARP9;ST6GALNAC4;CHMP4B;UBC;CHMP6;GALNT1;RB1;UVRAG;PARP14;PARP6;UBB;RPS27A;DDX5;VCP
prerank, KEGG_2021_Human__Cardiac muscle contraction                                                                                                 , -0.29209840746166926, -1.1514954027690187 , 0.27848101265822783 , 0.8088704895403996,       1.0 , 10/55  , 9.29% , CACNG8;COX6C;CACNG6;CACNB3;COX5A;ASPH;UQCRC1;UQCRFS1;ATP2A3;UQCRB
prerank, KEGG_2021_Human__Estrogen signaling pathway                                                                                                 , -0.2552404236528021 , -1.1510901183420064 , 0.225               , 0.8081586583956439,       1.0 , 36/88  , 34.46%, ADCY7;GPER1;CREB3L4;PLCB2;CALM2;PLCB1;MAPK1;PIK3R3;GNAI3;PIK3R1;NOS3;MMP9;CREB3L2;HSPA1A;TGFA;GRB2;PRKACB;CALM3;AKT1;FKBP4;NCOA3;PIK3CA;HSPA2;GNAI1;ADCY9;SHC4;HSP90B1;POMC;CTSD;NCOA1;SRC;HSP90AA1;HBEGF;AKT2;PLCB3;PIK3CB
prerank, Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604                                                                                , -0.3059728608862768 , -1.150268589828468  , 0.2911392405063291  , 0.8091122744820437,       1.0 , 5/31   , 9.19% , FCER1G;PTPN11;PDPK1;PIK3R3;PIK3R1
prerank, Reactome_2022__Complement Cascade R-HSA-166658                                                                                              , -0.3027020968303388 , -1.1492857080443313 , 0.2911392405063291  , 0.8105104626442992,       1.0 , 17/41  , 28.58%, PIKFYVE;ELANE;GZMM;C5;C4B;C1QC;CFHR1;CFH;C4A;C3AR1;CD81;C8G;SERPING1;FCN1;C5AR2;PROS1;C4BPA
prerank, KEGG_2021_Human__Dopaminergic synapse                                                                                                       , -0.2489326259794497 , -1.1484095669453909 , 0.2857142857142857  , 0.8116492753567415,       1.0 , 24/92  , 19.91%, CREB3L4;PLCB2;PPP2R3A;ARRB1;PPP2R5E;CALM2;PLCB1;CLOCK;GNAI3;PRKCA;GNB5;PPP2R5B;MAPK8;GNGT2;CAMK2G;CREB3L2;GNG5;PRKACB;GNG11;KIF5A;CALM3;AKT1;GNG3;PPP3CC
prerank, "Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721"                                       , -0.368054358495172  , -1.1481510122653482 , 0.3157894736842105  , 0.8104345395746967,       1.0 , 6/20   , 13.42%, CACNG8;TSPAN7;LGALS12;PRKCA;DLG1;CAMK2G
prerank, Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825                                                            , -0.2498199940290572 , -1.1476979579341957 , 0.2558139534883721  , 0.8103411144462992,       1.0 , 21/83  , 19.10%, VAMP7;CD3D;IGF2R;ARRB1;LDLRAP1;UBC;KIAA0319;SH3GL1;VAMP3;AREG;TFRC;COPS3;STAM2;TOR1A;TGFA;GRB2;STON2;EPS15L1;CLTC;UBB;RPS27A
prerank, KEGG_2021_Human__Gastric cancer                                                                                                             , -0.2506925613902149 , -1.1476449351170155 , 0.2289156626506024  , 0.8085241745463156,       1.0 , 31/96  , 27.65%, LRP6;TGFB3;BAX;TP53;WNT10A;GADD45G;MAPK1;PIK3R3;FZD6;POLK;PIK3R1;CDH1;RARB;LRP5;LEF1;SMAD3;RPS6KB1;RB1;DDB2;GRB2;HGF;AKT1;CDKN1A;GADD45A;ABCB1;FGFR2;PIK3CA;SHC4;JUP;FRAT1;DVL3
prerank, KEGG_2021_Human__Pertussis                                                                                                                  , -0.2713911350495209 , -1.1475819857927216 , 0.2558139534883721  , 0.8066610100409868,       1.0 , 24/68  , 24.58%, CASP3;IRAK1;CALM2;TIRAP;MAPK1;TICAM1;GNAI3;IL10;C5;LY96;MAPK8;C4B;C1QC;ITGAM;C4A;CASP7;TICAM2;CALM3;CFL2;CD14;SERPING1;ITGA5;MAPK11;GNAI1
prerank, Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606                                                                                 , -0.28075411753163587, -1.147323063751047  , 0.25                , 0.8056372581613422,       1.0 , 15/54  , 20.82%, PPP1R13B;BAX;REXO2;CASP3;CASP8;TP53;MAPK1;YWHAB;PMAIP1;MAPK8;GZMB;CASP7;AKT1;PPP3CC;UACA
prerank, Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580                                                                             , -0.2672381660526047 , -1.1471346705244558 , 0.25882352941176473 , 0.8043703336996891,       1.0 , 24/63  , 30.89%, OPLAH;GGT1;SLC35B3;GSTP1;CNDP2;GSTM1;BPNT2;MGST1;GGT5;GSTO1;GGT7;MAT2B;SULT1B1;MAT2A;SLC38A1;TPST2;GSTZ1;MGST2;UGP2;PODXL2;GSTO2;ACSM2A;SLC26A1;TPMT
prerank, Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678                                                                , 0.22931579509173577 , 1.1467554429603375  , 0.1875              , 1.0               ,       1.0 , 11/46  , 11.31%, RPS24;RPS29;RPS15A;SNRPG;RPS4X;RPS20;RPS4Y1;SNRPE;SNRPD2;SNRPB;RPS13
prerank, Reactome_2022__HDMs Demethylate Histones R-HSA-3214842                                                                                      , -0.3205904760514172 , -1.1464471923876136 , 0.30120481927710846 , 0.8047062834558157,       1.0 , 10/25  , 29.07%, RIOX2;PHF2;UTY;KDM4C;KDM3B;PHF8;KDM5A;KDM6B;JMJD6;KDM1A
prerank, KEGG_2021_Human__Autoimmune thyroid disease                                                                                                 , -0.31792642633524715, -1.144896486631529  , 0.2804878048780488  , 0.8075390465919547,       1.0 , 7/33   , 14.75%, FASLG;TSHR;HLA-G;IL10;IL4;TG;GZMB
prerank, Reactome_2022__MAP Kinase Activation R-HSA-450294                                                                                           , -0.26193778598820816, -1.1429091632346533 , 0.2676056338028169  , 0.8123842218201788,       1.0 , 16/59  , 19.10%, TNIP2;IRAK1;UBC;TAB3;MAPK1;DUSP6;CUL1;RPS6KA3;MAPK8;UBE2N;MAP3K8;MAP3K7;MAP2K7;MEF2C;UBB;RPS27A
prerank, Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634                                                                               , -0.35585022325133575, -1.1421643733479847 , 0.3125              , 0.8126429237389883,       1.0 , 13/20  , 41.60%, AKR1C3;BCO2;PLB1;LRP12;LPL;LRP10;APOE;AKR1C1;LRP8;LDLR;HSPG2;GPC2;C1D
prerank, Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326                                                          , -0.36401525401073476, -1.13998587487357   , 0.2597402597402597  , 0.8173966130239521,       1.0 , 8/21   , 19.82%, PLCB2;PLCB1;DLG1;GNB5;GNGT2;GNG5;GNG11;GNG3
prerank, Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827                                                      , -0.2521697640199085 , -1.1399142506540065 , 0.26506024096385544 , 0.8156572220272671,       1.0 , 34/76  , 36.51%, AQR;GTF2H3;UBC;SLC19A1;RPA3;POLK;RFC5;COPS3;XPA;POLR2G;POLR1B;USP7;POLR2B;CCNH;POLR2D;UBB;RPS27A;MNAT1;POLD4;ELL;ERCC1;ERCC6;TCEA1;GTF2H4;XRCC1;POLE3;POLD2;COPS8;ERCC3;GTF2H1;POLE4;POLR2E;ERCC4;POLE
prerank, Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165                                                                                    , 0.2532467726917313  , 1.1389538483866977  , 0.21428571428571427 , 1.0               ,       1.0 , 11/49  , 11.04%, PDCD7;POLR2I;YBX1;SNRNP35;SNRPG;POLR2F;SNRPE;SNRPD2;RNPC3;SNRPB;DDX23
prerank, KEGG_2021_Human__Olfactory transduction                                                                                                     , -0.2740925747954717 , -1.1385655838574091 , 0.26744186046511625 , 0.8182648229660082,       1.0 , 18/60  , 23.27%, OR2M3;ARRB1;OR2T33;CALM2;PDE1B;PDE2A;OR7D2;OR1A1;CAMK2G;OR11G2;OR2A7;OR56A4;OR2B6;PRKACB;OR10H1;CALM3;OR2AT4;OR7C1
prerank, KEGG_2021_Human__Parkinson disease                                                                                                          , -0.22998575909587313, -1.1385215456603301 , 0.1978021978021978  , 0.8162884838263919,       1.0 , 76/208 , 33.50%, NDUFB3;PSMD6;SDHC;ATP5PB;BAX;COX6C;CASP3;COX5A;TP53;UBC;HTRA2;UQCRC1;PSMD7;UQCRFS1;EIF2S1;CALM2;PPIF;NDUFB2;PSMD9;GNAI3;NDUFA7;UQCRB;PSMC3;ATF6;PSMB2;ADRM1;UBE2L3;MAPK8;UBE2J1;CAMK2G;NDUFB9;ADORA2A;UBE2G1;SNCA;ATP5MC3;UBE2J2;PRKACB;NDUFS1;NDUFB7;UBB;RPS27A;KIF5A;NDUFB5;CALM3;NDUFB4;SEPTIN5;NDUFS7;PSMD8;NDUFV3;TUBB6;PSMB6;DUSP1;UBA1;MAP3K5;GNAI1;PSMA1;ATP5F1E;COX4I1;PSMB4;HSPA5;TUBA1C;UCHL1;PSMA3;TXN;NDUFS3;PSMB1;NDUFC1;PSMC4;NDUFB10;SEM1;PSMA6;PSMD11;PSMA2;NDUFAB1;NDUFA13;CYCS
prerank, Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280                                                                          , -0.2913469596788685 , -1.137894824333685  , 0.2894736842105263  , 0.8167231826569632,       1.0 , 9/36   , 14.09%, NR3C2;THRA;NR1D1;AREG;RARB;NR2C1;NCOR2;NR2C2;NR5A2
prerank, Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710                                                                                  , 0.2753000214233652  , 1.1373857195368302  , 0.21621621621621623 , 1.0               ,       1.0 , 7/27   , 7.20% , RNF103-CHMP3;MVB12B;UBAP1;ARL13B;VPS37C;PLIN2;VPS37B
prerank, Reactome_2022__Translation Initiation Complex Formation R-HSA-72649                                                                         , 0.21587938956856872 , 1.136944484372763   , 0.15                , 1.0               ,       1.0 , 10/56  , 8.93% , RPS24;RPS29;EIF2S3;EIF4A1;EIF4H;RPS15A;RPS4X;RPS20;RPS4Y1;EIF3M
prerank, Reactome_2022__Biological Oxidations R-HSA-211859                                                                                           , -0.23559052728594024, -1.1365695742495536 , 0.2727272727272727  , 0.8196048874473275,       1.0 , 45/128 , 30.89%, OPLAH;GGT1;SLC35B3;PAOX;GSTP1;ADH5;CYP4F3;CYP2C9;MTARC1;FMO4;ACSS1;CNDP2;GSTM1;BPNT2;NQO2;PTGS1;MGST1;CYP2U1;MTARC2;ACSS2;ALDH1B1;GGT5;GSTO1;FDX1;CYP1B1;GGT7;AURKAIP1;MAT2B;SULT1B1;MAT2A;CMBL;AOC1;SLC38A1;TPST2;GSTZ1;ACY3;POMC;MGST2;UGP2;PODXL2;GSTO2;ACSM2A;SLC26A1;NCOA1;TPMT
prerank, KEGG_2021_Human__Cholinergic synapse                                                                                                        , -0.2504203642832864 , -1.1363994455727255 , 0.3146067415730337  , 0.8181768006474736,       1.0 , 21/77  , 19.82%, ADCY7;CREB3L4;PLCB2;PLCB1;MAPK1;PIK3R3;CHRM3;GNAI3;PIK3R1;PRKCA;GNB5;GNGT2;CAMK2G;CREB3L2;CHRNB4;KCNQ5;GNG5;PRKACB;GNG11;AKT1;GNG3
prerank, Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722                                                                             , -0.27101244136118524, -1.1350161506933993 , 0.2839506172839506  , 0.8212014622474952,       1.0 , 8/54   , 5.75% , VAMP7;PIK3C2A;SNX5;SNX2;IGF2R;ARRB1;AP4B1;NAPSA
prerank, KEGG_2021_Human__RNA degradation                                                                                                            , -0.25336003779029875, -1.1346820764777346 , 0.2727272727272727  , 0.8205512229218035,       1.0 , 25/68  , 30.43%, EXOSC6;CNOT10;PAN2;CNOT1;DCP1B;TOB2;PABPC1L;EDC3;DDX6;PARN;PNPT1;LSM4;PFKP;MPHOSPH6;NUDT16;DCPS;LSM6;EXOSC2;LSM2;LSM7;CNOT2;TOB1;TENT4A;DHX36;DCP1A
prerank, KEGG_2021_Human__GnRH secretion                                                                                                             , -0.2757741612335799 , -1.1337641806303138 , 0.2926829268292683  , 0.8218763039324772,       1.0 , 9/44   , 11.13%, GPER1;PLCB2;ARRB1;GNRH1;PLCB1;MAPK1;PIK3R3;PIK3R1;PRKCA
prerank, KEGG_2021_Human__Longevity regulating pathway                                                                                               , -0.2499258954953902 , -1.1332454307843556 , 0.21739130434782608 , 0.8216263737768366,       1.0 , 26/83  , 24.78%, ADCY7;CREB3L4;BAX;TP53;PRKAG2;PIK3R3;IRS1;PIK3R1;CAT;SESN3;RPS6KB1;ATG101;SIRT1;SESN1;CREB3L2;HSPA1A;SOD2;PRKACB;AKT1;PPARG;ATG13;PRKAG1;PIK3CA;HSPA2;FOXO1;ADCY9
prerank, KEGG_2021_Human__Retinol metabolism                                                                                                         , -0.3285857573766198 , -1.132519877695443  , 0.2894736842105263  , 0.8221467648644317,       1.0 , 3/19   , 4.83% , DHRS9;ADH5;CYP2C9
prerank, "Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988"                                                             , -0.2850328159169638 , -1.132504720160024  , 0.2631578947368421  , 0.8202041759926747,       1.0 , 8/40   , 11.13%, YES1;PTPN11;CRK;IL2RG;PIK3R3;PIK3R1;IL3RA;PRKCA
prerank, Reactome_2022__PD-1 Signaling R-HSA-389948                                                                                                  , -0.3275103372076859 , -1.131938735839966  , 0.3333333333333333  , 0.819669793282684 ,       1.0 , 2/19   , 3.42% , CD3D;PTPN11
prerank, Reactome_2022__Inwardly Rectifying K+ Channels R-HSA-1296065                                                                                , -0.34722863744550886, -1.1318102189551926 , 0.2926829268292683  , 0.8182954742688536,       1.0 , 7/18   , 23.11%, ABCC9;GNB5;GNGT2;GNG5;GNG11;GNG3;KCNJ11
prerank, Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264                                                                     , -0.37699929585747616, -1.1312956828920613 , 0.35294117647058826 , 0.8177157356972803,       1.0 , 6/16   , 19.10%, TNIP2;UBC;CUL1;MAP3K8;UBB;RPS27A
prerank, Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279                                                    , -0.26792566378439475, -1.130591144722372  , 0.35294117647058826 , 0.8182130705536043,       1.0 , 11/51  , 14.10%, CENPO;H2AX;CENPA;H2AC19;CENPU;CENPT;ITGB3BP;HJURP;H2AC7;RBBP7;H2BC11
prerank, Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395                                                                        , -0.2737972601633709 , -1.1303800098503722 , 0.36619718309859156 , 0.8171919425537415,       1.0 , 13/42  , 20.75%, GTF2H3;UBC;RPA3;PARP2;UBE2N;XPA;POLR1B;DDB2;XPC;CCNH;UBB;RPS27A;MNAT1
prerank, Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688                                                                               , -0.2384382202477043 , -1.1302822367512801 , 0.2804878048780488  , 0.8156020121837664,       1.0 , 41/102 , 32.92%, GALNT2;COPZ1;RAB6A;KIF21A;KIF22;NAPSA;PAFAH1B3;ACTR1A;ACTR10;CAPZA2;DYNC1LI1;KIF23;KIF18A;DCTN3;CAPZB;GALNT1;KIF3C;KDELR2;BICD1;DYNC1H1;KDELR1;COPE;KIF5A;UBE2Z;TMED9;DYNC1LI2;RAB1B;RAB18;PAFAH1B2;AGPAT3;SEC22B;KIF20B;COPB1;KIF13B;KIF20A;RAB3GAP1;KIF2C;RINT1;COPZ2;ARFGAP1;PLA2G4A
prerank, Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867                                                                              , -0.23910590862142259, -1.1293212820707255 , 0.3146067415730337  , 0.816985323803467 ,       1.0 , 44/107 , 33.96%, PSMD6;H2AX;UBC;H2AC19;MCM5;PSMD7;PSMD9;UBE2C;ORC3;PSMC3;PSMB2;CDC26;PSME2;KPNA1;H2AC7;SLC25A15;CDC6;H2BC11;UBE2E1;H3-3B;CDT1;UBB;RPS27A;PSMD8;PSME3;PSMB6;UBE2D1;PSMA1;PSMB4;KPNA6;PSMF1;PSME1;H2AC6;PSMA3;MCM6;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;GMNN
prerank, KEGG_2021_Human__Intestinal immune network for IgA production                                                                               , 0.22097863304100757 , 1.1282537949921545  , 0.20833333333333334 , 1.0               ,       1.0 , 12/41  , 15.86%, IL6;ICOS;CCR9;IL15;TNFRSF17;ITGB7;LTBR;ICOSLG;TNFRSF13C;AICDA;CD86;HLA-DMA
prerank, Reactome_2022__Expression And Translocation Of Olfactory Receptors R-HSA-9752946                                                            , -0.3030160476018644 , -1.1275188567297398 , 0.34210526315789475 , 0.8219175488309096,       1.0 , 26/37  , 51.20%, OR2M3;OR2T33;OR7D2;OR1A1;OR11G2;OR2A7;OR56A4;OR2B6;OR10H1;OR2AT4;OR7C1;OR10G3;OR10H5;OR2L2;OR4D9;EBF1;OR6C74;OR7G2;OR14J1;OR1I1;OR3A2;OR2G6;OR4F17;OR52N4;OR1F1;OR52K1
prerank, Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532                                                                                 , -0.2306573761587172 , -1.1266325476800496 , 0.32222222222222224 , 0.822839142084003 ,       1.0 , 49/139 , 30.90%, RAD50;H2AX;BABAM1;TP53;UBC;SLC19A1;XRCC5;CCNA1;CHEK1;POLM;RPA3;POLK;RAD9B;RAD51AP1;RFC5;BRCA1;DCLRE1C;MAPK8;PARP2;UBE2N;POLR1B;H2BC11;PAXIP1;ABRAXAS1;FEN1;UBB;RPS27A;HUS1;EYA3;CHEK2;BABAM2;XRCC4;CCNA2;UIMC1;POLD4;NHEJ1;RNF168;ERCC1;PRKDC;RHNO1;PALB2;LIG4;RMI1;XRCC3;RAD51D;XRCC1;POLE3;POLD2;TOP3A
prerank, Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834                                                                          , -0.24845128138833497, -1.125497559053622  , 0.29213483146067415 , 0.8254611186394982,       1.0 , 21/85  , 19.15%, ITGB3;TGFB3;ITGB5;SMURF1;BAMBI;UBC;ITGAV;MAPK1;USP9X;RNASEH2A;SMAD3;NCOR2;CCNK;TRIM33;XPO1;SMAD7;SMURF2;UBB;RPS27A;LTBP4;DAND5
prerank, Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795                                                                                  , -0.31386880790255034, -1.1254166755590094 , 0.3116883116883117  , 0.8238704328930792,       1.0 , 10/29  , 19.82%, PLCB2;PDPK1;PLCB1;GNB5;GNGT2;GNG5;CDC42;GNG11;AKT1;GNG3
prerank, Reactome_2022__Interleukin-7 Signaling R-HSA-1266695                                                                                        , -0.329296702401811  , -1.1246016794784905 , 0.3235294117647059  , 0.8249094381990736,       1.0 , 5/21   , 14.62%, IL2RG;PIK3R3;IRS1;PIK3R1;CISH
prerank, KEGG_2021_Human__Tyrosine metabolism                                                                                                        , 0.28435001795552317 , 1.1241006070827666  , 0.28125             , 1.0               ,       1.0 , 5/15   , 17.39%, AOC2;ALDH3B1;COMT;GOT1;IL4I1
prerank, Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404                                                                                              , -0.26106167981371353, -1.1233975981657056 , 0.3058823529411765  , 0.8268155600563579,       1.0 , 29/79  , 30.25%, CDC42EP4;ARHGAP35;ABI1;MTX1;PIK3R3;PIK3R1;CYBB;VAMP3;TFRC;ABI2;VANGL1;PLD2;NCKAP1L;TMPO;CDC42;LMAN1;ERBIN;BAIAP2L1;IQGAP1;ANKLE2;ARHGAP42;EMD;PIK3CA;DSG2;SWAP70;NCF2;NCF1;NHS;CDC42EP1
prerank, Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828                                                                                  , -0.23062225934313724, -1.1233603620861148 , 0.24175824175824176 , 0.8249002654901465,       1.0 , 30/119 , 19.10%, VAMP7;PIK3C2A;CD3D;IGF2R;ARRB1;LDLRAP1;UBC;CTTN;KIAA0319;SH3GL1;VAMP3;FNBP1;FNBP1L;AREG;TFRC;HIP1;COPS3;GAPVD1;STAM2;TOR1A;ARPC5;TGFA;ARF6;SNX18;GRB2;STON2;EPS15L1;CLTC;UBB;RPS27A
prerank, Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952                                                                             , -0.26114967898272234, -1.1227975975375277 , 0.3170731707317073  , 0.824576622516092 ,       1.0 , 16/55  , 24.97%, ITGB3;ARRB1;AKAP9;MAPK1;YWHAB;ZC3HAV1;CAMK2G;MARK3;TRIM24;ITGA2B;IQGAP1;FXR1;RAP1A;CNKSR2;RNASE3;KSR1
prerank, Reactome_2022__Intraflagellar Transport R-HSA-5620924                                                                                       , 0.22154555875169935 , 1.122738813393121   , 0.1935483870967742  , 1.0               ,       1.0 , 10/35  , 13.90%, DYNLT2B;KIF3B;DYNC2LI1;TRAF3IP1;DYNLL2;IFT27;IFT57;IFT52;IFT20;IFT43
prerank, KEGG_2021_Human__Glioma                                                                                                                     , -0.25966151997986125, -1.1226375878503763 , 0.27906976744186046 , 0.8231593909144328,       1.0 , 20/65  , 24.90%, BAX;TP53;GADD45G;CALM2;MAPK1;PIK3R3;POLK;PIK3R1;PRKCA;CAMK2G;RB1;TGFA;DDB2;GRB2;CALM3;AKT1;CDKN1A;GADD45A;PIK3CA;SHC4
prerank, Reactome_2022__Olfactory Signaling Pathway R-HSA-381753                                                                                     , -0.2970808433691981 , -1.1222156549063569 , 0.3026315789473684  , 0.822485601349748 ,       1.0 , 27/39  , 51.20%, OR2M3;OR2T33;OR7D2;OR1A1;OR11G2;OR2A7;OR56A4;OR2B6;OR10H1;OR2AT4;OR7C1;OR10G3;OR10H5;OR2L2;OR4D9;EBF1;OR6C74;OR7G2;OR14J1;OR1I1;OR3A2;OR2G6;OR4F17;OR52N4;OR1F1;GNAL;OR52K1
prerank, KEGG_2021_Human__Melanoma                                                                                                                   , -0.2679399791806666 , -1.1211069678110912 , 0.3026315789473684  , 0.8245779879195099,       1.0 , 16/51  , 23.85%, BAX;TP53;GADD45G;MAPK1;PIK3R3;POLK;PIK3R1;CDH1;RB1;DDB2;HGF;PDGFC;AKT1;CDKN1A;GADD45A;PIK3CA
prerank, Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291                                                                        , -0.21628097648965033, -1.1201543079931586 , 0.2127659574468085  , 0.8256996375578309,       1.0 , 116/304, 35.21%, AMDHD1;BCKDK;RPS3;RPL37A;PSMD6;HIBADH;PAOX;OAZ1;IDO1;OAZ2;ALDH9A1;ACADSB;PEMT;IVD;GCAT;RPS8;PSMD7;HAL;ARG2;RPL39;AGXT;GLUD1;EEF1E1;ALDH6A1;LIAS;PSTK;DUOX1;PSMD9;KYNU;TPH2;TPH1;PIPOX;RPS14;RPL36AL;PSMC3;RPL38;PSME4;PDHB;PSMB2;PSME2;OAZ3;IYD;HECA;INMT;BCKDHA;RPL19;SLC25A15;RPL6;VSIG2;CKB;RPS25;SLC6A8;RPL15;CHDH;RIDA;CRYM;CARNS1;LDHD;RPS27A;SLC6A12;RPS6;GSR;GCDH;SLC25A12;PCBD1;GAMT;ECHS1;PSMD8;PSME3;HSD17B10;ALDH4A1;PSMB6;BHMT2;RPS11;SLC38A1;PSMA1;SLC5A5;PHYKPL;ASRGL1;GSTZ1;SUOX;PSMB4;SLC44A1;RPSA;PSMF1;PSME1;RPS9;PSMA3;RPL28;HIBCH;AASS;BCKDHB;RPS15;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;RPL27A;PSMA2;NDUFAB1;CSAD;PSMD10;AHCY;RPL18A;HGD;SLC7A5;RPS16;RPL9;RPL21;PYCR3;DLAT;SEPSECS;SRR;PSMD5;RPL3L
prerank, Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531                                                                                     , -0.26375126171101987, -1.1192857689662932 , 0.2692307692307692  , 0.8262862296240852,       1.0 , 17/54  , 26.97%, NUP85;RPP25;NUP88;CSTF2;CPSF1;NUP107;RAN;CPSF4;FAM98B;RPP14;NUP98;NUP153;TSEN15;POM121C;TSEN34;ZBTB8OS;XPOT
prerank, Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340                                                   , -0.25530110462195665, -1.1191114586791704 , 0.2978723404255319  , 0.8250576286802838,       1.0 , 10/74  , 6.93% , MED27;CEBPD;MED18;CDK19;HDAC3;MED9;LIN9;CEBPB;MED12;MED23
prerank, Reactome_2022__Interleukin-1 Signaling R-HSA-9020702                                                                                        , -0.2420125667603152 , -1.1177098713417801 , 0.3023255813953488  , 0.8278029195066089,       1.0 , 49/110 , 35.15%, SQSTM1;TNIP2;PSMD6;USP18;IRAK1;CASP8;TP53;UBC;TAB3;IKBIP;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;CUL1;PSME2;UBE2N;MAP3K3;MAP3K8;TANK;MAP3K7;UBB;RPS27A;IL1R1;PSMD8;PSME3;PSMB6;HMGB1;PSMA1;TAB1;N4BP1;PSMB4;PSMF1;APP;PSME1;IRAK4;RIPK2;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;IKBKG;PSMD5;NKIRAS2
prerank, Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597                                                                                    , -0.3042234467101916 , -1.1173526435336185 , 0.32926829268292684 , 0.8272279793860555,       1.0 , 11/29  , 24.78%, ADCY7;PRKCH;GNAI3;PRKCA;GNB5;GNGT2;GNG5;GNG11;GNG3;GNAI1;ADCY9
prerank, Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473                                                                                       , -0.2604493870655086 , -1.1171637722557106 , 0.2911392405063291  , 0.8259056714552546,       1.0 , 24/71  , 28.71%, RAD50;H2AX;REXO2;BABAM1;TP53;CHEK1;RPA3;YWHAB;RAD9B;RFC5;BRCA1;UBE2N;POLR1B;H2BC11;ABRAXAS1;HUS1;CDC25C;CHEK2;BABAM2;UIMC1;RNF168;RHNO1;YWHAQ;RMI1
prerank, Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409                                                                         , -0.29902474055491113, -1.1165687736035412 , 0.2876712328767123  , 0.8259363352813822,       1.0 , 16/26  , 37.71%, UBC;CDC20;UBE2C;CDC26;UBE2E1;UBB;RPS27A;UBE2D1;NEK2;BUB1B;ANAPC4;BUB3;UBE2S;MAD2L1;ANAPC16;ANAPC2
prerank, Reactome_2022__Metabolism Of Cofactors R-HSA-8978934                                                                                        , -0.36523038975518196, -1.1164434259641498 , 0.3013698630136986  , 0.824473698151642 ,       1.0 , 9/16   , 43.03%, PTS;DHFR;AKT1;GCHFR;HSP90AA1;PDSS2;CALM1;PDSS1;IDH1
prerank, KEGG_2021_Human__Fluid shear stress and atherosclerosis                                                                                     , -0.24147083769960098, -1.115794266731623  , 0.2857142857142857  , 0.8247557774542031,       1.0 , 51/113 , 37.54%, ITGB3;SQSTM1;GSTP1;VEGFA;TP53;ITGAV;PLAT;CALM2;PIK3R3;GSTM1;PIK3R1;NOS3;MGST1;MAPK8;MMP9;TNFRSF1A;MAP3K7;GSTO1;MAP2K7;ACVR2B;MEF2C;CALM3;AKT1;IL1R1;ITGA2B;ACVR2A;KLF2;MAPK11;DUSP1;PIK3CA;MAP3K5;HSP90B1;MGST2;BMPR2;ARHGEF2;HMOX1;NCF2;GSTO2;NCF1;TXN;SRC;HSP90AA1;AKT2;PDGFB;PIK3CB;IKBKG;MAPK10;GSTA4;ACTG1;ICAM1;JUN
prerank, Reactome_2022__Condensation Of Prophase Chromosomes R-HSA-2299718                                                                           , 0.24181919451759928 , 1.1154231383830635  , 0.32                , 1.0               ,       1.0 , 13/40  , 15.18%, SMC4;NCAPH2;H2AZ2;H2BC3;NCAPD3;MCPH1;H2AB1;H2BC17;CDK1;H2BC5;H2BC9;H2AC20;H2AZ1
prerank, Reactome_2022__Neutrophil Degranulation R-HSA-6798695                                                                                       , -0.204416353300381  , -1.114798737906331  , 0.24                , 0.8261265820631464,       1.0 , 94/437 , 18.15%, FCER1G;CD58;DPP7;ENPP4;PSMD6;P2RX1;SRP14;GNS;PADI2;IGF2R;TMED7-TICAM2;GRN;GM2A;GSTP1;NCSTN;DIAPH1;TBC1D10C;PIKFYVE;SNAP25;RAB6A;ITGAV;EEF1A1;LOC112694756;XRCC5;AZU1;B4GALT1;PSMD7;FRMPD3;CD44;TMEM30A;SYNGR1;PTPRJ;ATP6V0A1;CDA;NFAM1;MAPK1;CEACAM1;EEF2;ELANE;CHIT1;CPNE3;SELL;FAF2;ACTR10;CEACAM6;ITGAL;CEACAM8;CYBB;PSMC3;RHOF;DYNC1LI1;YPEL5;QSOX1;MGST1;LYZ;FUCA1;CRACR2A;TCIRG1;PTAFR;TIMP2;ORM2;RAB44;PPBP;PRDX4;ARHGAP9;CAB39;ATP11A;MMP9;CAP1;HEBP2;TMBIM1;DNAJC5;STK11IP;ITGAM;CHRNB4;LRG1;GYG1;HVCN1;TMEM179B;ARMC8;STOM;ARPC5;PLAC8;ORMDL3;NCKAP1L;HSPA1A;AP1M1;FGR;CRISPLD2;CEACAM21;ADAM8;C3AR1;ADA2;DYNC1H1
prerank, Reactome_2022__Programmed Cell Death R-HSA-5357801                                                                                          , -0.2281837632774464 , -1.1147678438007609 , 0.30851063829787234 , 0.8244015794940732,       1.0 , 74/194 , 33.55%, PSMD6;RRM1;H1-3;PPP1R13B;CHMP4B;BAX;REXO2;TMED7-TICAM2;CASP3;FASLG;CASP8;TP53;UBC;PSMD7;MED12;MAPK1;PSMD9;ELANE;TICAM1;YWHAB;PSMC3;PSME4;PMAIP1;PSMB2;PSME2;KPNA1;BMX;STK26;LY96;CHMP6;MAPK8;HMGB2;GAS2;GZMB;TANK;CASP7;DAPK2;UBB;RPS27A;AKT1;PPP3CC;UACA;OMA1;PSMD8;PSME3;PSMB6;HMGB1;BID;FNTA;DSG2;PSMA1;DFFB;PSMB4;H1-0;YWHAQ;CHMP2A;MLKL;PSMF1;PSME1;PSMA3;DBNL;PSMB1;SDCBP;GSDME;PSMC4;SEM1;PSMA6;HSP90AA1;PSMD11;PSMA2;AKT2;BMF;CYCS;PSMD10
prerank, Reactome_2022__Signaling By SCF-KIT R-HSA-1433557                                                                                           , -0.29000710944105174, -1.1146209301133434 , 0.4050632911392405  , 0.8230049728032623,       1.0 , 10/38  , 20.71%, YES1;PTPN11;FER;CHEK1;PIK3R3;PIK3R1;PRKCA;MMP9;GRB2;GAB2
prerank, Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385                                                          , -0.3421815292085395 , -1.1139969799284124 , 0.3466666666666667  , 0.8232386102512808,       1.0 , 10/17  , 43.09%, EXOSC6;YWHAB;AKT1;EXOSC2;DCP1A;ZFP36L1;EXOSC5;EXOSC8;EXOSC3;DCP2
prerank, Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856                                                                      , -0.25253396509123255, -1.1132141483472346 , 0.32142857142857145 , 0.8237903416140692,       1.0 , 28/66  , 36.08%, MAGOH;FYTTD1;CSTF2;SYMPK;THOC1;SRSF3;CPSF1;SNRPF;CPSF4;LSM10;THOC7;EIF4A3;SRSF1;CDC40;NCBP1;SRRM1;SNRPD3;SRSF5;CPSF7;MAGOHB;CPSF3;UPF3B;CSTF2T;DDX39A;THOC2;FIP1L1;WDR33;SRSF9
prerank, Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315                                                                           , -0.23243225448508908, -1.1128363871605584 , 0.23595505617977527 , 0.8233353167260984,       1.0 , 69/140 , 40.03%, RASGRF2;ADCY7;CACNG8;PLCB2;TSPAN7;PDPK1;SNAP25;CACNB3;SLC6A13;PLCB1;PRKAG2;MAPK1;PPM1F;GNAI3;LGALS12;PRKCA;DLG1;RPS6KA3;GNB5;GNGT2;CAMK2G;STXBP1;DNAJC5;PRKAR2A;CHRNB4;CHRFAM7A;GNG5;SLC1A2;PRKACB;HTR3B;GNG11;SLC6A12;GNG3;PRKAG1;CACNA1E;GNAI1;RAB3A;ADCY9;PRKX;SLC38A1;LIN7A;NCALD;PRKAR1A;KCNJ15;AKAP5;ARL6IP5;LIN7C;SRC;STX1A;CHRNE;SH2D3C;CASK;GNB2;NPTN;PLCB3;CACNB1;GIT1;NSF;CACNB4;AP2S1;MAPT;CHRNA2;CALM1;MAOA;CAMKK1;SLC6A4;CACNA1A;NRG1;ALDH5A1
prerank, KEGG_2021_Human__Pathways of neurodegeneration                                                                                              , -0.21563601342895472, -1.1113184860831293 , 0.18085106382978725 , 0.8267437938025295,       1.0 , 95/364 , 23.79%, SQSTM1;NDUFB3;PSMD6;LRP6;WDR41;SDHC;ATP5PB;BAX;PLCB2;COX6C;FUS;CASP3;GPX3;FASLG;CASP8;COX5A;UBC;HTRA2;RAB39B;UQCRC1;PSMD7;WNT10A;UQCRFS1;EIF2S1;CALM2;PLCB1;PPIF;NDUFB2;MAPK1;ACTR1A;PSMD9;CHRM3;FZD6;NDUFA7;ACTR10;ATP2A3;CYBB;UQCRB;CSNK2A2;ATG14;PSMC3;CAT;ATF6;TBK1;PSMB2;PRKCA;LRP5;HIP1;ADRM1;UBE2L3;DCTN3;MAPK8;UBE2J1;CAMK2G;NDUFB9;ATG101;UBE2G1;CSF1;AMBRA1;SNCA;ATP5MC3;TANK;TNFRSF1A;WIPI2;TOMM40L;MAP2K7;ULK2;CASP7;UBE2J2;ATG2A;DNAH1;MAP3K10;NDUFS1;TOMM40;NDUFB7;UBB;CCS;RPS27A;KIF5A;NDUFB5;CALM3;PPP3CC;NDUFB4;ATG13;SEPTIN5;NDUFS7;DLG4;PSMD8;HSD17B10;VCP;MAPK11;NDUFV3;TUBB6;PSMB6;UBA1
prerank, Reactome_2022__Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430                                                                , 0.31533710586761754 , 1.1110931478170951  , 0.30303030303030304 , 1.0               ,       1.0 , 2/15   , 2.55% , ZAP70;PTPN22
prerank, "Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662"                        , 0.21354426897618994 , 1.1110000725072064  , 0.17647058823529413 , 1.0               ,       1.0 , 10/57  , 8.93% , RPS24;RPS29;EIF2S3;EIF4A1;EIF4H;RPS15A;RPS4X;RPS20;RPS4Y1;EIF3M
prerank, Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243                             , 0.24368981110069837 , 1.1106987974840268  , 0.35294117647058826 , 1.0               ,       1.0 , 7/33   , 9.82% , PCGF5;SMARCD2;RUNX1;PHC2;ARID1B;HIPK2;CBFB
prerank, KEGG_2021_Human__Lipid and atherosclerosis                                                                                                  , -0.23089237666259582, -1.1088494465604446 , 0.2736842105263158  , 0.8328193654637034,       1.0 , 91/177 , 42.71%, BAX;PLCB2;CASP3;IRAK1;FASLG;CASP8;PDPK1;TP53;CYP2C9;EIF2S1;CALM2;TIRAP;PLCB1;MAPK1;PIK3R3;TICAM1;PIK3R1;CYBB;ATF6;NOS3;TBK1;PRKCA;LY96;MAPK8;CAMK2G;ROCK2;MMP9;ERO1A;TANK;MIB1;TNFRSF1A;MAP3K7;MAP2K7;CASP7;HSPA1A;SOD2;TICAM2;CDC42;ABCA1;CALM3;AKT1;PPP3CC;PPARG;CD14;HSPA4;MAPK11;PIK3CA;HSPA2;MAP3K5;RAP1A;BID;ARHGEF1;TAB1;HSP90B1;NFATC2;HSPA5;NCF2;IRF7;NCF1;IRAK4;TLR2;SRC;FAS;HSP90AA1;AKT2;CYCS;NLRP3;PLCB3;PIK3CB;IKBKG;VAV3;MAPK10;IL12A;XBP1;LDLR;ICAM1;JUN;TRAF6;CALM1;TRAF2;ITPR1;RELA;IL18;CAMK2A;RXRB;CD40LG;IRF3;LYN;TNF;PYCARD;RAP1B
prerank, KEGG_2021_Human__Necroptosis                                                                                                                , -0.23276166255746916, -1.1082924147277555 , 0.3225806451612903  , 0.8327851829822498,       1.0 , 26/133 , 16.26%, SQSTM1;CHMP4B;BAX;H2AX;TRPM7;VPS4B;FASLG;ZBP1;CASP8;H2AC19;H2AC17;GLUD1;H2AC21;TYK2;FAF1;H2AC8;H2AB2;TICAM1;CYBB;H2AC7;CHMP6;MAPK8;CAMK2G;AIFM1;TNFRSF1A;TLR3
prerank, Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813                                                                                , -0.22030874441624365, -1.1081353347711387 , 0.25                , 0.8313674016110318,       1.0 , 73/165 , 36.35%, NUP85;PSMD6;CENPO;UBC;CENPA;CENPU;RANGAP1;PPP2R5E;PSMD7;CENPT;PSMD9;ITGB3BP;CLASP2;CDC20;UBE2C;PSMC3;PSME4;DYNC1LI1;PSMB2;PDS5B;KIF18A;CDC26;PSME2;CLASP1;NUP107;PPP2R5B;SMC1A;NUP98;UBE2E1;XPO1;DYNC1H1;CENPS-CORT;UBB;RPS27A;CKAP5;PSMD8;CENPM;PSME3;DYNC1LI2;INCENP;PSMB6;UBE2D1;WAPL;PMEPA1;PSMA1;PMF1-BGLAP;PSMB4;PPP2CA;MAPRE1;SKA2;PSMF1;KNL1;PSME1;PSMA3;KIF2C;PSMB1;PSMC4;BUB1B;SEM1;PSMA6;CENPQ;PSMD11;PSMA2;PSMD10;BIRC5;ANAPC4;MAD1L1;BUB3;PSMD5;CENPI;UBE2S;NDE1;MAD2L1
prerank, Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054                                                                                 , -0.3163130061592039 , -1.1077243124067224 , 0.35064935064935066 , 0.8310943737524952,       1.0 , 13/28  , 31.11%, HDAC3;NCOR2;NOTCH3;HDAC11;MAML2;KAT2B;RBPJ;HDAC9;MAMLD1;CREBBP;HDAC6;KAT2A;MAML1
prerank, Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202                               , -0.20876686672267522, -1.1075791778062953 , 0.21428571428571427 , 0.8297833034042779,       1.0 , 133/365, 33.19%, ITGB3;JAG1;SQSTM1;PSMD6;HDAC3;LRP6;YES1;FGFR1OP2;BCL2A1;PTPN11;ARRB1;HHAT;NCSTN;MYH9;PDPK1;UBC;PPP2R5E;PSMD7;AKAP9;CEBPB;MAPK1;TFG;PIK3R3;PSMD9;IRS1;EEF1G;FZD6;DUSP6;PIK3R1;HEY1;YWHAB;RNASEH2A;TRIP11;AREG;PSMC3;PSME4;PSMB2;CUL1;PSME2;LRP5;HIP1;PHB1;ZC3HAV1;PPP2R5B;SMAD3;NCOR2;CAMK2G;POLR2G;ZC3HC1;GATD3;STRN;MIB1;HDAC11;ERBB3;MAML2;TGFA;POLR2B;KAT2B;GRB2;RBPJ;MARK3;POLR2D;CLTC;UBB;RRBP1;RPS27A;ERBIN;AKT1;RPS6;ETV6;TRIM24;NCBP1;HDAC9;ITGA2B;GAB2;IQGAP1;PSENEN;CDKN1A;PSMD8;PSME3;DUSP7;FGFR2;ADAM10;MAP3K11;DUSP16;VCP;PSMB6;PIK3CA;FXR1;APH1B;RAP1A;PPFIBP1;FOXO1;CNKSR2;RNASE3;KSR1;MAMLD1;CREBBP;KANK1;PSMA1;PRKAR1A;SPTBN1;HDAC6;SPRED1;PSMB4;SHOC2;PPP2CA;RICTOR;AMER1;PSMF1;KAT2A;PSME1;TENT4A;QKI;PSMA3;ZMYM2;SRC;MAML1;FBXW7;PSMB1;PSMC4;SEM1;PSMA6;DUSP8;HSP90AA1;PSMD11;HBEGF;PSMA2;AKT2;ERLEC1;TPM4;VCL;MYO18A
prerank, Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482                                                                     , -0.3274150069311673 , -1.1059500345635276 , 0.3188405797101449  , 0.8327705416048434,       1.0 , 7/19   , 16.34%, MMUT;ABCD4;PCCA;TCN2;CUBN;HLCS;PCCB
prerank, Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453                                                                , -0.24059044614586614, -1.1058224920542097 , 0.30120481927710846 , 0.8314374975215133,       1.0 , 21/75  , 23.99%, NUP85;BAG3;NUP88;RPS19BP1;MRPL18;MAPK1;RPA3;NUP107;POLR1B;SIRT1;NUP98;HSPA1A;HSPH1;NUP153;UBB;FKBP4;BAG5;HSPA4;POM121C;DNAJC2;HSPA2
prerank, Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058                                                           , -0.23439446467898553, -1.1051581101896395 , 0.32926829268292684 , 0.8318629810862855,       1.0 , 25/104 , 19.10%, TNIP2;ECSIT;USP18;IRAK1;CASP8;TP53;UBC;TAB3;IKBIP;MAP3K1;TIRAP;MAPK1;DUSP6;CUL1;RPS6KA3;LY96;MAPK8;UBE2N;MAP3K8;TANK;MAP3K7;MAP2K7;MEF2C;UBB;RPS27A
prerank, KEGG_2021_Human__Serotonergic synapse                                                                                                       , -0.25956744329839254, -1.1049473628878204 , 0.3333333333333333  , 0.8306096598012765,       1.0 , 20/64  , 24.58%, PLCB2;CASP3;CYP2C9;PLCB1;MAPK1;TPH2;GNAI3;TPH1;PTGS1;PRKCA;GNB5;GNGT2;GNG5;PRKACB;HTR3B;GNG11;GNG3;DUSP1;RAPGEF3;GNAI1
prerank, Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070                                                                                  , 0.226730190485865   , 1.1043132210768194  , 0.19047619047619047 , 1.0               ,       1.0 , 4/46   , 2.30% , GFPT1;ZBTB17;DNAJC3;ADD1
prerank, Reactome_2022__Mitophagy R-HSA-5205647                                                                                                      , -0.2959813416017081 , -1.1032215489089252 , 0.3157894736842105  , 0.8345250288895892,       1.0 , 8/28   , 19.10%, SQSTM1;UBC;CSNK2A2;MTERF3;TOMM40;UBB;ATG12;RPS27A
prerank, Reactome_2022__Interleukin-17 Signaling R-HSA-448424                                                                                        , -0.24922413490833883, -1.1024042985968283 , 0.3194444444444444  , 0.8357042070126705,       1.0 , 16/62  , 19.10%, TNIP2;IRAK1;UBC;TAB3;MAPK1;DUSP6;CUL1;RPS6KA3;MAPK8;UBE2N;MAP3K8;MAP3K7;MAP2K7;MEF2C;UBB;RPS27A
prerank, KEGG_2021_Human__Epstein-Barr virus infection                                                                                               , -0.22388215448957025, -1.1022662153491005 , 0.28865979381443296 , 0.8343317118492273,       1.0 , 48/181 , 24.44%, NFKBIE;CD58;SAP30;PSMD6;CD3D;BAX;CASP3;IRAK1;CASP8;TP53;PSMD7;CD44;GADD45G;CCNA1;TYK2;PIK3R3;HLA-G;POLK;ITGAL;PIK3R1;PSMC3;OAS2;TBK1;ADRM1;MAPK8;NCOR2;CD3G;RUNX3;RB1;MAP3K7;USP7;MAP2K7;DDB2;SAP30L;RBPJ;TNFAIP3;AKT1;IRF9;CDKN1A;PSMD8;GADD45A;CCNA2;MAPK11;NEDD4;PIK3CA;BLNK;OAS1;BID
prerank, KEGG_2021_Human__Circadian entrainment                                                                                                      , -0.26385951244993605, -1.1016481528795707 , 0.3488372093023256  , 0.8341050741653948,       1.0 , 16/57  , 19.82%, ADCY7;PLCB2;CALM2;PLCB1;MAPK1;GNAI3;PRKCA;GNB5;GNGT2;CAMK2G;CACNA1H;GNG5;PRKACB;GNG11;CALM3;GNG3
prerank, Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334                                                                                           , -0.24783872172757082, -1.101236106134501  , 0.3333333333333333  , 0.8335239846394169,       1.0 , 44/75  , 44.41%, EPHB3;EFNB1;YES1;NCSTN;MYH9;EPHB4;ROCK2;MMP9;ARPC5;VPS72;CDC42;CLTC;PSENEN;LIMK1;ADAM10;ARPC3;APH1B;ARPC2;MYL12B;ACTR3;LIMK2;SRC;SDCBP;EPHB6;GIT1;VAV3;EPHA7;AP2S1;NCK2;MYL9;EPHA1;ACTG1;ROCK1;KALRN;ACTR2;CLTA;EFNA3;AP2M1;EFNA4;APH1A;LYN;CLTB;FYN;EPHB2
prerank, KEGG_2021_Human__RNA transport                                                                                                              , -0.2224053982354477 , -1.1007978053540628 , 0.3404255319148936  , 0.8333473711470768,       1.0 , 20/164 , 7.99% , NUP85;MAGOH;SNORD3A;RPP25;ELAC1;RNU5A-1;CYFIP2;GEMIN8;SNORD3B-1;NUP88;FUS;EEF1A1;RANGAP1;UPF1;EIF2S1;THOC1;PHAX;FXR2;SNUPN;PABPC1L
prerank, Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569                            , -0.3200115552034693 , -1.1005402584688269 , 0.4025974025974026  , 0.8325109116183218,       1.0 , 13/32  , 30.70%, CETP;HDAC3;PLTP;TNRC6C;AGO3;NCOR2;AGO1;ABCA1;MOV10;KDM1A;APOE;AGO2;NCOA1
prerank, Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422                                                                                           , -0.3269188185092775 , -1.1004093337493117 , 0.3382352941176471  , 0.8310424237917253,       1.0 , 9/23   , 27.58%, STK38;TXNL1;RBBP6;CUL3;ROCK2;RNF20;SRRM1;CPSF7;CCT2
prerank, Reactome_2022__Signaling By Interleukins R-HSA-449147                                                                                       , -0.19963789398349774, -1.0998326172921142 , 0.27                , 0.831412605822837 ,       1.0 , 86/381 , 19.97%, VAMP7;SQSTM1;CEBPD;TNIP2;PSMD6;YES1;USP18;IL18RAP;PTPN11;CASP3;IRAK1;FASLG;CASP8;VEGFA;STX4;SNAP25;TP53;UBC;CRK;IL2RG;TAB3;F13A1;IKBIP;PSMD7;STXBP2;SOCS3;TYK2;MAPK1;IL27;PIK3R3;PSMD9;IRS1;SERPINB2;PTPN18;DUSP6;PIK3R1;IL12RB1;IL10;RNASEH2A;PSMC3;PSME4;TBK1;IL3RA;PSMB2;CUL1;RHOU;IL4;PRKCA;PSME2;RPS6KA3;IL1RL1;HIF1A;PDCD4;MAPK8;SMAD3;PTAFR;UBE2N;HNRNPF;MAP3K3;CSF1;MMP9;CISH;IL18R1;ITGAM;CNTF;MAP3K8;TANK;TNFRSF1A;CCL20;MAP3K7;CLCF1;GSTO1;MAP2K7;IL24;VPS72;MEF2C;CDC42;GRB2;UBB;RPS27A;IL23R;HAVCR2;NANOG;AKT1;IL1R1;AURKAIP1
prerank, KEGG_2021_Human__Homologous recombination                                                                                                   , -0.2668116156294135 , -1.0990506124506605 , 0.345679012345679   , 0.8323906622239392,       1.0 , 17/41  , 33.80%, RAD50;BABAM1;RAD54B;RPA3;BRCA1;ABRAXAS1;RPA1;BABAM2;UIMC1;POLD4;PALB2;XRCC3;RAD51D;POLD2;TOP3A;SEM1;RAD51B
prerank, Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417                                                                    , -0.28587154932011877, -1.095675849177702  , 0.35064935064935066 , 0.8418319610778443,       1.0 , 11/33  , 25.93%, SLC19A1;RPA3;CTC1;PRIM2;RFC5;POLR1B;CHTF8;FEN1;POLD4;CHTF18;POT1
prerank, Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977                                                                               , -0.2310789244490033 , -1.0946210535789123 , 0.36363636363636365 , 0.8434137145943659,       1.0 , 28/122 , 19.09%, COPZ1;CSNK1D;SEC24D;F5;SEC24C;COG2;GOLGA2;STX17;LMAN2L;NAPSA;ACTR1A;TFG;ACTR10;AREG;LMAN2;CAPZA2;DYNC1LI1;MCFD2;DCTN3;CAPZB;TMEM115;KDELR2;TRAPPC2;TGFA;DYNC1H1;KDELR1;LMAN1;COPE
prerank, KEGG_2021_Human__Viral myocarditis                                                                                                          , -0.27138848158499385, -1.0943194525766458 , 0.30864197530864196 , 0.8426130511413071,       1.0 , 7/52   , 9.02% , DAG1;CASP3;CASP8;SGCA;SGCB;HLA-G;ITGAL
prerank, Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279                                                                            , -0.23174732439756196, -1.0939953985221031 , 0.2903225806451613  , 0.841932007520141 ,       1.0 , 64/146 , 35.85%, PSMD6;UBC;MCM5;LIN9;PSMD7;CCNA1;RPA3;PSMD9;PRIM2;ORC3;PSMC3;PSMB2;CUL1;PSME2;TK1;DHFR;SLC25A15;CDC6;POLR1B;RB1;CDKN2D;CDKN2C;E2F6;CCNH;CDT1;UBB;RPS27A;RRM2;AKT1;MNAT1;CDKN1A;PSMD8;PSME3;PPP2R2A;CCNA2;PTK6;PSMB6;RBBP4;PSMA1;PSMB4;PPP2CA;CDKN1C;PSMF1;LIN54;PSME1;POLE3;PSMA3;CKS1B;SRC;MCM6;RBL2;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;AKT2;PSMD10;GMNN;CDC45;PSMD5;TFDP2;POLE4
prerank, Reactome_2022__Voltage Gated Potassium Channels R-HSA-1296072                                                                               , 0.2774780771508419  , 1.093673068204544   , 0.2962962962962963  , 1.0               ,       1.0 , 2/16   , 2.94% , KCNA3;KCNQ1
prerank, Reactome_2022__RAF Activation R-HSA-5673000                                                                                                 , -0.28959722392875004, -1.0935543521066786 , 0.2894736842105263  , 0.8414857784431138,       1.0 , 17/31  , 41.06%, PPP2R5E;YWHAB;PHB1;PPP2R5B;CAMK2G;MARK3;MAP3K11;RNASE3;KSR1;SHOC2;PPP2CA;SRC;MAP2K2;CALM1;PPP1CB;CAMK2A;MAP2K1
prerank, Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712                                                                             , -0.32420213811662685, -1.0933642448217515 , 0.35064935064935066 , 0.840092605394307 ,       1.0 , 12/21  , 32.94%, NR5A2;GATD3;MAML2;KAT2B;RBPJ;AKT1;FOXO1;MAMLD1;CREBBP;KAT2A;MAML1;AKT2
prerank, Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481                                                                                 , -0.2265788847702935 , -1.0932346119343566 , 0.34444444444444444 , 0.8386822422422106,       1.0 , 46/119 , 33.55%, FCER1G;PSMD6;CASP8;PDPK1;UBC;TAB3;PSMD7;UBA3;PSMD9;PSMC3;PSME4;PSMB2;CUL1;PRKCA;PSME2;UBE2N;BCL10;MAP3K7;PRKACB;UBB;RPS27A;CLEC10A;PSMD8;PSME3;PSMB6;UBE2D1;RNASE3;CREBBP;PSMA1;TAB1;NFATC2;UBE2D2;PSMB4;SYK;RELB;PSMF1;PSME1;PSMA3;SRC;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310                                                                                         , 0.2004752863398327  , 1.0922849296665709  , 0.34615384615384615 , 1.0               ,       1.0 , 9/37   , 15.22%, FANCE;FANCI;FANCB;SLX4;EME1;FANCD2;POLR1A;UBE2T;UBA52
prerank, Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202                                                                          , -0.2255896652394842 , -1.0920890983597509 , 0.30337078651685395 , 0.8405962585927511,       1.0 , 56/128 , 36.17%, FCER1G;PSMD6;PDPK1;UBC;TAB3;PSMD7;MAP3K1;MAPK1;PSMD9;RASGRP2;PIK3R1;PSMC3;PSME4;PSMB2;CUL1;PSME2;MAPK8;UBE2N;BCL10;MAP3K7;MAP2K7;GRB2;FCER1A;UBB;RPS27A;GAB2;PSMD8;PSME3;PSMB6;UBE2D1;PIK3CA;PSMA1;TAB1;BTK;NFATC2;UBE2D2;PSMB4;SYK;PSMF1;MS4A2;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PIK3CB;IKBKG;PSMD5;ITK;VAV3;MAPK10;PLCG2
prerank, Reactome_2022__Interleukin-37 Signaling R-HSA-9008059                                                                                       , -0.33051007944970967, -1.0920724549988414 , 0.358974358974359   , 0.8388918365800045,       1.0 , 5/18   , 15.14%, PTPN11;PTPN18;TBK1;SMAD3;IL18R1
prerank, Reactome_2022__DNA Replication R-HSA-69306                                                                                                  , -0.22014040650304056, -1.0920629135343265 , 0.3076923076923077  , 0.8371486960289946,       1.0 , 66/150 , 37.71%, PSMD6;H2AX;UBC;H2AC19;SLC19A1;MCM5;PSMD7;CCNA1;RPA3;PSMD9;UBE2C;PRIM2;ORC3;PSMC3;PSME4;PSMB2;CUL1;CDC26;PSME2;KPNA1;RFC5;H2AC7;SLC25A15;CDC6;POLR1B;H2BC11;UBE2E1;H3-3B;CDT1;FEN1;UBB;RPS27A;PSMD8;PSME3;CCNA2;POLD4;PSMB6;UBE2D1;PSMA1;PSMB4;KPNA6;PSMF1;GINS1;PSME1;H2AC6;POLE3;PSMA3;POLD2;MCM6;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;GMNN;CDC45;PSMD5;POLE4;UBE2S;POLE;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382                                               , -0.3495243980051664 , -1.091983668906759  , 0.39705882352941174 , 0.8356647720839833,       1.0 , 6/17   , 23.85%, UBC;PIK3R1;GRB2;UBB;RPS27A;PIK3CA
prerank, KEGG_2021_Human__Shigellosis                                                                                                                , -0.2065424350140398 , -1.0915802245528086 , 0.30303030303030304 , 0.8349640145809012,       1.0 , 65/224 , 26.38%, SQSTM1;ARF1;HK3;BAX;PLCB2;H3C2;SEPTIN6;DIAPH1;TP53;UBC;CRK;TAB3;CTTN;CD44;H3C15;PLCB1;H3C6;MAPK1;PIK3R3;CYTH2;PIK3R1;H3C10;ATG14;FNBP1;CYTH1;FNBP1L;TBK1;CUL1;RRAGD;CBX3;MAPK8;RPS6KB1;MYL5;UBE2N;ROCK2;PFN1;BCL10;TNFRSF1A;WIPI2;MAP3K7;ARPC5;H3-3B;ARF6;CDC42;UBB;ATG12;RPS27A;PXN;AKT1;IL1R1;CAST;CD14;ITGA5;MAPK11;WASF1;UBE2D1;PIK3CA;ARPC3;FOXO1;RRAGB;GLMN;ARPC2;ATG16L1;TAB1;PLCD3
prerank, KEGG_2021_Human__Adherens junction                                                                                                          , -0.2514673166771054 , -1.0910913857535836 , 0.34831460674157305 , 0.834448617148548 ,       1.0 , 26/61  , 33.19%, YES1;FER;PTPRJ;MAPK1;WAS;CDH1;CSNK2A2;LEF1;NECTIN2;SORBS1;SMAD3;MAP3K7;PTPRF;CDC42;FARP2;IQGAP1;WASF1;CREBBP;CTNND1;NLK;AFDN;PTPRM;SRC;TCF7L1;INSR;VCL
prerank, Reactome_2022__Muscle Contraction R-HSA-397014                                                                                              , -0.23973567907470508, -1.091049467039088  , 0.33707865168539325 , 0.8327975768192217,       1.0 , 26/121 , 17.74%, ABCC9;CACNG8;ITGB5;RANGRF;MYH3;FGF12;TMOD4;CACNG6;ASPH;KCNE5;AKAP9;KCNK7;ATP2A3;MYL11;ACTA2;PRKCA;KCNE3;SORBS1;MYL5;CAMK2G;CACNA1H;ITGA1;KCND3;SCN1B;ATP1B1;KAT2B
prerank, Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038                                                                               , 0.235219470259103   , 1.0903838098020786  , 0.2727272727272727  , 1.0               ,       1.0 , 4/44   , 2.30% , GFPT1;ZBTB17;DNAJC3;ADD1
prerank, Reactome_2022__HCMV Early Events R-HSA-9609690                                                                                              , -0.23332664582300852, -1.0903318021031618 , 0.32941176470588235 , 0.8330382204341317,       1.0 , 18/86  , 19.25%, PML;NUP85;RRM1;HDAC3;NUP88;H2AC19;H2AC21;IRS1;DYNC1LI1;H2AC7;NUP107;NCOR2;RBBP7;H2BC11;NUP98;NUP153;DYNC1H1;HSD17B4
prerank, KEGG_2021_Human__Endometrial cancer                                                                                                         , -0.2550605440861394 , -1.0890315669954769 , 0.32432432432432434 , 0.8355893138359456,       1.0 , 16/54  , 23.85%, BAX;PDPK1;TP53;GADD45G;MAPK1;PIK3R3;POLK;PIK3R1;CDH1;LEF1;DDB2;GRB2;AKT1;CDKN1A;GADD45A;PIK3CA
prerank, Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372                                                           , -0.24758401635181052, -1.088883569075988  , 0.3563218390804598  , 0.8344889254168012,       1.0 , 32/77  , 35.04%, NFKBIE;PSMD6;UBC;PSMD7;PSMD9;PSMC3;PSME4;PSMB2;CUL1;PSME2;BCL10;MAP3K7;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;NFATC2;PSMB4;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;IKBKG;PSMD5
prerank, Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462                                                                         , -0.29134667462135067, -1.0888466513346098 , 0.3717948717948718  , 0.8329868795018658,       1.0 , 10/24  , 31.70%, UBC;CUL5;SOCS3;TYK2;UBB;RPS27A;UBE2D1;UBE2D2;SYK;ELOC
prerank, Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555                                                                                    , -0.24958044577676   , -1.0885904432819256 , 0.38202247191011235 , 0.8320765815991983,       1.0 , 30/81  , 26.86%, ADCY7;GPER1;ARRB1;PDE1B;PPAN-P2RY11;TSHR;GNAI3;PDE2A;RLN2;PRKCA;GNB5;CALCRL;GNGT2;ADORA2A;GPR15;PRKAR2A;GNG5;PRKACB;GNG11;GNG3;MC1R;PTGIR;ITGA5;PDE4D;PTGDR;GNAI1;ADCY9;ADM2;PRKAR1A;POMC
prerank, Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210                                                        , -0.2506948549087758 , -1.0885181900385141 , 0.3                 , 0.8308104474041609,       1.0 , 28/63  , 36.51%, AQR;GTF2H3;UBC;SLC19A1;RPA3;POLK;RFC5;POLR2G;POLR1B;USP7;POLR2B;CCNH;POLR2D;UBB;RPS27A;MNAT1;POLD4;ERCC6;TCEA1;GTF2H4;XRCC1;POLE3;POLD2;ERCC3;GTF2H1;POLE4;POLR2E;POLE
prerank, Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391                                                                               , -0.26597951077646775, -1.0882062849738139 , 0.358974358974359   , 0.8303345084522313,       1.0 , 17/61  , 19.82%, UHMK1;PDPK1;MAPK1;PIK3R3;GNAI3;PIK3R1;AREG;GNB5;GNGT2;MMP9;STRN;GNG5;TGFA;XPO1;GNG11;AKT1;GNG3
prerank, KEGG_2021_Human__ABC transporters                                                                                                           , -0.2898323343863368 , -1.088157681133817  , 0.3875              , 0.8287861840487404,       1.0 , 9/34   , 23.34%, ABCA6;ABCC9;ABCB4;ABCD4;ABCB11;ABCC4;ABCA1;ABCB1;ABCA2
prerank, Reactome_2022__Protein Localization R-HSA-9609507                                                                                           , -0.22591747050618857, -1.088086738048041  , 0.34408602150537637 , 0.827333550112889 ,       1.0 , 42/157 , 23.81%, CYB5A;CHCHD7;PEX2;PEX6;PAOX;OTOF;ACOT8;MTX1;ACOX2;UBC;AGXT;CRAT;USP9X;SLC25A17;PIPOX;SEC61B;GRPEL1;COA6;CMC2;PMPCA;PEX26;TIMM10B;IDH3G;CMC4;ACOT4;UBE2J2;ACOX1;TOMM40;UBB;LDHD;RPS27A;HSD17B4;DECR2;PEX5;CHCHD3;SLC25A12;ECH1;FXN;PEX14;SYCP2;EMD;UBE2D1
prerank, KEGG_2021_Human__Lysosome                                                                                                                   , -0.22258774480011634, -1.0879169294574802 , 0.29347826086956524 , 0.8261543439195229,       1.0 , 41/120 , 27.85%, DNASE2;AP3B2;LAMP3;GNS;IGF2R;GM2A;AP4B1;NAPSA;ATP6V0A1;CLN5;AP3D1;CTNS;FUCA1;CTSK;TCIRG1;GGA1;PPT1;AP1S2;AP4S1;AP1M1;CTSE;CLTC;NAGLU;SGSH;SLC11A2;AP3M2;ARSB;HYAL3;ATP6V0A2;AP1S1;ABCA2;CTSW;LAPTM4B;AP1G1;SLC17A5;SLC11A1;PSAP;GNPTG;ATP6V0D1;CTSD;MANBA
prerank, Reactome_2022__Potassium Channels R-HSA-1296071                                                                                             , -0.270849224744083  , -1.087490863513383  , 0.345679012345679   , 0.8259587330441159,       1.0 , 17/44  , 28.56%, KCNMA1;ABCC9;KCNK7;KCNA7;GNB5;GNGT2;KCNQ5;KCND3;GNG5;GNG11;GNG3;KCNMB1;KCNJ11;KCNAB3;KCNH2;KCNK6;KCNJ15
prerank, KEGG_2021_Human__MAPK signaling pathway                                                                                                     , -0.21341370354153993, -1.0874425983320124 , 0.3404255319148936  , 0.8244097345024818,       1.0 , 66/225 , 25.44%, RASGRF2;ECSIT;DUSP2;TGFB3;CACNG8;MKNK1;ARRB1;CASP3;IRAK1;FASLG;CACNG6;VEGFA;CACNB3;TP53;CRK;MAP3K1;GADD45G;MAPK1;RASGRP2;DUSP6;RPS6KA4;AREG;PRKCA;MAP3K20;RPS6KA3;MAPK8;MAP3K3;CSF1;MAP3K6;CACNA1H;RRAS;MAP3K8;TNFRSF1A;MAP3K7;MAP2K7;GNA12;HSPA1A;RASA2;ERBB3;TGFA;MEF2C;CDC42;GRB2;PRKACB;PAK1;HGF;PDGFC;AKT1;IL1R1;PPP3CC;CD14;DUSP7;GADD45A;CACNA1E;FGFR2;MAP3K11;DUSP16;MAP3K13;MAPK11;DUSP1;HSPA2;MAP3K5;RAP1A;ANGPT1;CSF1R;NLK
prerank, KEGG_2021_Human__Hepatitis C                                                                                                                , -0.23142281671785922, -1.0873301081242945 , 0.3409090909090909  , 0.8229999604449637,       1.0 , 63/124 , 43.75%, BAX;MX1;CASP3;FASLG;CASP8;TP53;EIF2S1;SOCS3;TYK2;MAPK1;PIK3R3;TICAM1;PIK3R1;YWHAB;CLDN9;OAS2;TBK1;RB1;TNFRSF1A;TLR3;GRB2;CLDN4;AKT1;IRF9;CD81;CDKN1A;CLDN5;PSME3;PPP2R2A;PIK3CA;OAS1;BID;RNASEL;EIF2AK1;PPP2CA;YWHAQ;IRF7;RSAD2;FAS;IFIT1;EIF2AK4;AKT2;CYCS;PIK3CB;IKBKG;LDLR;MAP2K2;TRAF6;TRAF2;RELA;CDK2;SOS2;MAP2K1;BAK1;IRF3;TNF;MAVS;EIF3E;SCARB1;CFLAR;PPARA;IKBKE;PPP2R1B
prerank, Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989                                                                    , -0.2603016363646303 , -1.0867467193667057 , 0.3076923076923077  , 0.8231214738373152,       1.0 , 7/44   , 5.55% , USP18;IRAK1;CASP8;TP53;UBC;TAB3;IKBIP
prerank, Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944                                                                            , -0.2771091066586999 , -1.086649654372286  , 0.3103448275862069  , 0.8216758853244928,       1.0 , 13/43  , 21.20%, HDAC3;PVALB;IRAK1;DGCR8;TNRC6C;PRKCA;AGO3;NCOR2;CAMK2G;AGO1;MEF2C;PPARG;GAMT
prerank, KEGG_2021_Human__Leukocyte transendothelial migration                                                                                       , -0.2444047124501738 , -1.086201669439286  , 0.3707865168539326  , 0.8216234198270127,       1.0 , 30/83  , 29.27%, ARHGAP35;PTPN11;CXCR4;ARHGAP5;PIK3R3;GNAI3;ITGAL;PIK3R1;CYBB;CLDN9;PRKCA;MYL5;ROCK2;MMP9;ITGAM;CDC42;CLDN4;PXN;CLDN5;RASSF5;MAPK11;PIK3CA;RAPGEF3;RAP1A;GNAI1;CTNND1;AFDN;NCF2;MYL12B;NCF1
prerank, Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274                                                                 , -0.28506966082524726, -1.0860613754442723 , 0.3918918918918919  , 0.8205382958880626,       1.0 , 9/35   , 17.92%, NUP85;NUP88;PBRM1;NUP107;RAN;NUP98;HSPA1A;XPO1;NUP153
prerank, Reactome_2022__HIV Elongation Arrest And Recovery R-HSA-167287                                                                              , 0.2525830110235366  , 1.0857645272892855  , 0.3076923076923077  , 1.0               ,       1.0 , 5/32   , 6.93% , NELFB;NELFA;POLR2I;SSRP1;POLR2F
prerank, "Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998"                                                                 , -0.2436362473162576 , -1.0853022938549175 , 0.3181818181818182  , 0.8214313952577742,       1.0 , 20/66  , 28.27%, RASGRF2;SQSTM1;CASP3;NCSTN;UBC;ITGB3BP;ARHGEF15;MAPK8;OBSCN;ARHGEF11;UBB;RPS27A;PSENEN;AKAP13;APH1B;PRPF38B;ARHGEF1;ARHGEF4;ARHGEF2;AATF
prerank, Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339                                                    , 0.16421337197608338 , 1.0836449327050985  , 0.35714285714285715 , 1.0               ,       1.0 , 15/106 , 8.91% , RPS24;RPS29;SEC61A2;RPL7A;RPL22L1;DDOST;SSR2;RPS15A;RPL32;RPS4X;RPS20;SSR3;RPS4Y1;RPL27;SEC11A
prerank, Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362                                                                       , -0.27215603561204527, -1.0833173508677043 , 0.34177215189873417 , 0.8262606939734988,       1.0 , 21/44  , 37.76%, PPFIBP2;APBA3;BEGAIN;DLG1;STXBP1;RTN3;PTPRF;LRRTM4;EPB41L2;NLGN3;NRXN2;PPFIBP1;LIN7A;LIN7C;STX1A;DBNL;CASK;DLGAP4;EPB41;EPB41L3;LRFN1
prerank, Reactome_2022__Neddylation R-HSA-8951664                                                                                                    , -0.21352341835050512, -1.0827843158658004 , 0.37777777777777777 , 0.8261994610478443,       1.0 , 82/210 , 33.64%, SQSTM1;COMMD7;PSMD6;NEURL2;UBC;PSMD7;UFD1;CUL5;SOCS3;FEM1B;FBXL14;UBA3;CUL3;PSMD9;LRRC41;KCTD7;COMMD6;PSMC3;PSME4;PSMB2;CUL1;FBXO32;ASB13;PSME2;KBTBD6;FBXO44;HIF1A;COPS3;CCDC22;MUL1;FBXL18;RBBP7;ASB2;FBXO7;CISH;FBXO41;KLHL22;COMMD10;DDB2;UBB;RPS27A;CUL7;FBXO11;DCUN1D1;FBXO21;FBXW4;PSMD8;PSME3;DCAF10;VCP;PSMB6;UBE2D1;FBXO31;WDTC1;BTBD1;FBXO4;FBXL4;PSMA1;UBE2D2;COMMD5;PSMB4;CUL2;FBXO2;PSMF1;KBTBD7;PSME1;ASB1;PSMA3;SENP8;DCAF13;FBXO6;FBXW7;ELOC;PSMB1;COPS8;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;BIRC5
prerank, Reactome_2022__Cell Cycle Checkpoints R-HSA-69620                                                                                           , -0.21214738883904674, -1.0826316910357818 , 0.32978723404255317 , 0.8252010666167665,       1.0 , 102/259, 35.04%, NUP85;PSMD6;CENPO;RAD50;H2AX;REXO2;BABAM1;TP53;UBC;CENPA;MCM5;CENPU;RANGAP1;PPP2R5E;PSMD7;MDM4;CCNA1;CHEK1;CENPT;RPA3;PSMD9;ITGB3BP;CLASP2;CDC20;UBE2C;YWHAB;RAD9B;ORC3;PSMC3;PSME4;DYNC1LI1;PSMB2;KIF18A;CDC26;PSME2;RFC5;CLASP1;NUP107;BRCA1;PPP2R5B;SLC25A15;UBE2N;CDC6;POLR1B;H2BC11;NUP98;UBE2E1;ABRAXAS1;XPO1;DYNC1H1;CENPS-CORT;UBB;RPS27A;HUS1;CDC25C;CKAP5;CDKN1A;PSMD8;CENPM;PSME3;DYNC1LI2;CHEK2;BABAM2;INCENP;CCNA2;UIMC1;PSMB6;UBE2D1;ZNF385A;RNF168;PSMA1;PMF1-BGLAP;RHNO1;PSMB4;PPP2CA;YWHAQ;MAPRE1;SKA2;RMI1;PSMF1;KNL1;PSME1;PSMA3;TOP3A;MCM6;KIF2C;PSMB1;PSMC4;BUB1B;SEM1;PSMA6;CENPQ;PSMD11;PSMA2;PSMD10;BIRC5;ANAPC4;MAD1L1;CDC45;BUB3;CLSPN;PSMD5
prerank, Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815                                                                                     , -0.26270939271895677, -1.0826270964884246 , 0.35714285714285715 , 0.8235539586993678,       1.0 , 13/58  , 18.14%, SAP30;GATAD2A;HDAC3;PHF21A;H2AC19;CHD4;H2AC21;H2AC7;NCOR2;RBBP7;H2BC11;SUDS3;SAP30L
prerank, Reactome_2022__Metabolism Of Nucleotides R-HSA-15869                                                                                        , -0.24243936142827557, -1.0825606824184264 , 0.375               , 0.8221739725230813,       1.0 , 25/83  , 25.06%, ENTPD7;RRM1;ENTPD5;ENTPD2;UCKL1;TK2;CDA;TK1;GDA;PFAS;NME4;ADSL;ADSS2;NUDT16;RRM2;NT5C3A;DTYMK;NME3;GSR;ADPRM;DPYD;ITPA;UCK2;GLRX;RRM2B
prerank, KEGG_2021_Human__Proximal tubule bicarbonate reclamation                                                                                    , -0.3226247552566311 , -1.082551726629818  , 0.3684210526315789  , 0.8205827720800943,       1.0 , 6/18   , 20.59%, GLUD1;SLC9A3;PCK2;CA2;ATP1B1;ATP1A3
prerank, Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002                                                                                   , -0.22746238471323482, -1.08185828495755   , 0.2808988764044944  , 0.820728056535738 ,       1.0 , 56/124 , 37.71%, PSMD6;H2AX;UBC;H2AC19;MCM5;PSMD7;RPA3;PSMD9;UBE2C;PRIM2;ORC3;PSMC3;PSMB2;CDC26;PSME2;KPNA1;H2AC7;SLC25A15;CDC6;POLR1B;H2BC11;UBE2E1;H3-3B;CDT1;UBB;RPS27A;PSMD8;PSME3;PSMB6;UBE2D1;PSMA1;PSMB4;KPNA6;PSMF1;PSME1;H2AC6;POLE3;PSMA3;MCM6;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;ANAPC4;GMNN;CDC45;PSMD5;POLE4;UBE2S;POLE;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242                                                       , 0.28804080159207945 , 1.081750169329821   , 0.3333333333333333  , 0.9952402745995423,       1.0 , 4/23   , 6.93% , NELFB;NELFA;POLR2I;POLR2F
prerank, Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788                                                                  , -0.32167618990830005, -1.0808076264900257 , 0.3698630136986301  , 0.8225779258315052,       1.0 , 9/26   , 19.10%, SMURF1;BAMBI;UBC;SMAD3;XPO1;SMAD7;SMURF2;UBB;RPS27A
prerank, Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926                                                   , -0.3113987831757369 , -1.0790265088085311 , 0.35526315789473684 , 0.8268331481799248,       1.0 , 9/27   , 19.82%, ARRB1;GNA15;MAPK1;GNB5;GNGT2;GNA12;GNG5;GNG11;GNG3
prerank, KEGG_2021_Human__Adrenergic signaling in cardiomyocytes                                                                                     , -0.22856393643713951, -1.0789864694626528 , 0.2840909090909091  , 0.8252453118910108,       1.0 , 29/103 , 24.78%, ADCY7;CREB3L4;CACNG8;PLCB2;PPP2R3A;CACNG6;CACNB3;PPP2R5E;CALM2;PLCB1;MAPK1;GNAI3;ATP2A3;PRKCA;PPP2R5B;CAMK2G;CREB3L2;SCN1B;ATP1B1;PRKACB;CALM3;AKT1;ATP1A3;CREM;PPP2R2A;MAPK11;RAPGEF3;GNAI1;ADCY9
prerank, Reactome_2022__Diseases Of DNA Repair R-HSA-9675135                                                                                         , -0.27065976661416746, -1.0787059337167386 , 0.3670886075949367  , 0.824479086855816 ,       1.0 , 30/48  , 45.10%, RAD50;RPA3;OGG1;RAD9B;RAD51AP1;RFC5;BRCA1;POLR1B;NEIL3;HUS1;RHNO1;MSH2;PALB2;RMI1;MUTYH;RAD51D;MLH1;TOP3A;PMS2;SEM1;RAD51B;MSH6;RFC2;ATM;RFC3;RAD17;TOPBP1;KAT5;RAD51C;NTHL1
prerank, Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418                                                                           , 0.23604451105117824 , 1.0786246017029342  , 0.3103448275862069  , 0.9889996730957831,       1.0 , 4/33   , 2.36% , NELFB;NELFA;POLR2I;ERCC2
prerank, Reactome_2022__Signaling By FGFR2 R-HSA-5654738                                                                                             , -0.2543367976520594 , -1.0785623475002917 , 0.3783783783783784  , 0.8233089935061114,       1.0 , 16/53  , 23.85%, PTPN11;MKNK1;UBC;MAPK1;PIK3R1;HNRNPF;POLR2G;POLR2B;GRB2;POLR2D;UBB;RPS27A;NCBP1;FGFR2;HNRNPM;PIK3CA
prerank, Reactome_2022__Sensory Perception R-HSA-9709957                                                                                             , -0.22163145869422426, -1.0762986347580696 , 0.26666666666666666 , 0.8286194155806035,       1.0 , 48/157 , 27.54%, KCNMA1;TRIOBP;PLS1;OR2M3;AKR1C3;PLCB2;OTOF;DHRS9;MYH9;SNAP25;BCO2;OR2T33;PLB1;TAS2R5;PJVK;SYP;OR7D2;LRP12;OR1A1;CAPZA2;PRKCA;GNB5;CHURC1-FNTB;TWF2;MYO15A;CAPZB;OR11G2;DNAJC5;OR2A7;OR56A4;SCN1B;LPL;OR2B6;OR10H1;CIB2;OR2AT4;KCNMB1;TPRN;OR7C1;RAB3A;FNTA;NMT2;METAP1;CDH23;SPTBN1;TAS2R20;OR10G3;LRP10
prerank, KEGG_2021_Human__Biosynthesis of unsaturated fatty acids                                                                                    , -0.311094721839034  , -1.0761009442657468 , 0.375               , 0.8275311229302647,       1.0 , 10/25  , 20.91%, ELOVL6;SCD;TECR;ACOT4;SCD5;ELOVL1;ACOX1;HSD17B4;ELOVL3;FADS1
prerank, KEGG_2021_Human__Cocaine addiction                                                                                                          , -0.3009291054546782 , -1.0760800172856877 , 0.3058823529411765  , 0.8259574296231755,       1.0 , 8/25   , 24.58%, CREB3L4;GNAI3;GPSM1;RGS9;CREB3L2;PRKACB;DLG4;GNAI1
prerank, Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315                                                                       , -0.255574536182286  , -1.0755296132343464 , 0.34615384615384615 , 0.8261321837319514,       1.0 , 10/41  , 19.17%, QTRT1;METTL1;FTSJ1;ADAT3;CTU2;TRMT9B;LAGE3;ADAT2;NSUN6;URM1
prerank, Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016                                                                             , -0.22205886626628404, -1.074379992204442  , 0.3103448275862069  , 0.8281087994244973,       1.0 , 30/131 , 19.10%, TNIP2;ECSIT;USP18;PTPN11;TMED7-TICAM2;IRAK1;CASP8;TP53;UBC;TAB3;IKBIP;MAP3K1;TIRAP;MAPK1;TICAM1;DUSP6;TBK1;CUL1;RPS6KA3;LY96;MAPK8;UBE2N;ITGAM;MAP3K8;TANK;MAP3K7;MAP2K7;MEF2C;UBB;RPS27A
prerank, Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149                                                                                              , -0.22446206148828704, -1.073350542819897  , 0.33707865168539325 , 0.8294851135108423,       1.0 , 51/159 , 28.19%, CDC42EP4;RASGRF2;JAG1;ARHGAP35;ABI1;ARHGAP23;CYFIP2;GMIP;ARHGAP5;PIK3R3;KTN1;PIK3R1;CYBB;WAS;VAMP3;TFRC;ABI2;FAM13A;WIPF2;ARHGEF15;ARHGAP33;ARHGAP9;ARHGAP25;VANGL1;PLD2;DOCK9;ARHGEF11;NCKAP1L;ARHGAP29;TMPO;CDC42;ERBIN;ARHGAP22;BAIAP2L1;FARP2;IQGAP1;ARHGAP30;DHDDS;ARHGAP42;WASF1;EMD;PIK3CA;YKT6;SRGAP2;SWAP70;MPZ;ARHGEF4;ARAP2;WIPF1;ARHGAP31;NCF2
prerank, KEGG_2021_Human__Huntington disease                                                                                                         , -0.21229477580141948, -1.0721186840685342 , 0.30927835051546393 , 0.8320179227301211,       1.0 , 60/247 , 21.77%, CREB3L4;NDUFB3;PSMD6;SDHC;ATP5PB;BAX;PLCB2;COX6C;CASP3;GPX3;CASP8;COX5A;TP53;UQCRC1;PSMD7;UQCRFS1;PLCB1;PPIF;NDUFB2;ACTR1A;PSMD9;NDUFA7;ACTR10;UQCRB;ATG14;PSMC3;POLR2J2;PSMB2;HIP1;ADRM1;DCTN3;MAPK8;NDUFB9;POLR2G;ATG101;CREB3L2;AMBRA1;ATP5MC3;WIPI2;MAP2K7;ULK2;SOD2;ATG2A;POLR2B;DNAH1;SLC1A2;MAP3K10;TAF4B;NDUFS1;POLR2D;CLTC;NDUFB7;KIF5A;NDUFB5;PPARG;NDUFB4;ATG13;NDUFS7;DLG4;PSMD8
prerank, KEGG_2021_Human__Breast cancer                                                                                                              , -0.23036111650655003, -1.0718232053484762 , 0.3780487804878049  , 0.8312308530907238,       1.0 , 24/94  , 22.14%, JAG1;LRP6;BAX;TP53;WNT10A;GADD45G;MAPK1;PIK3R3;FZD6;POLK;PIK3R1;HEY1;LRP5;LEF1;BRCA1;RPS6KB1;NOTCH3;RB1;DDB2;GRB2;AKT1;NCOA3;CDKN1A;GADD45A
prerank, Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516                                                                   , -0.34892038726458885, -1.071696517228619  , 0.4583333333333333  , 0.8300680552505028,       1.0 , 3/16   , 6.26% , PIK3C2A;PIKFYVE;VAC14
prerank, KEGG_2021_Human__Alzheimer disease                                                                                                          , -0.2063340614436301 , -1.0707717241926318 , 0.3711340206185567  , 0.8311149557820775,       1.0 , 75/292 , 24.44%, GAPDH;NDUFB3;PSMD6;LRP6;SDHC;ATP5PB;PLCB2;COX6C;CASP3;NCSTN;CASP8;COX5A;UQCRC1;PSMD7;WNT10A;UQCRFS1;EIF2S1;CALM2;PLCB1;PPIF;NDUFB2;MAPK1;PIK3R3;PSMD9;IRS1;CHRM3;FZD6;NDUFA7;ATP2A3;PIK3R1;CYBB;UQCRB;CSNK2A2;ATG14;PSMC3;ATF6;PSMB2;LRP5;ADRM1;MAPK8;NDUFB9;ATG101;CSF1;RTN3;AMBRA1;SNCA;ATP5MC3;TNFRSF1A;WIPI2;MAP2K7;ULK2;CASP7;ATG2A;LPL;NDUFS1;NDUFB7;KIF5A;NDUFB5;CALM3;AKT1;PPP3CC;NDUFB4;ATG13;PSENEN;NDUFS7;PSMD8;HSD17B10;ADAM10;NDUFV3;TUBB6;PSMB6;PIK3CA;MAP3K5;APH1B;BID
prerank, Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952                                                       , 0.26264881489751246 , 1.069997943629379   , 0.37037037037037035 , 1.0               ,       1.0 , 7/27   , 13.33%, PKN2;B2M;PACS1;AP2A1;AP1B1;DOCK2;AP2B1
prerank, Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171                                                                            , -0.22134712037433976, -1.0696669096173643 , 0.35555555555555557 , 0.8326609101508521,       1.0 , 72/185 , 33.66%, PML;KMT2D;LMO2;PSMD6;H2AX;PTPN11;PRMT6;UBC;SPI1;H2AC19;PSMD7;SOCS3;FOXP3;PSMD9;PAX5;CSNK2A2;ITCH;PSMC3;PSME4;TNRC6C;PSMB2;PSME2;AGO3;H2AC7;PBRM1;CTSK;H2BC11;SMARCC1;H3-3B;ASH2L;AGO1;KAT2B;KMT2B;CCNH;UBB;RPS27A;ITGA2B;RING1;MNAT1;ZFPM1;PSMD8;CLDN5;PSME3;PSMB6;CBX4;MOV10;SMARCA2;CREBBP;PSMA1;KMT2E;NFATC2;PSMB4;PSMF1;PSME1;H2AC6;AGO2;PSMA3;RNF2;CBX8;SRC;PSMB1;TCF7L1;SMARCC2;YAF2;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;COMMD3-BMI1;PSMD10;SCMH1
prerank, KEGG_2021_Human__Alcoholism                                                                                                                 , -0.2201217094196358 , -1.0695960570037233 , 0.3804347826086957  , 0.8312300842173618,       1.0 , 38/140 , 25.29%, CREB3L4;HDAC3;H2AX;H3C2;H2AC19;H2AC17;CALM2;H3C15;H4C1;H2AC21;H3C6;MAPK1;H2AC8;H2AB2;GNAI3;H3C10;H2AC7;GNB5;GNGT2;ADORA2A;H2BC11;CREB3L2;HDAC11;GNG5;H3-3B;GRB2;PRKACB;GNG11;CALM3;MACROH2A2;GNG3;HDAC9;H4C9;H2BC7;H4C5;GNAI1;SHC4;H2BC8
prerank, Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648                                                               , 0.1881614084137387  , 1.0673992207024765  , 0.4074074074074074  , 1.0               ,       1.0 , 7/59   , 4.47% , NELFB;NELFA;FANCI;POLR2I;ERCC2;CDK12;SSRP1
prerank, Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507                                                                 , -0.24386455396353196, -1.0673594976458176 , 0.4125              , 0.8371967451591071,       1.0 , 21/79  , 20.08%, KMT2D;HDAC3;HOXB3;H2AX;H2AC19;MAFB;HOXA1;RARB;MEIS1;H2AC7;HOXC4;POLR2G;RBBP7;H2BC11;PAXIP1;H3-3B;ASH2L;POLR2B;CTCF;POLR2D;NCOA3
prerank, Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509                                                                                    , -0.21532928030942047, -1.0672455483585022 , 0.3655913978494624  , 0.8361378640901753,       1.0 , 48/227 , 18.14%, KMT2D;SAP30;KAT6A;GATAD2A;TADA3;HDAC3;PHF21A;PADI2;RIOX2;ING5;H2AX;ASH1L;SETD3;PRMT6;H2AC19;PADI4;CHD4;H2AC21;SUPT20H;KAT7;CLOCK;PHF2;CARM1;COPRS;H2AC7;PBRM1;NCOR2;RBBP7;H2BC11;ING4;UTY;ZZZ3;MORF4L2;MEAF6;KDELR2;SMARCC1;KDM4C;DOT1L;VPS72;KDM3B;SETD6;USP22;ASH2L;SUDS3;KAT2B;KMT2B;ENY2;SAP30L
prerank, Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164                                                                             , -0.22242020583160052, -1.065833008281458  , 0.3253012048192771  , 0.8388481267426978,       1.0 , 24/99  , 19.10%, TNIP2;USP18;IRAK1;CASP8;TP53;UBC;TAB3;IKBIP;MAPK1;TICAM1;DUSP6;TBK1;CUL1;RPS6KA3;MAPK8;UBE2N;MAP3K8;TANK;MAP3K7;TLR3;MAP2K7;MEF2C;UBB;RPS27A
prerank, Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012                                                            , 0.1773449584289676  , 1.0657172835703117  , 0.2857142857142857  , 0.9935448422086905,       1.0 , 15/95  , 9.78% , RPS24;RPS29;RPL7A;RPL22L1;IMPACT;EIF2S3;ASNS;RPS15A;RPL32;RPS4X;RPS20;RPS4Y1;DDIT3;RPL27;ATF4
prerank, Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690                                                                                , -0.30586091479779465, -1.065316392379629  , 0.4142857142857143  , 0.8389320466210436,       1.0 , 8/21   , 26.96%, UBC;MAPK1;KPNA1;UBB;RPS27A;DUSP16;RAB5A;VPS33B
prerank, Reactome_2022__Toll-like Receptor Cascades R-HSA-168898                                                                                     , -0.21350235128023798, -1.0627449275918703 , 0.36363636363636365 , 0.8453774781710344,       1.0 , 30/151 , 16.44%, TNIP2;ECSIT;USP18;PTPN11;TMED7-TICAM2;IRAK1;CASP8;TP53;UBC;TAB3;IKBIP;MAP3K1;TIRAP;MAPK1;TICAM1;DUSP6;EEA1;TBK1;CUL1;RPS6KA3;CTSK;LY96;MAPK8;UBE2N;ITGAM;MAP3K8;TANK;MAP3K7;TLR3;MAP2K7
prerank, Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115                                                                                 , -0.25032884857882065, -1.0627059661556277 , 0.3684210526315789  , 0.8439181291117953,       1.0 , 14/52  , 19.97%, VAMP7;TYK2;IL27;SERPINB2;IL12RB1;IL10;PSME2;PDCD4;HNRNPF;GSTO1;VPS72;CDC42;IL23R;AURKAIP1
prerank, Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729                                                        , -0.29544482708227676, -1.0622390738211416 , 0.4507042253521127  , 0.8439300376519687,       1.0 , 9/28   , 19.10%, CHMP4B;VPS4B;UBC;VPS36;CHMP6;STAM2;VPS37A;UBB;RPS27A
prerank, Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849                                                              , -0.22959303774736597, -1.0618694815396927 , 0.36363636363636365 , 0.8435091949843224,       1.0 , 26/103 , 18.04%, CYB5A;PARP9;MMUT;ST20-MTHFS;MTHFD1;LDLRAP1;PANK1;SLC19A1;CD38;ABCD4;MTHFD2;PCCA;NAMPT;SLC5A6;NAXD;DHFR;PPCDC;TCN2;NADK;CUBN;HLCS;PARP14;PCCB;GSTO1;FPGS;PARP6
prerank, Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936                                                                               , -0.22950465703621997, -1.061745088865114  , 0.3655913978494624  , 0.8422467270647385,       1.0 , 24/99  , 19.15%, ITGB3;TGFB3;ITGB5;SMURF1;BAMBI;UBC;ITGAV;MAPK1;USP9X;RNASEH2A;SMAD3;NCOR2;CCNK;TRIM33;ACVR1B;ACVR2B;XPO1;SMAD7;SMURF2;SMAD5;UBB;RPS27A;LTBP4;DAND5
prerank, KEGG_2021_Human__Purine metabolism                                                                                                          , -0.2294921067909882 , -1.0610511276940744 , 0.36046511627906974 , 0.842918594308558 ,       1.0 , 30/101 , 25.06%, ENPP4;ADCY7;RRM1;NME6;ENTPD5;ENTPD2;IMPDH1;PDE1B;PDE2A;PDE9A;NUDT2;NT5C3B;GDA;PFAS;NME4;ADSL;ADSS2;NUDT16;ADA2;RRM2;NT5C3A;NME3;CANT1;ADPRM;ITPA;PDE4D;HDDC3;NME7;ADCY9;RRM2B
prerank, Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200                                                      , 0.21643382848811074 , 1.0610082039652078  , 0.3793103448275862  , 0.995556826849733 ,       1.0 , 6/42   , 6.93% , NELFB;NELFA;POLR2I;ERCC2;SSRP1;POLR2F
prerank, Reactome_2022__Signaling By ROBO Receptors R-HSA-376176                                                                                     , -0.21114936902361028, -1.0604180418110207 , 0.3956043956043956  , 0.8433010916606637,       1.0 , 77/181 , 37.23%, MAGOH;RPS3;RPL37A;PSMD6;ZSWIM8;DAG1;UBC;RPS8;PSMD7;RPL39;CXCR4;PSMD9;CLASP2;RPS14;RPL36AL;PSMC3;RPL38;PSME4;PSMB2;PRKCA;PSME2;RPL19;CLASP1;EVL;CAP1;PFN1;PRKAR2A;RPL6;RPS25;EIF4A3;RPL15;CDC42;PRKACB;UBB;RPS27A;RPS6;NCBP1;PSMD8;PSME3;PSMB6;RPS11;SRGAP2;PSMA1;PSMB4;CUL2;MAGOHB;RPSA;AKAP5;PSMF1;PSME1;UPF3B;RPS9;PSMA3;RPL28;SRC;RPS15;ELOC;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;RPL27A;PSMA2;PSMD10;RPL18A;RPS16;RPL9;RPL21;PSMD5;RPL3L;NCK2;ETF1;RPL26;RPL13A;ABL2;PSMD13
prerank, KEGG_2021_Human__Oxidative phosphorylation                                                                                                  , -0.22217124195429275, -1.0597391257456035 , 0.37777777777777777 , 0.8438457571255238,       1.0 , 14/106 , 9.29% , COX15;NDUFB3;SDHC;ATP5PB;COX6C;PPA2;COX5A;UQCRC1;UQCRFS1;ATP6V0A1;NDUFB2;COX10;NDUFA7;UQCRB
prerank, KEGG_2021_Human__Bladder cancer                                                                                                             , -0.2738201967075989 , -1.0577490458274725 , 0.3924050632911392  , 0.8481646258045705,       1.0 , 8/37   , 14.25%, VEGFA;TP53;MAPK1;CDH1;UPK3A;RASSF1;MMP9;RB1
prerank, Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220                                                                                   , -0.22625302398786823, -1.0571869944741596 , 0.375               , 0.8486777904471431,       1.0 , 40/114 , 29.31%, FMNL3;NUP85;SCAI;CENPO;DIAPH1;CENPA;CENPU;RANGAP1;PPP2R5E;CENPT;ITGB3BP;CLASP2;CDC20;DYNC1LI1;KIF18A;FMNL2;CLASP1;NUP107;PPP2R5B;EVL;PFN1;NUP98;XPO1;CDC42;DYNC1H1;CENPS-CORT;RHOC;CKAP5;CENPM;DYNC1LI2;INCENP;DAAM1;SRGAP2;PMF1-BGLAP;DVL3;PPP2CA;MAPRE1;SKA2;RHOB;KNL1
prerank, KEGG_2021_Human__Circadian rhythm                                                                                                           , -0.2770880930331757 , -1.056259974089922  , 0.3611111111111111  , 0.8498194550730628,       1.0 , 5/26   , 10.71%, CSNK1D;PRKAG2;CLOCK;NR1D1;CUL1
prerank, Reactome_2022__TNFs Bind Their Physiological Receptors R-HSA-5669034                                                                        , -0.3223461698029829 , -1.0553014469553657 , 0.3918918918918919  , 0.8517687913279586,       1.0 , 4/23   , 7.70% , TNFSF14;TNFSF13;FASLG;TNFRSF25
prerank, Reactome_2022__Interleukin-12 Signaling R-HSA-9020591                                                                                       , -0.2597381979432933 , -1.0549986173944743 , 0.38028169014084506 , 0.851137814983416 ,       1.0 , 12/42  , 19.97%, VAMP7;TYK2;SERPINB2;IL12RB1;IL10;PSME2;PDCD4;HNRNPF;GSTO1;VPS72;CDC42;AURKAIP1
prerank, Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942                                                                        , -0.2407194676536802 , -1.0548066253141444 , 0.379746835443038   , 0.8500238333629587,       1.0 , 35/64  , 44.34%, RAD50;UBC;SLC19A1;CHEK1;RPA3;POLK;RAD9B;RAD51AP1;RFC5;BRCA1;POLR1B;UBB;RPS27A;HUS1;POLD4;RHNO1;PALB2;RMI1;XRCC3;RAD51D;POLE3;POLD2;TOP3A;SEM1;RAD51B;POLE4;POLE;RFC2;ATM;RFC3;RAD17;TOPBP1;POLD1;KAT5;RAD51C
prerank, KEGG_2021_Human__Renin secretion                                                                                                            , -0.2692410271717886 , -1.0547101855937866 , 0.43902439024390244 , 0.8487121243623864,       1.0 , 6/40   , 8.45% , KCNMA1;PLCB2;CALM2;PDE1B;PLCB1;GNAI3
prerank, Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854                                                                            , -0.22505578746399857, -1.0542002209292698 , 0.3258426966292135  , 0.8484932572470585,       1.0 , 33/141 , 18.04%, CYB5A;PARP9;PTS;AKR1C3;MMUT;ST20-MTHFS;MTHFD1;LDLRAP1;BCO2;PANK1;SLC19A1;CD38;PLB1;ABCD4;MTHFD2;PCCA;NAMPT;LRP12;SLC5A6;NAXD;DHFR;PPCDC;TCN2;NADK;CUBN;HLCS;VKORC1L1;PARP14;PCCB;GSTO1;LPL;FPGS;PARP6
prerank, Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115                                                                        , -0.21290751316660492, -1.0540615572912098 , 0.3695652173913043  , 0.8473299883167245,       1.0 , 53/136 , 34.03%, NUP85;ABCC9;PSMD6;ABCB4;NUP88;UBC;RNF185;PSMD7;ABCD4;PSMD9;PSMC3;PSME4;BSG;PSMB2;PSME2;ABCB11;NUP107;NUP98;SLC3A1;NUP153;UBB;RPS27A;ABCA1;SLC35A1;SLC11A2;PSMD8;PSME3;SLC9A7;VCP;KCNJ11;POM121C;PSMB6;PSMA1;SLC17A5;SLC5A5;PSMB4;PSMF1;SLC2A9;PSME1;PSMA3;AAAS;NUP188;PSMB1;PSMC4;SLC7A7;SEM1;PSMA6;PSMD11;PSMA2;ERLEC1;PSMD10;SLC36A2;NLRP3
prerank, Reactome_2022__Lagging Strand Synthesis R-HSA-69186                                                                                         , -0.31523252868991103, -1.0536111527151304 , 0.4264705882352941  , 0.8470743251066927,       1.0 , 7/20   , 23.45%, SLC19A1;RPA3;PRIM2;RFC5;POLR1B;FEN1;POLD4
prerank, Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359                                                                      , -0.30760597273025037, -1.0534368768395048 , 0.3780487804878049  , 0.8461583840590877,       1.0 , 9/23   , 26.82%, ADCY7;PRKCA;PRKAR2A;GNG5;PRKACB;GNG11;GNG3;ADCY9;PRKAR1A
prerank, KEGG_2021_Human__beta-Alanine metabolism                                                                                                    , 0.23684445447857672 , 1.0529964061667754  , 0.42857142857142855 , 1.0               ,       1.0 , 6/24   , 10.96%, AOC2;ALDH3B1;ALDH2;ABAT;ALDH3A2;ACOX3
prerank, Reactome_2022__HCMV Infection R-HSA-9609646                                                                                                 , -0.2196575875237212 , -1.0528216912826625 , 0.3953488372093023  , 0.8467058142888535,       1.0 , 23/109 , 19.25%, PML;NUP85;CEBPD;RRM1;HDAC3;CHMP4B;NUP88;H2AC19;H2AC21;IRS1;VPS36;DYNC1LI1;H2AC7;NUP107;CHMP6;NCOR2;RBBP7;H2BC11;NUP98;VPS37A;NUP153;DYNC1H1;HSD17B4
prerank, KEGG_2021_Human__Neurotrophin signaling pathway                                                                                             , -0.2275250974252953 , -1.0520527056445257 , 0.37777777777777777 , 0.8475706553925116,       1.0 , 24/103 , 19.46%, NFKBIE;BAX;PTPN11;IRAK1;FASLG;PDPK1;TP53;CRK;MAP3K1;CALM2;MAPK1;PIK3R3;IRS1;PIK3R1;RPS6KA3;MAPK8;CAMK2G;MAP3K3;KIDINS220;MAP2K7;CDC42;GRB2;CALM3;AKT1
prerank, KEGG_2021_Human__Propanoate metabolism                                                                                                      , -0.298241597551081  , -1.0511174432881043 , 0.4246575342465753  , 0.8488707286067719,       1.0 , 15/31  , 31.00%, MMUT;ALDH6A1;ACSS1;PCCA;BCKDHA;ACSS2;ACAT1;PCCB;ECHDC1;ACOX1;ECHS1;SUCLA2;HIBCH;MLYCD;BCKDHB
prerank, KEGG_2021_Human__GnRH signaling pathway                                                                                                     , -0.24240390924414185, -1.0508553523193596 , 0.3780487804878049  , 0.8482565548647232,       1.0 , 19/71  , 19.42%, ADCY7;PLCB2;MAP3K1;CALM2;GNRH1;PLCB1;MAPK1;PRKCA;MAPK8;CAMK2G;MAP3K3;MMP14;EGR1;PLD2;MAP2K7;CDC42;GRB2;PRKACB;CALM3
prerank, Reactome_2022__Collagen Degradation R-HSA-1442490                                                                                           , -0.29757664848391974, -1.0501446187849537 , 0.3125              , 0.84875646589335  ,       1.0 , 8/23   , 27.76%, ELANE;CTSK;MMP9;MMP14;COL9A1;ADAM10;PHYKPL;CTSD
prerank, Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452                                                                                 , -0.29234427466716717, -1.0500187983659954 , 0.38666666666666666 , 0.8477087302667392,       1.0 , 8/29   , 19.91%, PPP1R13B;REXO2;TP53;YWHAB;PMAIP1;MAPK8;AKT1;PPP3CC
prerank, KEGG_2021_Human__Type II diabetes mellitus                                                                                                  , -0.2827958888912401 , -1.0499092231803235 , 0.3950617283950617  , 0.8465461035732528,       1.0 , 7/34   , 12.71%, HK3;SOCS3;MAPK1;PIK3R3;IRS1;PIK3R1;MAPK8
prerank, KEGG_2021_Human__Hepatitis B                                                                                                                , -0.21932803928337205, -1.0495766505077304 , 0.4222222222222222  , 0.846059070717261 ,       1.0 , 30/140 , 18.16%, CREB3L4;TGFB3;BAX;CASP3;IRAK1;FASLG;CASP8;TP53;MAP3K1;TIRAP;CCNA1;TYK2;MAPK1;PIK3R3;TICAM1;PIK3R1;YWHAB;TBK1;PRKCA;MAPK8;SMAD3;MMP9;RB1;CREB3L2;MAP3K7;TLR3;MAP2K7;TICAM2;DDB2;GRB2
prerank, Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927                                                                     , -0.25798749674204513, -1.0494056160316758 , 0.3972602739726027  , 0.8451204507801756,       1.0 , 10/43  , 19.46%, ARHGAP35;UBC;CRK;STAP2;SOCS3;HIF1A;ERBB3;UBB;RPS27A;AKT1
prerank, Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300                                                                         , 0.2324778676199209  , 1.0490443005919141  , 0.3181818181818182  , 1.0               ,       1.0 , 8/40   , 12.06%, PIAS2;ZNF131;PIAS3;PHC2;CTBP1;HIPK2;ING3;SAFB
prerank, KEGG_2021_Human__Mitophagy                                                                                                                  , -0.23343804058013826, -1.0490348790049777 , 0.38823529411764707 , 0.8447558008982036,       1.0 , 15/65  , 15.19%, BCL2L13;SQSTM1;ATG9A;RHOT2;TP53;UBC;CITED2;USP8;CSNK2A2;TBK1;BNIP3L;HIF1A;MAPK8;AMBRA1;RRAS
prerank, Reactome_2022__Nicotinamide Salvaging R-HSA-197264                                                                                          , -0.35170007761155675, -1.0480740973539049 , 0.4383561643835616  , 0.8462975231968495,       1.0 , 7/15   , 28.28%, PARP9;NAMPT;NAXD;PARP14;PARP6;PARP16;PTGS2
prerank, Reactome_2022__Signaling By ERBB4 R-HSA-1236394                                                                                             , -0.26068074654367296, -1.0465375581588987 , 0.38823529411764707 , 0.8495981003370956,       1.0 , 14/43  , 24.24%, NCSTN;UBC;PIK3R1;SPARC;ITCH;WWOX;ERBB3;GRB2;UBB;RPS27A;PSENEN;NEDD4;PIK3CA;APH1B
prerank, Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411                                                                    , -0.2804870906224041 , -1.04552562100325   , 0.3888888888888889  , 0.8512430088207785,       1.0 , 14/25  , 43.90%, SLC19A1;CTC1;PRIM2;RFC5;CHTF8;POLD4;CHTF18;POT1;POLD2;RFC2;TERF1;RFC3;POLD1;POLA2
prerank, Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122                                             , -0.29135879976191714, -1.0451927054659054 , 0.4177215189873418  , 0.8504793169038267,       1.0 , 10/31  , 19.82%, GNA15;RGS6;CCT3;CSNK2A2;GNB5;GNGT2;CCT6B;GNG5;GNG11;GNG3
prerank, KEGG_2021_Human__Calcium signaling pathway                                                                                                  , -0.22261403926933002, -1.044828863215322  , 0.43820224719101125 , 0.8499328489711098,       1.0 , 30/127 , 19.91%, ADCY7;SPHK2;STIM2;P2RX1;PLCB2;VEGFA;ASPH;GNA15;CD38;CALM2;CXCR4;PDE1B;PLCB1;PPIF;CHRM3;ATP2A3;NTSR1;NOS3;PRKCA;PTAFR;CAMK2G;ADORA2A;CACNA1H;ERBB3;LTB4R2;PRKACB;HGF;PDGFC;CALM3;PPP3CC
prerank, KEGG_2021_Human__Phospholipase D signaling pathway                                                                                          , -0.22020276475839207, -1.0445502027944689 , 0.40963855421686746 , 0.8492715461933276,       1.0 , 54/113 , 41.06%, FCER1G;ADCY7;SPHK2;ARF1;PLCB2;PTPN11;PLCB1;MAPK1;DGKG;PIK3R3;CYTH2;PIK3R1;CYTH1;PRKCA;DGKA;RRAS;PLD2;GNA12;ARF6;GRB2;FCER1A;PDGFC;AKT1;GAB2;CXCR2;PIK3CA;RAPGEF3;ADCY9;SHC4;LPAR2;DNM2;AGPAT5;AGPAT3;SYK;MS4A2;CXCR1;INSR;PLA2G4A;AKT2;PDGFB;PLCB3;TSC2;PIK3CB;PLCG2;RALA;MAP2K2;PIP5K1B;PTK2B;AGPAT4;DGKD;AGPAT1;LPAR1;SOS2;MAP2K1
prerank, Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607                                                                     , -0.23686818573187357, -1.0444481686038656 , 0.4024390243902439  , 0.8479519904042183,       1.0 , 21/74  , 24.75%, RAD50;H2AX;BABAM1;UBC;CCNA1;CHEK1;RPA3;RAD9B;RFC5;BRCA1;UBE2N;POLR1B;H2BC11;ABRAXAS1;UBB;RPS27A;HUS1;BABAM2;CCNA2;UIMC1;RNF168
prerank, Reactome_2022__GABA Receptor Activation R-HSA-977443                                                                                        , -0.283897277489336  , -1.0442431727913875 , 0.38961038961038963 , 0.8470250335627677,       1.0 , 12/27  , 33.87%, ADCY7;GNAI3;GNB5;GNGT2;GNG5;GNG11;GNG3;GNAI1;ADCY9;KCNJ15;GNB2;NPTN
prerank, Reactome_2022__Metabolism Of Steroids R-HSA-8957322                                                                                         , -0.22502997359218194, -1.0436580427151774 , 0.4065934065934066  , 0.8475921436434414,       1.0 , 19/110 , 13.72%, SQLE;PMVK;SEC24D;AKR1C3;ACOT8;ACOX2;SEC24C;LDLRAP1;SLCO1A2;LIN9;SLC27A5;GGPS1;NSDHL;CARM1;ELOVL6;OSBPL3;ABCB11;RAN;SCD
prerank, Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595                                                                               , -0.31217091554559273, -1.0430072043696943 , 0.4230769230769231  , 0.8479059998354356,       1.0 , 10/20  , 35.93%, CSTF2;SYMPK;CPSF1;CPSF4;NCBP1;CPSF7;CPSF3;CSTF2T;FIP1L1;WDR33
prerank, KEGG_2021_Human__Human cytomegalovirus infection                                                                                            , -0.21136373325501495, -1.0417240032691912 , 0.38144329896907214 , 0.8497235341264375,       1.0 , 51/186 , 24.78%, ITGB3;ADCY7;CREB3L4;BAX;PLCB2;CASP3;FASLG;CASP8;VEGFA;TP53;CRK;ITGAV;CALM2;CXCR4;PLCB1;MAPK1;PIK3R3;HLA-G;GNAI3;PIK3R1;TBK1;PRKCA;GNB5;RPS6KB1;GNGT2;ROCK2;RB1;CREB3L2;TNFRSF1A;GNA12;ARHGEF11;GNG5;GRB2;PRKACB;GNG11;CALM3;PXN;AKT1;GNG3;IL1R1;PPP3CC;CDKN1A;AKAP13;CXCR2;MAPK11;IL10RA;PIK3CA;CCL4L2;BID;GNAI1;ADCY9
prerank, KEGG_2021_Human__Cell adhesion molecules                                                                                                    , -0.230350360627482  , -1.0417143135977325 , 0.4065934065934066  , 0.8482415138803666,       1.0 , 25/109 , 22.32%, GLG1;CD58;NTNG2;MADCAM1;CD226;ITGAV;LRRC4;CADM1;HLA-G;SELL;ITGAL;CDH1;CLDN9;NECTIN2;VSIR;ITGA9;ITGAM;PTPRF;NLGN3;NRXN2;CLDN4;CDH15;CLDN5;SIGLEC1;PVR
prerank, KEGG_2021_Human__Fc epsilon RI signaling pathway                                                                                            , -0.24232076094256555, -1.0415854784201848 , 0.3875              , 0.8471684276948748,       1.0 , 32/60  , 44.32%, FCER1G;PDPK1;MAPK1;PIK3R3;PIK3R1;IL4;PRKCA;MAPK8;MAP2K7;GRB2;FCER1A;AKT1;GAB2;MAPK11;PIK3CA;BTK;SYK;MS4A2;PLA2G4A;AKT2;PIK3CB;VAV3;MAPK10;PLCG2;MAP2K2;ALOX5;SOS2;MAP2K1;LYN;TNF;RAF1;FYN
prerank, KEGG_2021_Human__Thyroid hormone signaling pathway                                                                                          , -0.2337160951215259 , -1.0411203780418412 , 0.4318181818181818  , 0.8470970141583031,       1.0 , 26/101 , 20.59%, ITGB3;MED27;HDAC3;PLCB2;PDPK1;TP53;ITGAV;MED12;PLCB1;THRA;MAPK1;PIK3R3;ATP2A3;PIK3R1;PRKCA;HIF1A;NOTCH3;MED1;PFKP;ATP1B1;MED13;KAT2B;PRKACB;AKT1;NCOA3;ATP1A3
prerank, Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740                                                                                      , -0.24398373209923752, -1.0402517160663203 , 0.3855421686746988  , 0.8482327140534397,       1.0 , 13/59  , 17.03%, H2AX;REXO2;MYH9;KLK2;PDPK1;H2AC19;YWHAB;AREG;H2AC7;H2BC11;PPP1R14A;KDM4C;H3-3B
prerank, Reactome_2022__Leishmania Infection R-HSA-9658195                                                                                           , -0.21993989463143476, -1.0402329658638405 , 0.4375              , 0.8468402011765942,       1.0 , 61/168 , 30.99%, ADCY7;GGT1;ENTPD5;YES1;ABI1;CYFIP2;MYH9;CRK;MAPK1;PPAN-P2RY11;TSHR;GNAI3;WAS;IL10;CD163;RLN2;PRKCA;ABI2;WIPF2;GNB5;MEFV;MAPK8;CALCRL;GNGT2;ADORA2A;GPR15;PRKAR2A;GGT5;ARPC5;NCKAP1L;GNG5;FGR;CDC42;C3AR1;GRB2;PRKACB;GNG11;GNG3;MC1R;PTGIR;WASF1;ARPC3;PTGDR;GNAI1;ADCY9;PRKX;ADM2;ARPC2;NCKIPSD;PRKAR1A;POMC;BTK;DVL3;WIPF1;HMOX1;SYK;RHBDF2;PTGER2;ACTR3;P2RX4;SRC
prerank, Reactome_2022__Nicotinate Metabolism R-HSA-196807                                                                                           , -0.29980665805119566, -1.0390855154699306 , 0.44871794871794873 , 0.8488504875100936,       1.0 , 7/25   , 18.04%, PARP9;CD38;NAMPT;NAXD;NADK;PARP14;PARP6
prerank, KEGG_2021_Human__Cushing syndrome                                                                                                           , -0.22789511490168002, -1.0388046911383004 , 0.4175824175824176  , 0.8482049504574767,       1.0 , 20/102 , 18.28%, KMT2D;ADCY7;CREB3L4;FH;PLCB2;WNT10A;PLCB1;USP8;MAPK1;FZD6;GNAI3;LEF1;CAMK2G;RB1;CREB3L2;CACNA1H;CDKN2C;WDR5B;ASH2L;PRKACB
prerank, Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722                                                           , -0.25063949498838023, -1.038474788908037  , 0.4666666666666667  , 0.8477138491341923,       1.0 , 13/55  , 17.65%, KMT2D;H2AX;H2AC19;BCL9L;TLE2;LEF1;H2AC7;LEO1;H2BC11;RUNX3;H3-3B;ASH2L;CDC73
prerank, KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism                                                                                , 0.21222827261743551 , 1.0373343830915984  , 0.4117647058823529  , 1.0               ,       1.0 , 6/45   , 6.19% , GFPT1;GMDS;HKDC1;PGM1;MPI;NAGK
prerank, Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275                                                                                     , -0.28150938072326337, -1.0350986754797729 , 0.45714285714285713 , 0.856453442200964 ,       1.0 , 5/25   , 12.61%, LRP6;PPP2R5E;FZD6;LRP5;PPP2R5B
prerank, Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556                                                                               , -0.22212105182561614, -1.0334176385424791 , 0.4069767441860465  , 0.8593429445456913,       1.0 , 28/90  , 27.80%, NUP85;BAG3;NUP88;EEF1A1;RPS19BP1;MRPL18;MAPK1;RPA3;NUP107;CAMK2G;POLR1B;SIRT1;NUP98;HSPA1A;HSPH1;NUP153;UBB;FKBP4;BAG5;HSPA4;VCP;POM121C;DNAJC2;HSPA2;CREBBP;TNFRSF21;HDAC6;HSPA5
prerank, Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886                           , -0.2679636997313672 , -1.0324651117471981 , 0.49333333333333335 , 0.861011294468355 ,       1.0 , 8/34   , 17.03%, H2AX;KLK2;H2AC19;AREG;H2AC7;H2BC11;KDM4C;H3-3B
prerank, Reactome_2022__Diseases Of Metabolism R-HSA-5668914                                                                                         , -0.2111115597841037 , -1.0310781240145948 , 0.449438202247191   , 0.8634672812088129,       1.0 , 39/157 , 21.50%, OPLAH;C1GALT1;GGT1;GNS;DAG1;MMUT;UBC;B4GALT1;ADAMTS6;ABCD4;CHSY1;PCCA;ALG2;GYS1;PMM2;NUS1;LFNG;CYP2U1;EXT1;ADAMTS2;ALG6;GALNT12;NOTCH3;B4GAT1;TCN2;CUBN;HLCS;GYG1;PCCB;FDX1;CYP1B1;UBB;NAGLU;RPS27A;SLPI;SGSH;MPDU1;DHDDS;ARSB
prerank, Reactome_2022__Neurexins And Neuroligins R-HSA-6794361                                                                                      , -0.2983796849320225 , -1.030359433755933  , 0.3972602739726027  , 0.8642363844974411,       1.0 , 15/28  , 37.29%, APBA3;BEGAIN;STXBP1;LRRTM4;EPB41L2;NLGN3;NRXN2;LIN7A;LIN7C;STX1A;DBNL;CASK;DLGAP4;EPB41;EPB41L3
prerank, Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508                                                            , -0.31288097004096727, -1.0297255014607936 , 0.4492753623188406  , 0.8648710512911999,       1.0 , 10/21  , 31.11%, HEY1;NOTCH3;GATD3;MAML2;KAT2B;RBPJ;MAMLD1;CREBBP;KAT2A;MAML1
prerank, Reactome_2022__M Phase R-HSA-68886                                                                                                          , -0.19061749871153663, -1.0297015258926878 , 0.42857142857142855 , 0.8634174807712162,       1.0 , 137/360, 33.91%, NCAPG;NUP85;PLK4;PSMD6;CENPO;CSNK1D;CHMP4B;H2AX;NUP88;CEP76;UBC;CENPA;H2AC19;GOLGA2;CENPU;RANGAP1;PPP2R5E;PSMD7;AKAP9;HAUS2;MAPK1;CENPT;ACTR1A;PSMD9;ITGB3BP;ENSA;LEMD2;CLASP2;CDC20;UBE2C;CEP250;CSNK2A2;PSMC3;PSME4;DYNC1LI1;KIF23;PSMB2;PDS5B;KIF18A;PRKCA;CDC26;PSME2;H2AC7;CLASP1;NCAPH;NUP107;CEP72;PPP2R5B;CHMP6;DCTN3;RAB2A;SMC1A;RAN;H2BC11;RB1;LPIN1;CEP57;NINL;NUP98;UBE2E1;H3-3B;TMPO;LPIN2;XPO1;NUP153;SET;DYNC1H1;CENPS-CORT;UBB;RPS27A;RAB33B;PHF8;IST1;CKAP5;ANKLE2;CEP70;PSMD8;CENPM;PSME3;DYNC1LI2;INCENP;PPP2R2A;NEK7;BLZF1;POM121C;MZT1;TUBB6;PSMB6;EMD;UBE2D1;NME7;RAB1B;VPS4A;WAPL;CEP164;PMEPA1;PSMA1;PMF1-BGLAP;TUBGCP6;NEDD1;PSMB4;PPP2CA;CEP78;TUBA1C;MAPRE1;SKA2;CHMP2A;SFI1;NEK2;PSMF1;KNL1;PSME1;SIRT2;HAUS7;H2AC6;TUBGCP5;KIF20A;PSMA3;AAAS;KIF2C;NUP188;CEP63;PSMB1;PSMC4;BUB1B;VRK1;SEM1;PSMA6;CENPQ;HSP90AA1;PSMD11;PSMA2;HAUS5;PSMD10;BIRC5;ANAPC4;MAD1L1
prerank, KEGG_2021_Human__Progesterone-mediated oocyte maturation                                                                                    , -0.22216594157207564, -1.0293848697666845 , 0.47126436781609193 , 0.8632446541941933,       1.0 , 23/77  , 24.78%, ADCY7;CPEB3;KIF22;CCNA1;MAPK1;PIK3R3;GNAI3;PIK3R1;CDC26;RPS6KA3;MAPK8;SPDYC;PRKACB;AKT1;ANAPC13;SPDYE18;CDC25C;MAD2L2;CCNA2;MAPK11;PIK3CA;GNAI1;ADCY9
prerank, "Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859"                                           , 0.2707373026328729  , 1.029160562332729   , 0.40625             , 1.0               ,       1.0 , 7/20   , 15.23%, METAP2;RNF7;CAMKMT;RCVRN;PDE6G;PDE6B;PRKCQ
prerank, Reactome_2022__G1/S-Specific Transcription R-HSA-69205                                                                                      , -0.28954976628343393, -1.028222771270329  , 0.4470588235294118  , 0.8652636736835607,       1.0 , 9/29   , 19.19%, LIN9;CCNA1;TK1;DHFR;SLC25A15;CDC6;E2F6;CDT1;RRM2
prerank, KEGG_2021_Human__FoxO signaling pathway                                                                                                     , -0.22007962044546117, -1.0269286432521771 , 0.4065934065934066  , 0.8676123043364385,       1.0 , 35/112 , 25.44%, PLK4;TGFB3;FASLG;PDPK1;SGK3;GADD45G;PRKAG2;MAPK1;PIK3R3;IRS1;PCK2;PIK3R1;IL10;CAT;FBXO32;MAPK8;SMAD3;SIRT1;CDKN2D;S1PR4;USP7;SOD2;GRB2;ATG12;AKT1;PRKAG1;CDKN1A;S1PR1;GADD45A;KLF2;MAPK11;PIK3CA;FOXO1;CREBBP;NLK
prerank, Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829                                                        , -0.24581038323295729, -1.026416325056483  , 0.4186046511627907  , 0.8676198277674104,       1.0 , 10/55  , 13.72%, SQLE;PMVK;SEC24D;SEC24C;LIN9;GGPS1;CARM1;ELOVL6;RAN;SCD
prerank, Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202                                                                      , -0.225684938017001  , -1.0259179057924028 , 0.4235294117647059  , 0.8674968972311786,       1.0 , 34/80  , 37.45%, NUP85;MAGOH;FYTTD1;NUP88;SYMPK;THOC1;SRSF3;CPSF1;NUP107;CPSF4;THOC7;NUP98;EIF4A3;SRSF1;NUP153;CDC40;NCBP1;SRRM1;SRSF5;POM121C;MAGOHB;CPSF3;UPF3B;NXT1;AAAS;NUP188;DDX39A;THOC2;FIP1L1;EIF4E;WDR33;SRSF9;POM121;SRSF7
prerank, KEGG_2021_Human__Acute myeloid leukemia                                                                                                     , -0.23931339468632185, -1.025851395927573  , 0.4473684210526316  , 0.8661281319613333,       1.0 , 20/65  , 26.05%, PML;BCL2A1;SPI1;PIM2;CCNA1;MAPK1;PIK3R3;RUNX1T1;DUSP6;PIK3R1;LEF1;RPS6KB1;ITGAM;GRB2;AKT1;CD14;CCNA2;PIK3CA;CSF1R;JUP
prerank, Reactome_2022__Deubiquitination R-HSA-5688426                                                                                               , -0.2009794443579737 , -1.0255216688045115 , 0.3979591836734694  , 0.8655996407950709,       1.0 , 97/248 , 35.17%, TNIP2;TADA3;PSMD6;USP18;ARRB1;BABAM1;TP53;UBC;RNF123;H2AC19;PSMD7;UFD1;USP20;MDM4;CCNA1;USP8;H2AC21;USP9X;PSMD9;CDC20;USP34;AREG;PSMC3;PSME4;PSMB2;JOSD1;PSME2;USP44;H2AC7;ADRM1;HIF1A;BRCA1;SMAD3;MUL1;H2BC11;USP49;TANK;STAM2;ASXL1;MAP3K7;USP7;ZRANB1;ABRAXAS1;USP22;SUDS3;DDB2;KAT2B;SMAD7;SMURF2;UBB;RPS27A;TNFAIP3;MAT2B;PSMD8;PSME3;BABAM2;OTUD5;CCNA2;VCP;UIMC1;PSMB6;UBE2D1;TNIP3;PSMA1;INO80D;TAB1;USP25;MYSM1;PSMB4;USP37;PSMF1;KAT2A;UCHL1;PSME1;H2AC6;ATXN7;RIPK2;PSMA3;WDR20;SENP8;TADA2B;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;FKBP8;PSMA2;ADRB2;PSMD10;NLRP3;IKBKG;NFRKB;PROC;CLSPN;PSMD5;FOXO4
prerank, Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410                                                                    , -0.22958921449287878, -1.0253850300230023 , 0.4625              , 0.8644612083231495,       1.0 , 23/81  , 24.73%, NUP85;USP18;MX1;NUP88;UBC;KPNA3;OAS2;KPNA1;NUP107;UBE2N;NUP98;UBE2E1;EIF4A3;PDE12;NUP153;EIF4E3;UBB;RPS27A;HERC5;NEDD4;POM121C;OAS1;RNASEL
prerank, Reactome_2022__G-protein Mediated Events R-HSA-112040                                                                                       , -0.26494043999749484, -1.0248652328626353 , 0.45121951219512196 , 0.8646035602818134,       1.0 , 10/40  , 14.83%, ADCY7;PLCB2;GNA15;PDE1B;PLCB1;MAPK1;GNAI3;PRKCA;CAMK2G;PRKAR2A
prerank, Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513                                                                                      , -0.2962048125694143 , -1.024404084115287  , 0.4225352112676056  , 0.8646900055820562,       1.0 , 4/21   , 12.61%, YES1;PTPN11;PPP2R5E;PPP2R5B
prerank, Reactome_2022__Phototransduction Cascade R-HSA-2514856                                                                                      , 0.26055601948861606 , 1.0240254920637486  , 0.4117647058823529  , 1.0               ,       1.0 , 7/21   , 15.23%, METAP2;RNF7;CAMKMT;RCVRN;PDE6G;PDE6B;PRKCQ
prerank, Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201                                                         , -0.25160233113717684, -1.023964300175567  , 0.4819277108433735  , 0.8644810632542023,       1.0 , 9/48   , 12.44%, HDAC3;MEF2D;GABPA;LIN9;GLUD1;NR1D1;POLRMT;CARM1;ACSS2
prerank, Reactome_2022__HATs Acetylate Histones R-HSA-3214847                                                                                        , -0.22239967729147633, -1.0234488944090905 , 0.42696629213483145 , 0.8648620200477423,       1.0 , 35/101 , 32.17%, KAT6A;TADA3;ING5;H2AC19;H2AC21;SUPT20H;KAT7;CLOCK;H2AC7;RBBP7;H2BC11;ING4;ZZZ3;MORF4L2;MEAF6;KDELR2;VPS72;USP22;KAT2B;ENY2;SUPT7L;ELP6;TAF6L;TAF12;KAT14;CREBBP;KAT8;MSL3;KAT2A;H2AC6;ATXN7;NCOA1;TADA2B;BRPF3;ELP5
prerank, Reactome_2022__Cholesterol Biosynthesis R-HSA-191273                                                                                        , -0.3114284288887007 , -1.023221979129696  , 0.4                 , 0.8639182427724652,       1.0 , 4/24   , 9.01% , SQLE;PMVK;GGPS1;NSDHL
prerank, Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934                                                                         , -0.19125522154531452, -1.02314306234415   , 0.46                , 0.8627390893717615,       1.0 , 80/386 , 19.46%, ITGB3;TNS3;HDAC3;COL6A3;YES1;ABI1;BAX;PTPRK;CYFIP2;PTPN11;MKNK1;FER;NCSTN;MEF2D;DIAPH1;VEGFA;PDPK1;UBC;CRK;IL2RG;ITGAV;PLAT;PTPRJ;CUL5;CHD4;USP8;ATP6V0A1;CHEK1;MAPK1;PIK3R3;IRS1;SPINT1;RANBP9;PTPN18;SH3GL1;TPH1;DUSP6;PIK3R1;SPARC;CYBB;YWHAB;RNASEH2A;ITCH;AREG;PRKCA;ABI2;RPS6KA3;HIF1A;FOSL1;TCIRG1;RANBP10;NAB2;HNRNPF;ADORA2A;POLR2G;ROCK2;MMP9;KIDINS220;COL9A1;EGR1;STAM2;WWOX;NCKAP1L;ERBB3;ID3;TGFA;POLR2B;MEF2C;ARF6;CDC42;GRB2;PRKACB;POLR2D;EPS15L1;CLTC;UBB;RPS27A;PDGFC;ERBIN;AKT1
prerank, Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198                                                                          , -0.21952108193959916, -1.0230086376828247 , 0.4939759036144578  , 0.86167381623308  ,       1.0 , 30/87  , 30.78%, RAB8B;SBF2;DENND4A;RAB6A;RAB39B;TRAPPC12;DENND2A;RABGEF1;GDI1;TRAPPC11;GAPVD1;RAB9A;DENND4C;TRAPPC2;RAB3IP;DENND2B;AKT1;RIC1;RAB1B;RAB3A;RAB5A;MPZ;RAB8A;RAB18;TRAPPC5;DENND6A;MON1B;RAB3GAP1;RAB5B;ANKRD27
prerank, Reactome_2022__Mitotic Anaphase R-HSA-68882                                                                                                 , -0.19622977919597406, -1.0230072881928893 , 0.4166666666666667  , 0.8602280547964475,       1.0 , 94/218 , 37.71%, NUP85;PSMD6;CENPO;CHMP4B;UBC;CENPA;CENPU;RANGAP1;PPP2R5E;PSMD7;CENPT;PSMD9;ITGB3BP;LEMD2;CLASP2;CDC20;UBE2C;PSMC3;PSME4;DYNC1LI1;PSMB2;PDS5B;KIF18A;CDC26;PSME2;CLASP1;NUP107;PPP2R5B;CHMP6;SMC1A;RAN;NUP98;UBE2E1;TMPO;XPO1;DYNC1H1;CENPS-CORT;UBB;RPS27A;IST1;CKAP5;ANKLE2;PSMD8;CENPM;PSME3;DYNC1LI2;INCENP;PPP2R2A;TUBB6;PSMB6;EMD;UBE2D1;VPS4A;WAPL;PMEPA1;PSMA1;PMF1-BGLAP;PSMB4;PPP2CA;TUBA1C;MAPRE1;SKA2;CHMP2A;PSMF1;KNL1;PSME1;SIRT2;PSMA3;KIF2C;NUP188;PSMB1;PSMC4;BUB1B;VRK1;SEM1;PSMA6;CENPQ;PSMD11;PSMA2;PSMD10;BIRC5;ANAPC4;MAD1L1;BUB3;PSMD5;CENPI;UBE2S;NDE1;MAD2L1;POM121;TUBA1A;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__PERK Regulates Gene Expression R-HSA-381042                                                                                  , -0.2651453453204323 , -1.022837640965589  , 0.43902439024390244 , 0.8594261696456333,       1.0 , 6/31   , 10.68%, EXOSC6;KHSRP;CEBPB;EIF2S1;ATF6;PARN
prerank, KEGG_2021_Human__GABAergic synapse                                                                                                          , 0.183940875496598   , 1.0207626919615451  , 0.5                 , 1.0               ,       1.0 , 10/53  , 9.41% , TRAK2;PLCL1;GNAO1;GABRD;GNG2;SLC38A5;ADCY3;ABAT;GNG4;GNG10
prerank, KEGG_2021_Human__Sphingolipid metabolism                                                                                                    , -0.2573311324570603 , -1.020753482778737  , 0.42105263157894735 , 0.8639676385106042,       1.0 , 6/40   , 9.89% , SMPD3;SPHK2;SGPP2;CERS5;SPTLC1;B4GALT6
prerank, Reactome_2022__Chromosome Maintenance R-HSA-73886                                                                                           , -0.21546649050929162, -1.0200525165175862 , 0.40229885057471265 , 0.8646725486839343,       1.0 , 32/114 , 24.72%, CENPO;H2AX;CENPA;H2AC19;SLC19A1;CENPU;CCNA1;CENPT;RPA3;ITGB3BP;CTC1;PRIM2;HJURP;RFC5;H2AC7;POLR2G;RBBP7;POLR1B;H2BC11;CHTF8;H3-3B;POLR2B;CENPS-CORT;FEN1;POLR2D;ATRX;CENPM;CCNA2;POLD4;CHTF18;PIF1;RBBP4
prerank, KEGG_2021_Human__Focal adhesion                                                                                                             , -0.20534481970047505, -1.018935860729524  , 0.42105263157894735 , 0.8663197823103793,       1.0 , 35/154 , 20.60%, ITGB3;ARHGAP35;COL6A3;PARVB;ITGB5;DIAPH1;PARVG;VEGFA;PDPK1;CRK;ITGAV;ARHGAP5;MAPK1;PIK3R3;PIK3R1;PRKCA;ITGA10;MAPK8;TNXB;MYL5;ITGA9;ROCK2;ITGA1;COL9A1;PPP1R12C;PAK6;CDC42;GRB2;PAK1;HGF;PDGFC;PXN;AKT1;LAMB2;ITGA2B
prerank, Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054                                                                          , -0.2647835137427964 , -1.0186243121825345 , 0.4657534246575342  , 0.8657126003815995,       1.0 , 8/34   , 17.92%, NUP85;NUP88;RANGAP1;NUP107;RAN;NUP98;XPO1;NUP153
prerank, Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064                                                                            , -0.2607363948505822 , -1.0184464721413118 , 0.39759036144578314 , 0.8648539455557324,       1.0 , 9/41   , 14.83%, RASGRF2;PDPK1;PRKAG2;MAPK1;PRKCA;DLG1;RPS6KA3;CAMK2G;PRKAR2A
prerank, Reactome_2022__Ca-dependent Events R-HSA-111996                                                                                             , -0.2919973614159995 , -1.0182305438264874 , 0.4533333333333333  , 0.8643596668603092,       1.0 , 10/25  , 26.82%, ADCY7;PDE1B;MAPK1;PRKCA;CAMK2G;PRKAR2A;PRKACB;ADCY9;PRKX;PRKAR1A
prerank, Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230                                                                                       , -0.22244714304733335, -1.0176235301536947 , 0.42857142857142855 , 0.8645527911478368,       1.0 , 12/83  , 9.33% , HDAC3;ATP5PB;MTX1;MEF2D;GABPA;MICOS13;LIN9;GLUD1;PRKAG2;NR1D1;POLRMT;CARM1
prerank, Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579                                                                     , -0.2670197804887247 , -1.017053395169697  , 0.41333333333333333 , 0.8646912270500323,       1.0 , 24/40  , 44.34%, RAD50;CHEK1;RPA3;RAD9B;RAD51AP1;RFC5;BRCA1;POLR1B;HUS1;RHNO1;PALB2;RMI1;XRCC3;RAD51D;TOP3A;SEM1;RAD51B;RFC2;ATM;RFC3;RAD17;TOPBP1;KAT5;RAD51C
prerank, Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423                                                                                              , -0.24201006856797266, -1.0170346331381885 , 0.4634146341463415  , 0.8633003176814688,       1.0 , 30/83  , 30.25%, JAG1;ARHGAP35;ABI1;ARHGAP6;ARHGAP5;PIK3R1;CYBB;VAMP3;TFRC;ABI2;VANGL1;NCKAP1L;TMPO;CDC42;LMAN1;ERBIN;BAIAP2L1;NCOA3;ARHGAP42;WASF1;EMD;YKT6;DSG2;SRGAP2;SWAP70;ARAP2;NCF2;NCF1;NHS;CDC42EP1
prerank, Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396                                                                                 , -0.19515433122801035, -1.0167812551812938 , 0.4270833333333333  , 0.8629016421440481,       1.0 , 94/219 , 37.71%, NUP85;PSMD6;CENPO;CHMP4B;UBC;CENPA;CENPU;RANGAP1;PPP2R5E;PSMD7;CENPT;PSMD9;ITGB3BP;LEMD2;CLASP2;CDC20;UBE2C;PSMC3;PSME4;DYNC1LI1;PSMB2;PDS5B;KIF18A;CDC26;PSME2;CLASP1;NUP107;PPP2R5B;CHMP6;SMC1A;RAN;NUP98;UBE2E1;TMPO;XPO1;DYNC1H1;CENPS-CORT;UBB;RPS27A;IST1;CKAP5;ANKLE2;PSMD8;CENPM;PSME3;DYNC1LI2;INCENP;PPP2R2A;TUBB6;PSMB6;EMD;UBE2D1;VPS4A;WAPL;PMEPA1;PSMA1;PMF1-BGLAP;PSMB4;PPP2CA;TUBA1C;MAPRE1;SKA2;CHMP2A;PSMF1;KNL1;PSME1;SIRT2;PSMA3;KIF2C;NUP188;PSMB1;PSMC4;BUB1B;VRK1;SEM1;PSMA6;CENPQ;PSMD11;PSMA2;PSMD10;BIRC5;ANAPC4;MAD1L1;BUB3;PSMD5;CENPI;UBE2S;NDE1;MAD2L1;POM121;TUBA1A;PSMD13;ANAPC16;ANAPC2
prerank, Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203                                                                               , -0.19909033394026585, -1.0163327879668025 , 0.43617021276595747 , 0.862809049869012 ,       1.0 , 81/255 , 29.67%, ST6GALNAC4;COPZ1;CSNK1D;SEC24D;TRIM13;F5;SEC24C;COG2;UBC;GOLGA2;STX17;LMAN2L;B4GALT1;RNF185;NAPSA;AMFR;ACTR1A;TFG;B4GALT3;ST6GALNAC1;ALG2;ACTR10;PMM2;NUS1;B4GALT6;AREG;LMAN2;CAPZA2;DYNC1LI1;MCFD2;MAN1A1;FUCA1;MGAT5;ASGR2;ALG6;DCTN3;CAPZB;ST6GALNAC6;GMPPB;TMEM115;MARCHF6;KDELR2;MOGAT3;TRAPPC2;TGFA;DYNC1H1;KDELR1;LMAN1;UBB;COPE;RPS27A;EDEM2;FUT8;SLC35A1;SLPI;MPDU1;NUDT14;TMED9;DHDDS;MAN2A2;DYNC1LI2;RPN1;VCP;DOLPP1;RAB1B;SEC22A;YKT6;SLC17A5;NPL;RFT1;SPTBN1;PDIA3;TRAPPC5;PPP6R1;MAN1B1;ST8SIA6;SERPINA1;SEC22B;NANP;COG8;COPB1
prerank, KEGG_2021_Human__Spliceosome                                                                                                                , -0.2123104875694679 , -1.0158126993762957 , 0.45263157894736844 , 0.8630747280070402,       1.0 , 38/139 , 25.01%, MAGOH;AQR;RNU5A-1;CRNKL1;FUS;SF3B5;DDX42;PUF60;THOC1;SRSF3;PRPF18;PRPF40B;PLRG1;LSM4;TCERG1;SNRPF;SF3B1;SART1;EIF4A3;HSPA1A;SRSF1;CDC40;PRPF8;NCBP1;DHX15;SNRPD3;PPIL1;RP9;SF3B2;DDX5;SRSF5;HNRNPM;LSM6;HSPA2;LSM2;PRPF38B;U2SURP;LSM7
prerank, KEGG_2021_Human__Legionellosis                                                                                                              , -0.23643834533951744, -1.01569184273291   , 0.45569620253164556 , 0.8621065757828604,       1.0 , 16/56  , 25.05%, BCL2L13;CR1L;ARF1;CASP3;CASP8;EEF1A1;EEF1G;EEF1A2;ITGAM;CASP7;HSPA1A;CD14;VCP;HSPA2;RAB1B;CLK4
prerank, KEGG_2021_Human__Chagas disease                                                                                                             , -0.21934804778400285, -1.015190569232629  , 0.4606741573033708  , 0.8622833353342415,       1.0 , 17/91  , 13.59%, CD3D;TGFB3;PLCB2;IRAK1;FASLG;CASP8;GNA15;PLCB1;MAPK1;PIK3R3;TICAM1;GNAI3;PIK3R1;IL10;MAPK8;CD3G;C1QC
prerank, Reactome_2022__DNA Damage Bypass R-HSA-73893                                                                                                , -0.2401188576271566 , -1.0129578957882948 , 0.4578313253012048  , 0.8674999113293022,       1.0 , 14/47  , 23.45%, UBC;SLC19A1;UFD1;RPA3;POLK;UBE2B;RFC5;RAD18;POLR1B;UBB;RPS27A;MAD2L2;VCP;POLD4
prerank, KEGG_2021_Human__Platelet activation                                                                                                        , -0.21846695632516067, -1.012702098117361  , 0.5494505494505495  , 0.8668315642369422,       1.0 , 14/105 , 10.53%, ITGB3;FCER1G;ADCY7;ARHGAP35;P2RX1;PLCB2;PLCB1;MAPK1;PIK3R3;RASGRP2;GNAI3;PIK3R1;NOS3;PTGS1
prerank, Reactome_2022__RET Signaling R-HSA-8853659                                                                                                  , -0.2724966209028229 , -1.0122433774563462 , 0.44871794871794873 , 0.8669465070266633,       1.0 , 9/27   , 25.53%, PTPN11;PIK3R3;PIK3R1;PRKCA;GRB2;PRKACB;GAB2;PIK3CA;RAP1GAP
prerank, KEGG_2021_Human__T cell receptor signaling pathway                                                                                          , -0.21536054767058127, -1.0108285609187244 , 0.4777777777777778  , 0.8704463025169173,       1.0 , 22/96  , 19.91%, NFKBIE;CD3D;CBLB;PDPK1;MAPK1;PIK3R3;PIK3R1;IL10;IL4;DLG1;MAPK8;CD3G;MAP3K8;BCL10;MAP3K7;MAP2K7;PAK6;CDC42;GRB2;PAK1;AKT1;PPP3CC
prerank, Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616                                                                              , -0.3175929325779775 , -1.0107117307731581 , 0.44155844155844154 , 0.8693517490181975,       1.0 , 6/17   , 19.82%, GNB5;GNGT2;GNG5;CDC42;GNG11;GNG3
prerank, Reactome_2022__Metabolism Of Steroid Hormones R-HSA-196071                                                                                  , 0.3036688700112406  , 1.0102928687706865  , 0.2903225806451613  , 1.0               ,       1.0 , 3/15   , 8.05% , AKR1B15;HSD17B11;STARD3
prerank, "KEGG_2021_Human__Growth hormone synthesis, secretion and action"                                                                           , -0.21964414302541752, -1.0102404254275474 , 0.4942528735632184  , 0.8693560508642358,       1.0 , 25/90  , 25.22%, ADCY7;CREB3L4;PLCB2;CRK;MAP3K1;SOCS3;PLCB1;MAPK1;PIK3R3;IRS1;GNAI3;PIK3R1;PRKCA;MAPK8;CREB3L2;GRB2;PRKACB;JUNB;AKT1;MAPK11;PIK3CA;GNAI1;ADCY9;SHC4;CREBBP
prerank, Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695                                                                      , -0.22208755953233836, -1.0096245713184673 , 0.4878048780487805  , 0.8694308894347228,       1.0 , 31/77  , 31.70%, GTF2H3;PAF1;CTR9;TAF11;CCNK;LEO1;POLR2G;SUPT6H;TAF15;CDC73;POLR2B;IWS1;CCNH;POLR2D;TAF1;AFF4;NCBP1;MNAT1;TAF5;TAF12;ELL;CTDP1;TAF4;GTF2A2;TCEA1;SKIC8;MLLT1;GTF2H4;RTF1;NELFCD;ELOC
prerank, Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604                                                                                   , -0.19552361219894052, -1.0091162878213915 , 0.47474747474747475 , 0.8692941761872055,       1.0 , 87/229 , 35.17%, PML;GATAD2A;PSMD6;HDAC3;PTPN11;IRAK1;PDPK1;TP53;UBC;PPP2R5E;PSMD7;CHD4;MAPK1;PIK3R3;PSMD9;IRS1;PHLPP2;PIK3R1;CSNK2A2;AREG;PSMC3;PSME4;TNRC6C;PSMB2;RRAGD;PSME2;AGO3;IL1RL1;PPP2R5B;ATN1;RBBP7;STRN;EGR1;USP7;ERBB3;TGFA;AGO1;GRB2;UBB;RPS27A;AKT1;PPARG;RING1;GAB2;CDKN1A;PSMD8;PSME3;FGFR2;NEDD4;PSMB6;PIK3CA;CBX4;FOXO1;RRAGB;RBBP4;MOV10;PSMA1;PSMB4;PPP2CA;RICTOR;PSMF1;KDM1A;PSME1;IRAK4;AGO2;PSMA3;RNF2;CBX8;SRC;PSMB1;PSMC4;INSR;SEM1;PSMA6;PSMD11;HBEGF;PSMA2;AKT2;COMMD3-BMI1;PSMD10;SCMH1;PDGFB;TSC2;PIK3CB;REST;PSMD5;FOXO4
prerank, Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553                                                                    , -0.20127902119724977, -1.0088112342826472 , 0.48314606741573035 , 0.8686480617394244,       1.0 , 62/150 , 37.23%, MAGOH;RPS3;RPL37A;PSMD6;ZSWIM8;DAG1;UBC;RPS8;PSMD7;RPL39;PSMD9;RPS14;RPL36AL;PSMC3;RPL38;PSME4;PSMB2;PSME2;RPL19;RPL6;RPS25;EIF4A3;RPL15;UBB;RPS27A;RPS6;NCBP1;PSMD8;PSME3;PSMB6;RPS11;PSMA1;PSMB4;CUL2;MAGOHB;RPSA;PSMF1;PSME1;UPF3B;RPS9;PSMA3;RPL28;RPS15;ELOC;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;RPL27A;PSMA2;PSMD10;RPL18A;RPS16;RPL9;RPL21;PSMD5;RPL3L;ETF1;RPL26;RPL13A;PSMD13
prerank, Reactome_2022__Death Receptor Signaling R-HSA-73887                                                                                         , -0.20901734844177922, -1.0082456713774892 , 0.40425531914893614 , 0.8686710214836028,       1.0 , 24/127 , 19.31%, SMPD3;RASGRF2;SQSTM1;HDAC3;CASP3;NCSTN;IRAK1;FASLG;CASP8;UBC;SPPL2A;TAB3;ITGB3BP;ARHGEF15;MAPK8;OBSCN;NSMAF;TANK;TNFRSF1A;MAP3K7;ARHGEF11;UBB;RPS27A;TNFAIP3
prerank, Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152                                                       , 0.2024451973188192  , 1.0081675035552278  , 0.48148148148148145 , 1.0               ,       1.0 , 6/44   , 6.93% , NELFB;NELFA;POLR2I;ERCC2;SSRP1;POLR2F
prerank, KEGG_2021_Human__mRNA surveillance pathway                                                                                                  , -0.22087077575008918, -1.0080613682979604 , 0.4642857142857143  , 0.8676424532366136,       1.0 , 12/84  , 9.34% , MAGOH;PPP2R3A;FUS;CSTF2;WDR82;PPP2R5E;UPF1;SYMPK;PABPC1L;CPSF1;SSU72;PABPN1L
prerank, Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821                                                         , -0.24438958059766486, -1.007679381300792  , 0.4482758620689655  , 0.8673695195884317,       1.0 , 25/63  , 26.86%, ADCY7;PPAN-P2RY11;TSHR;GNAI3;RLN2;PRKCA;GNB5;CALCRL;GNGT2;ADORA2A;GPR15;PRKAR2A;GNG5;PRKACB;GNG11;GNG3;MC1R;PTGIR;PTGDR;GNAI1;ADCY9;PRKX;ADM2;PRKAR1A;POMC
prerank, Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676                                                      , -0.27891319087900507, -1.0074326237647027 , 0.44047619047619047 , 0.8667655674228466,       1.0 , 13/30  , 28.89%, PRKCA;GNB5;GNGT2;PRKAR2A;GNG5;PRKACB;GNG11;GNG3;IQGAP1;RAPGEF3;RAP1A;PRKAR1A;AKAP5
prerank, Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994                                                , -0.2738444347951409 , -1.0068751395406985 , 0.4935064935064935  , 0.8670355538922156,       1.0 , 5/26   , 10.68%, EXOSC6;KHSRP;CEBPB;ATF6;PARN
prerank, Reactome_2022__Homology Directed Repair R-HSA-5693538                                                                                       , -0.209015767037667  , -1.0060991961779433 , 0.42528735632183906 , 0.867722572028467 ,       1.0 , 37/112 , 30.90%, RAD50;H2AX;BABAM1;UBC;SLC19A1;CCNA1;CHEK1;RPA3;POLK;RAD9B;RAD51AP1;RFC5;BRCA1;PARP2;UBE2N;POLR1B;H2BC11;ABRAXAS1;FEN1;UBB;RPS27A;HUS1;BABAM2;CCNA2;UIMC1;POLD4;RNF168;ERCC1;RHNO1;PALB2;RMI1;XRCC3;RAD51D;XRCC1;POLE3;POLD2;TOP3A
prerank, Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541                                                                              , -0.22367934012200727, -1.005882156989984  , 0.43529411764705883 , 0.8668949481419935,       1.0 , 35/91  , 33.55%, TNFSF14;PSMD6;TNFSF13;FASLG;UBC;PSMD7;UBA3;PSMD9;TNFRSF25;PSMC3;PSME4;PSMB2;CUL1;PSME2;TANK;TNFRSF1A;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;TNFSF12;PSMB4;RELB;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10
prerank, KEGG_2021_Human__Bacterial invasion of epithelial cells                                                                                     , -0.23197493574594852, -1.0043442096731874 , 0.47560975609756095 , 0.8696975326814523,       1.0 , 27/66  , 34.46%, ELMO3;SEPTIN6;CRK;CTTN;PIK3R3;SEPTIN1;PIK3R1;CDH1;ARPC5;CDC42;CLTC;PXN;MAD2L2;ITGA5;WASF1;PIK3CA;ARPC3;SHC4;ARPC2;DNM2;ACTR3;ARPC5L;CD2AP;SRC;VCL;ARPC4;PIK3CB
prerank, KEGG_2021_Human__Colorectal cancer                                                                                                          , -0.21635115107081665, -1.00337476344355   , 0.4642857142857143  , 0.8709489060432394,       1.0 , 21/82  , 22.14%, TGFB3;BAX;CASP3;TP53;GADD45G;MAPK1;PIK3R3;POLK;PIK3R1;AREG;PMAIP1;LEF1;MAPK8;SMAD3;RPS6KB1;TGFA;DDB2;GRB2;AKT1;CDKN1A;GADD45A
prerank, KEGG_2021_Human__Pancreatic cancer                                                                                                          , -0.2285804986353358 , -1.0030328706063725 , 0.43529411764705883 , 0.8703450242372397,       1.0 , 20/74  , 22.14%, TGFB3;BAX;VEGFA;TP53;GADD45G;MAPK1;PIK3R3;POLK;PIK3R1;MAPK8;SMAD3;RPS6KB1;RB1;PLD2;TGFA;DDB2;CDC42;AKT1;CDKN1A;GADD45A
prerank, Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508                                                                                      , -0.2864879253668754 , -1.002705258743835  , 0.45454545454545453 , 0.8698985250576502,       1.0 , 5/22   , 14.55%, TRPC6;DGKG;RASGRP2;PRKCH;DGKA
prerank, Reactome_2022__Signaling By Erythropoietin R-HSA-9006335                                                                                    , 0.2395542839014732  , 1.0021421656955896  , 0.44                , 1.0               ,       1.0 , 2/23   , 1.77% , PIK3CG;CRKL
prerank, Reactome_2022__Opioid Signaling R-HSA-111885                                                                                                , -0.22903154885093666, -1.0001184362690128 , 0.5116279069767442  , 0.8755243666148717,       1.0 , 25/70  , 27.95%, ADCY7;PLCB2;GNA15;PDE1B;PLCB1;MAPK1;GNAI3;PRKCA;GNB5;GNGT2;CAMK2G;PRKAR2A;GNG5;PRKACB;GNG11;GNG3;PPP3CC;PDE4D;GNAI1;ADCY9;PRKX;PRKAR1A;POMC;PDE4B;PPP2CA
prerank, Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901                                                                       , -0.2464839754846735 , -0.9991527420056078 , 0.41975308641975306 , 0.8766897484651549,       1.0 , 28/60  , 40.04%, UTP20;SPPL2A;FBL;UTP3;WDR43;RCL1;UTP18;RPS14;WDR75;RRP7A;UTP14C;NOP56;RPS6;RRP36;NAT10;RPS9;TSR3;DCAF13;NOP10;UTP15;BMS1;UTP11;TRMT112;IMP4;RPS2;FCF1;SNU13;KRR1
prerank, Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408                                                                                      , -0.22318521376903586, -0.9983814460258389 , 0.46835443037974683 , 0.8772325223370294,       1.0 , 19/73  , 23.21%, NUP85;USP18;MX1;NUP88;UBC;KPNA3;KPNA1;NUP107;UBE2N;NUP98;UBE2E1;EIF4A3;NUP153;EIF4E3;UBB;RPS27A;HERC5;NEDD4;POM121C
prerank, KEGG_2021_Human__Ribosome biogenesis in eukaryotes                                                                                          , -0.23318041058266725, -0.9980333048598826 , 0.5227272727272727  , 0.8766921619359705,       1.0 , 19/77  , 21.93%, SNORD3A;RPP25;SNORD3B-1;REXO2;FBL;WDR43;RCL1;RIOK1;UTP18;CSNK2A2;WDR75;LSG1;RAN;RRP7A;XPO1;UTP14C;NOP56;EIF6;NAT10
prerank, Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750                                                                             , -0.266276708557674  , -0.9979880080548938 , 0.5063291139240507  , 0.8755022384476331,       1.0 , 15/33  , 37.35%, CHEK1;CBX3;BRCA1;RBBP7;E2F6;PCGF6;RRM2;RING1;RBBP4;EHMT1;RNF2;YAF2;COMMD3-BMI1;TFDP2;PHC3
prerank, Reactome_2022__Complex I Biogenesis R-HSA-6799198                                                                                           , -0.24220297834226276, -0.9971733661160979 , 0.55                , 0.8765405560542964,       1.0 , 21/51  , 35.89%, NDUFB3;ECSIT;NDUFB2;NDUFA7;NDUFB9;NDUFS1;NDUFB7;NDUFB5;NDUFB4;NDUFS7;NDUFAF1;NDUFV3;NDUFAF5;NDUFS3;NDUFC1;NDUFB10;NDUFAB1;NDUFA13;NDUFAF3;NDUFV1;NDUFAF4
prerank, "Reactome_2022__Cell Cycle, Mitotic R-HSA-69278"                                                                                            , -0.1851574192125191 , -0.99705995102576   , 0.5151515151515151  , 0.8755937869558689,       1.0 , 181/500, 33.08%, NCAPG;NUP85;PLK4;PSMD6;CENPO;CSNK1D;CHMP4B;H2AX;NUP88;CEP76;TP53;UBC;CENPA;H2AC19;SLC19A1;MCM5;GOLGA2;CENPU;RANGAP1;PPP2R5E;LIN9;PSMD7;AKAP9;HMMR;HAUS2;CCNA1;MAPK1;CENPT;ACTR1A;RPA3;PSMD9;ITGB3BP;ENSA;LEMD2;CLASP2;CDC20;UBE2C;CEP250;CSNK2A2;PRIM2;ORC3;PSMC3;PSME4;DYNC1LI1;KIF23;PSMB2;CUL1;PDS5B;KIF18A;PRKCA;CDC26;PSME2;RFC5;H2AC7;TK1;CLASP1;NCAPH;NUP107;DHFR;CEP72;PPP2R5B;CHMP6;DCTN3;RAB2A;ESCO2;SMC1A;SLC25A15;FBXL18;RAN;CDC6;POLR1B;H2BC11;RB1;CDKN2D;LPIN1;CEP57;NINL;CDKN2C;NUP98;UBE2E1;CDK11B;E2F6;H3-3B;TMPO;LPIN2;XPO1;FOXM1;NUP153;SET;DYNC1H1;CCNH;CENPS-CORT;CDT1;FEN1;FKBPL;UBB;RPS27A;RRM2;AKT1;RAB33B;PHF8;MNAT1;IST1;CDC25C;CKAP5;ANKLE2;CEP70;CDKN1A;PSMD8;CENPM;PSME3;DYNC1LI2;INCENP;PPP2R2A;NEK7;CCNA2;BLZF1;POM121C;MZT1;TUBB6;PTK6;POLD4;PSMB6;EMD;UBE2D1;NME7;RAB1B;VPS4A;WAPL;RBBP4;CEP164;PMEPA1;PSMA1;PMF1-BGLAP;TUBGCP6;NEDD1;RAB8A;LCMT1;PSMB4;PPP2CA;CEP78;TUBA1C;MAPRE1;SKA2;CHMP2A;SFI1;CDKN1C;NEK2;PSMF1;LIN54;KNL1;GINS1;PSME1;SIRT2;HAUS7;H2AC6;POLE3;TUBGCP5;KIF20A;PSMA3;POLD2;CKS1B;SRC;AAAS;MCM6;KIF2C;NUP188;CEP63;RBL2;PSMB1;PSMC4;BUB1B;VRK1;SEM1;PSMA6;CENPQ;HSP90AA1;PSMD11;PSMA2;AKT2;HAUS5
prerank, Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440                                                                    , -0.24114143137498337, -0.996522154583133  , 0.41333333333333333 , 0.8759634486894754,       1.0 , 12/46  , 19.81%, IGF2R;COG2;RAB6A;VPS51;NAPSA;RABEPK;VAMP3;USP6NL;RAB9A;STX6;RIC1;SCOC
prerank, KEGG_2021_Human__Hepatocellular carcinoma                                                                                                   , -0.20665960277975853, -0.9964629491192375 , 0.4777777777777778  , 0.874645849901759 ,       1.0 , 29/130 , 19.46%, LRP6;TGFB3;BAX;GSTP1;TP53;WNT10A;GADD45G;MAPK1;PIK3R3;FZD6;POLK;GSTM1;PIK3R1;PRKCA;MGST1;LRP5;LEF1;PBRM1;SMAD3;RPS6KB1;RB1;TXNRD2;GSTO1;SMARCC1;TGFA;DDB2;GRB2;HGF;AKT1
prerank, Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243                                                                 , -0.2532733644676096 , -0.9963436749350895 , 0.5135135135135135  , 0.87357042934412  ,       1.0 , 8/36   , 17.92%, NUP85;NUP88;RANGAP1;NUP107;RAN;NUP98;XPO1;NUP153
prerank, Reactome_2022__Intra-Golgi Traffic R-HSA-6811438                                                                                            , -0.25218439216360045, -0.9951396137494282 , 0.5194805194805194  , 0.8752318668737292,       1.0 , 12/40  , 24.25%, COG2;NAPSA;CYTH2;TRIP11;CYTH1;MAN1A1;STX6;RIC1;RAB33B;MAN2A2;VPS45;YKT6
prerank, Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782                                                           , -0.2794277443253801 , -0.9951186802981229 , 0.5                 , 0.8739724089922799,       1.0 , 16/27  , 44.42%, HBA1;SCARF1;SPARC;MARCO;CD163;SCGB3A2;HSPH1;HSP90B1;FTL;APOE;HSP90AA1;MSR1;C1D;SAA2;SCARB1;JCHAIN
prerank, KEGG_2021_Human__IL-17 signaling pathway                                                                                                    , -0.22593873570115505, -0.994558345691863  , 0.4588235294117647  , 0.8739862811256369,       1.0 , 16/69  , 19.31%, MAPK6;CASP3;CASP8;TAB3;CEBPB;TRAF3IP2;MAPK1;TBK1;IL4;FOSL1;MAPK8;MMP9;CCL20;MAP3K7;SRSF1;TNFAIP3
prerank, Reactome_2022__Transport Of Small Molecules R-HSA-382551                                                                                    , -0.18554822041563634, -0.9941810186294551 , 0.53                , 0.8737973181543889,       1.0 , 188/500, 35.22%, SLC29A4;ABCA6;ABCC9;ADCY7;CETP;TRNP1;PSMD6;ABCB4;SLC35B3;PLTP;ARL2;TRPM7;HBA1;SLC44A4;TRPC6;RHBG;LDLRAP1;UBC;LSR;SGK3;ASPH;RNF185;SLCO1A2;ARL2BP;PSMD7;CLCN5;SLC35D2;SLC5A9;EIF2S1;SLC6A13;SLC39A1;ATP6V0A1;SLC25A26;ABCF1;PSMD9;SLC9A3;WNK1;SLC39A6;BMP1;ATP10B;LRRC8A;TFR2;ATP2A3;CTNS;CA2;SLC39A8;PSMC3;TFRC;PSME4;BSG;SLC5A6;PSMB2;CUL1;SLC28A2;SLC41A1;SLC1A4;PRKCA;PSME2;SLC13A5;SLC9B2;FLVCR1;TRPM3;ATP13A4;PHB1;GNB5;SLC4A8;TCIRG1;AQP3;GNGT2;CAMK2G;AKAP1;SLC22A15;ATP11A;SLC30A7;PMPCA;PRKAR2A;SLC39A3;AQP6;CUBN;GLRX3;ABCC4;RAB11A;STOM;SLC3A1;ATP9B;EMB;GNG5;BEST1;ATP1B1;LPL;LCAT;CLCN2;SLC1A2;ATP13A1;PRKACB;GNG11;CYB5R1;CLTC;HMOX2;UBB;RPS27A;ABCA1;SLC6A12;GNG3;SLC35A1;ATP1A3;SLC11A2;ATP8A2;PSMD8;PSME3;ABCB1;LRRC8E;ATP6V0A2;SLC9A7;AHCYL2;VCP;KCNJ11;ABCA2;PSMB6;STEAP3;SLC50A1;RNASE3;ADCY9;ATP8B3;SLC38A1;PSMA1;SLC17A5;SLC5A5;SLC11A1;SLC30A5;ABCC3;PRKAR1A;ANO8;MCOLN2;PSMB4;ATP6V0D1;SRI;HMOX1;ATP13A2;LCN15;SLC44A1;SLC22A16;ANO5;PSMF1;ATP8B2;SLC2A9;FTL;ADD3;YME1L1;ABCB5;PSME1;CYB5RL;APOE;PSMA3;SLC14A2;SLC26A1;P4HB;SLC15A1;SLC2A8;PSMB1;PSMC4;SLC47A1;SLC7A7;SEM1;PSMA6;PSMD11;PSMA2;UNC80;ERLEC1;GNB2;SLC9B1;ANO6;PSMD10;PDZD11;SLC36A2;NIPA2;SLC7A5;NLRP3;SLC39A10;SLC7A6;APOBR;SLC27A1;NEDD4L;SLC25A6;SLCO4C1;PSMD5;SLC12A4;HDLBP
prerank, Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592                                                                           , 0.2590176235070433  , 0.9936181316186038  , 0.43478260869565216 , 1.0               ,       1.0 , 6/21   , 10.90%, GNA11;GNG2;GNG4;GNG10;P2RY1;MAPK14
prerank, KEGG_2021_Human__Osteoclast differentiation                                                                                                 , -0.2102420767362628 , -0.9935821801140785 , 0.4772727272727273  , 0.8739801501872415,       1.0 , 36/117 , 29.27%, ITGB3;SQSTM1;SPI1;SOCS3;TYK2;MAPK1;PIK3R3;PIK3R1;CTSK;FOSL1;MAPK8;FOSL2;CSF1;TNFRSF1A;MAP3K7;MAP2K7;GRB2;FHL2;JUNB;AKT1;IL1R1;PPP3CC;PPARG;GAB2;IRF9;MAPK11;PIK3CA;BLNK;CSF1R;TAB1;BTK;NFATC2;NCF2;SYK;RELB;NCF1
prerank, Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471                                                , -0.2621305630413198 , -0.9933998879844813 , 0.5061728395061729  , 0.873168438046627 ,       1.0 , 14/37  , 31.46%, HDAC3;TP53;CCT3;ARFGEF2;CCT6B;NOP56;FBXW4;FBXO4;FKBP9;CCT2;KIF13A;CCT6A;FBXO6;FBXW7
prerank, Reactome_2022__Signaling By FGFR R-HSA-190236                                                                                               , -0.22205688737950813, -0.9933791564376847 , 0.4567901234567901  , 0.8718377769923116,       1.0 , 21/59  , 31.49%, PTPN11;MKNK1;UBC;MAPK1;PIK3R1;HNRNPF;POLR2G;POLR2B;GRB2;POLR2D;UBB;RPS27A;NCBP1;FGFR2;HNRNPM;PIK3CA;SPRED1;PPP2CA;HNRNPA1;SRC;SPRY2
prerank, Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931                                                                                 , -0.198558605969954  , -0.9932703041841173 , 0.5154639175257731  , 0.8707127588044251,       1.0 , 50/219 , 20.08%, UHMK1;CETP;HDAC3;AKR1C3;PLTP;H2AX;DHRS9;RDH14;PDPK1;H2AC19;PDK4;MAPK1;PIK3R3;GNAI3;PIK3R1;CARM1;AREG;PDHB;RARB;TNRC6C;AGO3;H2AC7;GNB5;NCOR2;SMC1A;GNGT2;POLR2G;SCD;NR5A2;H2BC11;MMP9;STRN;GNG5;H3-3B;TGFA;XPO1;AGO1;POLR2B;KAT2B;GNG11;CRABP2;POLR2D;NRIP1;LDHD;DAND5;ABCA1;AKT1;GNG3;FKBP4;NCOA3
prerank, KEGG_2021_Human__Vascular smooth muscle contraction                                                                                         , -0.21567833708649167, -0.9929250418877769 , 0.4725274725274725  , 0.8702116680101337,       1.0 , 19/86  , 19.42%, KCNMA1;ADCY7;PLCB2;MYH9;CALM2;PLCB1;MAPK1;PRKCH;ACTA2;PRKCA;CALCRL;ADORA2A;ROCK2;PPP1R14A;PPP1R12C;GNA12;ARHGEF11;PRKACB;CALM3
prerank, KEGG_2021_Human__Pyruvate metabolism                                                                                                        , -0.26355307466678957, -0.9905043999721573 , 0.4805194805194805  , 0.8759742180385772,       1.0 , 9/34   , 14.22%, FH;ALDH9A1;ADH5;ACSS1;PCK2;PDHB;ACSS2;ALDH1B1;ACAT1
prerank, Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594                                                                                   , -0.33387062815612883, -0.9904561771151171 , 0.4852941176470588  , 0.8747644425489511,       1.0 , 6/15   , 22.42%, XRCC5;CXCR4;KPNA1;PSIP1;FEN1;XRCC4
prerank, Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333                                                                , -0.2631582754880902 , -0.9901425301894994 , 0.527027027027027   , 0.8743596029609999,       1.0 , 8/34   , 17.92%, NUP85;NUP88;PBRM1;NUP107;RAN;NUP98;XPO1;NUP153
prerank, Reactome_2022__PI3K Cascade R-HSA-109704                                                                                                    , -0.28173495295068735, -0.9898250028062963 , 0.4305555555555556  , 0.8737893336034354,       1.0 , 8/25   , 23.85%, PTPN11;PDPK1;IRS1;PIK3R1;GRB2;GAB2;FGFR2;PIK3CA
prerank, Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091                                                                    , 0.21312841481891304 , 0.9885626177975736  , 0.5                 , 1.0               ,       1.0 , 7/31   , 12.19%, GLCE;IDUA;SDC3;HS3ST3A1;XYLT1;SDC2;GLB1L
prerank, Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170                                                                          , -0.31273088865443416, -0.9873626642063384 , 0.5416666666666666  , 0.879361458380948 ,       1.0 , 7/18   , 24.58%, GNAI3;GNB5;GNGT2;GNG5;GNG11;GNG3;GNAI1
prerank, KEGG_2021_Human__Asthma                                                                                                                     , -0.28738742207985235, -0.9858931454200976 , 0.48                , 0.8817927930343581,       1.0 , 10/22  , 42.33%, FCER1G;IL10;IL4;FCER1A;RNASE3;MS4A2;HLA-DRB1;HLA-DOB;CD40LG;TNF
prerank, Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382                                                                      , -0.22561877845510173, -0.9857463766639978 , 0.525               , 0.8808322282375887,       1.0 , 24/57  , 31.70%, GTF2H3;PAF1;CTR9;CCNK;LEO1;POLR2G;SUPT6H;CDC73;POLR2B;IWS1;CCNH;POLR2D;AFF4;NCBP1;MNAT1;ELL;CTDP1;TCEA1;SKIC8;MLLT1;GTF2H4;RTF1;NELFCD;ELOC
prerank, KEGG_2021_Human__Ether lipid metabolism                                                                                                     , 0.20259089022132043 , 0.9854388719797673  , 0.5                 , 1.0               ,       1.0 , 7/35   , 9.50% , LPCAT2;SELENOI;CHPT1;PAFAH1B1;PLA2G2C;GDPD3;PLPP1
prerank, Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042                                                                                     , -0.28552429415806063, -0.9846263952463121 , 0.4936708860759494  , 0.8823262716588101,       1.0 , 8/26   , 20.06%, TRIM13;UBC;RNF185;AMFR;MARCHF6;UBB;RPS27A;EDEM2
prerank, Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661                                                                              , 0.21262378865350784 , 0.9834628984230079  , 0.5                 , 1.0               ,       1.0 , 9/39   , 10.22%, DEGS1;ALDH3B1;SAMD8;CSNK1G2;SGMS2;ALDH3A2;VAPB;PLPP1;SPTSSB
prerank, Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854                                                                         , 0.19695813531681594 , 0.9828859095521443  , 0.56                , 1.0               ,       1.0 , 9/35   , 13.37%, NEK9;NUP160;NUP133;NUP54;NEK6;NUP210;SEC13;CDK1;NUP62
prerank, Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925                                                                   , -0.1906030104866599 , -0.9826621013648958 , 0.47474747474747475 , 0.8860652651449757,       1.0 , 96/257 , 35.17%, PML;ADCY7;GATAD2A;PSMD6;HDAC3;PTPN11;IRAK1;PDPK1;TP53;UBC;PPP2R5E;PSMD7;CHD4;PDE1B;MAPK1;PIK3R3;PSMD9;IRS1;PHLPP2;PIK3R1;CSNK2A2;AREG;PSMC3;PSME4;TNRC6C;PSMB2;RRAGD;PRKCA;PSME2;AGO3;IL1RL1;PPP2R5B;CAMK2G;ATN1;RBBP7;PRKAR2A;STRN;EGR1;USP7;ERBB3;TGFA;AGO1;GRB2;PRKACB;UBB;RPS27A;AKT1;PPARG;RING1;GAB2;CDKN1A;PSMD8;PSME3;FGFR2;NEDD4;PSMB6;PIK3CA;CBX4;FOXO1;RRAGB;RBBP4;ADCY9;MOV10;PRKX;PSMA1;PRKAR1A;PSMB4;PPP2CA;RICTOR;PSMF1;KDM1A;PSME1;IRAK4;AGO2;PSMA3;RNF2;CBX8;SRC;PSMB1;PSMC4;INSR;SEM1;PSMA6;PSMD11;HBEGF;PSMA2;AKT2;COMMD3-BMI1;PSMD10;SCMH1;PDGFB;TSC2;PIK3CB;REST;PSMD5;FOXO4
prerank, Reactome_2022__Drug ADME R-HSA-9748784                                                                                                      , -0.24409109698359915, -0.9826099029405576 , 0.5                 , 0.8848548641353655,       1.0 , 13/44  , 26.48%, GGT1;GSTP1;CYP2C9;CNDP2;GSTM1;BSG;SLC28A2;ABCC4;GGT5;GGT7;ABCB1;SLC38A1;ABCC3
prerank, Reactome_2022__Stimuli-sensing Channels R-HSA-2672351                                                                                       , -0.23389077036462366, -0.9818198340588935 , 0.55                , 0.8857753715337856,       1.0 , 14/57  , 19.10%, TRPM7;TRPC6;UBC;SGK3;ASPH;CLCN5;WNK1;SLC9B2;TRPM3;STOM;BEST1;CLCN2;UBB;RPS27A
prerank, Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486                                                                      , -0.2713614135371019 , -0.9812402435938898 , 0.4647887323943662  , 0.8858039679704035,       1.0 , 10/24  , 30.58%, UBC;MAPK1;KPNA1;UBB;RPS27A;DUSP16;RAB5A;VPS33B;LTF;TLR2
prerank, Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671                                            , -0.20454512113754222, -0.9804100501753314 , 0.5595238095238095  , 0.8869011129325061,       1.0 , 18/103 , 16.14%, NUP85;SEC24D;NUP88;PTPN11;SIKE1;IRAK1;G3BP1;SEC24C;TAB3;TYK2;HLA-G;ATG14;TBK1;NUP107;UBE2N;CNBP;NUP98;MAP3K7
prerank, Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313                              , -0.24396901326055462, -0.9803748304869955 , 0.4875              , 0.8856803289129572,       1.0 , 13/38  , 25.87%, UBC;SLC19A1;UFD1;RPA3;POLK;RFC5;POLR1B;UBB;RPS27A;MAD2L2;VCP;POLD4;REV3L
prerank, Reactome_2022__Attenuation Phase R-HSA-3371568                                                                                              , -0.2766953560265101 , -0.9772269034756361 , 0.4444444444444444  , 0.892970192134528 ,       1.0 , 8/23   , 25.72%, MRPL18;HSPA1A;HSPH1;UBB;FKBP4;HSPA2;CREBBP;TNFRSF21
prerank, Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676                                                                         , -0.3186378030103019 , -0.9770994318731767 , 0.47761194029850745 , 0.8919567256253258,       1.0 , 7/15   , 32.77%, SNAP25;STXBP1;RAB3A;LIN7A;LIN7C;STX1A;CASK
prerank, Reactome_2022__PLC Beta Mediated Events R-HSA-112043                                                                                        , -0.2605493449291585 , -0.9768200280774212 , 0.575               , 0.8912567948810026,       1.0 , 9/36   , 14.83%, ADCY7;PLCB2;GNA15;PDE1B;PLCB1;MAPK1;PRKCA;CAMK2G;PRKAR2A
prerank, Reactome_2022__Cellular Response To Starvation R-HSA-9711097                                                                                , 0.154925393737379   , 0.9763896644286748  , 0.4444444444444444  , 1.0               ,       1.0 , 24/145 , 11.70%, RPS24;RPS29;ATP6V1E2;RPL7A;RPL22L1;IMPACT;EIF2S3;ASNS;ATP6V0C;RPS15A;RPL32;RPS4X;RPS20;RPS4Y1;LAMTOR2;DDIT3;MTOR;RPL27;ATF4;ATP6V0E2;SZT2;RPS13;RRAGA;SEC13
prerank, Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972                                                                , 0.19607354731284182 , 0.976252149489158   , 0.4583333333333333  , 1.0               ,       1.0 , 9/27   , 17.69%, LAMTOR2;MTOR;RRAGA;STK11;PRKAB1;STRADA;LAMTOR1;LAMTOR5;LAMTOR3
prerank, Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616                                                                 , -0.25345595082054045, -0.97536951108873   , 0.4931506849315068  , 0.8932676609729643,       1.0 , 8/35   , 17.03%, H2AX;H2AC19;ORC3;KPNA1;H2AC7;SLC25A15;H2BC11;H3-3B
prerank, Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440                                                                    , -0.2538635066153886 , -0.9732804053850034 , 0.5394736842105263  , 0.8972928582297289,       1.0 , 21/35  , 43.64%, PCBP2;UBC;ITCH;TBK1;UBB;ATG12;RPS27A;TNFAIP3;HERC5;OTUD5;UBE2D1;UBE2D2;ATG5;CYLD;NLRC5;RNF125;UBE2K;IRF3;RNF135;MAVS;IKBKE
prerank, KEGG_2021_Human__Axon guidance                                                                                                              , -0.20850026585680453, -0.9713033165332988 , 0.5520833333333334  , 0.9017290279515595,       1.0 , 34/126 , 24.58%, EPHB3;NTNG2;EFNB1;PTPN11;TRPC6;PARD6B;PDPK1;LRRC4;CXCR4;MAPK1;ABLIM2;PIK3R3;GNAI3;PIK3R1;PRKCA;EPHB4;MYL5;CAMK2G;ROCK2;RRAS;PLXNC1;BMP7;PAK6;CDC42;PAK1;SEMA3C;PPP3CC;CFL2;SSH1;PLXNA3;LIMK1;ABLIM1;PIK3CA;GNAI1
prerank, Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593                                                                    , -0.3180232449800823 , -0.9706770046991717 , 0.5131578947368421  , 0.902188311528954 ,       1.0 , 4/17   , 11.51%, PML;PTPN11;TNRC6C;AGO3
prerank, Reactome_2022__Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860                                                           , -0.31511719502100205, -0.9694573074956007 , 0.5789473684210527  , 0.9040573985956658,       1.0 , 8/19   , 32.75%, B4GALT1;ALG2;ALG6;MPDU1;RFT1;MAN1B1;MOGS;ALG13
prerank, Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107                              , 0.1945656662202499  , 0.9678573702459173  , 0.5666666666666667  , 1.0               ,       1.0 , 8/31   , 13.37%, MAP4K5;NUP160;NUP133;MAP4K2;NUP54;NUP210;SEC13;NUP62
prerank, Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580                                                                            , -0.21122686619422248, -0.9676536450763432 , 0.5747126436781609  , 0.9076053409525673,       1.0 , 26/89  , 24.96%, H2AX;TP53;UBC;H2AC19;MDM4;MAPK1;TNRC6C;AGO3;H2AC7;MAPK8;RBBP7;H2BC11;CDKN2D;CDKN2C;MAP2K7;H3-3B;AGO1;MINK1;UBB;RPS27A;RING1;MAPK11;MAP3K5;CBX4;RBBP4;MOV10
prerank, KEGG_2021_Human__Systemic lupus erythematosus                                                                                               , -0.20363755908292502, -0.9674389951620608 , 0.5555555555555556  , 0.9068086008990921,       1.0 , 28/112 , 23.81%, H2AX;H3C2;H2AC19;H2AC17;H3C15;H4C1;H2AC21;H3C6;H2AC8;H2AB2;ELANE;IL10;H3C10;H2AC7;C5;C4B;C1QC;H2BC11;C4A;RO60;H3-3B;MACROH2A2;SSB;SNRPD3;H4C9;C8G;H2BC7;H4C5
prerank, KEGG_2021_Human__Selenocompound metabolism                                                                                                  , -0.3086098228771024 , -0.9673245667939991 , 0.4936708860759494  , 0.905739701153249 ,       1.0 , 4/16   , 15.47%, PSTK;MARS2;INMT;TXNRD2
prerank, Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241                                                                           , -0.17821740522753052, -0.9655202700755646 , 0.5684210526315789  , 0.9093339070749035,       1.0 , 47/256 , 16.55%, PLK4;HDAC3;CSNK1D;ATP5PB;B9D1;MTX1;NPHP4;MEF2D;CEP76;IQCB1;GABPA;AHI1;BBS7;BBS5;MICOS13;LIN9;AKAP9;GLUD1;HAUS2;PRKAG2;ACTR1A;CCT3;NPHP1;NR1D1;POLRMT;CARM1;IFT122;CEP250;TRIP11;CEP97;PRKCA;CLASP1;ACSS2;CEP72;DCTN3;DYNLT2;BBS2;C2CD3;KIF3C;CC2D2A;KIF24;CEP57;NINL;ATP5MC3;RAB11A;DYNC2H1;RPGRIP1L
prerank, Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422                                                                            , -0.2322972489022309 , -0.9645663341735291 , 0.5641025641025641  , 0.9105507135654836,       1.0 , 18/76  , 18.18%, RFNG;H2AX;TP53;RAB6A;H2AC19;B4GALT1;ATP2A3;TNRC6C;AGO3;LFNG;H2AC7;NOTCH3;H2BC11;H3-3B;MAML2;AGO1;KAT2B;RBPJ
prerank, Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092                                                                                  , 0.22809391613028784 , 0.9629841407211981  , 0.52                , 1.0               ,       1.0 , 4/20   , 9.41% , VIPR1;GNG2;GNG4;GNG10
prerank, KEGG_2021_Human__Hematopoietic cell lineage                                                                                                 , -0.21583368138545383, -0.9626907720676269 , 0.5487804878048781  , 0.9142397588672213,       1.0 , 23/84  , 26.33%, ITGB3;CR1L;CD3D;CD9;CD44;CD38;TFRC;IL3RA;IL4;CD3G;CSF1;ITGA1;ITGAM;CD7;IL1R1;CD1A;ITGA2B;CD1C;CD14;ITGA5;MS4A1;CSF1R;CD24
prerank, Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949                                                                   , -0.22064894036454186, -0.9619628847351502 , 0.4880952380952381  , 0.9145467808859454,       1.0 , 29/62  , 40.56%, DTX4;ZBP1;UBC;XRCC5;TICAM1;POLR3B;DHX9;TBK1;POLR1D;POLR3K;TLR3;UBB;RPS27A;TREX1;IFI16;CREBBP;PRKDC;IRF7;DHX36;POLR3C;LRRFIP1;IKBKG;NKIRAS2;POLR2E;XRCC6;POLR2L;POLR3H;POLR3D;RELA
prerank, Reactome_2022__Assembly Of HIV Virion R-HSA-175474                                                                                          , 0.2659575631515551  , 0.9609141677055202  , 0.5581395348837209  , 1.0               ,       1.0 , 4/16   , 7.20% , MVB12B;UBAP1;VPS37C;VPS37B
prerank, Reactome_2022__TCR Signaling R-HSA-202403                                                                                                   , -0.20393086625291235, -0.9608441263913234 , 0.5476190476190477  , 0.9160390845147939,       1.0 , 47/111 , 37.23%, PSMD6;CD3D;PDPK1;UBC;PSMD7;PTPRJ;PSMD9;PIK3R1;WAS;PSMC3;PSME4;PSMB2;CUL1;PSME2;EVL;UBE2N;BCL10;MAP3K7;UBB;RPS27A;PSMD8;PSME3;PSMB6;UBE2D1;PIK3CA;PSMA1;UBE2D2;PSMB4;PSMF1;PSME1;RIPK2;PSMA3;HLA-DRB1;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;PIK3CB;IKBKG;PSMD5;ITK;PLCG2;CD3E;PSMD13
prerank, Reactome_2022__HCMV Late Events R-HSA-9610379                                                                                               , -0.21113257023361798, -0.9603916397210123 , 0.5058823529411764  , 0.9158143652123067,       1.0 , 15/83  , 16.07%, NUP85;CEBPD;RRM1;CHMP4B;NUP88;H2AC19;H2AC21;IRS1;VPS36;H2AC7;NUP107;CHMP6;H2BC11;NUP98;VPS37A
prerank, Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589                                                                                 , -0.30163184497193524, -0.9593398652975582 , 0.5                 , 0.9173004339561346,       1.0 , 6/17   , 21.25%, PTPN11;SOCS3;TYK2;CNTF;CLCF1;IL31RA
prerank, Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909                                                                                , -0.1957429728389049 , -0.959290790021309  , 0.5764705882352941  , 0.9161488973005673,       1.0 , 48/127 , 35.04%, NUP85;PSMD6;NUP88;UBC;RANGAP1;PSMD7;CUL5;PSMD9;PSMC3;PSME4;PSMB2;PSME2;KPNA1;NUP107;RAN;NUP98;AP1S2;PSIP1;AP1M1;XPO1;NUP153;UBB;RPS27A;PSMD8;PSME3;AP1S1;POM121C;PSMB6;AP1G1;PSMA1;PSMB4;PSMF1;PSME1;PSMA3;AAAS;NUP188;ELOC;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;RANBP1;PSMA2;PSMD10;AP1S3;SLC25A6;PSMD5
prerank, Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476                                                                                    , -0.2032399982047248 , -0.9592777369903079 , 0.5340909090909091  , 0.9149051130195748,       1.0 , 30/123 , 20.00%, PLCB2;XCL1;TRPC6;GNA15;AGXT;GNRH1;PLCB1;MAPK1;PPAN-P2RY11;DGKG;UTS2R;PIK3R3;CHRM3;RASGRP2;PRKCH;F2RL1;NTSR1;PIK3R1;PRKCA;RPS6KA3;GNB5;PTAFR;GNGT2;DGKA;GNG5;LTB4R2;GRB2;GNG11;GNG3;UTS2B
prerank, Reactome_2022__RAB Geranylgeranylation R-HSA-8873719                                                                                        , -0.2224467033166601 , -0.959001898970727  , 0.5517241379310345  , 0.9142378108746012,       1.0 , 17/54  , 26.50%, RAB8B;RAB40B;RAB6A;RAB39B;RAB2A;RAB44;RAB9A;RAB11A;PTP4A2;RAB33B;RAB1B;RAB3A;RAB5A;RAB37;MPZ;RAB8A;RAB18
prerank, Reactome_2022__Axon Guidance R-HSA-422475                                                                                                   , -0.1784678317382435 , -0.958542536374112  , 0.5959595959595959  , 0.9141603591286814,       1.0 , 158/403, 37.23%, ITGB3;EPHB3;MAGOH;RPS3;RPL37A;EFNB1;ARHGAP35;PSMD6;COL6A3;YES1;ZSWIM8;DAG1;PTPN11;NCSTN;TRPC6;MYH9;SIAH1;SHTN1;CACNB3;UBC;ITGAV;RPS8;PSMD7;RPL39;CXCR4;MAPK1;ABLIM2;PIK3R3;PSMD9;RANBP9;CLASP2;PIK3R1;RPS6KA4;RPS14;CSNK2A2;RPL36AL;PSMC3;RPL38;PSME4;PSMB2;PRKCA;PSME2;DLG1;RPS6KA3;RPL19;CLASP1;ITGA10;MAPK8;EPHB4;EVL;ITGA9;ROCK2;MMP9;CAP1;PFN1;CACNA1H;PRKAR2A;RPL6;RRAS;ITGA1;RPS25;COL9A1;ARPC5;PLXNC1;EIF4A3;ARHGEF11;RPL15;SCN1B;VPS72;NUMB;CDC42;GRB2;PRKACB;CLTC;UBB;RPS27A;RHOC;RPS6;FARP2;NCBP1;ITGA2B;GAB2;PSENEN;PLXNA3;PSMD8;PSME3;LIMK1;ADAM10;ITGA5;MAPK11;SCN11A;ABLIM1;PSMB6;PIK3CA;ARPC3;APH1B;RPS11;SRGAP2;PSMA1;RAP1GAP;ARPC2;CD24;DNM2;SPTBN1;PSMB4;CUL2;RHOB;MAGOHB;RPSA;MYL12B;AKAP5;PSMF1;PSME1;UPF3B;RPS9;ACTR3;LIMK2;PSMA3;RPL28;SRC;RPS15;ELOC;PSMB1;SDCBP;PSMC4;SEM1;PSMA6;HSP90AA1;PSMD11;RPL27A;PSMA2;EPHB6;ARHGEF12;PSMD10;DPYSL2;RPL18A;RPS16;RPL9;CACNB1;RPL21;PIK3CB;PSMD5;GIT1;RPL3L;VAV3;EPHA7;CACNB4;AP2S1;NCK2;MYL9;RGMB;ETF1;EPHA1;RPL26;RPL13A;ABL2;ACTG1;PSMD13
prerank, Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928                                                                                            , 0.2608693906163029  , 0.9581594794035679  , 0.6206896551724138  , 1.0               ,       1.0 , 4/15   , 10.52%, GLCE;SDC3;HS3ST3A1;SDC2
prerank, Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737                                                                             , 0.1559926074920117  , 0.9560921327238279  , 0.5833333333333334  , 1.0               ,       1.0 , 15/114 , 8.93% , RPS24;RPS29;RPL7A;RPL22L1;EIF2B4;EIF2S3;EIF4A1;EIF4H;RPS15A;RPL32;RPS4X;RPS20;RPS4Y1;RPL27;EIF3M
prerank, Reactome_2022__Nucleotide Salvage R-HSA-8956321                                                                                             , -0.2936744605955887 , -0.9554723246369635 , 0.53125             , 0.9209690607867235,       1.0 , 4/19   , 11.99%, UCKL1;TK2;CDA;TK1
prerank, KEGG_2021_Human__Measles                                                                                                                    , -0.2037317299202578 , -0.9549604902722063 , 0.5591397849462365  , 0.9209929523221001,       1.0 , 19/117 , 13.03%, CD3D;BAX;MX1;CBLB;CASP3;IRAK1;FASLG;CASP8;TP53;IL2RG;EIF2S1;TYK2;PIK3R3;PIK3R1;CSNK2A2;OAS2;TBK1;MAPK8;CD3G
prerank, Reactome_2022__UCH Proteinases R-HSA-5689603                                                                                                , -0.2173468106056769 , -0.9538500442728906 , 0.5238095238095238  , 0.9224247667582107,       1.0 , 37/91  , 35.04%, PSMD6;UBC;H2AC19;PSMD7;H2AC21;PSMD9;PSMC3;PSME4;PSMB2;PSME2;H2AC7;ADRM1;ASXL1;SMAD7;UBB;RPS27A;PSMD8;PSME3;PSMB6;PSMA1;INO80D;PSMB4;PSMF1;UCHL1;PSME1;H2AC6;PSMA3;SENP8;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;NFRKB;PSMD5
prerank, Reactome_2022__Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029                                                            , -0.285584470217692  , -0.9527931532761893 , 0.5540540540540541  , 0.9239788086869739,       1.0 , 5/20   , 18.71%, OPLAH;GGT1;CYP2U1;FDX1;CYP1B1
prerank, Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273                                                          , -0.27190735908115427, -0.9524914954160149 , 0.5645161290322581  , 0.923414589959011 ,       1.0 , 10/25  , 27.95%, CCNA1;XPO1;FOXM1;CCNH;MNAT1;CDC25C;PPP2R2A;CCNA2;LCMT1;PPP2CA
prerank, Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876                                                                     , -0.287599192873027  , -0.9521473703857954 , 0.4626865671641791  , 0.9229622627937767,       1.0 , 9/19   , 26.44%, ACSL1;ELOVL6;TECR;ACSL5;ELOVL1;ACSL4;ELOVL3;ACSBG1;ELOVL5
prerank, Reactome_2022__Resolution Of Abasic Sites (AP Sites) R-HSA-73933                                                                            , -0.24986699063470366, -0.9521336321815477 , 0.5308641975308642  , 0.9216776133879427,       1.0 , 16/37  , 31.29%, SLC19A1;RPA3;OGG1;RFC5;PARP2;UNG;POLR1B;FEN1;TDG;POLD4;NEIL2;MUTYH;XRCC1;POLE3;POLD2;PNKP
prerank, Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706                                                              , 0.14894231861615165 , 0.9515935123348621  , 0.5                 , 1.0               ,       1.0 , 14/107 , 8.93% , RPS24;RPS29;RPL7A;RPL22L1;EIF2S3;EIF4A1;EIF4H;RPS15A;RPL32;RPS4X;RPS20;RPS4Y1;RPL27;EIF3M
prerank, Reactome_2022__Selective Autophagy R-HSA-9663891                                                                                            , -0.21220681870581476, -0.9512788549452521 , 0.5466666666666666  , 0.922626940822965 ,       1.0 , 22/56  , 32.65%, SQSTM1;UBC;PRKAG2;CSNK2A2;DYNC1LI1;MTERF3;UBE2N;DYNC1H1;TOMM40;UBB;ATG12;RPS27A;PEX5;PRKAG1;DYNC1LI2;VCP;PLIN3;HDAC6;SRC;ATG5;TOMM7;HSP90AA1
prerank, Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389                                                 , -0.2395199995860037 , -0.9511495585589299 , 0.525               , 0.9216758255072589,       1.0 , 9/43   , 17.03%, GATAD2A;H2AX;H2AC19;CHD4;CBX3;H2AC7;RBBP7;H2BC11;H3-3B
prerank, Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393                                             , 0.18053124102525583 , 0.9510452069825435  , 0.38461538461538464 , 1.0               ,       1.0 , 14/67  , 14.82%, SLC43A2;SLC7A8;SLC8B1;SLC6A15;SLC24A4;SLC38A5;SLC16A10;SLC24A3;SLC20A2;SLC1A7;SLC7A1;SLC15A3;SLC1A3;SLC9A8
prerank, Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823                                                                       , -0.22792076836868408, -0.9510395730693648 , 0.5394736842105263  , 0.9206334771190379,       1.0 , 13/52  , 20.75%, AQR;GTF2H3;UBC;COPS3;XPA;POLR2G;USP7;POLR2B;CCNH;POLR2D;UBB;RPS27A;MNAT1
prerank, Reactome_2022__Collagen Chain Trimerization R-HSA-8948216                                                                                   , -0.3034617106512688 , -0.9506329361031353 , 0.5217391304347826  , 0.9203134933504583,       1.0 , 4/18   , 18.16%, COL6A3;COL28A1;COL9A1;COL8A1
prerank, KEGG_2021_Human__Spinocerebellar ataxia                                                                                                     , -0.20697206906354013, -0.9504112049725366 , 0.6                 , 0.9196508710730401,       1.0 , 58/118 , 40.24%, PSMD6;PLCB2;PSMD7;PLCB1;PPIF;PIK3R3;PSMD9;ATP2A3;PIK3R1;ATG14;PSMC3;PSMB2;PRKCA;ADRM1;MAPK8;ATG101;AMBRA1;WIPI2;ULK2;KCND3;ATG2A;RBPJ;NOP56;AKT1;ATG13;OMA1;PSMD8;PSMB6;PIK3CA;MAP3K5;CIC;PSMA1;TWNK;PSMB4;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;AKT2;CYCS;PLCB3;PIK3CB;SLC25A6;ATXN1;MAPK10;XBP1;PSMD13;RORA;PUM2;NRBF2;ATXN3;ATXN2L;TRAF2;CACNA1A;ITPR1
prerank, KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications                                                                       , -0.2150250391962018 , -0.9500876922236152 , 0.5581395348837209  , 0.919255239520958 ,       1.0 , 15/82  , 12.75%, TGFB3;BAX;PLCB2;CASP3;DIAPH1;VEGFA;PLCB1;MAPK1;PIK3R3;PIK3R1;CYBB;NOS3;PRKCA;MAPK8;SMAD3
prerank, KEGG_2021_Human__Fructose and mannose metabolism                                                                                            , 0.22873735034883613 , 0.9498998484227543  , 0.4230769230769231  , 1.0               ,       1.0 , 8/29   , 16.18%, SORD;GMDS;HKDC1;MPI;PFKL;TKFC;ALDOC;PFKM
prerank, KEGG_2021_Human__RNA polymerase                                                                                                             , -0.2569854806467673 , -0.9488678518667488 , 0.5774647887323944  , 0.9208850379597946,       1.0 , 9/31   , 18.79%, POLR1C;POLR3B;POLR2J2;POLR1D;POLR3K;POLR2G;POLR1B;POLR2B;POLR2D
prerank, Reactome_2022__Cytosolic tRNA Aminoacylation R-HSA-379716                                                                                   , 0.23038241566870502 , 0.9485635554297555  , 0.5483870967741935  , 1.0               ,       1.0 , 9/24   , 22.27%, AIMP2;KARS1;GARS1;HARS1;AIMP1;YARS1;RARS1;CARS1;IARS1
prerank, KEGG_2021_Human__Basal transcription factors                                                                                                , -0.23439715238680575, -0.9483422843908491 , 0.5584415584415584  , 0.9208775076451946,       1.0 , 18/41  , 35.69%, GTF2H3;TAF8;TAF11;TAF15;CCNH;TAF4B;TAF1;MNAT1;TAF5;TAF6L;TAF12;TAF4;GTF2A2;GTF2H4;ERCC3;TAF9;GTF2H2C_2;GTF2H1
prerank, Reactome_2022__Platelet Sensitization By LDL R-HSA-432142                                                                                   , -0.28691136159538744, -0.9480605674259032 , 0.5555555555555556  , 0.9201868032098196,       1.0 , 4/16   , 17.46%, PTPN11;PPP2R5E;PPP2R5B;FGR
prerank, Reactome_2022__Nervous System Development R-HSA-9675108                                                                                     , -0.1767817560437112 , -0.9477233621505765 , 0.6161616161616161  , 0.9196996299009377,       1.0 , 164/420, 37.23%, ITGB3;EPHB3;MAGOH;RPS3;RPL37A;EFNB1;ARHGAP35;PSMD6;COL6A3;YES1;ZSWIM8;DAG1;PTPN11;NCSTN;TRPC6;MYH9;SIAH1;SHTN1;CACNB3;UBC;ITGAV;RPS8;PSMD7;RPL39;CXCR4;MAPK1;ABLIM2;PIK3R3;PSMD9;RANBP9;CLASP2;PIK3R1;RPS6KA4;RPS14;CSNK2A2;RPL36AL;PSMC3;RPL38;PSME4;PSMB2;PRKCA;PSME2;DLG1;RPS6KA3;RPL19;CLASP1;ITGA10;MAPK8;EPHB4;EVL;NAB2;ITGA9;ROCK2;MMP9;CAP1;PFN1;CACNA1H;PRKAR2A;RPL6;RRAS;ITGA1;RPS25;COL9A1;ARPC5;PLXNC1;EIF4A3;ARHGEF11;RPL15;SCN1B;VPS72;SCD5;NUMB;CDC42;GRB2;PRKACB;CLTC;UBB;RPS27A;RHOC;RPS6;FARP2;NCBP1;ITGA2B;GAB2;PSENEN;PLXNA3;PSMD8;PSME3;LIMK1;ADAM10;ITGA5;MAPK11;SCN11A;ABLIM1;PSMB6;PIK3CA;ARPC3;APH1B;RPS11;SRGAP2;PSMA1;RAP1GAP;ARPC2;MPZ;CD24;DNM2;UTRN;SPTBN1;PSMB4;CUL2;RHOB;MAGOHB;RPSA;MYL12B;AKAP5;PSMF1;PSME1;UPF3B;RPS9;ACTR3;LIMK2;PSMA3;RPL28;ADGRV1;SRC;RPS15;ELOC;PSMB1;SDCBP;PSMC4;SEM1;PSMA6;HSP90AA1;PSMD11;RPL27A;GJB1;PSMA2;EPHB6;ARHGEF12;PSMD10;DPYSL2;RPL18A;RPS16;RPL9;CACNB1;RPL21;PIK3CB;PSMD5;GIT1;RPL3L;VAV3;EPHA7;CACNB4;AP2S1;NCK2;MYL9;RGMB;ETF1;EPHA1;RPL26;RPL13A;ABL2;ACTG1;PSMD13
prerank, KEGG_2021_Human__Rap1 signaling pathway                                                                                                     , -0.19867906317850692, -0.9473473189618857 , 0.5930232558139535  , 0.919384154276674 ,       1.0 , 44/152 , 25.53%, ITGB3;ADCY7;MAGI2;PLCB2;VEGFA;PARD6B;CRK;CALM2;PLCB1;MAPK1;PIK3R3;RASGRP2;GNAI3;ITGAL;PIK3R1;CDH1;PRKCA;EVL;ADORA2A;CSF1;PFN1;RRAS;ITGAM;CDC42;HGF;PDGFC;CALM3;AKT1;FARP2;ITGA2B;RASSF5;FGFR2;MAPK11;PIK3CA;RAPGEF3;RAPGEF6;RAP1A;GNAI1;ADCY9;ANGPT1;CSF1R;LPAR2;CTNND1;RAP1GAP
prerank, Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190                                  , -0.2437534677950069 , -0.9472525578960692 , 0.569620253164557   , 0.9184202074574255,       1.0 , 22/38  , 44.34%, RAD50;RPA3;RAD9B;RAD51AP1;RFC5;BRCA1;POLR1B;HUS1;RHNO1;PALB2;RMI1;RAD51D;TOP3A;SEM1;RAD51B;RFC2;ATM;RFC3;RAD17;TOPBP1;KAT5;RAD51C
prerank, Reactome_2022__NGF-stimulated Transcription R-HSA-9031628                                                                                   , -0.2572341299066069 , -0.9469887313318619 , 0.5421686746987951  , 0.9177832145553086,       1.0 , 8/29   , 17.09%, MEF2D;CHD4;TPH1;RNASEH2A;FOSL1;NAB2;EGR1;ID3
prerank, Reactome_2022__Laminin Interactions R-HSA-3000157                                                                                           , 0.2646917049818588  , 0.9469151075231582  , 0.42857142857142855 , 1.0               ,       1.0 , 2/17   , 2.00% , ITGA3;ITGB1
prerank, KEGG_2021_Human__Retrograde endocannabinoid signaling                                                                                       , -0.2062648484502929 , -0.9462079959530515 , 0.5909090909090909  , 0.9182734910306684,       1.0 , 26/96  , 24.78%, ADCY7;NDUFB3;PLCB2;PLCB1;NDUFB2;MAPK1;GNAI3;NDUFA7;PRKCA;GNB5;MAPK8;GNGT2;NDUFB9;GNG5;PRKACB;GNG11;NDUFS1;NDUFB7;NDUFB5;GNG3;NDUFB4;NDUFS7;MAPK11;NDUFV3;GNAI1;ADCY9
prerank, Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009                                                                      , -0.2746504258277751 , -0.9459874681523113 , 0.5066666666666667  , 0.9174999444966001,       1.0 , 3/23   , 5.25% , FASLG;TP53;GOLGA2
prerank, Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751                                                                               , -0.2440216279952484 , -0.9452813139995904 , 0.5394736842105263  , 0.9180507329839616,       1.0 , 9/33   , 23.85%, PTPN11;PDPK1;MAPK1;IRS1;PIK3R1;GRB2;GAB2;FGFR2;PIK3CA
prerank, Reactome_2022__Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174                                                              , -0.3005206990911914 , -0.9446065902644303 , 0.5068493150684932  , 0.9185999699544573,       1.0 , 4/15   , 18.93%, PDPK1;PDK4;PDHB;LDHD
prerank, Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793                                                     , -0.22605138172368458, -0.9437236106691886 , 0.5454545454545454  , 0.9195769194732897,       1.0 , 13/49  , 19.15%, UBC;MAPK1;USP9X;RNASEH2A;SMAD3;NCOR2;CCNK;TRIM33;SMAD7;SMURF2;UBB;RPS27A;DAND5
prerank, KEGG_2021_Human__Amphetamine addiction                                                                                                      , -0.25083838880502596, -0.9435514412146311 , 0.55                , 0.918744651672778 ,       1.0 , 9/38   , 19.91%, CREB3L4;CALM2;PRKCA;CAMK2G;SIRT1;CREB3L2;PRKACB;CALM3;PPP3CC
prerank, Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482                                                                           , -0.24685470738480356, -0.9431199904026633 , 0.5185185185185185  , 0.9184803604572063,       1.0 , 6/29   , 19.10%, FASLG;CASP8;UBC;TANK;UBB;RPS27A
prerank, KEGG_2021_Human__Insulin resistance                                                                                                         , -0.20860671058492536, -0.9421165495701354 , 0.5348837209302325  , 0.9192549119198576,       1.0 , 19/91  , 16.22%, CREB3L4;PTPN11;PDPK1;SLC27A5;SOCS3;PRKAG2;MLXIP;PIK3R3;IRS1;PCK2;GYS1;PIK3R1;NOS3;RPS6KA3;MAPK8;RPS6KB1;CREB3L2;TNFRSF1A;PTPRF
prerank, Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989                                                                             , -0.17636467122698724, -0.94119465317974   , 0.63                , 0.9202407248440183,       1.0 , 108/336, 31.74%, PML;KAT6A;GATAD2A;CNOT10;RAD50;GTF2H3;PPP1R13B;BAX;ING5;COX6C;REXO2;CNOT1;PDPK1;COX5A;TP53;UBC;DYRK2;CHD4;MDM4;CCNA1;PRKAG2;CHEK1;CRADD;TTC5;RPA3;BCL2L14;CARM1;CSNK2A2;YWHAB;RAD9B;TAF11;PMAIP1;TNRC6C;RRAGD;AGO3;RFC5;BNIP3L;BRCA1;SESN3;CCNK;POLR2G;RBBP7;POLR1B;SESN1;TAF15;RFFL;MEAF6;USP7;AGO1;DDB2;E2F8;POLR2B;CCNH;POLR2D;UBB;RPS27A;AKT1;TAF1;HUS1;GSR;MNAT1;PRKAG1;CDC25C;TAF5;CDKN1A;CHEK2;GADD45A;CCNA2;MAPK11;TAF12;ZNF385A;STEAP3;BID;RRAGB;RBBP4;ELL;CTDP1;MOV10;RRM2B;CREBBP;AIFM2;TAF4;MPZ;BCL6;TCEA1;RHNO1;COX4I1;CNOT2;PPP2CA;MSH2;YWHAQ;RICTOR;GTF2H4;RMI1;RABGGTA;RAD51D;PRELID1;PRELID3A;AGO2;EHMT1;MLH1;TOP3A;NDRG1;NELFCD;RBL2;ELOC;PMS2;BRPF3
prerank, Reactome_2022__Regulation Of Complement Cascade R-HSA-977606                                                                                , -0.2514842120330292 , -0.9409101568238957 , 0.5822784810126582  , 0.9197318744145787,       1.0 , 15/37  , 31.14%, ELANE;C5;C4B;C1QC;CFHR1;CFH;C4A;C3AR1;CD81;C8G;SERPING1;C5AR2;PROS1;C4BPA;AKR1C1
prerank, Reactome_2022__HIV Infection R-HSA-162906                                                                                                   , -0.17987335244223127, -0.9404871271237979 , 0.5824175824175825  , 0.9194524784113781,       1.0 , 89/220 , 36.60%, NUP85;PSMD6;GTF2H3;CHMP4B;NUP88;VPS4B;UBC;RANGAP1;XRCC5;PSMD7;CUL5;CXCR4;PSMD9;PSMC3;PSME4;TAF11;PSMB2;PSME2;KPNA1;NUP107;CHMP6;CCNK;RAN;POLR2G;TAF15;NUP98;AP1S2;VPS37A;PSIP1;AP1M1;XPO1;POLR2B;NUP153;CCNH;FEN1;POLR2D;UBB;RPS27A;TAF1;NCBP1;MNAT1;TAF5;PSMD8;PSME3;XRCC4;AP1S1;POM121C;PSMB6;TAF12;VPS4A;AP1G1;ELL;CTDP1;PSMA1;NMT2;TAF4;GTF2A2;TCEA1;PSMB4;GTF2H4;CHMP2A;LIG4;PSMF1;PSME1;PSMA3;AAAS;MVB12A;NUP188;NELFCD;ELOC;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;RANBP1;PSMA2;ERCC3;PSMD10;AP1S3;NEDD4L;SLC25A6;PSMD5;TAF9;GTF2H1;AP2S1;POLR2E;XRCC6;POM121
prerank, Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851                                                       , -0.21750920052862197, -0.9401063476082269 , 0.6046511627906976  , 0.9192801288092339,       1.0 , 32/95  , 26.86%, ADCY7;GGT1;YES1;MYH9;PPAN-P2RY11;TSHR;GNAI3;IL10;CD163;RLN2;PRKCA;GNB5;CALCRL;GNGT2;ADORA2A;GPR15;PRKAR2A;GGT5;GNG5;FGR;PRKACB;GNG11;GNG3;MC1R;PTGIR;PTGDR;GNAI1;ADCY9;PRKX;ADM2;PRKAR1A;POMC
prerank, Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755                                                            , -0.24072155321118519, -0.9395539856859825 , 0.5662650602409639  , 0.9194114595912486,       1.0 , 10/47  , 14.83%, RASGRF2;PDPK1;PRKAG2;MAPK1;PPM1F;PRKCA;DLG1;RPS6KA3;CAMK2G;PRKAR2A
prerank, Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933                                                             , -0.23741452785876843, -0.9393318873224603 , 0.5774647887323944  , 0.9186492249875248,       1.0 , 5/27   , 15.23%, NUP85;RANGAP1;NUP107;RAN;NUP98
prerank, Reactome_2022__CaM Pathway R-HSA-111997                                                                                                     , -0.2776768353975277 , -0.9376741518990717 , 0.547945205479452   , 0.9215325417126912,       1.0 , 9/23   , 26.82%, ADCY7;PDE1B;PRKCA;CAMK2G;PRKAR2A;PRKACB;ADCY9;PRKX;PRKAR1A
prerank, "KEGG_2021_Human__Alanine, aspartate and glutamate metabolism"                                                                              , 0.22655534692193455 , 0.9375492354381525  , 0.4642857142857143  , 1.0               ,       1.0 , 10/25  , 22.18%, GFPT1;ASNS;ABAT;GPT2;GOT1;GLS2;IL4I1;CAD;NIT2;ADSS1
prerank, Reactome_2022__Mismatch Repair R-HSA-5358508                                                                                                , -0.2958574278024582 , -0.9373510158225252 , 0.5522388059701493  , 0.9211318101331962,       1.0 , 7/15   , 31.73%, RPA3;POLR1B;POLD4;MSH2;MLH1;POLD2;PMS2
prerank, "Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170"                                       , -0.26682461521992584, -0.937211522070498  , 0.5180722891566265  , 0.9201140638846788,       1.0 , 4/27   , 9.83% , SEC24D;SEC24C;HLA-G;ATG14
prerank, KEGG_2021_Human__Amyotrophic lateral sclerosis                                                                                              , -0.18124477608774764, -0.9358353993354953 , 0.6526315789473685  , 0.9220499780825091,       1.0 , 100/294, 33.50%, NUP85;SQSTM1;NDUFB3;PSMD6;WDR41;SDHC;ATP5PB;BAX;COX6C;NUP88;FUS;CASP3;GPX3;COX5A;TP53;RAB39B;UQCRC1;PSMD7;UQCRFS1;EIF2S1;NDUFB2;SRSF3;ACTR1A;PSMD9;NDUFA7;ACTR10;UQCRB;ATG14;PSMC3;CAT;ATF6;TBK1;PSMB2;ADRM1;NUP107;DCTN3;NDUFB9;ATG101;PFN1;AMBRA1;ATP5MC3;NUP98;TANK;TNFRSF1A;WIPI2;TOMM40L;ULK2;ATG2A;NUP153;DNAH1;SLC1A2;NDUFS1;TOMM40;NDUFB7;CCS;KIF5A;NDUFB5;PPP3CC;NDUFB4;NCBP1;ATG13;NDUFS7;PSMD8;VCP;MAPK11;POM121C;NDUFV3;TUBB6;PSMB6;MAP3K5;BID;RAB5A;PSMA1;SPG11;RAB8A;ATP5F1E;HDAC6;COX4I1;PSMB4;HSPA5;UBQLN2;TUBA1C;HNRNPA1;HNRNPA1L2;GPX1;PSMA3;NXT1;NUP188;NDUFS3;PSMB1;NDUFC1;PSMC4;NDUFB10;SEM1;PSMA6;PSMD11;PSMA2;NDUFAB1;NDUFA13;CYCS
prerank, KEGG_2021_Human__Fatty acid elongation                                                                                                      , -0.25486505258432995, -0.9358108822989807 , 0.5942028985507246  , 0.9208383233532934,       1.0 , 11/25  , 28.00%, THEM5;ELOVL6;HADHB;TECR;PPT1;ACOT4;ELOVL1;ELOVL3;ECHS1;ELOVL5;MECR
prerank, Reactome_2022__IRS-mediated Signaling R-HSA-112399                                                                                          , -0.2514312700221553 , -0.9353044370321444 , 0.5375              , 0.9207710611834183,       1.0 , 8/28   , 23.85%, PTPN11;PDPK1;IRS1;PIK3R1;GRB2;GAB2;FGFR2;PIK3CA
prerank, Reactome_2022__Cilium Assembly R-HSA-5617833                                                                                                , -0.17928543507386513, -0.935033786729096  , 0.5869565217391305  , 0.9201642279402681,       1.0 , 54/173 , 28.84%, PLK4;CSNK1D;B9D1;NPHP4;CEP76;IQCB1;AHI1;BBS7;BBS5;AKAP9;HAUS2;ACTR1A;CCT3;NPHP1;IFT122;CEP250;TRIP11;CEP97;PRKCA;CLASP1;CEP72;DCTN3;DYNLT2;BBS2;C2CD3;KIF3C;CC2D2A;KIF24;CEP57;NINL;RAB11A;DYNC2H1;RPGRIP1L;RAB3IP;DYNC1H1;CKAP5;CEP70;WDR35;MKS1;IFT81;DYNC2I1;EXOC6;IFT22;CEP164;TMEM216;TCTN2;NEDD1;RAB8A;HDAC6;CCT2;CEP78;MAPRE1;SFI1;NEK2
prerank, KEGG_2021_Human__Leishmaniasis                                                                                                              , -0.22183200443698686, -0.9341885288935293 , 0.6282051282051282  , 0.9210413522200106,       1.0 , 12/71  , 16.14%, CR1L;TGFB3;MARCKSL1;IRAK1;EEF1A1;MAPK1;CYBB;IL10;IL4;EEF1A2;ITGAM;MAP3K7
prerank, Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567                                       , -0.19502236443353835, -0.9337025653375084 , 0.5465116279069767  , 0.920779711153824 ,       1.0 , 41/108 , 36.51%, RAD50;H2AX;BABAM1;UBC;SLC19A1;CCNA1;CHEK1;RPA3;POLK;RAD9B;RAD51AP1;RFC5;BRCA1;UBE2N;POLR1B;H2BC11;ABRAXAS1;UBB;RPS27A;HUS1;BABAM2;CCNA2;UIMC1;POLD4;RNF168;ERCC1;RHNO1;PALB2;RMI1;XRCC3;RAD51D;POLE3;POLD2;TOP3A;SEM1;RAD51B;PPP4C;CLSPN;POLE4;ERCC4;POLE
prerank, KEGG_2021_Human__MicroRNAs in cancer                                                                                                        , -0.18666520548092275, -0.9334306583925378 , 0.5591397849462365  , 0.9200857702403412,       1.0 , 23/142 , 14.48%, ITGB3;CASP3;VEGFA;TP53;CRK;CD44;IGF2BP1;MDM4;MAPK1;PIK3R3;IRS1;PIK3R1;KIF23;RECK;PRKCA;BRCA1;PDCD4;TNXB;RASSF1;NOTCH3;SIRT1;MMP9;ZEB2
prerank, Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418                                                                                           , -0.26479160235777766, -0.9327571514730737 , 0.56                , 0.9206910008642086,       1.0 , 3/23   , 7.39% , STK38;TXNL1;CUL3
prerank, KEGG_2021_Human__Prostate cancer                                                                                                            , -0.2030986749604524 , -0.9318395778447012 , 0.6162790697674418  , 0.9216668481684173,       1.0 , 24/86  , 26.27%, CREB3L4;GSTP1;PDPK1;TP53;PLAT;MAPK1;PIK3R3;SPINT1;PIK3R1;LEF1;MMP9;RB1;CREB3L2;TGFA;GRB2;PDGFC;AKT1;ETV5;CDKN1A;FGFR2;PIK3CA;FOXO1;CREBBP;HSP90B1
prerank, Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725                                                     , -0.21522016608192404, -0.93104418947774   , 0.6419753086419753  , 0.9224764573853658,       1.0 , 12/50  , 17.89%, MEF2D;CHD4;MAPK1;TPH1;DUSP6;RNASEH2A;RPS6KA3;FOSL1;NAB2;EGR1;ID3;MEF2C
prerank, Reactome_2022__Sensory Perception Of Taste R-HSA-9717189                                                                                    , 0.23175678225694613 , 0.9307904013311458  , 0.56                , 1.0               ,       1.0 , 2/23   , 2.27% , TAS2R50;SCNN1A
prerank, Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791                                      , -0.31050170187356024, -0.9306246501356948 , 0.6025641025641025  , 0.9222740443839841,       1.0 , 4/15   , 19.10%, SMURF1;UBC;UBB;RPS27A
prerank, Reactome_2022__Ca2+ Pathway R-HSA-4086398                                                                                                   , -0.23076902708866995, -0.9305539464633183 , 0.5180722891566265  , 0.9211675501038739,       1.0 , 14/52  , 19.82%, PLCB2;PLCB1;FZD6;TNRC6C;PRKCA;AGO3;LEF1;GNB5;GNGT2;MAP3K7;GNG5;AGO1;GNG11;GNG3
prerank, KEGG_2021_Human__Chemical carcinogenesis                                                                                                    , -0.19621808228728327, -0.9292594363175012 , 0.5869565217391305  , 0.9231148987690379,       1.0 , 27/136 , 19.46%, JAG1;ADCY7;CREB3L4;ARRB1;GSTP1;VEGFA;CYP2C9;MAPK1;PIK3R3;GNAI3;KPNA3;GSTM1;PIK3R1;PRKCA;KPNA1;MGST1;RPS6KA3;RPS6KB1;CDC6;RB1;CREB3L2;CHRNB4;GSTO1;GRB2;PRKACB;CYP1B1;AKT1
prerank, KEGG_2021_Human__cGMP-PKG signaling pathway                                                                                                 , -0.19865918055562568, -0.9283286248229412 , 0.6352941176470588  , 0.9239477286945784,       1.0 , 15/113 , 10.25%, KCNMA1;ADCY7;CREB3L4;PLCB2;MEF2D;TRPC6;CALM2;PLCB1;PPIF;MAPK1;IRS1;GNAI3;PDE2A;ATP2A3;NOS3
prerank, Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921                                                                             , -0.3022735702976991 , -0.9268187695502507 , 0.581081081081081   , 0.926299585787774 ,       1.0 , 3/17   , 11.13%, VEGFA;PDPK1;PRKCA
prerank, Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762                                                                        , -0.2364524196117645 , -0.925717352749871  , 0.6172839506172839  , 0.9274355973438779,       1.0 , 20/46  , 36.05%, GATAD2A;GTF2H3;CHD4;POLR1D;RBBP7;POLR1B;TAF1B;KAT2B;CCNH;MNAT1;RBBP4;ERCC6;POLR1E;GTF2H4;TAF1C;KAT2A;POLR1F;ERCC3;GTF2H1;POLR2E
prerank, KEGG_2021_Human__Human immunodeficiency virus 1 infection                                                                                   , -0.1831598593710656 , -0.9256358704622218 , 0.6210526315789474  , 0.9262854148122673,       1.0 , 49/183 , 24.58%, CD3D;BAX;CASP3;IRAK1;FASLG;CASP8;CRK;CUL5;CALM2;CXCR4;CHEK1;MAPK1;PIK3R3;HLA-G;GNAI3;PIK3R1;TBK1;CUL1;PRKCA;GNB5;MAPK8;CD3G;RPS6KB1;GNGT2;AP1S2;TNFRSF1A;MAP3K7;MAP2K7;GNG5;PAK6;AP1M1;PAK1;GNG11;CALM3;PXN;AKT1;GNG3;PPP3CC;BST2;CFL2;CDC25C;DCAF1;LIMK1;AP1S1;MAPK11;PIK3CA;AP1G1;BID;GNAI1
prerank, Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236                                           , -0.20887710515956634, -0.9255135309147077 , 0.5903614457831325  , 0.925344276022853 ,       1.0 , 17/71  , 23.21%, NUP85;MAGOH;FYTTD1;NUP88;THOC1;SRSF3;NUP107;THOC7;NUP98;EIF4A3;SRSF1;NUP153;CDC40;NCBP1;SRRM1;SRSF5;POM121C
prerank, KEGG_2021_Human__cAMP signaling pathway                                                                                                     , -0.19482142058469637, -0.9251766367137364 , 0.6222222222222222  , 0.9248757580862534,       1.0 , 34/125 , 25.22%, ADCY7;CREB3L4;CALM2;MAPK1;PIK3R3;TSHR;GNAI3;ATP2A3;PIK3R1;MAPK8;CAMK2G;ADORA2A;ROCK2;CREB3L2;RRAS;ABCC4;PLD2;HCAR1;HCAR3;ATP1B1;PRKACB;ACOX1;PAK1;CALM3;AKT1;ATP1A3;SUCNR1;PDE4D;PIK3CA;RAPGEF3;RAP1A;GNAI1;ADCY9;CREBBP
prerank, Reactome_2022__Signaling By KIT In Disease R-HSA-9669938                                                                                    , -0.28060345358164207, -0.9248038339392766 , 0.5466666666666666  , 0.9244671827274119,       1.0 , 3/19   , 9.19% , YES1;PIK3R3;PIK3R1
prerank, KEGG_2021_Human__Salmonella infection                                                                                                       , -0.1771125101334507 , -0.9246383932838746 , 0.6421052631578947  , 0.9236201865422381,       1.0 , 70/226 , 30.97%, GAPDH;RPS3;ARF1;PIK3C2A;ABI1;BAX;CYFIP2;CASP3;IRAK1;CASP8;TAB3;TIRAP;SNX33;MAPK1;ACTR1A;KPNA3;ACTR10;CYTH2;CYTH1;DYNC1LI1;KPNA1;LEF1;LY96;DCTN3;MAPK8;MYL5;ROCK2;PFN1;RAB9A;RRAS;TNFRSF1A;MAP3K7;ARPC5;MAP2K7;DYNC2H1;NCKAP1L;CASP7;ARF6;CDC42;SNX18;DYNC1H1;PAK1;KIF5A;AKT1;CD14;DYNC1LI2;MAPK11;VPS16;TUBB6;PIK3CA;ARPC3;AHNAK;RAB5A;ARPC2;TAB1;HSP90B1;DNM2;STX10;TUBA1C;RHOB;MYL12B;MLKL;ACTR3;IRAK4;ARPC5L;RIPK2;TLR2;RAB5B;ACBD3;TXN
prerank, KEGG_2021_Human__Aldosterone synthesis and secretion                                                                                        , -0.2226260885270119 , -0.9240248853975285 , 0.5842696629213483  , 0.9240629897922276,       1.0 , 15/63  , 20.59%, ADCY7;CREB3L4;PLCB2;CALM2;PLCB1;PDE2A;PRKCA;CAMK2G;CREB3L2;CACNA1H;ATP1B1;PRKACB;CALM3;ATF1;ATP1A3
prerank, Reactome_2022__Surfactant Metabolism R-HSA-5683826                                                                                          , -0.2991581967124193 , -0.9240222324237383 , 0.6119402985074627  , 0.9228242994573855,       1.0 , 5/15   , 20.13%, NAPSA;ADORA2A;ADA2;ZDHHC2;CKAP4
prerank, Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914                                                                              , -0.21745439329070237, -0.9235431579019825 , 0.5930232558139535  , 0.9229897383946964,       1.0 , 19/55  , 30.43%, EXOSC6;CNOT10;CNOT1;DCP1B;EDC3;DDX6;PARN;NT5C3B;LSM4;EIF4A3;DCPS;LSM6;EXOSC2;LSM2;LSM7;SKIC8;CNOT2;EIF4A2;DCP1A
prerank, Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323                                                                                 , -0.2549922737826344 , -0.9229808480495372 , 0.5921052631578947  , 0.923038156641263 ,       1.0 , 12/31  , 30.99%, ADCY7;YES1;IL10;PRKCA;PRKAR2A;FGR;PRKACB;ADCY9;PRKX;PRKAR1A;SYK;SRC
prerank, Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383                                                                , -0.27753223728967613, -0.9224635959692271 , 0.5909090909090909  , 0.9231009984370377,       1.0 , 8/19   , 32.47%, LEMD2;TMPO;ANKLE2;PPP2R2A;EMD;PPP2CA;SIRT2;VRK1
prerank, Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638                                                                                        , -0.2371261244902296 , -0.9220474512505341 , 0.5512820512820513  , 0.9228439371257484,       1.0 , 9/32   , 26.18%, IRAK1;CASP8;TAB3;ITCH;UBE2N;MAP3K7;TNFAIP3;MAPK11;TAB1
prerank, Reactome_2022__HIV Life Cycle R-HSA-162587                                                                                                  , -0.18650018604023513, -0.9212574764233458 , 0.6091954022988506  , 0.9235454897462068,       1.0 , 50/142 , 31.70%, NUP85;GTF2H3;CHMP4B;NUP88;VPS4B;UBC;RANGAP1;XRCC5;CXCR4;TAF11;KPNA1;NUP107;CHMP6;CCNK;RAN;POLR2G;TAF15;NUP98;VPS37A;PSIP1;XPO1;POLR2B;NUP153;CCNH;FEN1;POLR2D;UBB;RPS27A;TAF1;NCBP1;MNAT1;TAF5;XRCC4;POM121C;TAF12;VPS4A;ELL;CTDP1;NMT2;TAF4;GTF2A2;TCEA1;GTF2H4;CHMP2A;LIG4;AAAS;MVB12A;NUP188;NELFCD;ELOC
prerank, "Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695"                                                    , 0.18802610165825445 , 0.9208975412039965  , 0.4375              , 1.0               ,       1.0 , 8/49   , 8.93% , RPS24;RPS29;EIF2S3;RPS15A;RPS4X;RPS20;RPS4Y1;EIF3M
prerank, KEGG_2021_Human__Taste transduction                                                                                                         , -0.2601650654175568 , -0.9205891759622888 , 0.569620253164557   , 0.9239697757078926,       1.0 , 6/33   , 7.76% , ENTPD2;PLCB2;PDE1B;TAS2R5;PLCB1;CHRM3
prerank, Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441                                                                                    , -0.22384058803066542, -0.9205122670547969 , 0.6296296296296297  , 0.922916430585045 ,       1.0 , 13/51  , 23.21%, NUP85;GEMIN8;NUP88;LIN9;PHAX;SNUPN;NUP107;SNRPF;NUP98;NUP153;NCBP1;SNRPD3;POM121C
prerank, Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616                                                , -0.23805322091681994, -0.9195931432163463 , 0.52                , 0.9237885717292205,       1.0 , 21/37  , 44.34%, RAD50;CHEK1;RPA3;RAD9B;RFC5;BRCA1;POLR1B;HUS1;RHNO1;RMI1;RAD51D;TOP3A;SEM1;RAD51B;RFC2;ATM;RFC3;RAD17;TOPBP1;KAT5;RAD51C
prerank, KEGG_2021_Human__Gastric acid secretion                                                                                                     , -0.22693519489616323, -0.9191232114019527 , 0.573170731707317   , 0.9236333624142444,       1.0 , 13/49  , 20.59%, ADCY7;PLCB2;CALM2;PLCB1;CHRM3;GNAI3;CA2;PRKCA;CAMK2G;ATP1B1;PRKACB;CALM3;ATP1A3
prerank, KEGG_2021_Human__Pathways in cancer                                                                                                         , -0.17501302415919745, -0.9163971002217599 , 0.7216494845360825  , 0.9284816403898553,       1.0 , 83/391 , 20.19%, PML;JAG1;ADCY7;LRP6;FH;TGFB3;BAX;PLCB2;CASP3;GSTP1;FASLG;CASP8;VEGFA;TP53;CRK;SPI1;IL2RG;ITGAV;WNT10A;PIM2;GADD45G;CALM2;CXCR4;PLCB1;CCNA1;MAPK1;TFG;PIK3R3;CKS2;RASGRP2;FZD6;POLK;GNAI3;RUNX1T1;GSTM1;PIK3R1;IL12RB1;CDH1;HEY1;RARB;IL3RA;PMAIP1;CUL1;IL4;PRKCA;MGST1;LRP5;LEF1;HIF1A;GNB5;MAPK8;SMAD3;RPS6KB1;GNGT2;CAMK2G;RASSF1;NOTCH3;ROCK2;MMP9;RB1;TXNRD2;PLD2;GSTO1;GNA12;ARHGEF11;CASP7;GNG5;TGFA;DDB2;CDC42;GRB2;PRKACB;DAPK2;GNG11;HGF;IL23R;CALM3;AKT1;GNG3;LAMB2;NCOA3;EGLN2;PPARG
prerank, Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360                                                                                    , -0.2863539452461171 , -0.9159727684355405 , 0.6125              , 0.9281046559457043,       1.0 , 3/18   , 8.82% , P2RX1;TRPC6;ATP2A3
prerank, Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123                                                                                      , -0.2784391815554453 , -0.9152670604242791 , 0.5652173913043478  , 0.9285770888960865,       1.0 , 3/20   , 5.52% , NF2;MYH9;CTTN
prerank, Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407                                                                            , -0.1777800540989011 , -0.9144941341659717 , 0.5789473684210527  , 0.9292636934628766,       1.0 , 61/156 , 35.19%, SLC29A4;SLC35B3;ARL2;SLC44A4;RHBG;SLCO1A2;ARL2BP;SLC35D2;SLC5A9;SLC6A13;SLC39A1;SLC25A26;SLC9A3;SLC39A6;CTNS;SLC39A8;BSG;SLC5A6;SLC28A2;SLC41A1;SLC1A4;SLC13A5;SLC4A8;SLC22A15;SLC30A7;SLC39A3;SLC3A1;EMB;SLC1A2;SLC6A12;SLC35A1;SLC11A2;SLC9A7;AHCYL2;SLC50A1;SLC38A1;SLC17A5;SLC5A5;SLC11A1;SLC30A5;SRI;LCN15;SLC44A1;SLC22A16;SLC2A9;SLC14A2;SLC26A1;SLC15A1;SLC2A8;SLC47A1;SLC7A7;PDZD11;SLC36A2;SLC7A5;NLRP3;SLC39A10;SLC7A6;SLC27A1;SLC25A6;SLCO4C1;SLC12A4
prerank, KEGG_2021_Human__Wnt signaling pathway                                                                                                      , -0.19958505553701728, -0.9138027878199656 , 0.5806451612903226  , 0.9292887498030254,       1.0 , 25/106 , 20.38%, LRP6;PLCB2;BAMBI;SIAH1;TP53;WNT10A;PLCB1;FZD6;TLE2;CSNK2A2;CUL1;PRKCA;LRP5;LEF1;FOSL1;MAPK8;SMAD3;CAMK2G;ROCK2;VANGL1;MAP3K7;LGR6;PRKACB;PPP3CC;SERPINF1
prerank, Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933                                        , -0.19622888085233783, -0.9134186176201496 , 0.6666666666666666  , 0.9289699797186178,       1.0 , 13/108 , 9.38% , MADCAM1;CD3D;CD226;CD200;NPDC1;SLAMF6;HLA-G;CD160;SELL;SIGLEC11;CD300LD;ITGAL;SIGLEC12
prerank, KEGG_2021_Human__Prion disease                                                                                                              , -0.1791777789909024 , -0.9130476786115164 , 0.6382978723404256  , 0.9285805235002437,       1.0 , 51/221 , 23.99%, CREB3L4;NDUFB3;PSMD6;SDHC;ATP5PB;BAX;COX6C;CASP3;COX5A;UQCRC1;PSMD7;UQCRFS1;EIF2S1;PPIF;NDUFB2;MAPK1;PIK3R3;PSMD9;NDUFA7;PIK3R1;CYBB;UQCRB;CSNK2A2;PSMC3;PSMB2;ADRM1;C5;MAPK8;STIP1;NDUFB9;C1QC;CREB3L2;ATP5MC3;EGR1;HSPA1A;PRKACB;NDUFS1;NDUFB7;KIF5A;NDUFB5;PPP3CC;NDUFB4;NDUFS7;PSMD8;C8G;MAPK11;NDUFV3;TUBB6;PSMB6;PIK3CA;HSPA2
prerank, Reactome_2022__BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922                                                                      , -0.2712542216498726 , -0.9129617211243257 , 0.5797101449275363  , 0.9276206556415347,       1.0 , 5/22   , 17.62%, BBS7;BBS5;CCT3;BBS2;RAB3IP
prerank, Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312                                                               , -0.23436685965441933, -0.9129612788584051 , 0.6071428571428571  , 0.9264064924797003,       1.0 , 7/47   , 9.33% , CNOT10;BAX;REXO2;CNOT1;TP53;CCNA1;CARM1
prerank, Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505                                                                      , -0.21284422063339425, -0.912439018547096  , 0.5862068965517241  , 0.9261786476067473,       1.0 , 23/74  , 27.12%, RPAP2;ICE1;TAF8;INTS9;SNAPC1;PHAX;SSU72;TAF11;RPRD2;CCNK;POLR2G;POLR2B;RPRD1B;POLR2D;DAND5;NCBP1;TAF5;ELL2;ELL;INTS10;GTF2A2;ZNF143;NABP2
prerank, KEGG_2021_Human__Amoebiasis                                                                                                                 , -0.2029751897635409 , -0.9103442593151312 , 0.6067415730337079  , 0.9295230931739654,       1.0 , 21/73  , 25.20%, TGFB3;PLCB2;CASP3;ARG2;GNA15;PLCB1;PIK3R3;PIK3R1;IL10;PRKCA;ITGAM;PRKACB;IL1R1;LAMB2;CD1A;CD1C;CD14;C8G;ARG1;PIK3CA;RAB5A
prerank, KEGG_2021_Human__Cell cycle                                                                                                                 , 0.14149702814487808 , 0.9078249192186664  , 0.75                , 1.0               ,       1.0 , 36/120 , 20.53%, ZBTB17;CDC16;SMAD2;TTK;CCND2;SKP1;GADD45B;ANAPC10;MYC;ANAPC5;E2F4;WEE1;CDC14B;E2F3;DBF4;STAG1;SKP2;PTTG2;E2F5;CDK1;GSK3B;BUB1;ESPL1;HDAC1;CDC7;SMC3;CDKN2A;HDAC2;CDC27;PKMYT1;E2F1;CCND3;CDK6;RBL1;STAG2;ANAPC7
prerank, Reactome_2022__CD28 Co-Stimulation R-HSA-389356                                                                                             , -0.2389670555387019 , -0.9075148176147975 , 0.6052631578947368  , 0.9349620917877415,       1.0 , 8/33   , 19.46%, YES1;PDPK1;PIK3R3;PIK3R1;MAP3K8;CDC42;GRB2;AKT1
prerank, Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399                                                              , -0.19552284982441903, -0.9074091392608934 , 0.6097560975609756  , 0.9340143565408247,       1.0 , 41/80  , 43.90%, GTF2H3;UBC;SLC19A1;RPA3;POLK;RFC5;COPS3;PARP2;UBE2N;XPA;POLR1B;DDB2;XPC;CCNH;UBB;RPS27A;MNAT1;POLD4;ERCC1;INO80D;GTF2H4;XRCC1;POLE3;POLD2;COPS8;ERCC3;USP45;NFRKB;GTF2H1;POLE4;ERCC4;POLE;RUVBL1;RFC2;GPS1;UBE2I;RFC3;YY1;POLD1;ACTR8;COPS5
prerank, KEGG_2021_Human__Complement and coagulation cascades                                                                                        , -0.22978933526961814, -0.9065474878072791 , 0.6486486486486487  , 0.9346282646021351,       1.0 , 19/56  , 28.58%, CR1L;F5;F13A1;PLAT;SERPINB2;C5;C4B;C1QC;CFHR1;CFH;ITGAM;C4A;C3AR1;C8G;SERPING1;A2M;PROS1;SERPINA1;C4BPA
prerank, Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564                                                                                        , -0.21205886017949507, -0.9058222950604695 , 0.5555555555555556  , 0.9351839543315965,       1.0 , 9/55   , 12.86%, HDAC3;COX6C;HBA1;COX5A;STAP2;LIN9;CARM1;BLVRA;NCOR2
prerank, Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723                                                            , 0.23260322869147848 , 0.9057417208912507  , 0.5714285714285714  , 1.0               ,       1.0 , 7/15   , 27.89%, SMAD2;EPAS1;STAT3;HHEX;NR6A1;SMAD4;PBX1
prerank, KEGG_2021_Human__Glutamatergic synapse                                                                                                      , -0.2057620061011587 , -0.9057188464332473 , 0.6190476190476191  , 0.9341689311066584,       1.0 , 19/65  , 25.43%, ADCY7;PLCB2;PLCB1;MAPK1;GNAI3;PRKCA;GNB5;GNGT2;PLD2;GNG5;SLC1A2;PRKACB;GNG11;GNG3;PPP3CC;DLG4;GNAI1;ADCY9;SLC38A1
prerank, Reactome_2022__Diseases Of Glycosylation R-HSA-3781865                                                                                      , -0.20675683846778622, -0.9053659713094319 , 0.5869565217391305  , 0.9337213081931991,       1.0 , 15/84  , 13.77%, C1GALT1;DAG1;B4GALT1;ADAMTS6;CHSY1;ALG2;PMM2;NUS1;LFNG;EXT1;ADAMTS2;ALG6;GALNT12;NOTCH3;B4GAT1
prerank, Reactome_2022__Protein Methylation R-HSA-8876725                                                                                            , -0.29704643430258054, -0.9039137519900725 , 0.581081081081081   , 0.9357848218504775,       1.0 , 12/17  , 41.53%, EEF1A1;EEF2;VCP;EEF2KMT;KIN;EEF1AKMT2;METTL21A;ETFBKMT;EEF1AKMT1;CALM1;RPS2;VCPKMT
prerank, Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662                                                                                , -0.24707148044751007, -0.9028805282531542 , 0.620253164556962   , 0.9366600495713999,       1.0 , 16/30  , 41.92%, YES1;ROCK2;ARPC5;VPS72;CDC42;LIMK1;ARPC3;ARPC2;ACTR3;LIMK2;SRC;ACTG1;ROCK1;KALRN;ACTR2;LYN
prerank, KEGG_2021_Human__Pantothenate and CoA biosynthesis                                                                                          , 0.24856033963378182 , 0.9022887500177665  , 0.625               , 1.0               ,       1.0 , 5/18   , 10.66%, ALDH2;ALDH3A2;ENPP1;COASY;ENPP3
prerank, KEGG_2021_Human__Toll-like receptor signaling pathway                                                                                       , -0.19876591908351635, -0.902128756718366  , 0.6896551724137931  , 0.9373361140621982,       1.0 , 43/84  , 43.64%, IRAK1;CASP8;TIRAP;MAPK1;PIK3R3;TICAM1;PIK3R1;TBK1;CTSK;LY96;MAPK8;MAP3K8;MAP3K7;TLR3;MAP2K7;TICAM2;AKT1;CD14;MAPK11;PIK3CA;CCL4L2;TAB1;IRF7;IRAK4;TLR2;AKT2;IRF5;PIK3CB;IKBKG;MAPK10;IL12A;JUN;MAP2K2;TRAF6;TLR9;TLR8;RELA;MAP2K1;TOLLIP;IRF3;TNF;TLR7;IKBKE
prerank, KEGG_2021_Human__Insulin signaling pathway                                                                                                  , -0.1913548993827045 , -0.9019466637354087 , 0.5888888888888889  , 0.9366057872978271,       1.0 , 27/115 , 21.06%, HK3;CBLB;MKNK1;PDPK1;CRK;SOCS3;CALM2;PRKAG2;MAPK1;PIK3R3;IRS1;PCK2;GYS1;PIK3R1;SORBS1;MAPK8;RPS6KB1;PRKAR2A;PTPRF;GRB2;PRKACB;INPP5A;CALM3;AKT1;RPS6;TRIP10;PRKAG1
prerank, Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851                                                               , -0.2960443164540271 , -0.9012460994678398 , 0.6712328767123288  , 0.9370837836874513,       1.0 , 6/16   , 22.96%, GNB5;GNGT2;GNG5;GNG11;GNG3;PTGIR
prerank, KEGG_2021_Human__Glycosaminoglycan biosynthesis                                                                                             , -0.23047099567917903, -0.9011707781726956 , 0.6375              , 0.9360614407431922,       1.0 , 14/41  , 30.10%, B4GALT1;HS2ST1;CHST13;CHSY1;B4GALT3;EXT1;CHPF;CHPF2;FUT8;B4GALT7;EXTL3;NDST1;CHST14;B4GALT4
prerank, Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526                                                                              , -0.2565084993082762 , -0.9011494526427404 , 0.6212121212121212  , 0.9349017986171431,       1.0 , 7/23   , 23.85%, IL2RG;PIK3R3;PIK3R1;IL3RA;GRB2;GAB2;PIK3CA
prerank, Reactome_2022__FOXO-mediated Transcription R-HSA-9614085                                                                                    , -0.21867509473751567, -0.899942483270172  , 0.6551724137931034  , 0.9361627106364195,       1.0 , 18/53  , 28.06%, ABCA6;REXO2;FASLG;CITED2;YWHAB;FBXO32;SMAD3;SIRT1;KAT2B;AKT1;CDKN1A;GADD45A;FOXO1;CREBBP;BCL6;POMC;RETN;YWHAQ
prerank, KEGG_2021_Human__Cytokine-cytokine receptor interaction                                                                                     , -0.1829167548043725 , -0.8998956463946998 , 0.6629213483146067  , 0.93507569128708  ,       1.0 , 46/164 , 25.72%, TNFSF14;TGFB3;TNFSF13;GDF11;IL18RAP;XCL1;FASLG;CXCR6;IL2RG;MPL;GDF15;CXCR4;IL27;TNFRSF25;PF4V1;IL12RB1;IL10;IL3RA;IL4;IL1RL1;PPBP;ACVR1B;CSF1;IL18R1;CNTF;LEPR;TNFRSF1A;CCL20;CLCF1;BMP7;ACVR2B;IL24;IL23R;CCL28;IL1R1;IL31RA;ACVR2A;CXCR3;CXCR2;IL10RA;IL21R;CCL4L2;BMP6;CSF1R;IL17RA;TNFRSF21
prerank, Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827                                               , 0.15232249517606414 , 0.8996573425556368  , 0.7272727272727273  , 1.0               ,       1.0 , 14/106 , 8.93% , RPS24;RPS29;RPL7A;RPL22L1;EIF2S3;EIF4A1;EIF4H;RPS15A;RPL32;RPS4X;RPS20;RPS4Y1;RPL27;EIF3M
prerank, Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772                                                                               , -0.2688792192727306 , -0.8988945719590055 , 0.547945205479452   , 0.9360543818054429,       1.0 , 4/20   , 14.62%, SOCS3;MAPK1;IRS1;CISH
prerank, Reactome_2022__Activation Of Pre-Replicative Complex R-HSA-68962                                                                            , -0.2570209370533967 , -0.8985856363205937 , 0.6111111111111112  , 0.9356663230053305,       1.0 , 7/31   , 14.06%, MCM5;RPA3;PRIM2;ORC3;SLC25A15;CDC6;POLR1B
prerank, Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101                                                                                  , -0.18564567583353297, -0.8961030120598861 , 0.6626506024096386  , 0.9396170390405414,       1.0 , 45/119 , 35.10%, RAB8B;SBF2;DENND4A;TBC1D10B;TBC1D10C;RAB6A;RAB39B;TRAPPC12;DENND2A;TBC1D3I;RABGEF1;GDI1;TRAPPC11;GAPVD1;RAB9A;GGA1;RAB11A;DENND4C;TRAPPC2;RAB3IP;ARF6;DENND2B;AKT1;RIC1;RAB33B;RAB1B;RAB3A;RAB5A;MPZ;RAB8A;RAB18;TRAPPC5;DENND6A;TBC1D14;MON1B;RAB3GAP1;RAB5B;ANKRD27;CCZ1B;AKT2;TBC1D13;GDI2;TSC2;TBC1D2;RAB32
prerank, KEGG_2021_Human__Morphine addiction                                                                                                         , -0.21637658786544384, -0.8959291570249946 , 0.5925925925925926  , 0.9387255544643197,       1.0 , 17/51  , 28.42%, ADCY7;ARRB1;PDE1B;GNAI3;PDE2A;PRKCA;GNB5;GNGT2;GNG5;PRKACB;GNG11;GNG3;PDE4D;GNAI1;ADCY9;PDE4B;GRK6
prerank, Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226                                                      , -0.17294225790398526, -0.8956578023567233 , 0.59375             , 0.9381275616705519,       1.0 , 28/177 , 15.86%, EXOSC6;RPS3;RPP25;RPL37A;CSNK1D;UTP20;TEX10;SPPL2A;FBL;UTP3;RPS8;WDR43;RPL39;RCL1;RIOK1;UTP18;RIOK3;RPS14;RPL36AL;RPL38;WDR75;RPL19;DNAJC5;RPP14;RPL6;RRP7A;RPS25;MPHOSPH6
prerank, Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704                                                                             , -0.19602769356150024, -0.8946878250814859 , 0.6333333333333333  , 0.939331609176818 ,       1.0 , 22/84  , 28.27%, RASGRF2;SQSTM1;HDAC3;CASP3;NCSTN;IRAK1;UBC;ITGB3BP;ARHGEF15;MAPK8;OBSCN;ARHGEF11;UBB;RPS27A;PSENEN;AKAP13;APH1B;PRPF38B;ARHGEF1;ARHGEF4;ARHGEF2;AATF
prerank, Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097                                                                                           , -0.20586730826263214, -0.894387083113706  , 0.6941176470588235  , 0.9387066998616979,       1.0 , 16/82  , 19.46%, ITGB3;ABI1;CYFIP2;VEGFA;PDPK1;CRK;ITGAV;PIK3R1;CYBB;PRKCA;ABI2;ROCK2;NCKAP1L;CDC42;PRKACB;AKT1
prerank, Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459                          , -0.21940890667054672, -0.8943831870192219 , 0.625               , 0.9375307725803147,       1.0 , 15/63  , 20.97%, KMT2D;H2AX;PRMT6;H2AC19;TNRC6C;AGO3;H2AC7;H2BC11;H3-3B;ASH2L;AGO1;KAT2B;KMT2B;ITGA2B;ZFPM1
prerank, Reactome_2022__Signaling To RAS R-HSA-167044                                                                                                , 0.22418054075828614 , 0.8938379566329635  , 0.6052631578947368  , 1.0               ,       1.0 , 6/16   , 22.13%, NTRK1;MAPK14;RALGDS;MAPK12;NRAS;RALB
prerank, KEGG_2021_Human__Thermogenesis                                                                                                              , -0.17620005095700506, -0.8918631887791056 , 0.6526315789473685  , 0.9418078597551731,       1.0 , 45/187 , 25.02%, COX15;ADCY7;CREB3L4;NDUFB3;ACSL1;SDHC;ATP5PB;COX6C;COX5A;UQCRC1;UQCRFS1;PRKAG2;NDUFB2;CPT2;COX10;NDUFA7;UQCRB;COA6;RPS6KA3;RPS6KB1;NDUFB9;CREB3L2;ATP5MC3;ACSL5;SMARCC1;KDM3B;GRB2;PRKACB;NDUFS1;NDUFB7;NDUFB5;RPS6;PPARG;ACSL4;NDUFB4;PRKAG1;NDUFS7;NDUFAF1;MAPK11;NDUFV3;COA7;NDUFAF5;MAP3K5;ADCY9;SMARCA2
prerank, Reactome_2022__Mitotic Prometaphase R-HSA-68877                                                                                             , -0.17551102602153829, -0.8918130177430789 , 0.648936170212766   , 0.9407412261444242,       1.0 , 33/182 , 15.23%, NCAPG;NUP85;PLK4;CENPO;CSNK1D;CEP76;CENPA;CENPU;RANGAP1;PPP2R5E;AKAP9;HAUS2;CENPT;ACTR1A;ITGB3BP;CLASP2;CDC20;CEP250;CSNK2A2;DYNC1LI1;PDS5B;KIF18A;PRKCA;CLASP1;NCAPH;NUP107;CEP72;PPP2R5B;DCTN3;SMC1A;CEP57;NINL;NUP98
prerank, Reactome_2022__Mitotic Prophase R-HSA-68875                                                                                                 , -0.1872930292637578 , -0.8917904652946205 , 0.6428571428571429  , 0.9395947097282709,       1.0 , 28/107 , 24.05%, NUP85;H2AX;NUP88;H2AC19;GOLGA2;MAPK1;ENSA;LEMD2;PRKCA;H2AC7;NUP107;RAB2A;H2BC11;RB1;LPIN1;NUP98;H3-3B;TMPO;LPIN2;NUP153;SET;RAB33B;PHF8;NEK7;BLZF1;POM121C;EMD;RAB1B
prerank, KEGG_2021_Human__Chronic myeloid leukemia                                                                                                   , -0.20933373219210732, -0.8912617862100637 , 0.6551724137931034  , 0.9396606770695682,       1.0 , 20/73  , 24.90%, TGFB3;BAX;PTPN11;TP53;CRK;GADD45G;MAPK1;PIK3R3;POLK;PIK3R1;SMAD3;RB1;DDB2;GRB2;AKT1;GAB2;CDKN1A;GADD45A;PIK3CA;SHC4
prerank, KEGG_2021_Human__Th1 and Th2 cell differentiation                                                                                           , -0.1954881105248236 , -0.890349924463205  , 0.6506024096385542  , 0.9402344162430807,       1.0 , 12/81  , 14.21%, NFKBIE;JAG1;CD3D;IL2RG;TYK2;MAPK1;IL12RB1;IL4;MAPK8;CD3G;NOTCH3;RUNX3
prerank, Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858                                                                               , -0.2171180420791355 , -0.8897317502033499 , 0.6233766233766234  , 0.9404776531841976,       1.0 , 10/47  , 16.56%, H2AX;PRMT6;H2AC19;H2AC21;CARM1;COPRS;H2AC7;PBRM1;RBBP7;SMARCC1
prerank, Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310                                                                                  , -0.24033680287134293, -0.8893607337432657 , 0.6521739130434783  , 0.9400629880314747,       1.0 , 13/32  , 32.77%, SNAP25;SLC6A13;STXBP1;DNAJC5;SLC1A2;SLC6A12;RAB3A;LIN7A;ARL6IP5;LIN7C;STX1A;SH2D3C;CASK
prerank, Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916                                                                                 , 0.23318652887094266 , 0.8892130607251297  , 0.7096774193548387  , 1.0               ,       1.0 , 4/17   , 13.78%, PKD1;EXOC2;PTGES2;EXOC4
prerank, Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142                                                                       , -0.22412375776761145, -0.8891663535525166 , 0.6805555555555556  , 0.9391843665241661,       1.0 , 3/38   , 3.35% , PML;NUP85;NUP88
prerank, Reactome_2022__L1CAM Interactions R-HSA-373760                                                                                              , -0.20526920946955493, -0.8883505626813127 , 0.65                , 0.9395919157924751,       1.0 , 21/71  , 26.90%, ITGB3;SHTN1;ITGAV;MAPK1;RANBP9;RPS6KA4;CSNK2A2;DLG1;RPS6KA3;ITGA10;ITGA9;ITGA1;SCN1B;NUMB;CLTC;ITGA2B;ITGA5;SCN11A;CD24;DNM2;SPTBN1
prerank, Reactome_2022__Common Pathway Of Fibrin Clot Formation R-HSA-140875                                                                         , -0.31311644105155656, -0.8879068754333376 , 0.625               , 0.9393026954538981,       1.0 , 3/15   , 8.13% , F5;F13A1;PF4V1
prerank, Reactome_2022__SARS-CoV Infections R-HSA-9679506                                                                                            , -0.16771793877464258, -0.8855160914324971 , 0.7857142857142857  , 0.9434287284805389,       1.0 , 103/331, 31.42%, NUP85;PARP9;RPS3;SAP30;GATAD2A;ST6GALNAC4;PHF21A;SEC24D;CHMP4B;GEMIN8;NUP88;REXO2;PTPN11;SIKE1;IRAK1;ZBP1;G3BP1;VEGFA;SEC24C;PDPK1;UBC;RPS8;TAB3;CHD4;TYK2;CUL3;HLA-G;ZDHHC3;ZDHHC11;RPS14;YWHAB;ATG14;ZDHHC9;TBK1;MGAT5;NUP107;CHMP6;CHURC1-FNTB;UBE2N;RBBP7;SNRPF;ROCK2;GALNT1;RB1;CNBP;NUP98;UVRAG;RPS25;PARP14;MAP3K7;ATP1B1;SUDS3;NUP153;PARP6;SAP30L;GRB2;ZDHHC2;UBB;RPS27A;AKT1;IL1R1;FKBP4;RPS6;EDEM2;FUT8;ATP1A3;SNRPD3;S1PR1;VPS45;RPN1;DDX5;VCP;POM121C;VPS16;HAVCR1;BLNK;RBBP4;FNTA;RPS11;CREBBP;IL17RA;CD79B;TAB1;VPS33B;BTK;MAN1B1;PARP16;YWHAQ;SYK;IRF7;CHMP2A;RPSA;GOLGA7;KDM1A;RPS9;G3BP2;IL6R;RIPK2;TLR2;AAAS;RPS15;MOGS;NUP188
prerank, Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878                                                                            , -0.20159365226480414, -0.8852751295037146 , 0.6049382716049383  , 0.9426183330903737,       1.0 , 19/73  , 24.25%, COPZ1;COG2;GOLGA2;NAPSA;ACTR1A;ACTR10;CAPZA2;DYNC1LI1;DCTN3;CAPZB;TMEM115;KDELR2;DYNC1H1;KDELR1;COPE;TMED9;DYNC1LI2;RAB1B;YKT6
prerank, Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300                                                                                , 0.196107500890023   , 0.8850209414634228  , 0.6666666666666666  , 1.0               ,       1.0 , 12/40  , 16.04%, H2AZ2;SUZ12;H2BC3;H2AB1;H2BC17;DNMT3A;H2BC5;H2BC9;H2AC20;H2AZ1;MTF2;AEBP2
prerank, KEGG_2021_Human__Hippo signaling pathway                                                                                                    , -0.18946217366479484, -0.8848416801596634 , 0.6989247311827957  , 0.9425302877723356,       1.0 , 18/111 , 13.60%, LATS2;TGFB3;CSNK1D;NF2;PARD6B;DCHS1;WNT10A;FZD6;CDH1;YWHAB;AREG;DLG1;MOB1A;LEF1;DLG5;SMAD3;RASSF2;RASSF1
prerank, Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295                                                                              , -0.187337038538554  , -0.8844029315248566 , 0.6511627906976745  , 0.9423745907935064,       1.0 , 19/94  , 19.27%, SEC24D;SEC24C;KIF22;ACTR1A;ACTR10;CAPZA2;DYNC1LI1;KIF23;KIF18A;CTSK;DCTN3;CAPZB;KIF3C;AP1S2;AP1M1;DYNC1H1;CTSE;CLTC;KIF5A
prerank, Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749                                                                       , -0.1956213676954369 , -0.8842955714123876 , 0.6049382716049383  , 0.9414871865410969,       1.0 , 16/73  , 19.57%, NUP85;H2AX;NUP88;H2AC19;H2AC7;NUP107;RAN;POLR2G;H2BC11;NUP98;H3-3B;AGO1;POLR2B;NUP153;POLR2D;IPO8
prerank, Reactome_2022__Processive Synthesis On Lagging Strand R-HSA-69183                                                                           , -0.2815887639561775 , -0.8830366176503331 , 0.6086956521739131  , 0.9429038661806822,       1.0 , 5/15   , 23.45%, RPA3;PRIM2;POLR1B;FEN1;POLD4
prerank, Reactome_2022__RORA Activates Gene Expression R-HSA-1368082                                                                                 , -0.26845859083891144, -0.8827511210568947 , 0.6666666666666666  , 0.9423290515742708,       1.0 , 12/18  , 45.73%, LIN9;CARM1;CREBBP;CPT1A;NCOA1;CHD9;RORA;SMARCD3;HELZ2;PPARA;EP300;NCOA2
prerank, Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928                                                         , -0.19996994545394461, -0.8820437290465242 , 0.6341463414634146  , 0.9427281589237881,       1.0 , 37/67  , 44.12%, PCBP2;SIKE1;CASP8;UBC;MAP3K1;ITCH;TBK1;TANK;UBB;ATG12;RPS27A;TNFAIP3;HERC5;OTUD5;UBE2D1;HMGB1;CREBBP;UBE2D2;IRF7;APP;ATG5;HSP90AA1;IKBKG;NKIRAS2;CYLD;NLRC5;TRAF6;RNF125;UBE2K;RELA;IRF3;RNF135;SAA2;MAVS;IKBKE;EP300;NFKBIB
prerank, KEGG_2021_Human__Inflammatory bowel disease                                                                                                 , -0.20097851310290674, -0.8812710609658415 , 0.6463414634146342  , 0.9433286312585224,       1.0 , 9/54   , 15.14%, TGFB3;IL18RAP;IL2RG;FOXP3;IL12RB1;IL10;IL4;SMAD3;IL18R1
prerank, Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516                                                                                           , -0.17058181254618035, -0.8799577056373757 , 0.7849462365591398  , 0.9448572917514786,       1.0 , 57/249 , 23.65%, NUP85;PARP9;RPS3;ST6GALNAC4;SEC24D;CHMP4B;GEMIN8;NUP88;REXO2;PTPN11;SIKE1;IRAK1;G3BP1;SEC24C;PDPK1;UBC;RPS8;TAB3;TYK2;HLA-G;ZDHHC3;ZDHHC11;RPS14;YWHAB;ATG14;ZDHHC9;TBK1;MGAT5;NUP107;CHMP6;UBE2N;SNRPF;GALNT1;RB1;CNBP;NUP98;UVRAG;RPS25;PARP14;MAP3K7;NUP153;PARP6;ZDHHC2;UBB;RPS27A;AKT1;RPS6;EDEM2;FUT8;SNRPD3;VPS45;RPN1;DDX5;VCP;POM121C;VPS16;HAVCR1
prerank, KEGG_2021_Human__Glycerophospholipid metabolism                                                                                             , -0.1890388296052464 , -0.879765784768488  , 0.6551724137931034  , 0.944107964626303 ,       1.0 , 17/75  , 18.40%, PEMT;PLPP5;PGS1;PLB1;GPAT3;DGKG;MBOAT1;MBOAT2;PLAAT3;PLD3;DGKA;LPIN1;PLD2;LCLAT1;LPIN2;LCAT;PHOSPHO1
prerank, Reactome_2022__RAS Processing R-HSA-9648002                                                                                                 , -0.2665641207830735 , -0.879180253026411  , 0.6363636363636364  , 0.9441534624954776,       1.0 , 6/17   , 28.83%, ARL2;ZDHHC9;CHURC1-FNTB;ICMT;FNTA;GOLGA7
prerank, KEGG_2021_Human__Metabolism of xenobiotics by cytochrome P450                                                                               , -0.23983791531664897, -0.879077681286849  , 0.7                 , 0.9432726104134097,       1.0 , 11/30  , 31.14%, GSTP1;ADH5;CYP2C9;GSTM1;MGST1;GSTO1;CYP1B1;MGST2;GSTO2;CBR1;AKR1C1
prerank, Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938                       , 0.22714329857890514 , 0.8790321977691347  , 0.5185185185185185  , 1.0               ,       1.0 , 8/20   , 22.38%, B2M;PACS1;AP2A1;AP1B1;AP2B1;CD8B;CD28;CD4
prerank, KEGG_2021_Human__Fc gamma R-mediated phagocytosis                                                                                           , -0.19379101010399852, -0.8789278856562073 , 0.6904761904761905  , 0.9424743686059615,       1.0 , 36/89  , 36.17%, SPHK2;MARCKSL1;CRK;MAPK1;PIK3R3;PIK3R1;WAS;PRKCA;RPS6KB1;PLD2;ARPC5;ARF6;CDC42;PAK1;AKT1;CFL2;GAB2;LIMK1;WASF1;PIK3CA;ARPC3;ASAP3;ARPC2;DNM2;SYK;NCF1;ACTR3;LIMK2;ARPC5L;ASAP2;PLA2G4A;AKT2;ARPC4;PIK3CB;VAV3;PLCG2
prerank, Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043                                                                                   , -0.25511521749512023, -0.8786761222536816 , 0.6351351351351351  , 0.9417718233680061,       1.0 , 16/30  , 42.84%, LDLRAP1;UBC;LSR;CUBN;CLTC;UBB;RPS27A;APOE;APOBR;HDLBP;AP2S1;LDLR;CLTA;AP2M1;NPC2;SCARB1
prerank, Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231                                                  , -0.21795751881830522, -0.8779200618358374 , 0.6172839506172839  , 0.9420473278902317,       1.0 , 17/41  , 36.60%, NUP85;NUP88;SYMPK;CPSF1;NUP107;CPSF4;NUP98;NUP153;NCBP1;POM121C;CPSF3;AAAS;NUP188;FIP1L1;EIF4E;WDR33;POM121
prerank, Reactome_2022__Adherens Junctions Interactions R-HSA-418990                                                                                 , -0.3035454511457139 , -0.8776168955736626 , 0.6111111111111112  , 0.9416141866084009,       1.0 , 7/16   , 27.59%, CADM1;NECTIN2;CDH15;CDH18;PVR;JUP;AFDN
prerank, Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444                                       , -0.18944613391607426, -0.8773853262384789 , 0.6923076923076923  , 0.941008665044452 ,       1.0 , 23/90  , 22.57%, NUP85;CENPO;CENPA;CENPU;RANGAP1;PPP2R5E;CENPT;ITGB3BP;CLASP2;CDC20;DYNC1LI1;KIF18A;CLASP1;NUP107;PPP2R5B;NUP98;XPO1;DYNC1H1;CENPS-CORT;CKAP5;CENPM;DYNC1LI2;INCENP
prerank, Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169                                                                       , -0.23041795566217488, -0.8773487052956475 , 0.6363636363636364  , 0.9399382393525906,       1.0 , 8/31   , 19.10%, UBC;SLC19A1;RPA3;POLK;RFC5;POLR1B;UBB;RPS27A
prerank, Reactome_2022__Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302                                                                     , -0.24989819328215096, -0.8763255065606429 , 0.5625              , 0.940999868395078 ,       1.0 , 9/19   , 38.01%, IRAK1;TAB3;UBE2N;MAP3K7;MAPK11;TAB1;RIPK2;IKBKG;TRAF6
prerank, "Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042"                                                           , -0.2616565091452939 , -0.875469645106521  , 0.56                , 0.9414607332590915,       1.0 , 7/20   , 24.58%, CACNB3;GNB5;GNGT2;GNG5;GNG11;GNG3;GNAI1
prerank, KEGG_2021_Human__Arginine biosynthesis                                                                                                      , -0.27882395962064266, -0.873892938238869  , 0.7014925373134329  , 0.9437128141706843,       1.0 , 3/15   , 10.25%, ARG2;GLUD1;NOS3
prerank, Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262                                         , -0.24245852217579406, -0.8730318261729583 , 0.6470588235294118  , 0.9444344659221703,       1.0 , 8/25   , 28.61%, LRP6;PPP2R5E;LRP5;PPP2R5B;FRAT1;DVL3;PPP2CA;AMER1
prerank, Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271                                                               , -0.23520864118469953, -0.8725805052080136 , 0.6438356164383562  , 0.9441610400098952,       1.0 , 7/34   , 17.92%, NUP85;NUP88;KPNA1;PBRM1;NUP107;NUP98;NUP153
prerank, Reactome_2022__Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277                                           , 0.24450987111983175 , 0.8722590612179332  , 0.6428571428571429  , 1.0               ,       1.0 , 8/19   , 20.15%, MYC;E2F4;LIN37;E2F5;HDAC1;TOP2A;E2F1;RBL1
prerank, Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518                                                                                       , -0.19664690287406483, -0.8720344140907462 , 0.7375              , 0.9442189839071855,       1.0 , 14/71  , 15.00%, PLK4;CSNK1D;CEP76;AKAP9;HMMR;HAUS2;ACTR1A;CEP250;PRKCA;CLASP1;CEP72;DCTN3;CEP57;NINL
prerank, Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692                                                                    , -0.25198254403759224, -0.8718801516954808 , 0.6097560975609756  , 0.9434840546180367,       1.0 , 7/29   , 17.56%, HDAC3;TNRC6C;PRKCA;AGO3;NCOR2;CAMK2G;AGO1
prerank, Reactome_2022__Centrosome Maturation R-HSA-380287                                                                                           , -0.1858253811959079 , -0.8717366658697978 , 0.6829268292682927  , 0.9426849237360628,       1.0 , 31/80  , 33.08%, PLK4;CSNK1D;CEP76;AKAP9;HAUS2;ACTR1A;CEP250;PRKCA;CLASP1;CEP72;DCTN3;CEP57;NINL;CDK11B;DYNC1H1;CKAP5;CEP70;MZT1;NME7;CEP164;TUBGCP6;NEDD1;CEP78;MAPRE1;SFI1;NEK2;HAUS7;TUBGCP5;CEP63;HSP90AA1;HAUS5
prerank, Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163                                                                                    , -0.1747167238405619 , -0.8709795873243761 , 0.7052631578947368  , 0.9430607685777176,       1.0 , 45/180 , 24.31%, MAGOH;AQR;PCBP2;CRNKL1;FUS;CSTF2;SF3B5;DDX42;RBM5;PUF60;SYMPK;SRSF3;CPSF1;SF1;DHX9;PLRG1;SNRPN;LSM4;HNRNPF;POLR2G;SNRPF;CPSF4;CWC22;PPIL6;SF3B1;SART1;HNRNPD;EIF4A3;SRSF1;POLR2B;POLR2D;CDC40;PRPF8;NCBP1;SRRM1;DHX15;SNRPD3;PPIL1;SF3B2;DDX5;SRSF5;HNRNPM;LSM6;LSM2;U2SURP
prerank, Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841                                                                                , -0.22149469959797408, -0.8708177479621316 , 0.691358024691358   , 0.9422114218121729,       1.0 , 19/46  , 34.14%, KMT2D;ASH1L;SETD3;RBBP7;DOT1L;SETD6;ASH2L;KMT2B;KMT5B;SETDB1;RBBP4;SETDB2;KMT2E;EHMT1;SMYD3;SUV39H1;KMT5C;ATF7IP;WDR5
prerank, Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447                                                             , -0.284799192591076  , -0.8701798633220323 , 0.6285714285714286  , 0.9422450710761829,       1.0 , 7/15   , 32.94%, REXO2;YWHAB;AKT1;PPP3CC;BID;YWHAQ;AKT2
prerank, KEGG_2021_Human__Oxytocin signaling pathway                                                                                                 , -0.18021236289837952, -0.8699066538098613 , 0.6818181818181818  , 0.9415826103816464,       1.0 , 48/110 , 41.11%, ADCY7;CACNG8;PLCB2;CACNG6;CACNB3;CD38;CALM2;PLCB1;PRKAG2;MAPK1;EEF2;GNAI3;NOS3;PRKCA;CAMK2G;ROCK2;PPP1R12C;MEF2C;PRKACB;CALM3;PPP3CC;PRKAG1;CDKN1A;GNAI1;ADCY9;NFATC2;MYLK3;PTGS2;CACNA2D4;ELK1;SRC;PLA2G4A;PLCB3;CACNB1;CACNB4;MYL9;EEF2K;ACTG1;JUN;MAP2K2;ROCK1;CALM1;PPP1CB;ITPR1;PPP1R12A;CAMK2A;MAP2K1;CAMK1D
prerank, KEGG_2021_Human__Glycosaminoglycan degradation                                                                                              , -0.274579452359471  , -0.8691414521951316 , 0.676056338028169   , 0.942036673494167 ,       1.0 , 5/16   , 21.81%, GNS;NAGLU;SGSH;ARSB;HYAL3
prerank, Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119                                                                                 , 0.15683810628951114 , 0.868907725837992   , 0.7647058823529411  , 1.0               ,       1.0 , 10/83  , 7.87% , GFPT1;ZBTB17;DNAJC3;EIF2S3;CCL2;ADD1;ASNS;NFYA;DNAJB9;DDIT3
prerank, Reactome_2022__Synthesis Of Leukotrienes (LT) And Eoxins (EX) R-HSA-2142691                                                                 , -0.2670458833909404 , -0.8686293814150282 , 0.5915492957746479  , 0.9419656030487104,       1.0 , 2/17   , 4.27% , GGT1;CYP4F3
prerank, Reactome_2022__TBC/RABGAPs R-HSA-8854214                                                                                                    , -0.21474035834750077, -0.8677662777905276 , 0.6578947368421053  , 0.9426929080015239,       1.0 , 19/43  , 37.20%, RAB8B;TBC1D10B;TBC1D10C;RAB6A;TBC1D3I;RABGEF1;GGA1;RAB11A;ARF6;RAB33B;RAB5A;RAB8A;TBC1D14;RAB5B;TBC1D13;TSC2;TBC1D2;TBC1D20;GGA3
prerank, Reactome_2022__G0 And Early G1 R-HSA-1538133                                                                                                , 0.1979352857515152  , 0.8675840319158897  , 0.5333333333333333  , 1.0               ,       1.0 , 10/27  , 20.15%, MYC;E2F4;DYRK1A;LIN37;E2F5;CDK1;HDAC1;TOP2A;E2F1;RBL1
prerank, KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor                                                              , -0.20131140701136663, -0.867368398129226  , 0.6794871794871795  , 0.9423075499181494,       1.0 , 19/68  , 25.16%, TNFSF14;IL18RAP;XCL1;IL2RG;CXCR4;PF4V1;IL10;PPBP;CSF1;IL18R1;TNFRSF1A;CCL20;IL24;CCL28;CXCR3;CXCR2;IL10RA;CCL4L2;CSF1R
prerank, Reactome_2022__Striated Muscle Contraction R-HSA-390522                                                                                     , -0.25345243993835626, -0.8670528628322042 , 0.6301369863013698  , 0.9418708989207213,       1.0 , 2/21   , 3.38% , MYH3;TMOD4
prerank, Reactome_2022__Cell-cell Junction Organization R-HSA-421270                                                                                 , -0.24308163714913694, -0.8669628948522045 , 0.68                , 0.9408616043928889,       1.0 , 11/34  , 27.59%, PARD6B;CADM1;CLDN9;NECTIN2;CLDN4;CDH15;CLDN5;CDH18;PVR;JUP;AFDN
prerank, Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938                                                                         , -0.23006249002248974, -0.8658124758381414 , 0.6266666666666667  , 0.9423681199429099,       1.0 , 19/34  , 43.51%, RAD50;RPA3;RAD9B;RFC5;BRCA1;POLR1B;HUS1;ERCC1;RHNO1;RMI1;TOP3A;ERCC4;RAD52;RFC2;ATM;RFC3;RAD17;TOPBP1;KAT5
prerank, KEGG_2021_Human__Cholesterol metabolism                                                                                                     , -0.2367038465510522 , -0.8647800684046266 , 0.6351351351351351  , 0.9435718732582568,       1.0 , 7/33   , 19.20%, CETP;PLTP;LDLRAP1;ABCB11;LPL;LCAT;ABCA1
prerank, KEGG_2021_Human__Fatty acid biosynthesis                                                                                                    , -0.26980420484337264, -0.8642951516121788 , 0.6486486486486487  , 0.9434995659753199,       1.0 , 8/17   , 28.00%, ACSL1;OLAH;ACSL5;ACSL4;ACSBG1;HTD2;CBR4;MECR
prerank, Reactome_2022__Class C/3 (Metabotropic Glutamate/Pheromone Receptors) R-HSA-420499                                                          , 0.24470513545236713 , 0.863797909198723   , 0.75                , 1.0               ,       1.0 , 1/15   , 0.13% , TAS2R50
prerank, KEGG_2021_Human__PI3K-Akt signaling pathway                                                                                                 , -0.1700820869276228 , -0.8637455800050146 , 0.7789473684210526  , 0.9433495731750783,       1.0 , 50/244 , 20.03%, ITGB3;CREB3L4;COL6A3;MAGI2;ITGB5;PPP2R3A;FASLG;VEGFA;PDPK1;TP53;IL2RG;SGK3;ITGAV;PPP2R5E;MAPK1;PIK3R3;IRS1;PCK2;GYS1;PHLPP2;PIK3R1;YWHAB;AREG;NOS3;IL3RA;IL4;PRKCA;GNB5;ITGA10;BRCA1;PPP2R5B;RPS6KB1;TNXB;GNGT2;ITGA9;CSF1;CREB3L2;ITGA1;COL9A1;GNG5;ERBB3;TGFA;GRB2;GNG11;HGF;PDGFC;AKT1;GNG3;LAMB2;RPS6
prerank, Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807                                                                     , -0.1927480321887383 , -0.8620754614255706 , 0.6813186813186813  , 0.9459994806759845,       1.0 , 27/87  , 28.28%, CEBPD;FASLG;VEGFA;TP53;IL2RG;F13A1;SOCS3;TYK2;PIK3R1;IL10;RNASEH2A;RHOU;IL4;HIF1A;MMP9;ITGAM;IL23R;NANOG;AKT1;CDKN1A;S1PR1;FOXO1;HSP90B1;BCL6;POMC;HMOX1;PTGS2
prerank, Reactome_2022__Nucleotide Excision Repair R-HSA-5696398                                                                                     , -0.17893838054411665, -0.8616738760646905 , 0.7272727272727273  , 0.9456526932773407,       1.0 , 52/106 , 43.99%, AQR;GTF2H3;UBC;SLC19A1;RPA3;POLK;RFC5;COPS3;PARP2;UBE2N;XPA;POLR2G;POLR1B;USP7;DDB2;XPC;POLR2B;CCNH;POLR2D;UBB;RPS27A;MNAT1;POLD4;ELL;ERCC1;ERCC6;INO80D;TCEA1;GTF2H4;XRCC1;POLE3;POLD2;COPS8;ERCC3;USP45;NFRKB;GTF2H1;POLE4;POLR2E;ERCC4;POLE;RUVBL1;RFC2;POLR2L;GPS1;UBE2I;RFC3;YY1;POLD1;ACTR8;COPS5;EP300
prerank, Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345                                                                     , 0.21289255873997054 , 0.8612957492060421  , 0.6774193548387096  , 1.0               ,       1.0 , 2/20   , 2.30% , NIPAL2;ADD1
prerank, Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555                                                                                  , -0.2749365262551206 , -0.8607570331266944 , 0.6417910447761194  , 0.9461601152676853,       1.0 , 8/18   , 35.52%, PIK3R1;STRN;GRB2;ETV6;PIK3CA;KANK1;PIK3CB;FIP1L1
prerank, Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257                                                                        , -0.17922617630094656, -0.8595929941905651 , 0.7446808510638298  , 0.9479190685571983,       1.0 , 17/103 , 13.13%, NUP85;CENPO;CENPA;CENPU;RANGAP1;PPP2R5E;CENPT;ITGB3BP;CLASP2;CDC20;DYNC1LI1;PDS5B;KIF18A;CLASP1;NUP107;PPP2R5B;SMC1A
prerank, Reactome_2022__Triglyceride Metabolism R-HSA-8979227                                                                                        , -0.25458540870253377, -0.8591663320160784 , 0.6623376623376623  , 0.947661537132835 ,       1.0 , 7/20   , 26.31%, PRKCA;LPIN1;MOGAT3;LPIN2;PRKACB;GPAT2;PLIN3
prerank, KEGG_2021_Human__Glucagon signaling pathway                                                                                                 , -0.18663844898858395, -0.8581745376930948 , 0.7441860465116279  , 0.9487574606991691,       1.0 , 18/77  , 21.06%, CREB3L4;PLCB2;CALM2;PLCB1;PRKAG2;PCK2;GYS1;PDHB;PGAM1;CAMK2G;SIRT1;CREB3L2;PFKP;PRKACB;CALM3;AKT1;PPP3CC;PRKAG1
prerank, Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584                                                                        , -0.26712643819017823, -0.8564176270636318 , 0.6527777777777778  , 0.9509961408352126,       1.0 , 6/16   , 30.61%, SLC35B3;BPNT2;SULT1B1;TPST2;PODXL2;SLC26A1
prerank, KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer                                                                     , -0.18480475189892864, -0.8561982931178105 , 0.6867469879518072  , 0.9502345912538132,       1.0 , 13/85  , 13.79%, NFKBIE;CD3D;PTPN11;TIRAP;MAPK1;PIK3R3;TICAM1;PIK3R1;CSNK2A2;HIF1A;CD3G;RPS6KB1;MAP3K3
prerank, Reactome_2022__Signaling By NTRKs R-HSA-166520                                                                                              , -0.179746061621053  , -0.8559951679057867 , 0.7261904761904762  , 0.9495647067173073,       1.0 , 22/107 , 18.84%, BAX;PTPN11;MEF2D;CRK;CHD4;MAPK1;IRS1;TPH1;DUSP6;PIK3R1;YWHAB;RNASEH2A;RPS6KA3;FOSL1;NAB2;ADORA2A;KIDINS220;EGR1;ID3;MEF2C;GRB2;CLTC
prerank, KEGG_2021_Human__Steroid hormone biosynthesis                                                                                               , 0.2192344829849487  , 0.8559536555591523  , 0.6875              , 1.0               ,       1.0 , 4/15   , 11.38%, CYP3A5;STS;COMT;DHRS11
prerank, KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption                                                                  , -0.23664847407719267, -0.855408655241171  , 0.6973684210526315  , 0.9496401681930258,       1.0 , 23/38  , 43.82%, PLCB2;KLK2;PLCB1;PRKCA;KLK1;RAB11A;ATP1B1;PRKACB;CLTC;ATP1A3;ADCY9;DNM2;VDR;PLCB3;ATP1A1;AP2S1;SLC8A1;CLTA;AP2M1;ATP2B1;ESR1;ATP1B2;CLTB
prerank, Reactome_2022__Macroautophagy R-HSA-1632852                                                                                                 , -0.17440137142577808, -0.854995809234924  , 0.7294117647058823  , 0.9494336642519895,       1.0 , 38/108 , 32.65%, SQSTM1;CHMP4B;ATG9A;UBC;PRKAG2;CSNK2A2;ATG14;DYNC1LI1;RRAGD;CHMP6;ATG10;MTERF3;UBE2N;ATG101;AMBRA1;UVRAG;WIPI2;DYNC1H1;TOMM40;UBB;ATG12;RPS27A;PEX5;ATG13;PRKAG1;DYNC1LI2;VCP;RRAGB;ATG16L1;PLIN3;HDAC6;ATG4D;CHMP2A;ATG4A;SRC;ATG5;TOMM7;HSP90AA1
prerank, Reactome_2022__Respiratory Electron Transport R-HSA-611105                                                                                  , -0.17979127369532416, -0.8534424494069487 , 0.735632183908046   , 0.9511082917791179,       1.0 , 10/90  , 9.29% , NDUFB3;ECSIT;COQ10A;COX6C;COX5A;UQCRC1;UQCRFS1;NDUFB2;NDUFA7;UQCRB
prerank, KEGG_2021_Human__Tuberculosis                                                                                                               , -0.17664956851319089, -0.8525607679880708 , 0.7912087912087912  , 0.9517822685519933,       1.0 , 45/148 , 31.44%, FCER1G;SPHK2;CR1L;TGFB3;BAX;CASP3;IRAK1;CASP8;CEBPB;CALM2;TIRAP;ATP6V0A1;MAPK1;EEA1;IL10;RFXAP;MRC2;TCIRG1;MAPK8;CAMK2G;ITGAM;BCL10;TNFRSF1A;CALM3;AKT1;PPP3CC;CD14;ATP6V0A2;MAPK11;IL10RA;BID;KSR1;RAB5A;CREBBP;ATP6V0D1;CTSD;VDR;SYK;IRAK4;RIPK2;TLR2;RAB5B;LAMP1;SRC;HLA-DRB1
prerank, Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048                                                                    , -0.2445476366018664 , -0.8524820410041929 , 0.6216216216216216  , 0.9508464591601341,       1.0 , 7/24   , 19.10%, UBC;CDC20;UBE2C;CDC26;UBE2E1;UBB;RPS27A
prerank, KEGG_2021_Human__Ribosome                                                                                                                   , -0.1716963865277786 , -0.8519807126568333 , 0.797752808988764   , 0.9506905049550023,       1.0 , 27/133 , 20.23%, MRPL28;RPS3;RPL37A;MRPL21;RPL24;RPS8;RPL39;MRPL3;MRPL20;MRPL18;MRPS7;RPS14;RPL36AL;RPL38;RPL19;RPS26;RPL6;RPS25;MRPL24;RPL17;MRPL16;RPL15;RPS27A;MRPL23;MRPL15;RPS6;MRPS17
prerank, Reactome_2022__Viral mRNA Translation R-HSA-192823                                                                                          , 0.14855556702046407 , 0.8516309645164255  , 0.7692307692307693  , 1.0               ,       1.0 , 10/88  , 7.31% , RPS24;RPS29;RPL7A;RPL22L1;DNAJC3;RPS15A;RPL32;RPS4X;RPS20;RPS4Y1
prerank, Reactome_2022__Costimulation By CD28 Family R-HSA-388841                                                                                    , -0.19110589585617338, -0.8514034766714059 , 0.7023809523809523  , 0.9505476488611563,       1.0 , 12/65  , 19.46%, CD3D;YES1;PTPN11;PDPK1;PPP2R5E;PIK3R3;PIK3R1;PPP2R5B;MAP3K8;CDC42;GRB2;AKT1
prerank, Reactome_2022__Phosphorylation Of APC/C R-HSA-176412                                                                                        , 0.21400944520882512 , 0.850470549478003   , 0.68                , 1.0               ,       1.0 , 3/20   , 5.80% , CDC16;ANAPC10;ANAPC5
prerank, Reactome_2022__Ion Channel Transport R-HSA-983712                                                                                           , -0.1808959865348355 , -0.8498591350912351 , 0.7912087912087912  , 0.9527072423123415,       1.0 , 36/115 , 28.97%, TRPM7;TRPC6;UBC;SGK3;ASPH;CLCN5;ATP6V0A1;WNK1;ATP10B;ATP2A3;SLC9B2;TRPM3;ATP13A4;TCIRG1;CAMK2G;ATP11A;STOM;ATP9B;BEST1;ATP1B1;CLCN2;ATP13A1;UBB;RPS27A;ATP1A3;ATP8A2;ATP6V0A2;RNASE3;ATP8B3;ANO8;MCOLN2;ATP6V0D1;SRI;ATP13A2;ANO5;ATP8B2
prerank, KEGG_2021_Human__Influenza A                                                                                                                , -0.18120943223538483, -0.8491368070501335 , 0.7419354838709677  , 0.9529053780550786,       1.0 , 24/139 , 16.26%, PML;BAX;MX1;CASP3;FASLG;CASP8;EIF2S1;SOCS3;TYK2;MAPK1;PIK3R3;TICAM1;PIK3R1;PABPN1L;OAS2;TBK1;PRKCA;KPNA1;RAB11B;CPSF4;NUP98;RAB11A;TNFRSF1A;TLR3
prerank, Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234                                                   , -0.20807695241270213, -0.8484124203667787 , 0.65                , 0.9532807021289202,       1.0 , 17/42  , 36.60%, NUP85;NUP88;SYMPK;CPSF1;NUP107;CPSF4;NUP98;NUP153;NCBP1;POM121C;CPSF3;AAAS;NUP188;FIP1L1;EIF4E;WDR33;POM121
prerank, KEGG_2021_Human__Yersinia infection                                                                                                         , 0.11899024262219995 , 0.848186915238778   , 0.9                 , 1.0               ,       1.0 , 21/128 , 13.91%, IL6;ZAP70;PKN2;CRKL;ITGB1;CCL2;PIP5K1C;ARPC1A;NFKB1;FCGR2A;RPS6KA1;RAC3;MAPK9;MAPK14;SKAP2;MAP2K3;BAIAP2;GSK3B;MAPK12;CXCL8;MAP2K6
prerank, KEGG_2021_Human__Protein export                                                                                                             , -0.24818213414054877, -0.8470642871895863 , 0.6901408450704225  , 0.9548338823805876,       1.0 , 9/23   , 27.80%, SRP14;SRP19;SEC61B;IMMP1L;SPCS3;SRP9;SEC63;SPCS2;HSPA5
prerank, Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139                                                   , 0.18285727226154389 , 0.8468962536526605  , 0.5789473684210527  , 1.0               ,       1.0 , 11/36  , 20.53%, CDC16;CCND2;ANAPC10;ANAPC5;E2F3;SKP2;CDC27;E2F1;CCND3;CDK6;ANAPC7
prerank, Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809                                                                               , 0.2134075017935038  , 0.8458251920338679  , 0.5909090909090909  , 1.0               ,       1.0 , 28/29  , 72.78%, TXK;IGLL5;ITPR3;NFATC3;PPP3CB;PPP3R1;LCP2;GRAP2;NFATC1;SPNS1;VAV1;ITPR2;VAV2;PLCG1;AHCYL1;PPP3CA;SOS1;TEC;SHC1;LYN;ITPR1;CALM1;PLCG2;VAV3;ITK;SYK;NFATC2;BTK
prerank, KEGG_2021_Human__ErbB signaling pathway                                                                                                     , -0.1936809797693804 , -0.8456792396119619 , 0.7802197802197802  , 0.9563074960705766,       1.0 , 36/73  , 41.06%, CBLB;CRK;MAPK1;PIK3R3;PIK3R1;AREG;PRKCA;MAPK8;RPS6KB1;CAMK2G;MAP2K7;ERBB3;PAK6;TGFA;GRB2;PAK1;AKT1;CDKN1A;PIK3CA;SHC4;ELK1;SRC;HBEGF;AKT2;PIK3CB;MAPK10;PLCG2;NCK2;ABL2;JUN;MAP2K2;EREG;NRG1;SOS2;CAMK2A;MAP2K1
prerank, Reactome_2022__Extension Of Telomeres R-HSA-180786                                                                                          , -0.20604827237461676, -0.845569705125003  , 0.7125              , 0.9554004121976464,       1.0 , 14/49  , 25.93%, SLC19A1;CCNA1;RPA3;CTC1;PRIM2;RFC5;POLR1B;CHTF8;FEN1;CCNA2;POLD4;CHTF18;PIF1;POT1
prerank, Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482                                                                                , -0.1965056386586225 , -0.8443551249546125 , 0.6744186046511628  , 0.9565163018401204,       1.0 , 24/67  , 33.68%, RASGRF2;ARHGEF15;GNB5;GNGT2;OBSCN;ROCK2;GNA12;ARHGEF11;GNG5;GNG11;RHOC;GNG3;AKAP13;PRPF38B;ARHGEF1;ARHGEF4;BTK;ARHGEF2;RHOB;FGD4;GNB2;TBXA2R;ARHGEF12;ECT2
prerank, Reactome_2022__Glycogen Metabolism R-HSA-8982491                                                                                            , 0.21056064567246646 , 0.8441214260970691  , 0.6451612903225806  , 1.0               ,       1.0 , 3/20   , 4.38% , PYGB;PGM1;PHKG1
prerank, KEGG_2021_Human__Carbohydrate digestion and absorption                                                                                      , -0.22475886797240624, -0.8440117673464176 , 0.6753246753246753  , 0.9561661724294468,       1.0 , 14/33  , 35.25%, HK3;PLCB2;PLCB1;PIK3R3;PIK3R1;ATP1B1;AKT1;ATP1A3;PIK3CA;AKT2;PLCB3;PIK3CB;G6PC3;ATP1A1
prerank, Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500                                                                        , -0.2683183463855156 , -0.843713460308686  , 0.6615384615384615  , 0.9556530364127236,       1.0 , 6/15   , 31.04%, SNAP25;STXBP1;SLC1A2;RAB3A;ARL6IP5;STX1A
prerank, Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387                                                                                      , -0.16171324485286936, -0.8436530897863772 , 0.7916666666666666  , 0.9546124444240849,       1.0 , 47/219 , 22.31%, NUP85;SLC37A2;GNS;TKT;SLC35B3;NUP88;UBC;GLYCTK;LOC112694756;B4GALT1;SLC35D2;CD44;HMMR;HS2ST1;CHST13;CHSY1;B4GALT3;PCK2;GYS1;B4GALT6;PRKCA;LYVE1;EXT1;NUP107;CHPF;B4GAT1;ST6GALNAC6;NUP98;PFKP;GYG1;FUT1;CHORDC1;NUP153;TPI1;PRKACB;UBB;NAGLU;PGM2L1;MAN2C1;RPS27A;CHPF2;SGSH;SLC25A12;ARSB;HYAL3;HAS3;B4GALT7
prerank, Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638                                                                 , 0.16298886821967343 , 0.8417076808703373  , 0.75                , 1.0               ,       1.0 , 13/54  , 17.94%, PIAS2;NUP160;PHC2;SUZ12;NUP133;SATB2;NUP54;NUP210;SEC13;NUP62;HDAC1;HDAC2;NDC1
prerank, Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766                                                                                     , -0.19804669077866416, -0.8406504810227785 , 0.6585365853658537  , 0.9593951694362141,       1.0 , 13/51  , 23.55%, NUP85;NUP88;LEMD2;PRKCA;NUP107;LPIN1;NUP98;TMPO;LPIN2;NUP153;NEK7;POM121C;EMD
prerank, Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910                                                                             , -0.22517611868322174, -0.8403648540937319 , 0.7361111111111112  , 0.9587796253690776,       1.0 , 7/34   , 17.92%, NUP85;NUP88;KPNA1;NUP107;NUP98;PSIP1;NUP153
prerank, KEGG_2021_Human__Adipocytokine signaling pathway                                                                                            , -0.21041738744845623, -0.8398438984784066 , 0.7125              , 0.9586672275414647,       1.0 , 14/56  , 21.06%, NFKBIE;ACSL1;PTPN11;SOCS3;PRKAG2;IRS1;PCK2;MAPK8;LEPR;TNFRSF1A;ACSL5;AKT1;ACSL4;PRKAG1
prerank, Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168                                                                 , -0.20954118955535678, -0.8395005027526269 , 0.6707317073170732  , 0.9582669252013214,       1.0 , 6/42   , 10.18%, SQLE;PMVK;LIN9;GGPS1;CARM1;ELOVL6
prerank, KEGG_2021_Human__Long-term potentiation                                                                                                     , -0.20659444921944148, -0.8384312027666992 , 0.7272727272727273  , 0.9592816734498855,       1.0 , 13/46  , 25.22%, PLCB2;CALM2;PLCB1;MAPK1;PRKCA;RPS6KA3;CAMK2G;PRKACB;CALM3;PPP3CC;RAPGEF3;RAP1A;CREBBP
prerank, KEGG_2021_Human__Apoptosis                                                                                                                  , -0.17712061014550984, -0.8371987175019232 , 0.7613636363636364  , 0.9605940963543098,       1.0 , 22/129 , 16.75%, BCL2A1;BAX;CASP3;FASLG;CASP8;PDPK1;TP53;HTRA2;EIF2S1;GADD45G;MAPK1;PIK3R3;PIK3R1;IL3RA;PMAIP1;CTSK;MAPK8;PARP2;GZMB;AIFM1;TNFRSF1A;CASP7
prerank, KEGG_2021_Human__Base excision repair                                                                                                       , -0.21923345690781765, -0.8368790815434942 , 0.7375              , 0.960155505140921 ,       1.0 , 15/33  , 30.66%, LIG1;OGG1;PARP2;UNG;FEN1;TDG;NEIL3;POLD4;HMGB1;NEIL2;MUTYH;POLB;XRCC1;POLE3;POLD2
prerank, Reactome_2022__Iron Uptake And Transport R-HSA-917937                                                                                       , -0.20034429573326856, -0.8363148595037243 , 0.7058823529411765  , 0.9601294764589814,       1.0 , 17/50  , 29.22%, UBC;ATP6V0A1;TFR2;TFRC;CUL1;FLVCR1;TCIRG1;GLRX3;HMOX2;UBB;RPS27A;SLC11A2;ATP6V0A2;STEAP3;ATP6V0D1;HMOX1;FTL
prerank, Reactome_2022__Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427                                                                      , -0.24591833026673124, -0.8357908372230048 , 0.6811594202898551  , 0.9600536783575706,       1.0 , 2/18   , 6.02% , CD3D;PTPRJ
prerank, Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080                                                                           , 0.16465890261190264 , 0.8350977816376366  , 0.7647058823529411  , 1.0               ,       1.0 , 6/43   , 9.41% , ADM;RAMP1;VIPR1;GNG2;GNG4;GNG10
prerank, Reactome_2022__RNA Polymerase I Transcription R-HSA-73864                                                                                   , -0.18686379064400893, -0.8336510884910115 , 0.7209302325581395  , 0.961804210137308 ,       1.0 , 15/76  , 18.41%, GATAD2A;GTF2H3;H2AX;H2AC19;CHD4;POLR1D;CBX3;H2AC7;RBBP7;POLR1B;H2BC11;TAF1B;H3-3B;KAT2B;CCNH
prerank, Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854                                                                              , -0.18686379064400893, -0.8336510884910115 , 0.7209302325581395  , 0.961804210137308 ,       1.0 , 15/76  , 18.41%, GATAD2A;GTF2H3;H2AX;H2AC19;CHD4;POLR1D;CBX3;H2AC7;RBBP7;POLR1B;H2BC11;TAF1B;H3-3B;KAT2B;CCNH
prerank, Reactome_2022__Defective Pyroptosis R-HSA-9710421                                                                                           , 0.18330253947199923 , 0.8336234570746511  , 0.8                 , 1.0               ,       1.0 , 11/40  , 15.18%, H2AZ2;SUZ12;H2BC3;PRIM1;H2AB1;H2BC17;DNMT3A;H2BC5;H2BC9;H2AC20;H2AZ1
prerank, Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942                                                                 , -0.17586853898548593, -0.8324918556325287 , 0.7272727272727273  , 0.9630551326163163,       1.0 , 28/85  , 29.77%, PLK4;CSNK1D;CEP76;UBC;AKAP9;HAUS2;ACTR1A;CEP250;CUL1;PRKCA;CLASP1;CEP72;DCTN3;CEP57;NINL;DYNC1H1;UBB;RPS27A;CKAP5;CEP70;CEP164;NEDD1;RAB8A;CEP78;MAPRE1;SFI1;NEK2;HAUS7
prerank, Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586                                                                  , -0.20083923085909286, -0.8316910020443723 , 0.7228915662650602  , 0.9635343753619042,       1.0 , 9/56   , 14.25%, RAD50;H1-3;H2AX;TP53;H2AC19;CCNA1;H2AC7;H2BC11;RB1
prerank, Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705                                                                              , -0.18002469573099625, -0.8310389818306109 , 0.6629213483146067  , 0.9635046845229994,       1.0 , 49/107 , 42.24%, NFKBIE;PSMD6;UBC;PSMD7;PSMD9;PIK3R1;PSMC3;PSME4;PSMB2;CUL1;PSME2;BCL10;MAP3K7;GRB2;UBB;RPS27A;PSMD8;PSME3;PSMB6;BLNK;PSMA1;CD79B;BTK;NFATC2;PSMB4;SYK;PSMF1;PSME1;PSMA3;PSMB1;PSMC4;SEM1;PSMA6;PSMD11;PSMA2;PSMD10;IKBKG;PSMD5;PLCG2;PSMD13;CALM1;PTPN6;RASGRP1;ITPR1;RELA;SH3KBP1;MALT1;LYN;PSMD3
prerank, Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451                                                                           , -0.25111791834449426, -0.8308351079399721 , 0.7236842105263158  , 0.9628811864069817,       1.0 , 7/22   , 19.82%, PDPK1;GNB5;GNGT2;GNG5;GNG11;AKT1;GNG3
prerank, Reactome_2022__Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523                                        , -0.25878295086699976, -0.8297351881520364 , 0.7428571428571429  , 0.9638038973074261,       1.0 , 8/22   , 31.04%, CYB5A;OTOF;SEC61B;UBE2J2;EMD;HMOX1;APP;STX1A
prerank, Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913                                                              , -0.19028562172684976, -0.8270420088985826 , 0.7752808988764045  , 0.9679340533259642,       1.0 , 14/71  , 17.74%, GATAD2A;H2AX;H2AC19;CHD4;POLR1D;CBX3;H2AC7;RBBP7;POLR1B;H2BC11;SF3B1;TAF1B;H3-3B;KAT2B
prerank, Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185                                                                , 0.1702915719187717  , 0.8265255472749977  , 0.75                , 1.0               ,       1.0 , 6/33   , 10.52%, IDUA;CHST11;SDC3;XYLT1;CHST7;SDC2
prerank, Reactome_2022__ERK/MAPK Targets R-HSA-198753                                                                                                , -0.24178615184878635, -0.8265041742265351 , 0.6779661016949152  , 0.9677515550065028,       1.0 , 7/20   , 27.95%, MAPK1;DUSP6;RPS6KA3;MEF2C;DUSP7;MAPK11;PPP2CA
prerank, Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574                                                                                            , -0.2175059850559859 , -0.8256089009675485 , 0.6753246753246753  , 0.9682961407693088,       1.0 , 4/35   , 7.39% , STK38;TXNL1;RBBP6;CUL3
prerank, Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599                                                                                    , -0.16669527009074447, -0.8249962053153772 , 0.7386363636363636  , 0.9683227893817331,       1.0 , 43/129 , 31.70%, NUP85;GTF2H3;CHMP4B;NUP88;VPS4B;UBC;RANGAP1;TAF11;NUP107;CHMP6;CCNK;RAN;POLR2G;TAF15;NUP98;VPS37A;XPO1;POLR2B;NUP153;CCNH;POLR2D;UBB;RPS27A;TAF1;NCBP1;MNAT1;TAF5;POM121C;TAF12;VPS4A;ELL;CTDP1;NMT2;TAF4;GTF2A2;TCEA1;GTF2H4;CHMP2A;AAAS;MVB12A;NUP188;NELFCD;ELOC
prerank, Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294                                                                         , -0.23268655889841527, -0.8245995983514884 , 0.765625            , 0.9678824073949058,       1.0 , 5/24   , 14.09%, NR3C2;THRA;AREG;NR2C1;NR5A2
prerank, "Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108"                                                        , -0.23173979646423626, -0.824556033287505  , 0.7                 , 0.9668538240242488,       1.0 , 4/25   , 9.33% , LIN9;CLOCK;NAMPT;CARM1
prerank, Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320                                                                      , -0.17595743602646538, -0.8245332558540472 , 0.7804878048780488  , 0.9658275546769228,       1.0 , 30/79  , 33.08%, PLK4;CSNK1D;CEP76;AKAP9;HAUS2;ACTR1A;CEP250;PRKCA;CLASP1;CEP72;DCTN3;CEP57;NINL;DYNC1H1;CKAP5;CEP70;MZT1;NME7;CEP164;TUBGCP6;NEDD1;CEP78;MAPRE1;SFI1;NEK2;HAUS7;TUBGCP5;CEP63;HSP90AA1;HAUS5
prerank, KEGG_2021_Human__Cellular senescence                                                                                                        , -0.17981729513884845, -0.8245106258992249 , 0.7956989247311828  , 0.9647913442777367,       1.0 , 36/143 , 24.72%, SQSTM1;TGFB3;RAD50;TRPM7;TP53;LIN9;GADD45G;CALM2;CCNA1;CHEK1;TRAF3IP2;MAPK1;PIK3R3;HLA-G;PIK3R1;RAD9B;SMAD3;SIRT1;RB1;RRAS;HIPK3;ZFP36L2;FOXM1;CALM3;AKT1;PPP3CC;HUS1;CDKN1A;CHEK2;GADD45A;RASSF5;CCNA2;MAPK11;PIK3CA;FOXO1;RBBP4
prerank, Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896                                                                                 , -0.2127030637859297 , -0.8241315006930893 , 0.6621621621621622  , 0.9644670045431024,       1.0 , 11/36  , 24.48%, TNIP2;TP53;UBC;ZRANB1;UBB;RPS27A;TNFAIP3;OTUD5;VCP;UBE2D1;TNIP3
prerank, Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357                                                                               , -0.23924197710936995, -0.8236403684645807 , 0.72                , 0.9642655901761499,       1.0 , 7/22   , 28.46%, PDPK1;PIK3R3;PIK3R1;MAP3K8;AKT1;PIK3CA;RICTOR
prerank, Reactome_2022__Meiotic Recombination R-HSA-912446                                                                                           , -0.20328193333754407, -0.8234421532537082 , 0.6923076923076923  , 0.963600793932851 ,       1.0 , 9/48   , 17.03%, RAD50;H2AX;H2AC19;RPA3;H2AC7;BRCA1;POLR1B;H2BC11;H3-3B
prerank, Reactome_2022__GPCR Downstream Signaling R-HSA-388396                                                                                       , -0.1592364986531291 , -0.8234297398493798 , 0.8163265306122449  , 0.9625351331732508,       1.0 , 100/351, 27.95%, RASGRF2;ADCY7;GPER1;PLCB2;ARRB1;XCL1;TRPC6;PDPK1;CXCR6;GNA15;AGXT;CXCR4;PDE1B;GNRH1;TAS2R5;PLCB1;MAPK1;PPAN-P2RY11;DGKG;UTS2R;PIK3R3;TSHR;CHRM3;RGS6;RASGRP2;PRKCH;GNAI3;PDE2A;F2RL1;NTSR1;PIK3R1;RLN2;PRKCA;RPS6KA3;ARHGEF15;C5;GNB5;CALCRL;PTAFR;GNGT2;RGS12;OBSCN;PPBP;CAMK2G;GPSM1;ADORA2A;ROCK2;DGKA;GPR15;PRKAR2A;S1PR4;TAS2R60;CCL20;GNA12;ARHGEF11;HCAR1;HCAR3;GNG5;LTB4R2;CDC42;C3AR1;GRB2;PRKACB;GNG11;CCL28;AKT1;RHOC;GNG3;PPP3CC;UTS2B;MC1R;CXCR3;GPR65;AKAP13;S1PR5;SUCNR1;CXCR2;NMUR1;PTGIR;ITGA5;PDE4D;PIK3CA;PTGDR;PRPF38B;GNAI1;ADCY9;PRKX;LPAR2;ARHGEF1;ADM2;RGS1;PRKAR1A;ARHGEF4;GPR18;POMC;TAS2R20;BTK;ARHGEF2;PDE4B;PPP2CA
prerank, Reactome_2022__Acyl Chain Remodelling Of PE R-HSA-1482839                                                                                   , -0.2562514821431062 , -0.8231371517650183 , 0.6721311475409836  , 0.9618493982704981,       1.0 , 3/16   , 10.54%, MBOAT1;MBOAT2;PLAAT3
prerank, Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683                                                                                   , -0.16360205425467544, -0.8224708767171188 , 0.8222222222222222  , 0.9616518045103989,       1.0 , 28/175 , 16.14%, NUP85;RPS3;SEC24D;GEMIN8;NUP88;REXO2;PTPN11;SIKE1;IRAK1;G3BP1;SEC24C;PDPK1;RPS8;TAB3;TYK2;HLA-G;RPS14;YWHAB;ATG14;TBK1;NUP107;UBE2N;SNRPF;CNBP;NUP98;UVRAG;RPS25;MAP3K7
prerank, Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025                                                                     , -0.17547457372693293, -0.8212334584690181 , 0.7142857142857143  , 0.9628399451097804,       1.0 , 24/94  , 22.88%, NUP85;CENPO;CENPA;CENPU;RANGAP1;PPP2R5E;CENPT;ITGB3BP;CLASP2;CDC20;DYNC1LI1;KIF18A;CLASP1;NUP107;PPP2R5B;NUP98;XPO1;DYNC1H1;CENPS-CORT;CKAP5;CENPM;DYNC1LI2;INCENP;NEK7
prerank, Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259                                                                            , -0.18296778507983308, -0.8204369781495509 , 0.8148148148148148  , 0.9631029387494499,       1.0 , 13/68  , 15.00%, PLK4;CSNK1D;CEP76;AKAP9;HAUS2;ACTR1A;CEP250;PRKCA;CLASP1;CEP72;DCTN3;CEP57;NINL
prerank, Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773                                                                         , -0.15890373161242952, -0.8197574568292176 , 0.8041237113402062  , 0.9632925993119434,       1.0 , 28/187 , 15.86%, EXOSC6;RPS3;RPP25;RPL37A;CSNK1D;UTP20;TEX10;SPPL2A;FBL;UTP3;RPS8;WDR43;RPL39;RCL1;RIOK1;UTP18;RIOK3;RPS14;RPL36AL;RPL38;WDR75;RPL19;DNAJC5;RPP14;RPL6;RRP7A;RPS25;MPHOSPH6
prerank, Reactome_2022__Nephrin Family Interactions R-HSA-373753                                                                                     , -0.26888948676193425, -0.8197547098544099 , 0.6891891891891891  , 0.9622222742015969,       1.0 , 9/17   , 36.21%, MAGI2;PIK3R1;IQGAP1;PIK3CA;SPTBN1;CD2AP;CASK;PIK3CB;NCK2
prerank, Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273                                                               , 0.12966271271888063 , 0.819714491845758   , 0.875               , 1.0               ,       1.0 , 23/134 , 13.82%, RPS24;RPS29;RPL7A;RPL22L1;POLR2I;DNAJC3;NUP160;RPS15A;RPL32;RPS4X;NUP133;RPS20;POLR2F;RPS4Y1;RPL27;NUP54;NUP210;RPS13;SEC13;RPL14;NUP62;RPL34;RPS19
prerank, KEGG_2021_Human__Chemokine signaling pathway                                                                                                , -0.17004736473449775, -0.8190285555061788 , 0.797752808988764   , 0.9623399046800959,       1.0 , 39/153 , 24.90%, ADCY7;PLCB2;ARRB1;XCL1;CXCR6;CRK;CXCR4;PLCB1;MAPK1;PIK3R3;RASGRP2;PF4V1;GNAI3;PIK3R1;WAS;GNB5;GNGT2;PPBP;ROCK2;CCL20;GNG5;FGR;CDC42;GRB2;PRKACB;PAK1;GNG11;CCL28;PXN;AKT1;GNG3;CXCR3;CXCR2;PIK3CA;CCL4L2;RAP1A;GNAI1;ADCY9;SHC4
prerank, KEGG_2021_Human__Ferroptosis                                                                                                                , -0.2191771893842121 , -0.817909331514476  , 0.7012987012987013  , 0.9632306721092184,       1.0 , 7/39   , 11.71%, PCBP2;ACSL1;TP53;CYBB;SLC39A8;TFRC;MAP1LC3B2
prerank, Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570                                                                                , -0.21494641792517838, -0.817852887901219  , 0.6794871794871795  , 0.9622484681799193,       1.0 , 6/32   , 14.06%, RAD50;RPA3;RAD9B;RFC5;BRCA1;POLR1B
prerank, Reactome_2022__DNA Strand Elongation R-HSA-69190                                                                                            , -0.2253748143747739 , -0.8171517943012039 , 0.6842105263157895  , 0.9622451032669175,       1.0 , 17/31  , 43.90%, SLC19A1;MCM5;RPA3;PRIM2;RFC5;POLR1B;FEN1;POLD4;GINS1;POLD2;MCM6;CDC45;RFC2;RFC3;MCM4;POLD1;POLA2
prerank, Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584                                                 , -0.2600192087003651 , -0.8170717591535207 , 0.7402597402597403  , 0.9613263803883945,       1.0 , 5/16   , 21.69%, H1-3;TP53;RB1;ASF1A;CDKN1A
prerank, KEGG_2021_Human__Long-term depression                                                                                                       , 0.16853694010373044 , 0.8166432393912202  , 0.6190476190476191  , 1.0               ,       1.0 , 3/44   , 1.27% , PLCB4;GNA11;IGF1R
prerank, Reactome_2022__FLT3 Signaling R-HSA-9607240                                                                                                 , -0.218309543230931  , -0.8160839199423452 , 0.7631578947368421  , 0.9620940238727842,       1.0 , 10/37  , 23.85%, PTPN11;UBC;PTPRJ;PIK3R1;GRB2;UBB;RPS27A;AKT1;GAB2;PIK3CA
prerank, Reactome_2022__Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943                                                             , -0.2217067635390571 , -0.8160775764076358 , 0.6621621621621622  , 0.9610452984604109,       1.0 , 9/27   , 27.28%, RRM1;NME4;RRM2;DTYMK;NME3;GSR;GLRX;RRM2B;DCTD
prerank, KEGG_2021_Human__HIF-1 signaling pathway                                                                                                    , -0.183083888532249  , -0.8154787207177833 , 0.7560975609756098  , 0.9609112240826717,       1.0 , 15/90  , 13.42%, GAPDH;HK3;MKNK1;VEGFA;MAPK1;PIK3R3;PIK3R1;CYBB;TFRC;NOS3;PDHB;PRKCA;HIF1A;RPS6KB1;CAMK2G
prerank, Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723                                                                              , -0.18738010825766338, -0.8146996632269752 , 0.7721518987341772  , 0.9611611657048938,       1.0 , 12/68  , 17.03%, H2AX;FASLG;CASP8;TP53;H2AC19;GOLGA2;PRIM2;H2AC7;RBBP7;H2BC11;TANK;H3-3B
prerank, Reactome_2022__Sphingolipid Metabolism R-HSA-428157                                                                                         , -0.1860092517838662 , -0.8146859206491672 , 0.7441860465116279  , 0.9601289008521419,       1.0 , 6/71   , 4.60% , SMPD3;SPHK2;SGPP2;PPM1L;GM2A;SPNS2
prerank, Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471                                                                              , -0.24966936966833986, -0.8144798785367567 , 0.7468354430379747  , 0.9595655355041838,       1.0 , 3/20   , 7.15% , BAX;CASP3;MAPK1
prerank, Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037                                                                                       , -0.17440047381461832, -0.814307652291294  , 0.7654320987654321  , 0.9588599835690461,       1.0 , 20/95  , 18.84%, MEF2D;CRK;CHD4;MAPK1;IRS1;TPH1;DUSP6;PIK3R1;YWHAB;RNASEH2A;RPS6KA3;FOSL1;NAB2;ADORA2A;KIDINS220;EGR1;ID3;MEF2C;GRB2;CLTC
prerank, Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618                                                                                       , -0.16854067431380376, -0.814118123111467  , 0.7684210526315789  , 0.9581201609650359,       1.0 , 26/107 , 22.57%, NUP85;CENPO;CENPA;CENPU;RANGAP1;PPP2R5E;CENPT;ITGB3BP;CLASP2;CDC20;UBE2C;DYNC1LI1;KIF18A;CDC26;CLASP1;NUP107;PPP2R5B;NUP98;UBE2E1;XPO1;DYNC1H1;CENPS-CORT;CKAP5;CENPM;DYNC1LI2;INCENP
prerank, Reactome_2022__RNA Polymerase I Transcription Termination R-HSA-73863                                                                       , -0.216212001865062  , -0.8141010467898477 , 0.717948717948718   , 0.9571076665050642,       1.0 , 13/29  , 36.05%, GTF2H3;POLR1D;POLR1B;TAF1B;CCNH;MNAT1;POLR1E;GTF2H4;TAF1C;POLR1F;ERCC3;GTF2H1;POLR2E
prerank, KEGG_2021_Human__Central carbon metabolism in cancer                                                                                        , -0.1836239087807051 , -0.8140383815212857 , 0.6973684210526315  , 0.9561331230980662,       1.0 , 9/58   , 12.22%, HK3;TP53;G6PD;MAPK1;PIK3R3;PIK3R1;PDHB;HIF1A;PGAM1
prerank, Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076                                                                            , -0.16310611239645442, -0.8139231206336873 , 0.8260869565217391  , 0.9552321053852992,       1.0 , 35/143 , 22.96%, GPER1;XCL1;CXCR6;AGXT;CXCR4;GNRH1;PPAN-P2RY11;UTS2R;TSHR;CHRM3;F2RL1;NTSR1;RLN2;C5;GPR35;PTAFR;PPBP;ADORA2A;S1PR4;CCL20;HCAR1;HCAR3;LTB4R2;C3AR1;CCL28;UTS2B;MC1R;CXCR3;GPR65;S1PR1;S1PR5;SUCNR1;CXCR2;NMUR1;PTGIR
prerank, KEGG_2021_Human__Viral carcinogenesis                                                                                                       , -0.16821957396157455, -0.8138227218899028 , 0.865979381443299   , 0.9543330528147631,       1.0 , 53/188 , 29.34%, CREB3L4;HDAC3;GTF2H3;UBE3A;BAX;CASP3;MRPS18B;CASP8;TP53;VAC14;CHD4;H4C1;CCNA1;CHEK1;MAPK1;PIK3R3;HLA-G;PIK3R1;CDC20;YWHAB;PMAIP1;DLG1;H2BC11;RB1;CREB3L2;USP7;HDAC11;RASA2;KAT2B;CDC42;GRB2;RBPJ;PRKACB;PXN;HDAC9;IRF9;CDKN1A;H4C9;CCNA2;H2BC7;H4C5;PIK3CA;CREBBP;H2BC8;GTF2A2;HDAC6;ATP6V0D1;YWHAQ;SYK;IRF7;GTF2H4;KAT2A;POLB
prerank, Reactome_2022__Kinesins R-HSA-983189                                                                                                        , 0.1815315746540996  , 0.8137184594208152  , 0.7307692307692307  , 1.0               ,       1.0 , 6/35   , 9.09% , KIFC2;CENPE;KIF19;KIF3B;KLC1;KIF1C
prerank, KEGG_2021_Human__Ras signaling pathway                                                                                                      , -0.16340196832594572, -0.8134066762890054 , 0.7916666666666666  , 0.9540415186783298,       1.0 , 45/159 , 25.20%, RASGRF2;PTPN11;FASLG;VEGFA;RGL1;CALM2;MAPK1;PIK3R3;RASGRP2;PIK3R1;PLAAT3;TBK1;PRKCA;GNB5;MAPK8;GNGT2;RASSF1;CSF1;RRAS;PLD2;GNG5;RASA2;PAK6;TGFA;ARF6;CDC42;GRB2;PRKACB;PAK1;GNG11;HGF;PDGFC;CALM3;AKT1;GNG3;GAB2;RASSF5;FGFR2;PIK3CA;RAP1A;ANGPT1;SHC4;KSR1;CSF1R;RAB5A
prerank, Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796                                                         , -0.21504589880308456, -0.8129490519780779 , 0.7402597402597403  , 0.9539166701960605,       1.0 , 9/35   , 19.15%, UBC;MAPK1;RNASEH2A;SMAD3;CCNK;SMAD7;UBB;RPS27A;DAND5
prerank, Reactome_2022__Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300       , 0.22841643725543886 , 0.812807100217361   , 0.5416666666666666  , 1.0               ,       1.0 , 7/16   , 20.15%, E2F4;LIN37;E2F5;CDK1;HDAC1;E2F1;RBL1
prerank, Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214                                                         , -0.17882689851021347, -0.8122044013419986 , 0.8                 , 0.9543489447734965,       1.0 , 19/73  , 25.27%, PML;NUP85;SMC5;NUP88;NUP107;BRCA1;SMC1A;NUP98;NSMCE4A;NSMCE2;XPC;NUP153;TDG;RING1;XRCC4;POM121C;CBX4;RNF168;PMEPA1
prerank, Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430                                                    , -0.23887542333951575, -0.8099340622483167 , 0.726027397260274   , 0.9571117841678206,       1.0 , 12/21  , 37.71%, CDC20;UBE2C;CDC26;UBE2E1;UBE2D1;BUB1B;ANAPC4;BUB3;UBE2S;MAD2L1;ANAPC16;ANAPC2
prerank, Reactome_2022__Signaling By VEGF R-HSA-194138                                                                                               , -0.18475593245523544, -0.8096381537656339 , 0.7840909090909091  , 0.9566648123222103,       1.0 , 11/89  , 11.26%, ITGB3;ABI1;CYFIP2;VEGFA;PDPK1;CRK;ITGAV;PIK3R1;CYBB;PRKCA;ABI2
prerank, Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522                                                                                    , 0.12193722749855308 , 0.8091180001296159  , 0.8666666666666667  , 1.0               ,       1.0 , 19/110 , 14.35%, RPS24;RPS29;RPL7A;RPL22L1;AIMP2;RPS15A;KARS1;RPL32;RPS4X;RPS20;RPS4Y1;RPL27;RPS13;NNMT;RPL14;SECISBP2;RPL34;RPS19;GNMT
prerank, Reactome_2022__Removal Of Flap Intermediate From C-strand R-HSA-174437                                                                      , -0.25683431149325886, -0.8086714990395985 , 0.7571428571428571  , 0.9572698454661641,       1.0 , 6/17   , 30.66%, RPA3;POLR1B;FEN1;POLD4;POT1;POLD2
prerank, Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905                                                                                  , -0.218270153731765  , -0.8080692350190297 , 0.810126582278481   , 0.95703600915053  ,       1.0 , 8/34   , 19.31%, CASP8;UBC;SPPL2A;TANK;TNFRSF1A;UBB;RPS27A;TNFAIP3
prerank, "Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558"                                                              , -0.1770964111957688 , -0.8076880828851454 , 0.8048780487804879  , 0.9566141365916816,       1.0 , 18/78  , 23.85%, PTPN11;IRAK1;PPP2R5E;MAPK1;PIK3R3;IRS1;PIK3R1;AREG;IL1RL1;PPP2R5B;STRN;ERBB3;TGFA;GRB2;AKT1;GAB2;FGFR2;PIK3CA
prerank, Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433                                                                        , 0.18692976950955367 , 0.8070041886292079  , 0.8125              , 1.0               ,       1.0 , 2/29   , 1.54% , ZAP70;PKN2
prerank, Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418                                                                         , -0.17143308934469226, -0.8066476374720495 , 0.813953488372093   , 0.9572878911453551,       1.0 , 17/85  , 20.71%, PTPN11;IRAK1;PPP2R5E;MAPK1;PIK3R3;IRS1;PHLPP2;PIK3R1;AREG;IL1RL1;PPP2R5B;STRN;ERBB3;TGFA;GRB2;AKT1;GAB2
prerank, Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276                                                                           , -0.20894045322108482, -0.8065057485841624 , 0.7777777777777778  , 0.9564433531803707,       1.0 , 8/40   , 17.92%, NUP85;NUP88;KPNA3;KPNA1;NUP107;CPSF4;NUP98;NUP153
prerank, Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125                                             , -0.19970784992573287, -0.8063104694954067 , 0.7428571428571429  , 0.9556593641918748,       1.0 , 11/49  , 20.20%, NTNG2;PIGV;PIGQ;PGAP1;RECK;PIGP;PIGS;PIGM;PIGT;PIGZ;CD52
prerank, Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588                                                                            , -0.23243245930933676, -0.805848143428063  , 0.71875             , 0.9554871856126284,       1.0 , 7/26   , 19.10%, CHMP4B;VPS4B;UBC;CHMP6;VPS37A;UBB;RPS27A
prerank, KEGG_2021_Human__Neuroactive ligand-receptor interaction                                                                                    , -0.17319184862918735, -0.8057884980763045 , 0.7954545454545454  , 0.9545183825896594,       1.0 , 26/104 , 22.96%, P2RX1;GNRH1;THRA;UTS2R;TSHR;CHRM3;NMB;F2RL1;NTSR1;RLN2;C5;GPR35;CALCRL;PTAFR;ADORA2A;CHRNB4;S1PR4;LEPR;LTB4R2;C3AR1;UTS2B;MC1R;S1PR1;S1PR5;NMUR1;PTGIR
prerank, Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885                                                                        , -0.20236211651235692, -0.8053911061056703 , 0.7777777777777778  , 0.9542541360619256,       1.0 , 4/44   , 5.28% , NUP85;TOP1;NUP88;RANGAP1
prerank, Reactome_2022__RNA Polymerase I Promoter Opening R-HSA-73728                                                                                , 0.17858628605222257 , 0.8050133899160783  , 0.8076923076923077  , 1.0               ,       1.0 , 10/30  , 19.87%, H2AZ2;H2BC3;H2AB1;H2BC17;H2BC5;H2BC9;H2AC20;H2AZ1;H2BC14;UBTF
prerank, Reactome_2022__Signaling By GPCR R-HSA-372790                                                                                               , -0.1529775952373359 , -0.8046473091218428 , 0.88                , 0.9545284431137725,       1.0 , 106/381, 27.95%, RASGRF2;ADCY7;GPER1;PLCB2;ARRB1;XCL1;TRPC6;PDPK1;CXCR6;GNA15;WNT10A;AGXT;CXCR4;PDE1B;GNRH1;TAS2R5;PLCB1;MAPK1;PPAN-P2RY11;DGKG;UTS2R;PIK3R3;TSHR;CHRM3;RGS6;RASGRP2;PRKCH;FZD6;GNAI3;PDE2A;F2RL1;NTSR1;PIK3R1;RLN2;PRKCA;RPS6KA3;ARHGEF15;C5;GNB5;GPR35;CALCRL;PTAFR;GNGT2;RGS12;OBSCN;PPBP;CAMK2G;GPSM1;ADORA2A;ROCK2;DGKA;GPR15;PRKAR2A;CRHBP;S1PR4;TAS2R60;CCL20;GNA12;ARHGEF11;HCAR1;HCAR3;GNG5;LTB4R2;CDC42;C3AR1;GRB2;PRKACB;GNG11;CCL28;AKT1;RHOC;GNG3;PPP3CC;UTS2B;MC1R;CXCR3;GPR65;S1PR1;AKAP13;S1PR5;SUCNR1;CXCR2;NMUR1;PTGIR;ITGA5;PDE4D;PIK3CA;PTGDR;PRPF38B;GNAI1;ADCY9;C5AR2;PRKX;LPAR2;ARHGEF1;ADM2;RGS1;PRKAR1A;ARHGEF4;GPR18;POMC;TAS2R20;BTK;ARHGEF2;PDE4B;PPP2CA
prerank, KEGG_2021_Human__Glycosphingolipid biosynthesis                                                                                             , -0.2260752113853951 , -0.8043022312745357 , 0.7945205479452054  , 0.9540895098869785,       1.0 , 4/34   , 7.57% , A4GALT;ST6GALNAC4;B4GALT1;B4GALT3
prerank, Reactome_2022__Cristae Formation R-HSA-8949613                                                                                              , -0.21483344483056585, -0.8039640400784227 , 0.7631578947368421  , 0.9534531211933734,       1.0 , 3/29   , 5.57% , ATP5PB;MTX1;MICOS13
prerank, Reactome_2022__PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801                                                                 , -0.2421627915289848 , -0.803741406622302  , 0.7361111111111112  , 0.9527947780908771,       1.0 , 13/21  , 43.01%, SLC19A1;RPA3;RFC5;POLR1B;FEN1;POLD4;POLE3;POLD2;POLE4;POLE;RFC2;RFC3;POLD1
prerank, Reactome_2022__DARPP-32 Events R-HSA-180024                                                                                                 , -0.22936003115928547, -0.8035450990147213 , 0.7333333333333333  , 0.9522775862537746,       1.0 , 8/22   , 27.95%, PRKCA;PRKAR2A;PRKACB;PPP3CC;PDE4D;PRKAR1A;PDE4B;PPP2CA
prerank, KEGG_2021_Human__VEGF signaling pathway                                                                                                     , -0.1909955810263014 , -0.8031431666055089 , 0.7974683544303798  , 0.9519243596584845,       1.0 , 19/52  , 34.46%, SPHK2;VEGFA;MAPK1;PIK3R3;PIK3R1;NOS3;PRKCA;CDC42;PXN;AKT1;PPP3CC;MAPK11;PIK3CA;NFATC2;PTGS2;SRC;PLA2G4A;AKT2;PIK3CB
prerank, Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095                                                                    , 0.15221823806548407 , 0.8023268539939695  , 0.782608695652174   , 1.0               ,       1.0 , 11/45  , 16.46%, POLR2I;H2AZ2;H2BC3;POLR2F;H2AB1;H2BC17;H2BC5;H2BC9;H2AC20;H2AZ1;POLR2C
prerank, Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126                                                                                 , 0.16494846100221916 , 0.801961406193392   , 0.6521739130434783  , 1.0               ,       1.0 , 11/38  , 20.53%, CDC16;CCND2;ANAPC10;ANAPC5;E2F3;SKP2;CDC27;E2F1;CCND3;CDK6;ANAPC7
prerank, Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276                                                                                , -0.1692847930743963 , -0.8015166228192283 , 0.7865168539325843  , 0.953582241167984 ,       1.0 , 19/85  , 22.76%, GPER1;XCL1;CXCR6;AGXT;CXCR4;UTS2R;F2RL1;NTSR1;RLN2;C5;PPBP;CCL20;C3AR1;CCL28;UTS2B;MC1R;CXCR3;CXCR2;NMUR1
prerank, Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559                                                                                    , -0.2593662192730901 , -0.8010085627640439 , 0.6911764705882353  , 0.9533560674178798,       1.0 , 9/15   , 46.72%, YES1;PRKCA;GRB2;SRC;SOCS6;PTPN6;LYN;FYN;SOCS1
prerank, Reactome_2022__G Beta:Gamma Signaling Thru BTK R-HSA-8964315                                                                                , -0.26891935007205603, -0.8009225025756869 , 0.75                , 0.9524694129029176,       1.0 , 5/15   , 19.82%, GNB5;GNGT2;GNG5;GNG11;GNG3
prerank, Reactome_2022__Insulin Receptor Recycling R-HSA-77387                                                                                       , 0.1960951882912891  , 0.7996613722637733  , 0.6666666666666666  , 1.0               ,       1.0 , 3/20   , 9.79% , ATP6V1E2;ATP6V0C;ATP6V0E2
prerank, KEGG_2021_Human__Inflammatory mediator regulation of TRP channels                                                                           , -0.18677329018924682, -0.7993831113730866 , 0.7816091954022989  , 0.9538665926648298,       1.0 , 11/67  , 13.42%, ADCY7;PLCB2;CALM2;PLCB1;PIK3R3;PRKCH;F2RL1;PIK3R1;PRKCA;MAPK8;CAMK2G
prerank, Reactome_2022__Reproduction R-HSA-1474165                                                                                                   , -0.17543636712718935, -0.7993487413750872 , 0.7954545454545454  , 0.9529002802515987,       1.0 , 21/85  , 25.93%, RAD50;CD9;H2AX;H2AC19;B4GALT1;RPA3;H2AC7;BRCA1;SMC1A;POLR1B;H2BC11;HVCN1;H3-3B;IZUMO4;ZP3;MLH3;SYCP2;HSPA2;PMEPA1;PSMC3IP;POT1
prerank, Reactome_2022__Deadenylation Of mRNA R-HSA-429947                                                                                           , 0.18374352300753385 , 0.7993462988851412  , 0.7307692307692307  , 1.0               ,       1.0 , 3/24   , 4.12% , EIF4A1;CNOT7;CNOT9
prerank, KEGG_2021_Human__RIG-I-like receptor signaling pathway                                                                                      , -0.19389590745512564, -0.7988613492609923 , 0.825               , 0.9525024050520381,       1.0 , 26/51  , 44.12%, SIKE1;CASP8;MAP3K1;TBK1;AZI2;MAPK8;TANK;MAP3K7;ATG12;OTUD5;MAPK11;IRF7;ATG5;IKBKG;MAPK10;IL12A;CYLD;TRAF6;RNF125;TRAF2;RELA;IRF3;TNF;MAVS;IKBKE;NFKBIB
prerank, Reactome_2022__ESR-mediated Signaling R-HSA-8939211                                                                                         , -0.16373486394866757, -0.798680500314222  , 0.8404255319148937  , 0.9518051588824469,       1.0 , 45/167 , 25.43%, UHMK1;H2AX;PDPK1;H2AC19;MAPK1;PIK3R3;GNAI3;PIK3R1;CARM1;AREG;TNRC6C;AGO3;H2AC7;GNB5;SMC1A;GNGT2;POLR2G;NR5A2;H2BC11;MMP9;STRN;GNG5;H3-3B;TGFA;XPO1;AGO1;POLR2B;KAT2B;GNG11;POLR2D;NRIP1;DAND5;AKT1;GNG3;FKBP4;NCOA3;CHD1;DDX5;CXXC5;PIK3CA;GNAI1;MOV10;CREBBP;PMEPA1;KANK1
prerank, Reactome_2022__Pyruvate Metabolism R-HSA-70268                                                                                              , -0.23091254301810693, -0.7985143415121269 , 0.725               , 0.951120922836866 ,       1.0 , 4/25   , 10.48%, PDPK1;PDK4;PDHB;BSG
prerank, Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541                                                                                  , -0.2573986557552692 , -0.7972980703449951 , 0.7391304347826086  , 0.9519936408894684,       1.0 , 11/15  , 43.99%, SIKE1;TBK1;TANK;CREBBP;IRF7;TRAF6;IRF3;RNF135;MAVS;IKBKE;EP300
prerank, Reactome_2022__Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373                                        , -0.22413828628166468, -0.7972093831848597 , 0.7432432432432432  , 0.9511610194342044,       1.0 , 14/25  , 43.01%, SLC19A1;RPA3;RFC5;PARP2;POLR1B;FEN1;POLD4;POLE3;POLD2;POLE4;POLE;RFC2;RFC3;POLD1
prerank, Reactome_2022__Translation R-HSA-72766                                                                                                      , -0.14883687524368294, -0.7958177142229645 , 0.9270833333333334  , 0.9523767930910331,       1.0 , 32/276 , 10.40%, RPS3;RPL37A;MTFMT;SRP14;CHCHD1;MRPL53;PPA2;MRPS18B;CARS2;MRPS30;MRPL21;MRPS23;EEF1A1;RPS8;RPL39;MRPL3;EIF2S1;MRPL57;EEF1E1;MRPL20;MRPL18;MRPS25;EEF2;EEF1G;MRPL39;MRPS7;SRP19;RPS14;RPL36AL;MARS2;RPL38;SEC61B
prerank, KEGG_2021_Human__Steroid biosynthesis                                                                                                       , -0.2711551192712388 , -0.795354653215592  , 0.7123287671232876  , 0.9521198152956469,       1.0 , 6/16   , 31.17%, SQLE;NSDHL;FDFT1;DHCR7;DHCR24;SC5D
prerank, KEGG_2021_Human__Ovarian steroidogenesis                                                                                                    , -0.22339815105085198, -0.7925261061045671 , 0.7564102564102564  , 0.9559136168452568,       1.0 , 10/25  , 32.92%, ADCY7;AKR1C3;ACOT4;PRKACB;CYP1B1;BMP6;ADCY9;PTGS2;INSR;PLA2G4A
prerank, Reactome_2022__Protein Folding R-HSA-391251                                                                                                 , -0.18613333035879875, -0.7920577687645732 , 0.8181818181818182  , 0.9556993072215192,       1.0 , 27/82  , 31.46%, HDAC3;ARL2;TP53;GNA15;RGS6;CCT3;ARFGEF2;CSNK2A2;GNB5;GNGT2;CCT6B;GNG5;GNG11;NOP56;GNG3;FBXW4;TUBB6;FBXO4;TBCD;FKBP9;CCT2;KIF13A;TUBA1C;TBCA;CCT6A;FBXO6;FBXW7
prerank, Reactome_2022__SLC Transporter Disorders R-HSA-5619102                                                                                      , 0.1434745734006371  , 0.7916917902439462  , 0.9375              , 1.0               ,       1.0 , 14/67  , 13.95%, MAP4K5;SLC24A4;NUP160;NUP133;MAP4K2;SLC27A4;NUP54;SLC40A1;SLC20A2;NUP210;SEC13;SLC2A1;NUP62;SLC1A3
prerank, Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724                                                                          , -0.19568341401726647, -0.7914222636648766 , 0.8765432098765432  , 0.9558174879233131,       1.0 , 23/55  , 38.14%, GATAD2A;HDAC3;TP53;CHD4;MAPK1;RRAGD;ATN1;RBBP7;EGR1;PPARG;RING1;CBX4;RRAGB;RBBP4;KDM1A;RNF2;CBX8;COMMD3-BMI1;SCMH1;REST;PHC3;JUN;SLC38A9
prerank, KEGG_2021_Human__Coronavirus disease                                                                                                        , -0.15943300305033464, -0.7912891520691451 , 0.8817204301075269  , 0.9550661596534109,       1.0 , 33/188 , 16.68%, RPS3;RPL37A;MX1;IRAK1;RPL24;RPS8;F13A1;RPL39;TYK2;MAPK1;PIK3R3;PIK3R1;CYBB;RPS14;RPL36AL;RPL38;OAS2;TBK1;PRKCA;RPL19;RPS26;C5;MAPK8;C4B;C1QC;RPL6;RPS25;C4A;TNFRSF1A;MAP3K7;RPL17;TLR3;RPL15
prerank, Reactome_2022__G-protein Activation R-HSA-202040                                                                                            , -0.2482021209599692 , -0.7894605013786246 , 0.7368421052631579  , 0.9567500710057871,       1.0 , 6/18   , 19.82%, GNA15;GNB5;GNGT2;GNG5;GNG11;GNG3
prerank, Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289                                                                          , -0.1973307628423683 , -0.7892645341457711 , 0.7051282051282052  , 0.9559765122895569,       1.0 , 7/34   , 16.50%, MMUT;PCCA;THEM5;HADHB;ACSM3;PCCB;ACOT13
prerank, Reactome_2022__Tight Junction Interactions R-HSA-420029                                                                                     , -0.24468666419008647, -0.7891893918712176 , 0.7837837837837838  , 0.9551589648892592,       1.0 , 4/17   , 21.95%, PARD6B;CLDN9;CLDN4;CLDN5
prerank, Reactome_2022__NCAM1 Interactions R-HSA-419037                                                                                              , -0.23116555818872792, -0.7885677566035667 , 0.7323943661971831  , 0.95511763502775  ,       1.0 , 4/21   , 15.60%, COL6A3;CACNB3;CACNA1H;COL9A1
prerank, Reactome_2022__HIV Transcription Initiation R-HSA-167161                                                                                    , -0.18918891368397558, -0.7881210019173371 , 0.7564102564102564  , 0.9548374545272711,       1.0 , 21/44  , 40.65%, GTF2H3;TAF11;POLR2G;TAF15;POLR2B;CCNH;POLR2D;TAF1;MNAT1;TAF5;TAF12;TAF4;GTF2A2;GTF2H4;ERCC3;TAF9;GTF2H1;POLR2E;POLR2L;TAF2;GTF2F1
prerank, Reactome_2022__Telomere Maintenance R-HSA-157579                                                                                            , -0.17483351326335897, -0.78767479922274   , 0.7654320987654321  , 0.9545464922605258,       1.0 , 22/88  , 24.08%, H2AX;H2AC19;SLC19A1;CCNA1;RPA3;CTC1;PRIM2;RFC5;H2AC7;POLR2G;POLR1B;H2BC11;CHTF8;H3-3B;POLR2B;FEN1;POLR2D;ATRX;CCNA2;POLD4;CHTF18;PIF1
prerank, Reactome_2022__Activation Of G Protein Gated Potassium Channels R-HSA-1296041                                                               , -0.2559122934188241 , -0.7864497503611748 , 0.7916666666666666  , 0.9553461436501997,       1.0 , 5/16   , 19.82%, GNB5;GNGT2;GNG5;GNG11;GNG3
prerank, KEGG_2021_Human__Staphylococcus aureus infection                                                                                            , -0.19280751831280252, -0.7860918814624365 , 0.75                , 0.9548851211468842,       1.0 , 11/57  , 18.08%, ITGAL;IL10;DEFA3;C5;PTAFR;C4B;C1QC;CFH;ITGAM;C4A;C3AR1
prerank, Reactome_2022__DAG And IP3 Signaling R-HSA-1489509                                                                                          , -0.21423612388304217, -0.7858883068786789 , 0.7590361445783133  , 0.9542890894406614,       1.0 , 9/29   , 26.82%, ADCY7;PDE1B;PRKCA;CAMK2G;PRKAR2A;PRKACB;ADCY9;PRKX;PRKAR1A
prerank, Reactome_2022__DNA Methylation R-HSA-5334118                                                                                                , -0.21317704335870008, -0.7850683356399684 , 0.75                , 0.9545771677050883,       1.0 , 6/31   , 17.03%, H2AX;H2AC19;UHRF1;H2AC7;H2BC11;H3-3B
prerank, Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928                                                                          , -0.21118955955337967, -0.7844161669123282 , 0.7283950617283951  , 0.9546611199281934,       1.0 , 8/29   , 23.85%, PTPN11;PDPK1;IRS1;PIK3R1;GRB2;GAB2;FGFR2;PIK3CA
prerank, Reactome_2022__Gene Silencing By RNA R-HSA-211000                                                                                           , -0.1691191003037043 , -0.7841443228330034 , 0.8045977011494253  , 0.9541462411963637,       1.0 , 19/97  , 19.57%, NUP85;H2AX;NUP88;H2AC19;DGCR8;TNRC6C;AGO3;H2AC7;NUP107;RAN;POLR2G;H2BC11;NUP98;H3-3B;AGO1;POLR2B;NUP153;POLR2D;IPO8
prerank, "Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513"                                                      , -0.23705378741405606, -0.7829810891792993 , 0.7066666666666667  , 0.9548962052602868,       1.0 , 9/17   , 43.09%, EXOSC6;YWHAB;EXOSC2;DCP1A;EXOSC5;EXOSC8;EXOSC3;TNPO1;DCP2
prerank, Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594                                                                                    , -0.162356387539018  , -0.7826132611420494 , 0.8478260869565217  , 0.9543821483196998,       1.0 , 51/175 , 27.95%, ADCY7;GPER1;PLCB2;CXCR6;GNA15;AGXT;CXCR4;PDE1B;TAS2R5;PLCB1;MAPK1;RGS6;GNAI3;PRKCA;C5;GNB5;GNGT2;RGS12;PPBP;CAMK2G;GPSM1;PRKAR2A;S1PR4;TAS2R60;CCL20;HCAR1;HCAR3;GNG5;C3AR1;PRKACB;GNG11;CCL28;GNG3;PPP3CC;CXCR3;S1PR5;SUCNR1;CXCR2;NMUR1;PDE4D;GNAI1;ADCY9;PRKX;LPAR2;RGS1;PRKAR1A;GPR18;POMC;TAS2R20;PDE4B;PPP2CA
prerank, Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067                                                                         , -0.2258401490930657 , -0.7817425124340016 , 0.7916666666666666  , 0.9547362048887761,       1.0 , 13/29  , 35.93%, CSTF2;SYMPK;CPSF1;SNRPF;CPSF4;LSM10;NCBP1;SNRPD3;CPSF7;CPSF3;CSTF2T;FIP1L1;WDR33
prerank, Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582                                                               , -0.17579334543561526, -0.7816249984403724 , 0.8571428571428571  , 0.9540321446889504,       1.0 , 17/78  , 19.10%, H2AX;UBC;H2AC19;CEBPB;CCNA1;MAPK1;UBE2C;CDC26;RPS6KA3;H2AC7;H2BC11;CDKN2D;CDKN2C;UBE2E1;H3-3B;UBB;RPS27A
prerank, Reactome_2022__Gluconeogenesis R-HSA-70263                                                                                                  , -0.20748907166741581, -0.7804739483772355 , 0.6805555555555556  , 0.9547566593616891,       1.0 , 3/25   , 8.17% , SLC37A2;LOC112694756;PCK2
prerank, Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124                                                                               , -0.22546440174624321, -0.780171241123433  , 0.7534246575342466  , 0.9542785406272933,       1.0 , 10/21  , 35.98%, FGFR1OP2;PIK3R1;GRB2;TRIM24;GAB2;PIK3CA;ZMYM2;MYO18A;LRRFIP1;FGF13
prerank, KEGG_2021_Human__Pentose phosphate pathway                                                                                                  , -0.22414959537755036, -0.7791757512406838 , 0.7368421052631579  , 0.9548106718661442,       1.0 , 3/24   , 5.76% , TKT;GLYCTK;G6PD
prerank, KEGG_2021_Human__Tight junction                                                                                                             , -0.1665024377217688 , -0.7782735747471227 , 0.8409090909090909  , 0.9553081016794777,       1.0 , 40/129 , 30.99%, RAB8B;NF2;MYH9;PARD6B;CTTN;MAP3K1;SYMPK;PRKAG2;WAS;CLDN9;DLG1;MAPK8;ROCK2;ARPC5;MAP2K7;CDC42;PRKACB;CLDN4;CD1A;PRKAG1;CD1C;HSPA4;CLDN5;PPP2R2A;NEDD4;ARPC3;MAP3K5;RAPGEF6;RAP1A;ARPC2;RAB8A;ARHGEF2;AFDN;PPP2CA;TUBA1C;MYL12B;ACTR3;ARPC5L;SCRIB;SRC
prerank, Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369                                                                                    , -0.2504039992134545 , -0.7774546950726928 , 0.7435897435897436  , 0.9555247340278377,       1.0 , 4/15   , 19.10%, UBC;PTPRJ;UBB;RPS27A
prerank, Reactome_2022__Transcription Of HIV Genome R-HSA-167172                                                                                     , 0.14629251112355632 , 0.7773122990494684  , 0.7619047619047619  , 1.0               ,       1.0 , 7/66   , 6.93% , NELFB;NELFA;POLR2I;ERCC2;SSRP1;GTF2E2;POLR2F
prerank, Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556                                                                           , -0.21553888390294434, -0.7766746458614122 , 0.7901234567901234  , 0.9558974358974359,       1.0 , 10/28  , 29.27%, ATP6V0A1;CYBB;TCIRG1;HVCN1;LPO;ATP6V0A2;SLC11A1;ATP6V0D1;NCF2;NCF1
prerank, Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842                                                                               , -0.16194272919430644, -0.7760696673736274 , 0.8314606741573034  , 0.9559566669683175,       1.0 , 15/88  , 16.68%, RPS3;RPL37A;EEF1A1;RPS8;RPL39;EEF2;EEF1G;RPS14;RPL36AL;RPL38;RPL19;EEF1A2;RPL6;RPS25;RPL15
prerank, "Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200", -0.16028597339973233, -0.7752515631107962 , 0.8409090909090909  , 0.9561050302159243,       1.0 , 11/110 , 9.29% , NDUFB3;ECSIT;COQ10A;ATP5PB;COX6C;COX5A;UQCRC1;UQCRFS1;NDUFB2;NDUFA7;UQCRB
prerank, "KEGG_2021_Human__Glycine, serine and threonine metabolism"                                                                                 , -0.21078362344371973, -0.7747260493852068 , 0.788235294117647   , 0.9560413299168534,       1.0 , 7/34   , 16.79%, GLYCTK;GCAT;AGXT;PIPOX;PGAM1;ALAS2;CHDH
prerank, Reactome_2022__mRNA Splicing R-HSA-72172                                                                                                    , -0.15294453632257085, -0.7742775916069412 , 0.8556701030927835  , 0.9556660109301316,       1.0 , 43/188 , 23.12%, MAGOH;AQR;PCBP2;CRNKL1;FUS;CSTF2;SF3B5;DDX42;RBM5;PUF60;SYMPK;SRSF3;CPSF1;SF1;DHX9;PLRG1;SNRPN;LSM4;HNRNPF;POLR2G;SNRPF;CPSF4;CWC22;PPIL6;SF3B1;SART1;HNRNPD;EIF4A3;SRSF1;POLR2B;POLR2D;CDC40;PRPF8;NCBP1;SRRM1;DHX15;SNRPD3;PPIL1;SF3B2;DDX5;SRSF5;HNRNPM;LSM6
prerank, KEGG_2021_Human__Allograft rejection                                                                                                        , -0.2142558508855922 , -0.7721411687864493 , 0.7215189873417721  , 0.9576494332763045,       1.0 , 5/33   , 14.75%, FASLG;HLA-G;IL10;IL4;GZMB
prerank, KEGG_2021_Human__C-type lectin receptor signaling pathway                                                                                   , -0.16586166922004456, -0.7715988903291283 , 0.7802197802197802  , 0.9575510199020918,       1.0 , 43/93  , 42.35%, FCER1G;PTPN11;CBLB;CASP8;CALM2;MAPK1;PIK3R3;PIK3R1;BCL3;IL10;MAPK8;RRAS;BCL10;PAK1;CALM3;AKT1;PPP3CC;IRF9;MAPK11;PIK3CA;KSR1;NFATC2;PTGS2;SYK;RELB;SRC;AKT2;ARHGEF12;NLRP3;PIK3CB;IKBKG;MAPK10;IL12A;PLCG2;CYLD;JUN;CALM1;IL23A;ITPR1;RELA;MALT1;TNF;PYCARD
prerank, Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746                                                                                   , -0.20162889125928818, -0.7713780356693958 , 0.7857142857142857  , 0.9569311129523032,       1.0 , 6/33   , 17.92%, NUP85;NUP88;NUP107;RAN;NUP98;NUP153
prerank, Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476                                                                          , -0.24588885523051954, -0.7706193338830934 , 0.7083333333333334  , 0.9570775793276114,       1.0 , 4/17   , 16.26%, ZBP1;TICAM1;DHX9;TLR3
prerank, Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407                                                      , 0.19859746433363568 , 0.7702929029414676  , 0.7142857142857143  , 1.0               ,       1.0 , 3/20   , 5.80% , CDC16;ANAPC10;ANAPC5
prerank, Reactome_2022__DNA Repair R-HSA-73894                                                                                                       , -0.14521642443719276, -0.7687681787718345 , 0.9175257731958762  , 0.9589628859658731,       1.0 , 93/298 , 31.76%, ALKBH5;AQR;RAD50;GTF2H3;H2AX;POLN;BABAM1;TP53;UBC;H2AC19;SLC19A1;XRCC5;UFD1;CCNA1;CHEK1;POLM;RPA3;POLK;OGG1;RAD9B;UBE2B;RAD51AP1;RFC5;H2AC7;FAAP20;BRCA1;COPS3;DCLRE1C;MAPK8;PARP2;RAD18;UBE2N;XPA;UNG;POLR2G;POLR1B;H2BC11;USP7;PAXIP1;ABRAXAS1;DDB2;XPC;POLR2B;CCNH;CENPS-CORT;FEN1;POLR2D;UBB;RPS27A;TDG;NEIL3;HUS1;MNAT1;EYA3;MAD2L2;CHEK2;BABAM2;XRCC4;CCNA2;VCP;UIMC1;POLD4;NHEJ1;RNF168;ELL;ERCC1;PRKDC;ERCC6;INO80D;REV3L;POT1;TCEA1;RHNO1;NEIL2;MSH2;PALB2;GTF2H4;LIG4;RMI1;XRCC3;MUTYH;RAD51D;XRCC1;H2AC6;POLE3;MLH1;POLD2;ASCC3;TOP3A;PNKP;MGMT;PMS2;COPS8
prerank, Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203                                                                  , -0.14717567721486063, -0.7684584537672975 , 0.8787878787878788  , 0.9584430282835344,       1.0 , 52/238 , 23.21%, NUP85;MAGOH;AQR;PCBP2;CRNKL1;FYTTD1;NUP88;FUS;CSTF2;SF3B5;DDX42;RBM5;PUF60;SYMPK;THOC1;SRSF3;CPSF1;SF1;DHX9;PLRG1;NUP107;SNRPN;LSM4;HNRNPF;POLR2G;SNRPF;CPSF4;CWC22;THOC7;PPIL6;NUP98;SF3B1;SART1;HNRNPD;EIF4A3;SRSF1;POLR2B;NUP153;POLR2D;CDC40;PRPF8;NCBP1;SRRM1;DHX15;SNRPD3;PPIL1;SF3B2;DDX5;SRSF5;HNRNPM;LSM6;POM121C
prerank, KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection                                                                            , -0.15410845368316486, -0.7681418697345247 , 0.84375             , 0.95797949929249  ,       1.0 , 33/166 , 19.91%, BAX;CASP3;CASP8;VEGFA;TP53;UBC;CALM2;TYK2;MAPK1;PIK3R3;HLA-G;TICAM1;PIK3R1;ATG14;TBK1;CLEC2B;LEF1;HIF1A;GNB5;MAPK8;GNGT2;RB1;TNFRSF1A;TLR3;MAP2K7;GNG5;GNG11;UBB;RPS27A;CALM3;AKT1;GNG3;PPP3CC
prerank, Reactome_2022__Autophagy R-HSA-9612973                                                                                                      , -0.1547833428479076 , -0.7678920726135894 , 0.8690476190476191  , 0.9573843858635313,       1.0 , 27/121 , 21.06%, SQSTM1;CHMP4B;ATG9A;UBC;EEF1A1;PRKAG2;CSNK2A2;ATG14;DYNC1LI1;RRAGD;CHMP6;ATG10;MTERF3;UBE2N;ATG101;AMBRA1;UVRAG;VPS37A;WIPI2;DYNC1H1;TOMM40;UBB;ATG12;RPS27A;PEX5;ATG13;PRKAG1
prerank, KEGG_2021_Human__Cortisol synthesis and secretion                                                                                           , -0.20271432711263393, -0.7671272397694071 , 0.7590361445783133  , 0.9573972626609131,       1.0 , 4/38   , 6.54% , ADCY7;CREB3L4;PLCB2;PLCB1
prerank, Reactome_2022__Cellular Senescence R-HSA-2559583                                                                                            , -0.15587228760008234, -0.7669381982057888 , 0.8617021276595744  , 0.9567378135538832,       1.0 , 42/157 , 26.28%, RAD50;H1-3;H2AX;TP53;UBC;H2AC19;CEBPB;MDM4;CCNA1;MAPK1;UBE2C;TNRC6C;CDC26;AGO3;RPS6KA3;H2AC7;MAPK8;RBBP7;H2BC11;RB1;CDKN2D;CDKN2C;UBE2E1;MAP2K7;H3-3B;AGO1;MINK1;UBB;RPS27A;DAND5;ASF1A;RING1;CDKN1A;CCNA2;MAPK11;UBE2D1;MAP3K5;CBX4;RBBP4;MOV10;POT1;KDM6B
prerank, KEGG_2021_Human__Malaria                                                                                                                    , 0.16801073189972798 , 0.766429191338973   , 1.0                 , 1.0               ,       1.0 , 5/43   , 5.94% , IL6;HBA2;CCL2;KLRK1;SELP
prerank, Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165                                                                        , -0.16397189676351404, -0.7657363898829674 , 0.8791208791208791  , 0.9575660705104942,       1.0 , 22/112 , 19.51%, SAP30;GATAD2A;GTF2H3;H2AX;H2AC19;UHRF1;CHD4;POLR1D;CBX3;H2AC7;RBBP7;POLR1B;H2BC11;SIRT1;SF3B1;TAF1B;H3-3B;SUDS3;KAT2B;SAP30L;CCNH;TDG
prerank, Reactome_2022__Recycling Pathway Of L1 R-HSA-437239                                                                                         , 0.19684569065467955 , 0.7655204462448688  , 0.868421052631579   , 1.0               ,       1.0 , 7/25   , 13.72%, L1CAM;MSN;RPS6KA1;EZR;AP2A1;AP2B1;DNM1
prerank, KEGG_2021_Human__Oocyte meiosis                                                                                                             , -0.16290923296026538, -0.7645783318337492 , 0.8539325842696629  , 0.9581066801815139,       1.0 , 25/99  , 24.84%, ADCY7;CPEB3;PPP2R5E;CALM2;MAPK1;CDC20;YWHAB;CUL1;CDC26;RPS6KA3;PPP2R5B;SMC1A;CAMK2G;SPDYC;PRKACB;CALM3;PPP3CC;ANAPC13;SPDYE18;CDC25C;MAD2L2;MAPK11;FBXO43;ADCY9;SLK
prerank, Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165                                                                           , 0.14509883135071    , 0.764474424540196   , 0.7407407407407407  , 1.0               ,       1.0 , 5/38   , 7.64% , SPTAN1;PRNP;NCAM1;COL4A3;CREB1
prerank, Reactome_2022__Arachidonic Acid Metabolism R-HSA-2142753                                                                                    , -0.1939895933181749 , -0.7639872119870275 , 0.8                 , 0.9581187769370533,       1.0 , 6/40   , 11.87%, GGT1;AKR1C3;CYP4F3;CYP2C9;PTGS1;CYP2U1
prerank, Reactome_2022__Inflammasomes R-HSA-622312                                                                                                   , 0.18265294312450236 , 0.7626556329107212  , 0.6666666666666666  , 1.0               ,       1.0 , 20/21  , 71.91%, NFKB2;NFKB1;TXNIP;NLRP1;NLRC4;BCL2;AIM2;SUGT1;P2RX7;HSP90AB1;PANX1;CASP1;BCL2L1;TXN2;PYCARD;RELA;PSTPIP1;NLRP3;APP;HMOX1
prerank, KEGG_2021_Human__Collecting duct acid secretion                                                                                             , 0.18959613867343336 , 0.7613230388731866  , 0.7619047619047619  , 1.0               ,       1.0 , 2/19   , 3.64% , ATP6V1E2;ATP6V0C
prerank, Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328                                                                  , -0.2283671505737659 , -0.7609260241271437 , 0.7972972972972973  , 0.9615556462603494,       1.0 , 8/22   , 28.56%, CHMP4B;LEMD2;CHMP6;IST1;TUBB6;VPS4A;TUBA1C;CHMP2A
prerank, Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920                                                                          , 0.16284831796018    , 0.7601525248793124  , 0.7727272727272727  , 1.0               ,       1.0 , 3/24   , 8.23% , PKN2;CTNNA1;MTOR
prerank, Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505                             , -0.19745302034395867, -0.7584538811147329 , 0.8133333333333334  , 0.9643495798895168,       1.0 , 9/34   , 19.97%, SERPINB2;IL10;PSME2;PDCD4;HNRNPF;GSTO1;VPS72;CDC42;AURKAIP1
prerank, Reactome_2022__SIRT1 Negatively Regulates rRNA Expression R-HSA-427359                                                                      , -0.19746944691274324, -0.7581967388804199 , 0.7837837837837838  , 0.9636542555592332,       1.0 , 7/35   , 17.03%, H2AX;H2AC19;H2AC7;H2BC11;SIRT1;TAF1B;H3-3B
prerank, Reactome_2022__Keratinization R-HSA-6805567                                                                                                 , -0.2096438884106247 , -0.7571207266597981 , 0.7222222222222222  , 0.9642735894927014,       1.0 , 2/30   , 0.73% , TGM1;KRTAP5-11
prerank, KEGG_2021_Human__mTOR signaling pathway                                                                                                     , -0.15853457799974294, -0.7551590274261072 , 0.875               , 0.9658647067700107,       1.0 , 29/124 , 24.46%, LRP6;FNIP1;PDPK1;WNT10A;MAPK1;PIK3R3;IRS1;FZD6;PIK3R1;RRAGD;PRKCA;LRP5;RPS6KA3;RPS6KB1;CAB39;DEPTOR;LPIN1;TNFRSF1A;ULK2;NPRL3;LPIN2;GRB2;AKT1;RPS6;CASTOR1;MIOS;FNIP2;PIK3CA;RRAGB
prerank, Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927                                                                                     , -0.22346734039441932, -0.7551315091566111 , 0.8285714285714286  , 0.9649405941373765,       1.0 , 7/24   , 18.79%, DGCR8;AGO3;RAN;POLR2G;AGO1;POLR2B;POLR2D
prerank, Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410                                                                               , -0.1631890184873152 , -0.7547217208118956 , 0.8148148148148148  , 0.9645311479143814,       1.0 , 21/66  , 32.47%, NUP85;CHMP4B;RANGAP1;LEMD2;NUP107;CHMP6;RAN;NUP98;TMPO;IST1;ANKLE2;PPP2R2A;TUBB6;EMD;VPS4A;PPP2CA;TUBA1C;CHMP2A;SIRT2;NUP188;VRK1
prerank, KEGG_2021_Human__Vibrio cholerae infection                                                                                                  , -0.19400762985175768, -0.7519809186538374 , 0.8395061728395061  , 0.9670546407185628,       1.0 , 12/41  , 24.78%, ARF1;ATP6V0A1;SEC61B;PRKCA;TCIRG1;ERO1A;KDELR2;KDELR1;PRKACB;ATP6V0A2;PDIA4;ADCY9
prerank, Reactome_2022__Packaging Of Telomere Ends R-HSA-171306                                                                                      , 0.17887490267184686 , 0.7519092249325516  , 0.7727272727272727  , 1.0               ,       1.0 , 8/30   , 15.18%, H2AZ2;H2BC3;H2AB1;H2BC17;H2BC5;H2BC9;H2AC20;H2AZ1
prerank, Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930                                                                          , -0.22834027096670007, -0.7516838697925589 , 0.7402597402597403  , 0.9664370061076648,       1.0 , 6/20   , 19.82%, GNA15;GNB5;GNGT2;GNG5;GNG11;GNG3
prerank, Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924                                                                                        , -0.2026772840127    , -0.7513430610750252 , 0.7848101265822784  , 0.9649663472158375,       1.0 , 8/30   , 23.85%, PTPN11;PDPK1;IRS1;PIK3R1;GRB2;GAB2;FGFR2;PIK3CA
prerank, Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192                                              , -0.2026772840127    , -0.7513430610750252 , 0.7848101265822784  , 0.9649663472158375,       1.0 , 8/30   , 23.85%, PTPN11;PDPK1;IRS1;PIK3R1;GRB2;GAB2;FGFR2;PIK3CA
prerank, Reactome_2022__rRNA Processing R-HSA-72312                                                                                                  , -0.14578105791068496, -0.7511757468649753 , 0.8865979381443299  , 0.9642549282659779,       1.0 , 33/197 , 19.28%, EXOSC6;RPS3;RPP25;RPL37A;CSNK1D;UTP20;TEX10;SPPL2A;FBL;UTP3;RPS8;WDR43;RPL39;RCL1;RIOK1;UTP18;RIOK3;RPS14;RPL36AL;RPL38;WDR75;RPL19;DNAJC5;RPP14;RPL6;RRP7A;RPS25;MPHOSPH6;RPL15;MRM2;UTP14C;RPS27A;NOP56
prerank, Reactome_2022__NLRP3 Inflammasome R-HSA-844456                                                                                              , 0.20300112210903432 , 0.750137714792296   , 0.8214285714285714  , 1.0               ,       1.0 , 2/16   , 6.95% , NFKB2;NFKB1
prerank, Reactome_2022__Sialic Acid Metabolism R-HSA-4085001                                                                                         , -0.22634194070878966, -0.7500227901149166 , 0.8055555555555556  , 0.964889809932374 ,       1.0 , 9/26   , 30.91%, ST6GALNAC4;ST6GALNAC1;ST6GALNAC6;SLC35A1;SLC17A5;NPL;ST8SIA6;NANP;GNE
prerank, Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325                                                                                   , -0.1803730072412695 , -0.7491423280342462 , 0.8607594936708861  , 0.9650900268300378,       1.0 , 9/46   , 18.79%, NUP85;NUP88;PBRM1;NUP107;POLR2G;NUP98;POLR2B;NUP153;POLR2D
prerank, Reactome_2022__Eukaryotic Translation Termination R-HSA-72764                                                                               , 0.13637868757540061 , 0.7486117486934052  , 0.8333333333333334  , 1.0               ,       1.0 , 15/87  , 13.82%, RPS24;RPS29;RPL7A;RPL22L1;RPS15A;RPL32;RPS4X;RPS20;RPS4Y1;RPL27;GSPT2;RPS13;RPL14;RPL34;RPS19
prerank, Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136                                               , 0.1967722854122606  , 0.7482769945755297  , 0.6923076923076923  , 1.0               ,       1.0 , 3/20   , 5.80% , CDC16;ANAPC10;ANAPC5
prerank, Reactome_2022__TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594                                 , -0.2543625295955093 , -0.7482193833435768 , 0.7611940298507462  , 0.9652790217727405,       1.0 , 1/15   , 0.60% , TNFSF14
prerank, Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115                                                                                      , -0.2384819300255043 , -0.7481254264515617 , 0.8115942028985508  , 0.9644619800577418,       1.0 , 4/18   , 23.85%, PTPN11;PIK3R1;GRB2;PIK3CA
prerank, Reactome_2022__Base Excision Repair R-HSA-73884                                                                                             , -0.17852926377338074, -0.7468511686376107 , 0.8313253012048193  , 0.965072533945983 ,       1.0 , 23/68  , 31.29%, H2AX;H2AC19;SLC19A1;RPA3;OGG1;RFC5;H2AC7;PARP2;UNG;POLR1B;H2BC11;FEN1;TDG;NEIL3;POLD4;POT1;NEIL2;MUTYH;XRCC1;H2AC6;POLE3;POLD2;PNKP
prerank, Reactome_2022__Visual Phototransduction R-HSA-2187338                                                                                       , -0.19124216537863956, -0.7443897104690292 , 0.8533333333333334  , 0.9674733762672675,       1.0 , 8/49   , 12.82%, AKR1C3;DHRS9;BCO2;PLB1;LRP12;PRKCA;GNB5;CHURC1-FNTB
prerank, Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803                              , -0.2138825064823407 , -0.742612642712604  , 0.7662337662337663  , 0.9688775731178592,       1.0 , 2/20   , 5.25% , FASLG;GOLGA2
prerank, Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253                                                                                  , -0.20955215540841665, -0.7423601745163878 , 0.8133333333333334  , 0.9682863922599465,       1.0 , 8/27   , 23.85%, PIK3R1;POLR2G;POLR2B;GRB2;POLR2D;NCBP1;FGFR2;PIK3CA
prerank, Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941                                                              , -0.15999885910316008, -0.7421224846279608 , 0.8131868131868132  , 0.967696378590302 ,       1.0 , 14/75  , 18.41%, SAP30;GTF2H3;H2AX;H2AC19;POLR1D;H2AC7;POLR1B;H2BC11;SIRT1;TAF1B;H3-3B;SUDS3;SAP30L;CCNH
prerank, KEGG_2021_Human__Human T-cell leukemia virus 1 infection                                                                                    , -0.1523721078614634 , -0.7419727903398818 , 0.8936170212765957  , 0.9669785336870638,       1.0 , 37/200 , 19.91%, ADCY7;CREB3L4;CD3D;TGFB3;BAX;TP53;SPI1;IL2RG;MAP3K1;VAC14;CCNA1;CHEK1;MAPK1;PIK3R3;HLA-G;ITGAL;PIK3R1;CDC20;CDC26;DLG1;FOSL1;MAPK8;SMAD3;CD3G;RAN;MAP3K3;RB1;CREB3L2;CDKN2C;EGR1;TNFRSF1A;XPO1;KAT2B;PRKACB;AKT1;IL1R1;PPP3CC
prerank, KEGG_2021_Human__Phagosome                                                                                                                  , -0.1558681656398094 , -0.7418873895768267 , 0.9139784946236559  , 0.9661332353765377,       1.0 , 17/127 , 13.83%, ITGB3;ITGB5;PIKFYVE;ITGAV;ATP6V0A1;HLA-G;EEA1;CYBB;MARCO;VAMP3;TFRC;SEC61B;DYNC1LI1;STX12;MRC2;TCIRG1;STX7
prerank, Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033                                                                 , -0.19705121321307578, -0.7416142999085548 , 0.7837837837837838  , 0.9655041694416285,       1.0 , 7/37   , 17.92%, NUP85;NUP88;KPNA1;NUP107;NUP98;PSIP1;NUP153
prerank, Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665                                                 , -0.232680907087899  , -0.7411828291040444 , 0.7638888888888888  , 0.9651657231260193,       1.0 , 7/19   , 32.80%, DAG1;NAB2;SCD5;MPZ;UTRN;ADGRV1;GJB1
prerank, Reactome_2022__Signaling By PDGF R-HSA-186797                                                                                               , -0.18559783748039366, -0.740052105871564  , 0.8918918918918919  , 0.9656524071209251,       1.0 , 5/44   , 9.19% , COL6A3;PTPN11;CRK;PLAT;PIK3R1
prerank, Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900                                                                                       , -0.22956487945919768, -0.7392961664108388 , 0.7397260273972602  , 0.9655819004777492,       1.0 , 8/18   , 40.85%, MYH9;RHOC;DHDDS;RHOB;MYL12B;MYL9;PPP1CB;PPP1R12A
prerank, KEGG_2021_Human__NOD-like receptor signaling pathway                                                                                        , -0.15533882245872402, -0.7370296390715588 , 0.8924731182795699  , 0.967103797918868 ,       1.0 , 70/151 , 45.49%, PLCB2;TRPM7;CASP8;GBP2;TAB3;PLCB1;TYK2;MAPK1;DHX33;NAMPT;TICAM1;TRIP6;CYBB;ANTXR2;OAS2;TBK1;DEFA3;MEFV;MAPK8;NLRP6;TANK;GBP3;MAP3K7;ATG12;ERBIN;TNFAIP3;IRF9;NEK7;MAPK11;OAS1;IFI16;RNASEL;ATG16L1;TAB1;IRF7;IRAK4;RIPK2;TXN;CARD6;ATG5;DEFA4;HSP90AA1;GBP1;NLRP3;PLCB3;IKBKG;MFN1;MAPK10;MFN2;JUN;TRAF6;PSTPIP1;TRAF2;ITPR1;RELA;IL18;IRF3;XIAP;GABARAPL1;TNF;PYCARD;MAVS;IKBKE;NFKBIB;BIRC2;TXN2;BCL2L1;GBP5;TLR4;SHARPIN
prerank, KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells                                                                   , -0.16103472442497177, -0.7365367831114462 , 0.9176470588235294  , 0.96669037964717  ,       1.0 , 23/88  , 24.49%, KAT6A;OTX1;WNT10A;MAPK1;PIK3R3;FZD6;PIK3R1;HOXA1;MEIS1;SMAD3;ACVR1B;PCGF6;ACVR2B;ID3;GRB2;SMAD5;NANOG;AKT1;ACVR2A;FGFR2;MAPK11;PIK3CA;SETDB1
prerank, KEGG_2021_Human__Fat digestion and absorption                                                                                               , 0.19006485103508275 , 0.7363350539798478  , 0.88                , 1.0               ,       1.0 , 6/19   , 17.26%, SLC27A4;PLA2G2C;PLPP1;DGAT2;PLA2G12A;DGAT1
prerank, Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689                                                                         , 0.12088067619749018 , 0.7362496397845415  , 1.0                 , 1.0               ,       1.0 , 11/96  , 8.93% , RPS24;RPS29;RPL7A;RPL22L1;RPS15A;RPL32;RPS4X;RPS20;RPS4Y1;RPL27;EIF3M
prerank, KEGG_2021_Human__NF-kappa B signaling pathway                                                                                               , -0.16147333475707532, -0.7350239579125687 , 0.9080459770114943  , 0.967632280693017 ,       1.0 , 46/90  , 45.81%, TNFSF14;BCL2A1;IRAK1;TAB3;GADD45G;TIRAP;TICAM1;CSNK2A2;LY96;BCL10;TNFRSF1A;MAP3K7;TICAM2;TNFAIP3;IL1R1;CD14;GADD45A;BLNK;CCL4L2;TAB1;BTK;PTGS2;SYK;RELB;ERC1;IRAK4;IKBKG;PLCG2;CYLD;ICAM1;TRAF6;TRAF2;ATM;UBE2I;RELA;CD40LG;XIAP;MALT1;LYN;TNF;CFLAR;BIRC2;BCL2L1;LTB;TLR4;EDAR
prerank, Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408                                                                        , -0.18371195784701536, -0.7349698623275526 , 0.8266666666666667  , 0.9667503336435633,       1.0 , 13/60  , 18.18%, H2AX;TP53;H2AC19;TNRC6C;AGO3;H2AC7;NOTCH3;H2BC11;H3-3B;MAML2;AGO1;KAT2B;RBPJ
prerank, Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191                                                                                , -0.16432102968663717, -0.7348392820727145 , 0.872093023255814   , 0.9659126875643245,       1.0 , 27/92  , 29.07%, SAP30;GATAD2A;PHF21A;ZBP1;VEGFA;CHD4;TYK2;CUL3;TBK1;CHURC1-FNTB;RBBP7;ROCK2;ATP1B1;SUDS3;SAP30L;GRB2;IL1R1;FKBP4;ATP1A3;S1PR1;BLNK;RBBP4;FNTA;CD79B;BTK;SYK;KDM1A
prerank, Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466                                                                             , -0.17130459566513034, -0.732393257324566  , 0.8977272727272727  , 0.9678415729516576,       1.0 , 24/76  , 31.46%, HDAC3;TP53;GNA15;RGS6;CCT3;ARFGEF2;CSNK2A2;GNB5;GNGT2;CCT6B;GNG5;GNG11;NOP56;GNG3;FBXW4;TUBB6;FBXO4;FKBP9;CCT2;KIF13A;TUBA1C;CCT6A;FBXO6;FBXW7
prerank, Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427                                                                          , -0.23741793131476935, -0.7322282700836352 , 0.7083333333333334  , 0.9671001108163789,       1.0 , 4/15   , 19.10%, UBC;CLTC;UBB;RPS27A
prerank, Reactome_2022__Selenocysteine Synthesis R-HSA-2408557                                                                                       , 0.12928908892133403 , 0.7311995422435227  , 1.0                 , 1.0               ,       1.0 , 15/88  , 13.82%, RPS24;RPS29;RPL7A;RPL22L1;RPS15A;RPL32;RPS4X;RPS20;RPS4Y1;RPL27;RPS13;RPL14;SECISBP2;RPL34;RPS19
prerank, Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772                                                                                 , -0.16845137150111383, -0.7303446361208303 , 0.8313253012048193  , 0.9685252486749966,       1.0 , 11/57  , 18.41%, GTF2H3;H2AX;H2AC19;POLR1D;CBX3;H2AC7;POLR1B;H2BC11;TAF1B;H3-3B;CCNH
prerank, KEGG_2021_Human__Mineral absorption                                                                                                         , -0.17919327825484688, -0.7299779626276153 , 0.8823529411764706  , 0.968155675516671 ,       1.0 , 17/36  , 42.43%, TRPM7;SLC9A3;ATP1B1;CLCN2;HMOX2;ATP1A3;SLC11A2;VDR;HMOX1;FTL;ATP1A1;SLC8A1;TF;ATP7A;ATP2B1;MT1X;ATP1B2
prerank, KEGG_2021_Human__Small cell lung cancer                                                                                                     , -0.16368060926998146, -0.7281776392764758 , 0.8804347826086957  , 0.9692274525293436,       1.0 , 17/79  , 22.14%, BAX;CASP3;TP53;ITGAV;GADD45G;PIK3R3;CKS2;POLK;PIK3R1;RARB;RB1;DDB2;AKT1;LAMB2;ITGA2B;CDKN1A;GADD45A
prerank, Reactome_2022__Cell Junction Organization R-HSA-446728                                                                                      , -0.1767235228878212 , -0.7250179547649425 , 0.8837209302325582  , 0.9720009465292716,       1.0 , 14/54  , 27.59%, DST;PARVB;PARD6B;CADM1;CLDN9;NECTIN2;CLDN4;CDH15;CLDN5;CDH18;PVR;LIMS1;JUP;AFDN
prerank, Reactome_2022__Ion Homeostasis R-HSA-5578775                                                                                                , -0.20247054927499875, -0.7235752007638514 , 0.918918918918919   , 0.9727286001469417,       1.0 , 8/36   , 23.11%, ABCC9;ASPH;ATP2A3;PRKCA;CAMK2G;ATP1B1;ATP1A3;KCNJ11
prerank, Reactome_2022__Myogenesis R-HSA-525793                                                                                                      , -0.22767962989195695, -0.7233850924259455 , 0.8484848484848485  , 0.9720183996106624,       1.0 , 6/19   , 23.13%, MEF2D;BNIP2;MEF2C;CDC42;CDH15;MAPK11
prerank, Reactome_2022__Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877                                                                     , -0.21337933727112554, -0.7218499236069407 , 0.8823529411764706  , 0.9728079386966628,       1.0 , 4/27   , 8.41% , F5;F13A1;PF4V1;ZNF160
prerank, Reactome_2022__Influenza Infection R-HSA-168255                                                                                             , -0.1407843320650839 , -0.7214565828606467 , 0.9                 , 0.9723731182460997,       1.0 , 28/153 , 19.10%, NUP85;RPS3;RPL37A;NUP88;RPS8;RPL39;KPNA3;RPS14;RPL36AL;RPL38;KPNA1;RPL19;PBRM1;NUP107;RAN;POLR2G;CPSF4;RPL6;NUP98;RPS25;RPL15;HSPA1A;XPO1;POLR2B;NUP153;POLR2D;CLTC;RPS27A
prerank, Reactome_2022__Smooth Muscle Contraction R-HSA-445355                                                                                       , -0.19767371098743636, -0.7197748753416379 , 0.8354430379746836  , 0.9733292925019527,       1.0 , 7/34   , 15.20%, ITGB5;MYL11;ACTA2;SORBS1;MYL5;CACNA1H;ITGA1
prerank, Reactome_2022__GPCR Ligand Binding R-HSA-500792                                                                                             , -0.14320852682652033, -0.7182402389435418 , 0.9278350515463918  , 0.9742836208615587,       1.0 , 46/200 , 22.96%, GPER1;XCL1;CXCR6;WNT10A;AGXT;CXCR4;GNRH1;TAS2R5;PPAN-P2RY11;UTS2R;TSHR;CHRM3;FZD6;F2RL1;NTSR1;RLN2;C5;GNB5;GPR35;CALCRL;PTAFR;GNGT2;PPBP;ADORA2A;CRHBP;S1PR4;TAS2R60;CCL20;HCAR1;HCAR3;GNG5;LTB4R2;C3AR1;GNG11;CCL28;GNG3;UTS2B;MC1R;CXCR3;GPR65;S1PR1;S1PR5;SUCNR1;CXCR2;NMUR1;PTGIR
prerank, Reactome_2022__Cell-Cell Communication R-HSA-1500931                                                                                        , -0.16555382247573397, -0.7180635047942161 , 0.9090909090909091  , 0.9735648339290561,       1.0 , 39/83  , 44.32%, DST;MAGI2;PARVB;PTPN11;PARD6B;CADM1;PIK3R1;CLDN9;NECTIN2;GRB2;CLDN4;IQGAP1;CDH15;CLDN5;CDH18;PVR;PIK3CA;LIMS1;JUP;SPTBN1;AFDN;LIMS2;CD2AP;SRC;CASK;PIK3CB;NCK2;NECTIN3;SIRPB1;PTPN6;PLEC;PTK2B;SIRPG;F11R;FZR1;PRKCI;PARD6G;ANG;FYN
prerank, Reactome_2022__Signal Amplification R-HSA-392518                                                                                            , -0.20303074021326414, -0.7177196789197663 , 0.7894736842105263  , 0.9730574526524984,       1.0 , 12/28  , 33.18%, GNA15;GNAI3;GNB5;GNGT2;GNG5;GNG11;GNG3;GNAI1;SRC;PLA2G4A;GNB2;TBXA2R
prerank, Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232                                                                      , -0.14748002677600697, -0.716670542882814  , 0.9333333333333333  , 0.9731595219090212,       1.0 , 36/155 , 25.27%, PML;NUP85;NR3C2;TOP1;ZNF350;SMC5;NUP88;TP53;RANGAP1;THRA;AREG;NR2C1;NUP107;BRCA1;NCOR2;SP3;SMC1A;NR5A2;NUP98;NSMCE4A;NSMCE2;XPC;NUP153;NRIP1;MBD1;TDG;PPARG;RING1;XRCC4;DDX5;INCENP;POM121C;CBX4;RNF168;CREBBP;PMEPA1
prerank, Reactome_2022__mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958                                                                            , -0.22327942342224377, -0.7154916345258288 , 0.8472222222222222  , 0.9736282243205896,       1.0 , 5/16   , 27.16%, EXOSC6;NT5C3B;DCPS;EXOSC2;SKIC8
prerank, Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657                                                                , -0.22878626156716   , -0.7121193796916967 , 0.8026315789473685  , 0.976671836442389 ,       1.0 , 2/16   , 4.84% , FASLG;CITED2
prerank, Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282                                                            , -0.18198615104485488, -0.7112688751222809 , 0.7681159420289855  , 0.9766132322686681,       1.0 , 7/27   , 23.13%, MAPK1;DUSP6;RPS6KA3;MAPK8;MEF2C;DUSP7;MAPK11
prerank, Reactome_2022__mTORC1-mediated Signaling R-HSA-166208                                                                                       , 0.17459533483478654 , 0.7103185907793288  , 0.8095238095238095  , 1.0               ,       1.0 , 7/24   , 17.69%, AKT1S1;LAMTOR2;MTOR;RRAGA;LAMTOR1;LAMTOR5;LAMTOR3
prerank, Reactome_2022__Signaling By Insulin Receptor R-HSA-74752                                                                                    , -0.17153003085966217, -0.7102628258444592 , 0.9375              , 0.9769100640999879,       1.0 , 12/52  , 23.85%, PTPN11;PDPK1;ATP6V0A1;MAPK1;IRS1;PIK3R1;TCIRG1;GRB2;GAB2;ATP6V0A2;FGFR2;PIK3CA
prerank, Reactome_2022__Acyl Chain Remodelling Of PC R-HSA-1482788                                                                                   , -0.2427015361928752 , -0.7101949665818962 , 0.8412698412698413  , 0.9760056485448644,       1.0 , 3/15   , 10.54%, PLB1;MBOAT2;PLAAT3
prerank, Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572                                                                              , -0.19581194258337548, -0.7075477385878073 , 0.8860759493670886  , 0.9782008799386872,       1.0 , 17/27  , 47.69%, CHMP4B;CHMP6;RB1;UVRAG;DDX5;VCP;HAVCR1;CHMP2A;ZCRB1;HSPG2;GPC2;MAP1LC3B;ISCU;FURIN;CHMP7;BECN1;PIK3C3
prerank, Reactome_2022__RHOH GTPase Cycle R-HSA-9013407                                                                                              , -0.19353064961558597, -0.7071891964876921 , 0.8227848101265823  , 0.9776825263192545,       1.0 , 10/34  , 23.01%, VAMP3;TFRC;NIPSNAP2;OSBPL11;ROCK2;VANGL1;STOM;RALGAPA1;UACA;VCP
prerank, Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599                                                                            , -0.20391321189356038, -0.7061453566770224 , 0.8513513513513513  , 0.9777377551487283,       1.0 , 7/21   , 33.57%, MAPK1;CYBB;PRKCA;MAPK11;NCF2;NCF1;S100A9
prerank, KEGG_2021_Human__Cysteine and methionine metabolism                                                                                         , 0.13573864684896034 , 0.7030502971639327  , 0.9411764705882353  , 1.0               ,       1.0 , 9/40   , 18.87%, MDH1;MTAP;SDSL;LDHA;DNMT3A;GSS;GOT1;IL4I1;MPST
prerank, KEGG_2021_Human__Various types of N-glycan biosynthesis                                                                                     , -0.18902256697048947, -0.7023333381147568 , 0.8780487804878049  , 0.9808507240052338,       1.0 , 8/35   , 22.19%, B4GALT1;B4GALT3;ALG2;MAN1A1;HEXD;FUT8;MAN2A2;RPN1
prerank, Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884                                                                            , -0.18910698609314755, -0.7010972115873396 , 0.9090909090909091  , 0.9810690820456323,       1.0 , 12/39  , 25.16%, TP53;CEBPB;UBE2C;TNRC6C;CDC26;AGO3;LEF1;UBE2E1;AGO1;UBE2D1;MOV10;CSF1R
prerank, Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837                                                                                 , -0.18387976073031692, -0.7010811261943135 , 0.9113924050632911  , 0.9801451115625891,       1.0 , 14/41  , 28.97%, ATP10B;ATP2A3;ATP13A4;CAMK2G;ATP11A;ATP9B;ATP1B1;ATP13A1;ATP1A3;ATP8A2;ATP8B3;SRI;ATP13A2;ATP8B2
prerank, Reactome_2022__Mitochondrial tRNA Aminoacylation R-HSA-379726                                                                               , -0.21179278538021287, -0.699952376443444  , 0.8                 , 0.9806956021354057,       1.0 , 4/21   , 15.22%, PPA2;CARS2;MARS2;FARS2
prerank, KEGG_2021_Human__Protein processing in endoplasmic reticulum                                                                                , -0.14631217360980076, -0.6998117741186184 , 0.9680851063829787  , 0.9799498851631337,       1.0 , 45/159 , 28.07%, SEC23B;SEC24D;BAX;SEC24C;RNF185;AMFR;UFD1;EIF2S1;ERO1B;ATF6;LMAN2;SEC61B;CUL1;MAN1A1;MAPK8;UBE2J1;UBE2G1;DNAJC5;ERO1A;MARCHF6;MAP2K7;HSPA1A;UBE2J2;HSPH1;LMAN1;RRBP1;HERPUD1;EDEM2;CKAP4;SIL1;RPN1;VCP;SEC63;PDIA4;UBE2D1;HSPA2;MAP3K5;EIF2AK1;HSP90B1;PDIA3;UBE2D2;MAN1B1;HSPA5;UBQLN2;FBXO2
prerank, Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530                                                              , -0.1707559759550878 , -0.699697513144347  , 0.9113924050632911  , 0.9791227729725734,       1.0 , 12/52  , 23.85%, PTPN11;PIK3R3;IRS1;PIK3R1;AREG;STRN;ERBB3;TGFA;GRB2;GAB2;FGFR2;PIK3CA
prerank, Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275                                                                     , -0.1598937083465762 , -0.6995955916251569 , 0.975609756097561   , 0.9783489383898237,       1.0 , 38/62  , 48.64%, SGPP2;F5;KTN1;QSOX1;CSF1;DMTF1;C4A;MXRA8;CKAP4;CALU;ADAM10;HSP90B1;APLP2;ANO8;FSTL1;SERPINA1;APP;APOE;P4HB;FAM20A;SHISA5;LMNB2;FAM20C;PROC;RCN1;TF;MIA3;MELTF;TGOLN2;PDIA6;MEN1;LGALS1;VCAN;C3;CXXC1;PRSS23;MBTPS1;PNPLA2
prerank, Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565                                                                                  , -0.21673055123582216, -0.6992520575832958 , 0.863013698630137   , 0.9778038709311235,       1.0 , 9/19   , 39.87%, PIK3R1;ERBB3;GRB2;ERBIN;PIK3CA;HSP90AA1;HBEGF;EREG;NRG1
prerank, Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829                                                                                   , -0.20994547149930698, -0.6979564453024176 , 0.8732394366197183  , 0.9782507516926373,       1.0 , 6/18   , 26.95%, UBC;EEF1A1;UBB;RPS27A;PLIN3;HDAC6
prerank, Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571                                                                                 , -0.1938249224604619 , -0.6974180450298915 , 0.8333333333333334  , 0.9776964961987096,       1.0 , 9/30   , 25.72%, MRPL18;CAMK2G;HSPA1A;HSPH1;UBB;FKBP4;HSPA2;CREBBP;TNFRSF21
prerank, Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668                                                         , -0.18816773603097947, -0.6954713495246451 , 0.8481012658227848  , 0.9785135246991837,       1.0 , 11/35  , 27.44%, TRIM13;UBC;RNF185;AMFR;MARCHF6;UBB;RPS27A;EDEM2;VCP;PDIA3;MAN1B1
prerank, KEGG_2021_Human__Aminoacyl-tRNA biosynthesis                                                                                                , -0.17962733264374156, -0.694947304959733  , 0.9027777777777778  , 0.9781453382187467,       1.0 , 11/44  , 25.55%, MTFMT;CARS2;PSTK;GATB;MARS2;FARS2;TARS3;AARS1;WARS2;VARS1;IARS2
prerank, Reactome_2022__Netrin-1 Signaling R-HSA-373752                                                                                              , -0.19588949743680104, -0.6937082338454024 , 0.8289473684210527  , 0.9784668134250368,       1.0 , 4/30   , 7.61% , PTPN11;TRPC6;SIAH1;ABLIM2
prerank, Reactome_2022__SUMOylation R-HSA-2990846                                                                                                    , -0.14121835273932512, -0.6935260651972146 , 0.967391304347826   , 0.9777295226935384,       1.0 , 37/161 , 25.27%, PML;NUP85;NR3C2;TOP1;ZNF350;SMC5;NUP88;TP53;RANGAP1;THRA;AREG;NR2C1;NUP107;BRCA1;NCOR2;SP3;SMC1A;NR5A2;NUP98;NSMCE4A;NSMCE2;XPC;NUP153;NRIP1;MBD1;TDG;PPARG;RING1;XRCC4;DDX5;INCENP;SAE1;POM121C;CBX4;RNF168;CREBBP;PMEPA1
prerank, Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782                                                          , -0.20600834838349177, -0.6912452971277342 , 0.8493150684931506  , 0.9791490024893716,       1.0 , 6/21   , 28.11%, B4GALT1;CHSY1;EXT1;B4GALT7;DCN;CHST14
prerank, "Reactome_2022__Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207"                                             , 0.18599272458295926 , 0.6903702695799105  , 0.9629629629629629  , 1.0               ,       1.0 , 1/20   , 0.13% , TAS2R50
prerank, Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413                                                                       , -0.15323426857728978, -0.6898990469083737 , 0.9195402298850575  , 0.9797147238918212,       1.0 , 13/72  , 18.41%, SAP30;GTF2H3;H2AX;H2AC19;POLR1D;H2AC7;POLR1B;H2BC11;TAF1B;H3-3B;SUDS3;SAP30L;CCNH
prerank, Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897                                                                                 , -0.1558982941996216 , -0.6898612892067486 , 0.9080459770114943  , 0.978855405964387 ,       1.0 , 18/78  , 25.06%, COX6C;REXO2;COX5A;TP53;PRKAG2;YWHAB;TNRC6C;RRAGD;AGO3;SESN3;SESN1;AGO1;AKT1;GSR;PRKAG1;RRAGB;MOV10;RRM2B
prerank, Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231                                                                                 , -0.17337865872492736, -0.6896926831450838 , 0.9                 , 0.9780591106519355,       1.0 , 17/47  , 31.68%, UBC;CUL1;RB1;CDKN2D;CDKN2C;CCNH;UBB;RPS27A;MNAT1;CDKN1A;PPP2R2A;PTK6;PPP2CA;CDKN1C;CKS1B;SRC;RBL2
prerank, Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828                                                                , 0.19657693565304923 , 0.6893592456793949  , 0.9333333333333333  , 1.0               ,       1.0 , 4/15   , 14.94%, SMAD2;BTG1;PCBP4;FOXO3
prerank, KEGG_2021_Human__Lysine degradation                                                                                                         , -0.16175921516014394, -0.6887298796167074 , 0.8809523809523809  , 0.978184578310546 ,       1.0 , 22/58  , 33.28%, KMT2D;ALDH9A1;ASH1L;PIPOX;ALDH1B1;ACAT1;DOT1L;KMT2B;PLOD1;GCDH;ECHS1;KMT5B;SETDB1;PHYKPL;SETDB2;KMT2E;COLGALT2;EHMT1;SMYD3;AASS;SUV39H1;KMT5C
prerank, Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956                                        , 0.12446066843935281 , 0.6884405933418517  , 0.9166666666666666  , 1.0               ,       1.0 , 15/90  , 13.82%, RPS24;RPS29;RPL7A;RPL22L1;RPS15A;RPL32;RPS4X;RPS20;RPS4Y1;RPL27;GSPT2;RPS13;RPL14;RPL34;RPS19
prerank, Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957                                           , -0.14104380307833336, -0.6796335398249073 , 0.9512195121951219  , 0.9854811814982967,       1.0 , 64/110 , 50.54%, MAGOH;RPS3;RPL37A;RPS8;UPF1;RPL39;RPS14;RPL36AL;RPL38;RPL19;RPL6;RPS25;SMG1;EIF4A3;RPL15;PNRC2;RPS27A;RPS6;NCBP1;PPP2R2A;SMG6;RPS11;PPP2CA;MAGOHB;RPSA;SMG7;UPF3B;RPS9;DCP1A;RPL28;RPS15;RPL27A;RPL18A;RPS16;RPL9;RPL21;RPL3L;ETF1;RPL26;RPL13A;RPL10A;RPS2;UPF3A;CASC3;RPL37;PABPC1;RPL11;RPS27L;RPL3;RPL18;RPLP2;MRPL13;RPLP1;RPL12;RPS17;RPL29;RPS3A;RPL31;NCBP2;RPL36A;RPL35A;RPL22;RSL24D1;RPS27
prerank, Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510                                                                      , -0.20377800125723697, -0.6764825303725653 , 0.8769230769230769  , 0.9874977923366749,       1.0 , 4/21   , 14.25%, PRIM2;ORC3;SLC25A15;RB1
prerank, Reactome_2022__Formation Of Cornified Envelope R-HSA-6809371                                                                                , -0.208228813022636  , -0.6750923441869703 , 0.890625            , 0.9878791878357411,       1.0 , 1/19   , 0.20% , TGM1
prerank, Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927                                                                                  , -0.16340222242000063, -0.6731994843119936 , 0.918918918918919   , 0.9885552930354244,       1.0 , 17/38  , 42.23%, IL2RG;PIK3R3;PIK3R1;IL3RA;GRB2;HAVCR2;GAB2;PIK3CA;IL21R;SYK;CSF2RA;PIK3CB;PTPN6;PTK2B;IL15RA;SOS2;JAK3
prerank, Reactome_2022__Glyoxylate Metabolism And Glycine Degradation R-HSA-389661                                                                   , -0.186226236232769  , -0.6715013764616514 , 0.8461538461538461  , 0.9891385383993917,       1.0 , 4/26   , 11.52%, AGXT;LIAS;PDHB;BCKDHA
prerank, Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686                                                                             , 0.17041853349360736 , 0.6684746355367546  , 1.0                 , 1.0               ,       1.0 , 16/16  , 82.97%, NRG4;ERBB2;NRAS;CDC37;EGF;PLCG1;HRAS;SOS1;SHC1;NRG1;EREG;HBEGF;HSP90AA1;ERBIN;GRB2;ERBB3
prerank, KEGG_2021_Human__Gap junction                                                                                                               , -0.1514756802135659 , -0.6684035635525242 , 0.9634146341463414  , 0.9906663177842077,       1.0 , 7/61   , 11.13%, ADCY7;CSNK1D;PLCB2;PLCB1;MAPK1;GNAI3;PRKCA
prerank, KEGG_2021_Human__Choline metabolism in cancer                                                                                               , -0.14387985480876875, -0.6682224608444091 , 0.9375              , 0.9899462200947592,       1.0 , 16/85  , 19.46%, SLC44A4;PDPK1;MAPK1;DGKG;PIK3R3;PIK3R1;WAS;PRKCA;HIF1A;MAPK8;RPS6KB1;DGKA;PLD2;GRB2;PDGFC;AKT1
prerank, KEGG_2021_Human__Toxoplasmosis                                                                                                              , -0.1428972670207747 , -0.6634652493671171 , 0.9767441860465116  , 0.9930638025624727,       1.0 , 15/102 , 16.81%, TGFB3;CASP3;IRAK1;CASP8;PDPK1;PPIF;TYK2;MAPK1;GNAI3;IL10;LY96;MAPK8;TNFRSF1A;MAP3K7;HSPA1A
prerank, Reactome_2022__mRNA Capping R-HSA-72086                                                                                                     , -0.17768263587464367, -0.662588984190078  , 0.9                 , 0.9929106322239243,       1.0 , 7/29   , 20.75%, GTF2H3;POLR2G;POLR2B;CCNH;POLR2D;NCBP1;MNAT1
prerank, Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695                                        , 0.14899165662766778 , 0.6576372783376727  , 0.9565217391304348  , 1.0               ,       1.0 , 4/31   , 9.60% , STIM1;IGLL5;CD79A;ITPR3
prerank, Reactome_2022__Processive Synthesis On C-strand Of Telomere R-HSA-174414                                                                    , -0.20517135852235616, -0.6572446188001414 , 0.8450704225352113  , 0.9964147419612447,       1.0 , 6/19   , 30.66%, RPA3;POLR1B;FEN1;POLD4;POT1;POLD2
prerank, Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528                                                                                   , 0.12088705642336521 , 0.6567764266241882  , 0.9375              , 1.0               ,       1.0 , 16/78  , 16.42%, FLT3LG;BAD;AKT1S1;ICOS;RPS6KB2;NRG4;CREB1;MTOR;NR4A1;GSK3B;KIT;FOXO3;AKT3;CD86;FGFR1;ERBB2
prerank, Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219                                                                 , 0.13690164252681394 , 0.655879888827642   , 0.9166666666666666  , 1.0               ,       1.0 , 5/55   , 6.19% , GFPT1;GMDS;ALG5;ST3GAL4;NAGK
prerank, Reactome_2022__Insulin Processing R-HSA-264876                                                                                              , -0.20121037945583953, -0.6558017575516636 , 0.9066666666666666  , 0.9966838172540713,       1.0 , 7/20   , 31.04%, ERO1B;SLC30A7;ERO1A;KIF5A;EXOC6;SLC30A5;STX1A
prerank, KEGG_2021_Human__Natural killer cell mediated cytotoxicity                                                                                  , -0.14719255866769634, -0.6555009494452199 , 0.9438202247191011  , 0.9960120343728128,       1.0 , 10/94  , 11.13%, FCER1G;PTPN11;CASP3;FASLG;MAPK1;PIK3R3;HLA-G;ITGAL;PIK3R1;PRKCA
prerank, Reactome_2022__Apoptotic Execution Phase R-HSA-75153                                                                                        , -0.17024711007732926, -0.6552999730205094 , 0.9620253164556962  , 0.9952101704838701,       1.0 , 9/46   , 16.75%, H1-3;CASP3;CASP8;KPNA1;BMX;STK26;HMGB2;GAS2;CASP7
prerank, Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575                                                                                      , 0.16046402035987783 , 0.6500192348167297  , 0.8518518518518519  , 1.0               ,       1.0 , 2/18   , 6.95% , PKN2;NFKB1
prerank, Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662                                                                                   , -0.17665402343805067, -0.6494974569038993 , 0.9027777777777778  , 0.9987193581586826,       1.0 , 2/32   , 3.74% , SMPD3;GM2A
prerank, Reactome_2022__Peptide Chain Elongation R-HSA-156902                                                                                        , -0.1385046421579623 , -0.6494433871104893 , 0.9655172413793104  , 0.9978358067629772,       1.0 , 13/84  , 16.68%, RPS3;RPL37A;EEF1A1;RPS8;RPL39;EEF2;RPS14;RPL36AL;RPL38;RPL19;RPL6;RPS25;RPL15
prerank, Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787                                    , 0.16744480179688795 , 0.6489071617041857  , 0.9523809523809523  , 1.0               ,       1.0 , 5/17   , 20.01%, CCND2;E2F3;E2F1;CCND3;CDK6
prerank, KEGG_2021_Human__Th17 cell differentiation                                                                                                  , -0.13751047216154505, -0.6479698695855319 , 0.9425287356321839  , 0.9979512151759329,       1.0 , 12/98  , 13.03%, NFKBIE;CD3D;IL2RG;FOXP3;TYK2;MAPK1;IL12RB1;IL4;HIF1A;MAPK8;SMAD3;CD3G
prerank, Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231                                           , -0.14413650257398108, -0.6447895961768405 , 0.9767441860465116  , 0.9991936573528841,       1.0 , 34/110 , 31.98%, PHF21A;HBG2;TP53;KIF21A;KIF22;JMJD1C;CAPZA2;KIF23;KIF18A;PRKCA;AKAP1;CAPZB;KIF3C;HBG1;PRKAR2A;DOCK9;H3-3B;CDC42;PRKACB;KIF5A;ZFPM1;VPS45;EHD3;RAB5A;PRKAR1A;KIF20B;KDM1A;SH2B1;KIF13B;KIF20A;ZFPM2;KIF2C;HBE1;EHD2
prerank, Reactome_2022__Mitochondrial Protein Import R-HSA-1268020                                                                                   , -0.15306896353671262, -0.6436964094775137 , 0.9438202247191011  , 0.9991467134918355,       1.0 , 14/64  , 22.76%, CHCHD7;MTX1;GRPEL1;COA6;CMC2;PMPCA;TIMM10B;IDH3G;CMC4;TOMM40;LDHD;CHCHD3;SLC25A12;FXN
prerank, Reactome_2022__Glycolysis R-HSA-70171                                                                                                       , -0.14573469140931777, -0.6422521149916852 , 0.9382716049382716  , 0.999210363834543 ,       1.0 , 11/62  , 18.90%, NUP85;NUP88;LOC112694756;PRKCA;NUP107;NUP98;PFKP;NUP153;TPI1;PRKACB;PGM2L1
prerank, Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260                                     , -0.17676478813921132, -0.6407989017918738 , 0.8780487804878049  , 0.9991534541414409,       1.0 , 7/27   , 25.22%, VEGFA;CITED2;ATAD2;WWOX;TGFA;CDKN1A;CREBBP
prerank, Reactome_2022__RNA Polymerase III Transcription Termination R-HSA-73980                                                                     , -0.18505388104267784, -0.6400730550041588 , 0.8888888888888888  , 0.9986353764412298,       1.0 , 10/20  , 40.40%, POLR3B;POLR1D;POLR3K;SSB;POLR3C;POLR2E;NFIA;POLR2L;POLR3H;POLR3D
prerank, Reactome_2022__RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061                                                 , 0.1540326684992042  , 0.6398472002805197  , 0.8095238095238095  , 1.0               ,       1.0 , 4/27   , 9.80% , GTF3A;POLR2F;POLR3G;CRCP
prerank, Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956                                                                       , -0.180131737883039  , -0.6393808723604625 , 0.8974358974358975  , 0.998158324894329 ,       1.0 , 14/25  , 45.49%, TAB3;TANK;TNFRSF1A;MAP3K7;TNFAIP3;TAB1;USP25;IKBKG;CYLD;XIAP;TNF;BIRC2;USP4;SHARPIN
prerank, "Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017"                                , -0.19399234567973825, -0.6384752280890081 , 0.88                , 0.9979123622589533,       1.0 , 10/19  , 39.75%, ABCA6;FBXO32;SMAD3;FOXO1;POMC;RETN;NR3C1;FOXO4;ATXN3;PLXNA4
prerank, Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517                                                     , -0.12998800292515866, -0.6341592907190721 , 0.978021978021978   , 1.0               ,       1.0 , 15/153 , 10.48%, NDUFB3;ECSIT;COQ10A;ATP5PB;COX6C;PDPK1;COX5A;UQCRC1;UQCRFS1;PDK4;NDUFB2;NDUFA7;UQCRB;PDHB;BSG
prerank, Reactome_2022__Glucose Metabolism R-HSA-70326                                                                                               , -0.13694810983863093, -0.6319676547526218 , 0.9634146341463414  , 1.0               ,       1.0 , 13/78  , 18.90%, NUP85;SLC37A2;NUP88;LOC112694756;PCK2;PRKCA;NUP107;NUP98;PFKP;NUP153;TPI1;PRKACB;PGM2L1
prerank, Reactome_2022__Cleavage Of Damaged Purine R-HSA-110331                                                                                      , -0.1670216371814848 , -0.6288431590704379 , 0.9166666666666666  , 1.0               ,       1.0 , 5/34   , 14.10%, H2AX;H2AC19;OGG1;H2AC7;H2BC11
prerank, Reactome_2022__Polo-like Kinase Mediated Events R-HSA-156711                                                                                , -0.21306085464885596, -0.6280245783756944 , 0.9210526315789473  , 1.0               ,       1.0 , 11/16  , 51.00%, LIN9;FOXM1;CDC25C;RBBP4;LIN54;EP300;LIN52;MYBL2;CENPF;PLK1;CCNB2
prerank, Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227                                                                       , -0.16315399704115768, -0.6274729120674069 , 0.9230769230769231  , 1.0               ,       1.0 , 7/34   , 23.21%, NUP85;NUP88;NUP107;NUP98;NUP153;NCBP1;POM121C
prerank, Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977                                                                           , -0.17360521457191025, -0.6273426616307866 , 0.8928571428571429  , 1.0               ,       1.0 , 4/25   , 12.60%, ATP6V0A1;TFR2;TFRC;TCIRG1
prerank, Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332                                                    , -0.18502932719860465, -0.6273002629592752 , 0.935064935064935   , 0.9997437265068404,       1.0 , 15/28  , 44.93%, TTLL4;TTLL7;VASH1;TTLL11;TUBB6;TUBA1C;AGBL2;TTL;LRRC49;NICN1;TUBA1A;AGBL5;AGTPBP1;TUBB4B;TPGS2
prerank, KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection                                                                 , -0.14486172537298228, -0.6247955156803313 , 0.9425287356321839  , 1.0               ,       1.0 , 27/60  , 43.05%, PTPN11;CASP3;ATP6V0A1;TCIRG1;MAPK8;CDC42;PAK1;CXCR2;ATP6V0A2;ADAM10;MAPK11;ATP6V0D1;SRC;CXCR1;HBEGF;IKBKG;GIT1;MAPK10;PLCG2;JUN;ATP6V1D;ATP6V1F;RELA;F11R;LYN;ATP6V1G1;ATP6V1A
prerank, Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377                                                                            , -0.16321985084072396, -0.6243573113425357 , 0.9166666666666666  , 0.9999974862433604,       1.0 , 2/34   , 3.35% , NUP85;NUP88
prerank, KEGG_2021_Human__Prolactin signaling pathway                                                                                                , 0.11959357658494496 , 0.6240908675986202  , 1.0                 , 1.0               ,       1.0 , 13/54  , 16.24%, CCND2;PRLR;NFKB1;MAPK9;MAPK14;GSK3B;MAPK12;FOXO3;STAT5B;KRAS;AKT3;GALT;STAT3
prerank, Reactome_2022__Downstream Signal Transduction R-HSA-186763                                                                                  , -0.17866592497737582, -0.6235204399808336 , 0.8533333333333334  , 0.9996231518991134,       1.0 , 3/26   , 9.19% , PTPN11;CRK;PIK3R1
prerank, Reactome_2022__Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554                               , -0.18498645214201034, -0.6215450782952158 , 0.9428571428571428  , 0.9998935934948285,       1.0 , 10/26  , 33.80%, RAD50;RAD51AP1;BRCA1;PALB2;RMI1;XRCC3;RAD51D;TOP3A;SEM1;RAD51B
prerank, Reactome_2022__Cleavage Of Damaged Pyrimidine R-HSA-110329                                                                                  , -0.1640779651311452 , -0.6187280749912808 , 0.9487179487179487  , 1.0               ,       1.0 , 8/39   , 20.17%, H2AX;H2AC19;OGG1;H2AC7;UNG;H2BC11;TDG;NEIL3
prerank, KEGG_2021_Human__JAK-STAT signaling pathway                                                                                                 , -0.12489341288172345, -0.6152626770862769 , 0.978021978021978   , 1.0               ,       1.0 , 24/108 , 24.13%, PTPN11;IL2RG;MPL;SOCS3;TYK2;PIK3R3;PIK3R1;IL12RB1;IL10;IL3RA;IL4;CISH;CNTF;LEPR;STAM2;IL24;GRB2;IL23R;AKT1;IRF9;CDKN1A;IL10RA;PIK3CA;IL21R
prerank, Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299                                                                            , -0.19352594137997634, -0.6143888954827058 , 0.9                 , 1.0               ,       1.0 , 5/17   , 28.61%, PPP2R5E;PPP2R5B;FRAT1;PPP2CA;AMER1
prerank, Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426                                                                , -0.140015289585942  , -0.614346880402449  , 0.9761904761904762  , 1.0               ,       1.0 , 41/71  , 48.64%, SGPP2;F5;KLK2;KTN1;QSOX1;CSF1;DMTF1;KLK1;C4A;MXRA8;CKAP4;CALU;ADAM10;HSP90B1;APLP2;ANO8;FSTL1;SERPINA1;APP;APOE;P4HB;FAM20A;SHISA5;LMNB2;FAM20C;PROC;RCN1;TF;MIA3;MELTF;TGOLN2;GZMH;PDIA6;MEN1;LGALS1;VCAN;C3;CXXC1;PRSS23;MBTPS1;PNPLA2
prerank, Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464                                                                            , -0.1526813891281486 , -0.6112915226074446 , 0.9583333333333334  , 1.0               ,       1.0 , 17/44  , 37.35%, NUP85;NUP88;NUP107;NUP98;NUP153;RING1;POM121C;CBX4;RNF2;CBX8;AAAS;NUP188;COMMD3-BMI1;SCMH1;HNRNPK;POM121;PHC3
prerank, Reactome_2022__RNA Polymerase III Transcription Initiation R-HSA-76046                                                                      , 0.13469608793713933 , 0.6104733920092129  , 1.0                 , 1.0               ,       1.0 , 5/35   , 9.80% , GTF3A;POLR2F;POU2F1;POLR3G;CRCP
prerank, Reactome_2022__Endogenous Sterols R-HSA-211976                                                                                              , -0.1982659904110542 , -0.6075419132669087 , 0.875               , 1.0               ,       1.0 , 10/15  , 52.14%, FDX1;CYP1B1;POMC;NCOA1;AHR;MIA3;NCOA2;FDX2;ARNT2;FDXR
prerank, Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519                                                                             , -0.130528297076822  , -0.6075277750732092 , 0.9565217391304348  , 1.0               ,       1.0 , 34/110 , 30.70%, H2AX;H2AC19;CARM1;TNRC6C;AGO3;H2AC7;SMC1A;POLR2G;NR5A2;H2BC11;H3-3B;TGFA;AGO1;POLR2B;KAT2B;POLR2D;NRIP1;DAND5;FKBP4;NCOA3;CHD1;DDX5;CXXC5;MOV10;CREBBP;PMEPA1;KANK1;GTF2A2;CTSD;ZNF217;KDM1A;H2AC6;AGO2;NCOA1
prerank, Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230                                                                         , -0.154657259691869  , -0.6041201339806707 , 0.9487179487179487  , 1.0               ,       1.0 , 7/35   , 23.21%, NUP85;NUP88;NUP107;NUP98;NUP153;NCBP1;POM121C
prerank, KEGG_2021_Human__Primary immunodeficiency                                                                                                   , -0.16483690295739872, -0.6015724275497033 , 0.9342105263157895  , 1.0               ,       1.0 , 5/32   , 13.64%, CD3D;IL2RG;RFXAP;DCLRE1C;UNG
prerank, Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193                                       , -0.13722733905450382, -0.6012547241184305 , 0.975               , 1.0               ,       1.0 , 21/69  , 30.93%, ST6GALNAC4;ST6GALNAC1;ALG2;PMM2;NUS1;ALG6;ST6GALNAC6;GMPPB;SLC35A1;SLPI;MPDU1;NUDT14;DHDDS;DOLPP1;SLC17A5;NPL;RFT1;ST8SIA6;NANP;GNE;RENBP
prerank, Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924                                                            , -0.1439016123244603 , -0.6006287479716186 , 0.9259259259259259  , 1.0               ,       1.0 , 10/56  , 17.74%, H2AX;H2AC19;POLR1D;H2AC7;POLR1B;H2BC11;SF3B1;TAF1B;H3-3B;KAT2B
prerank, KEGG_2021_Human__N-Glycan biosynthesis                                                                                                      , -0.14681142462611915, -0.599311566589637  , 0.9761904761904762  , 1.0               ,       1.0 , 10/45  , 23.26%, B4GALT1;B4GALT3;ALG2;MAN1A1;MGAT5;ALG6;FUT8;MAN2A2;RPN1;DOLPP1
prerank, KEGG_2021_Human__Protein digestion and absorption                                                                                           , -0.15499821009627007, -0.599222731146215  , 0.95                , 1.0               ,       1.0 , 10/49  , 20.59%, COL6A3;CTRL;COL28A1;SLC9A3;KCNE3;COL9A1;SLC3A1;ATP1B1;COL8A1;ATP1A3
prerank, Reactome_2022__RNA Polymerase III Chain Elongation R-HSA-73780                                                                              , -0.17940769810539092, -0.5987856396098545 , 0.8787878787878788  , 0.9998421441452823,       1.0 , 3/17   , 13.10%, POLR3B;POLR1D;POLR3K
prerank, Reactome_2022__Meiosis R-HSA-1500620                                                                                                        , -0.13433786678240167, -0.5979661634598391 , 0.9534883720930233  , 0.9994537690314438,       1.0 , 28/74  , 40.59%, RAD50;H2AX;H2AC19;RPA3;H2AC7;BRCA1;SMC1A;POLR1B;H2BC11;H3-3B;MLH3;SYCP2;HSPA2;PMEPA1;PSMC3IP;POT1;H2AC6;MLH1;TOP3A;MND1;SYNE1;SUN1;SYNE2;ATM;H2AC4;TERF1;UBE2I;CDK2
prerank, Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434                                                                  , -0.14001860548051304, -0.5971460929840342 , 0.948051948051948   , 0.9989684190087568,       1.0 , 23/70  , 32.61%, COPZ1;KIF21A;KIF22;NAPSA;KIF23;KIF18A;KIF3C;KDELR2;KDELR1;COPE;KIF5A;UBE2Z;TMED9;RAB1B;SEC22B;KIF20B;COPB1;KIF13B;KIF20A;KIF2C;RINT1;COPZ2;ARFGAP1
prerank, Reactome_2022__Class I Peroxisomal Membrane Protein Import R-HSA-9603798                                                                    , -0.17729161593292797, -0.5955603610791299 , 0.9324324324324325  , 0.9988937886313318,       1.0 , 3/20   , 14.37%, PEX2;SLC25A17;PEX26
prerank, Reactome_2022__Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837                                                                      , 0.17138564373790782 , 0.595177669632194   , 0.9142857142857143  , 1.0               ,       1.0 , 1/16   , 1.15% , PRCP
prerank, Reactome_2022__RHOG GTPase Cycle R-HSA-9013408                                                                                              , -0.14089164373126037, -0.5945937017720635 , 0.975               , 0.9984585558310927,       1.0 , 16/65  , 25.14%, ARHGAP35;ARHGAP5;KTN1;PIK3R1;VAMP3;TFRC;VANGL1;TMPO;CDC42;LMAN1;ERBIN;ANKLE2;MAP3K11;EMD;YKT6;DSG2
prerank, Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990                                                                                   , -0.17970574684195878, -0.5933790659624786 , 0.9726027397260274  , 0.9982286599722806,       1.0 , 9/20   , 39.87%, PIK3R1;ERBB3;GRB2;ERBIN;PIK3CA;HSP90AA1;HBEGF;EREG;NRG1
prerank, Reactome_2022__Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192                                , -0.1769560091312542 , -0.5930005565207023 , 0.9577464788732394  , 0.9975417607864627,       1.0 , 9/24   , 33.80%, RAD50;RAD51AP1;BRCA1;PALB2;RMI1;RAD51D;TOP3A;SEM1;RAD51B
prerank, Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099                                                                                   , -0.14405791184879002, -0.591165537249299  , 0.9518072289156626  , 0.9975464575977395,       1.0 , 11/45  , 23.85%, FGFR1OP2;PIK3R1;POLR2G;POLR2B;GRB2;POLR2D;TRIM24;NCBP1;GAB2;FGFR2;PIK3CA
prerank, Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485                                                                          , -0.16703599871910468, -0.5906293683035075 , 0.9466666666666667  , 0.9968031016843318,       1.0 , 4/24   , 16.19%, PLPP5;PIK3R1;PLD3;PLD2
prerank, KEGG_2021_Human__Synaptic vesicle cycle                                                                                                     , -0.14580550261732061, -0.5887331114615543 , 0.926829268292683   , 0.996856978940605 ,       1.0 , 25/50  , 43.82%, SNAP25;SLC6A13;ATP6V0A1;TCIRG1;STXBP1;SLC1A2;CLTC;SLC6A12;ATP6V0A2;RAB3A;DNM2;ATP6V0D1;STX1A;NAPA;NSF;AP2S1;ATP6V1D;ATP6V1F;SLC6A4;CACNA1A;CLTA;AP2M1;ATP6V1G1;ATP6V1A;CLTB
prerank, "Reactome_2022__Base-Excision Repair, AP Site Formation R-HSA-73929"                                                                        , -0.15463452922961463, -0.5877737249994499 , 0.9625              , 0.996367696102457 ,       1.0 , 12/41  , 29.99%, H2AX;H2AC19;OGG1;H2AC7;UNG;H2BC11;TDG;NEIL3;POT1;NEIL2;MUTYH;H2AC6
prerank, "Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643"                              , -0.140535735236421  , -0.5847992740681321 , 0.9642857142857143  , 0.9968191117764471,       1.0 , 23/52  , 44.76%, IRAK1;CASP8;TAB3;ITCH;MEFV;UBE2N;MAP3K7;TNFAIP3;MAPK11;TAB1;HMOX1;APP;RIPK2;NLRP3;IKBKG;CYLD;TRAF6;PSTPIP1;RELA;PYCARD;BIRC2;TXN2;BCL2L1
prerank, Reactome_2022__Cytochrome P450 - Arranged By Substrate Type R-HSA-211897                                                                    , -0.16191325515184066, -0.5834332722896283 , 0.971830985915493   , 0.9965146582944235,       1.0 , 17/29  , 52.14%, CYP4F3;CYP2C9;CYP2U1;FDX1;CYP1B1;POMC;NCOA1;CYP4F2;AHR;CYP2R1;MIA3;CYP4B1;NCOA2;FDX2;CYP2S1;ARNT2;FDXR
prerank, Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476                                                           , 0.11904357491396256 , 0.5828628259495727  , 0.9130434782608695  , 1.0               ,       1.0 , 5/38   , 9.80% , GTF3A;POLR2F;POU2F1;POLR3G;CRCP
prerank, Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465                                                                         , -0.16307559681499564, -0.5822678013296619 , 1.0                 , 0.9961236992518955,       1.0 , 6/33   , 16.75%, CASP3;CASP8;BMX;STK26;GAS2;CASP7
prerank, Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075                                                           , -0.1564478090073465 , -0.5784356946633863 , 0.9402985074626866  , 0.9968253735215739,       1.0 , 6/27   , 20.75%, GTF2H3;POLR2G;POLR2B;CCNH;POLR2D;MNAT1
prerank, Reactome_2022__Signaling To ERKs R-HSA-187687                                                                                               , -0.1556487138011095 , -0.577851845237013  , 0.958904109589041   , 0.9962031207735105,       1.0 , 7/29   , 24.28%, CRK;MAPK1;YWHAB;KIDINS220;GRB2;MAPK11;RAP1A
prerank, Reactome_2022__MTOR Signaling R-HSA-165159                                                                                                  , -0.14573548603811437, -0.5770737898172886 , 0.9404761904761905  , 0.9955916154416831,       1.0 , 20/39  , 45.56%, PRKAG2;YWHAB;RRAGD;RPS6KB1;CAB39;AKT1;RPS6;PRKAG1;RRAGB;AKT2;TSC2;EIF4E;EEF2K;EIF4B;SLC38A9;FKBP1A;PRKAA1;RRAGC;RPTOR;PPM1A
prerank, Reactome_2022__RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071                                                 , -0.1605312788970238 , -0.5765121116784651 , 0.9459459459459459  , 0.9950004665734844,       1.0 , 4/27   , 13.10%, SNAPC1;POLR3B;POLR1D;POLR3K
prerank, Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302                                                                                  , -0.15557020894715973, -0.5759864525545305 , 0.9102564102564102  , 0.9943140717240432,       1.0 , 10/27  , 35.98%, FGFR1OP2;PIK3R1;GRB2;TRIM24;GAB2;PIK3CA;ZMYM2;MYO18A;LRRFIP1;FGF13
prerank, Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358                                                                 , -0.15140319057668403, -0.5682540521911863 , 0.9506172839506173  , 0.9965631540317423,       1.0 , 10/27  , 34.77%, TIRAP;TICAM1;LY96;TLR3;HMGB1;BTK;IRAK4;TLR2;S100A9;IKBKG
prerank, Reactome_2022__RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066                                                 , -0.16304872611104926, -0.5679948120185561 , 0.9305555555555556  , 0.995751634957598 ,       1.0 , 19/26  , 55.80%, POLR3B;POLR1D;POLR3K;GTF3C1;GTF3C5;POLR3C;GTF3C6;POLR2E;POLR2L;POLR3H;POLR3D;GTF3C4;POLR2H;BRF1;POLR3F;POLR3GL;BDP1;POLR2K;GTF3C2
prerank, Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148                                                             , -0.14529734926564888, -0.5674906278553832 , 0.9529411764705882  , 0.9950375817747764,       1.0 , 19/49  , 40.10%, REXO2;MYH9;STX4;PRKAG2;YWHAB;RAB11A;AKT1;PRKAG1;TBC1D1;EXOC6;RAB8A;YWHAQ;AKT2;KIF3A;EXOC1;RALA;CALM1;RHOQ;EXOC3
prerank, Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394                                                                               , -0.14195833989737372, -0.5616944699507965 , 0.9605263157894737  , 0.9963205740807117,       1.0 , 7/36   , 19.10%, UBC;COPS3;PARP2;DDB2;XPC;UBB;RPS27A
prerank, Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288                                                                                    , -0.1352937019115103 , -0.5571092787583148 , 0.9767441860465116  , 0.9969781742583435,       1.0 , 14/50  , 28.19%, FNIP1;RRAGD;TCIRG1;KPTN;SESN1;NPRL3;CASTOR1;MIOS;ITFG2;FNIP2;RRAGB;WDR24;ATP6V0D1;FLCN
prerank, KEGG_2021_Human__Cytosolic DNA-sensing pathway                                                                                              , -0.1364250610925652 , -0.556075158970722  , 0.9529411764705882  , 0.9963798649405933,       1.0 , 6/46   , 13.10%, ZBP1;POLR1C;POLR3B;TBK1;POLR1D;POLR3K
prerank, Reactome_2022__Semaphorin Interactions R-HSA-373755                                                                                         , -0.13093676886672406, -0.5555579441551992 , 0.9534883720930233  , 0.9956677678444691,       1.0 , 12/55  , 22.15%, ARHGAP35;MYH9;ROCK2;RRAS;ITGA1;PLXNC1;ARHGEF11;VPS72;RHOC;FARP2;PLXNA3;LIMK1
prerank, Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920                                                                      , 0.10853863773345512 , 0.549453593168617   , 0.9583333333333334  , 1.0               ,       1.0 , 12/44  , 21.43%, PKD1;ARL13B;EXOC2;MKKS;PTGES2;EXOC4;INPP5E;NUDT19;CCT8;CCT5;SMOX;CCT4
prerank, KEGG_2021_Human__Other glycan degradation                                                                                                   , -0.179501581951652  , -0.5490825613982169 , 0.9625              , 0.9967544762448787,       1.0 , 4/15   , 27.85%, FUCA1;MAN2C1;HEXD;MANBA
prerank, Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985                                                                                     , -0.15880994924018463, -0.5438108714909654 , 0.9736842105263158  , 0.99804944777404  ,       1.0 , 12/25  , 42.28%, NCSTN;SPARC;WWOX;PSENEN;APH1B;APOE;SRC;HBEGF;EREG;NRG1;APH1A;ESR1
prerank, Reactome_2022__PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884                                                                        , 0.13679838224845603 , 0.541999284228962   , 0.9666666666666667  , 1.0               ,       1.0 , 21/21  , 86.34%, POLR2I;POLR2F;POLR2C;POLR2J;PIWIL4;MYBL1;HENMT1;POLR2A;TDRD9;POLR2K;PLD6;POLR2H;TDRKH;POLR2L;POLR2E;HSP90AA1;PIWIL2;TDRD12;POLR2D;POLR2B;POLR2G
prerank, KEGG_2021_Human__Type I diabetes mellitus                                                                                                   , -0.14993438793986347, -0.5369564271652184 , 0.9753086419753086  , 0.9993516961261365,       1.0 , 3/35   , 8.69% , FASLG;HLA-G;ICA1
prerank, Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796                                                                                 , -0.14841237566243115, -0.5362280539015846 , 0.9459459459459459  , 0.99871578201864  ,       1.0 , 5/29   , 18.16%, MAP3K1;MAPK1;MAPK8;MAP2K7;GRB2
prerank, Reactome_2022__Formation Of ATP By Chemiosmotic Coupling R-HSA-163210                                                                       , -0.16446327795690888, -0.5321301432441127 , 0.958904109589041   , 0.9990718955445751,       1.0 , 1/16   , 2.54% , ATP5PB
prerank, Reactome_2022__Blood Group Systems Biosynthesis R-HSA-9033658                                                                               , 0.14500355133038298 , 0.5286675159484515  , 1.0                 , 1.0               ,       1.0 , 15/15  , 85.51%, ST3GAL4;B4GALNT2;RHD;ABO;ST3GAL3;FUT6;FUT2;ST3GAL6;B3GALT4;FUT4;B3GALT2;RHCE;FUT7;FUT1;ST6GALNAC6
prerank, Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747                                                                          , -0.1696859161230051 , -0.527594840286114  , 0.96875             , 0.9993226701618597,       1.0 , 2/15   , 12.61%, PPP2R5E;PPP2R5B
prerank, Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529                                                                                     , -0.15520553591073383, -0.526863564621859  , 0.953125            , 0.9986979574881649,       1.0 , 12/23  , 43.37%, HNRNPF;POLR2G;POLR2B;POLR2D;NCBP1;HNRNPM;HNRNPA1;POLR2E;POLR2L;TIA1;GTF2F1;HNRNPH1
prerank, Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568                                           , 0.11270175772970875 , 0.526159050234116   , 1.0                 , 1.0               ,       1.0 , 4/32   , 10.31%, BRIP1;RMI2;SLX4;EME1
prerank, Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648                                                                                    , -0.12100030806374118, -0.5244983789631655 , 0.9772727272727273  , 0.998378433847214 ,       1.0 , 15/49  , 35.51%, RASGRF2;ARHGEF15;MAPK8;OBSCN;ARHGEF11;AKAP13;PRPF38B;ARHGEF1;ARHGEF4;ARHGEF2;AATF;FGD4;ARHGEF12;ECT2;VAV3
prerank, Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537                                                                                , 0.10862099551689149 , 0.5230824237040502  , 1.0                 , 1.0               ,       1.0 , 4/33   , 10.31%, BRIP1;RMI2;SLX4;EME1
prerank, Reactome_2022__Impaired BRCA2 Binding To PALB2 R-HSA-9709603                                                                                , -0.15720594924268252, -0.5193949384967556 , 0.9857142857142858  , 0.9988475384813996,       1.0 , 8/23   , 33.80%, RAD50;RAD51AP1;BRCA1;PALB2;RMI1;RAD51D;TOP3A;RAD51B
prerank, Reactome_2022__tRNA Aminoacylation R-HSA-379724                                                                                             , -0.12854987578392327, -0.5185799602847432 , 1.0                 , 0.9981584644027871,       1.0 , 9/42   , 25.55%, PPA2;CARS2;EEF1E1;MARS2;FARS2;AARS1;WARS2;VARS1;IARS2
prerank, KEGG_2021_Human__Rheumatoid arthritis                                                                                                       , -0.1158667798974141 , -0.5173953609663654 , 0.9891304347826086  , 0.9975274586696172,       1.0 , 9/73   , 16.08%, TGFB3;TNFSF13;VEGFA;ATP6V0A1;ITGAL;CTSK;TCIRG1;CSF1;CCL20
prerank, KEGG_2021_Human__Butanoate metabolism                                                                                                       , 0.14224821028471504 , 0.514793375183295   , 1.0                 , 1.0               ,       1.0 , 19/19  , 85.79%, HADH;ABAT;HMGCL;HMGCS1;ACSM2B;OXCT1;AACS;EHHADH;L2HGDH;ACADS;HADHA;BDH1;ACAT2;ALDH5A1;ACSM2A;BDH2;ECHS1;ACSM3;ACAT1
prerank, KEGG_2021_Human__Graft-versus-host disease                                                                                                  , 0.11506819678291853 , 0.5087746286284206  , 1.0                 , 1.0               ,       1.0 , 1/32   , 0.50% , IL6
prerank, Reactome_2022__Signaling By FGFR2 IIIa TM R-HSA-8851708                                                                                     , -0.16355106334071637, -0.5030900786583478 , 0.9852941176470589  , 0.9985301207480871,       1.0 , 5/18   , 22.47%, POLR2G;POLR2B;POLR2D;NCBP1;FGFR2
prerank, Reactome_2022__FGFR2 Mutant Receptor Activation R-HSA-1839126                                                                               , -0.16355106334071637, -0.5030900786583478 , 0.9852941176470589  , 0.9985301207480871,       1.0 , 5/18   , 22.47%, POLR2G;POLR2B;POLR2D;NCBP1;FGFR2
prerank, Reactome_2022__Synthesis Of PA R-HSA-1483166                                                                                                , -0.1375431042180644 , -0.49627127385685105, 0.9864864864864865  , 0.9989214302314712,       1.0 , 12/27  , 40.54%, GPAT3;MIGA2;PLD2;LCLAT1;GPAT2;AGPAT5;AGPAT3;PLA2G4A;DDHD2;GPD2;AGPAT4;AGPAT1
prerank, Reactome_2022__Azathioprine ADME R-HSA-9748787                                                                                              , -0.15770713016275265, -0.49461518243992747, 0.9393939393939394  , 0.9984052962100064,       1.0 , 3/17   , 15.75%, GSTM1;SLC28A2;ABCC4
prerank, Reactome_2022__Sulfur Amino Acid Metabolism R-HSA-1614635                                                                                   , -0.1533294934465801 , -0.48514275863741374, 0.974025974025974   , 0.9992112771210825,       1.0 , 12/20  , 48.41%, VSIG2;BHMT2;SUOX;CSAD;AHCY;MRI1;GOT2;APIP;TXN2;ENOPH1;ADI1;ADO
prerank, Reactome_2022__DAP12 Interactions R-HSA-2172127                                                                                             , -0.12354549534072358, -0.4643290561811086 , 1.0                 , 1.0               ,       1.0 , 14/37  , 37.32%, SIGLEC16;PIK3R1;GRB2;TREM1;PIK3CA;BTK;SYK;KLRC2;SIGLEC15;PIK3CB;VAV3;PLCG2;KLRD1;SIRPB1
prerank, Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977                                                                         , -0.14998669817208246, -0.45492960184173187, 0.9861111111111112  , 1.0               ,       1.0 , 7/17   , 36.88%, ARL2;TUBB6;TBCD;TUBA1C;TBCA;TBCB;TUBA1A
prerank, Reactome_2022__DAP12 Signaling R-HSA-2424491                                                                                                , -0.13042485547203228, -0.4545674471933416 , 1.0                 , 1.0               ,       1.0 , 10/27  , 36.30%, PIK3R1;GRB2;PIK3CA;BTK;SYK;KLRC2;PIK3CB;VAV3;PLCG2;KLRD1
prerank, Reactome_2022__Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960                                                          , -0.14041019725746315, -0.45295787967835355, 1.0                 , 1.0               ,       1.0 , 8/20   , 37.25%, CCT3;CCT6B;TUBB6;CCT2;TUBA1C;CCT6A;TUBA1A;TCP1
prerank, Reactome_2022__Meiotic Synapsis R-HSA-1221632                                                                                               , -0.10885815693684138, -0.4491067722408777 , 1.0                 , 0.9996496231674581,       1.0 , 6/51   , 14.10%, H2AX;H2AC19;H2AC7;BRCA1;SMC1A;H2BC11
prerank, KEGG_2021_Human__Antigen processing and presentation                                                                                        , 0.08096411941933727 , 0.444001997481807   , 1.0                 , 1.0               ,       1.0 , 63/63  , 91.93%, NFYA;B2M;CREB1;CALR;CTSL;HLA-DMA;IFNG;NFYB;CD8B;CD4;CTSS;HSPA1B;IFI30;CD74;NFYC;HLA-DPA1;LGMN;HLA-F;CTSB;HLA-DQB1;HLA-DRB5;HLA-A;HSPA1L;CIITA;KLRC4;TAPBP;HLA-DPB1;HLA-DOA;CANX;HSPA6;HLA-DQA1;TAP2;HLA-DRB4;HLA-B;HSP90AB1;HLA-DMB;HLA-C;HLA-E;HLA-DRA;HLA-DRB3;HSPA8;KLRC1;CD8A;TNF;TAP1;RFX5;KLRD1;HLA-DOB;RFXANK;HSP90AA1;HLA-DRB1;KLRC2;PSME1;HSPA5;PDIA3;HSPA2;PSME3;HSPA4;KLRC3;HSPA1A;PSME2;RFXAP;HLA-G
prerank, Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196                                                                                 , -0.13876691052569382, -0.44388167519346944, 0.9736842105263158  , 0.9992674131710739,       1.0 , 3/16   , 18.16%, PRKCA;ERBB3;GRB2
prerank, Reactome_2022__Telomere Extension By Telomerase R-HSA-171319                                                                                , 0.11789616718314724 , 0.43602941359691305 , 1.0                 , 1.0               ,       1.0 , 21/22  , 77.13%, PPP6C;DKC1;PPP6R3;RUVBL2;ACD;WRAP53;RTEL1;NHP2;TINF2;GAR1;TERF2;TERF2IP;ANKRD28;CDK2;TERF1;RUVBL1;SHQ1;NOP10;POT1;PIF1;CCNA2
prerank, Reactome_2022__Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958                                              , 0.09320478251465444 , 0.413630512125694   , 1.0                 , 0.9991228070175439,       1.0 , 1/26   , 1.65% , TUBB3
prerank, KEGG_2021_Human__B cell receptor signaling pathway                                                                                          , -0.09034508538000825, -0.4027082356203524 , 1.0                 , 1.0               ,       1.0 , 29/79  , 41.92%, NFKBIE;MAPK1;PIK3R3;PIK3R1;BCL10;GRB2;AKT1;PPP3CC;CD81;PIK3CA;BLNK;CD79B;BTK;NFATC2;SYK;AKT2;PIK3CB;IKBKG;VAV3;PLCG2;LILRA4;JUN;MAP2K2;PTPN6;RELA;SOS2;MAP2K1;MALT1;LYN
prerank, Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736                                                                                     , -0.10104825821139529, -0.4011210382670316 , 0.9883720930232558  , 0.9999108216284541,       1.0 , 11/47  , 27.76%, AGXT;ERO1B;SLC30A7;ERO1A;SPCS3;KIF5A;EXOC6;SPCS2;SLC30A5;POMC;CTSD
prerank, Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424                                                                   , -0.11456102796442368, -0.39523996482524604, 0.9873417721518988  , 0.9992578068733666,       1.0 , 13/24  , 49.55%, ENTPD5;MEFV;C3AR1;HMOX1;P2RX4;NLRP3;PSTPIP1;RELA;IL18;PYCARD;TXN2;C3;CASP1
prerank, Reactome_2022__Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957                                                            , -0.10862024196194994, -0.3648971107744831 , 0.9850746268656716  , 0.9991953592814371,       1.0 , 12/24  , 46.10%, CCT3;CCT6B;TUBB6;CCT2;TUBA1C;CCT6A;TUBA1A;TCP1;VBP1;TUBB4B;PFDN6;PFDN5
